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Abstract 
 
 
The quality of healthcare is increasingly the subject of scrutiny by a range of stakeholders, 
including healthcare provider organisations, health professionals and their representative bodies, 
healthcare purchasers and funders, policy makers and national governments, patients and users 
of health services.   The use of a variety of quality measures has become widespread in the 
healthcare systems of many developed countries, including the United Kingdom.  The twin tasks 
of measuring and improving the quality of care - often termed quality assurance - have been 
addressed by new arrangements for professional accountability, new approaches to managing 
and comparing organisational performance, and new statutory and legal mechanisms. 
 
Adverse events in healthcare, which can be loosely defined as instances which indicate or may 
indicate that a patient has received poor quality care, offer an important opportunity for quality 
measurement and improvement.   There is extensive evidence that adverse events are relatively 
common, that they can have serious and lasting impacts on patients, and that they represent a 
considerable cost to healthcare organisations.  Equally importantly, evidence in healthcare and 
experience in other sectors suggests that adverse events offer an important insight into the 
strengths and weaknesses of healthcare processes, and an invaluable opportunity to bring about 
improvements in the quality of care. 
 
Adverse events have been used quite widely, particularly in the United States of America, as the 
basis of a number of measures of the quality of healthcare.  However, these measures have rarely 
been developed and tested rigorously before they have entered widespread usage, and there has 
been considerable debate about their advantages and disadvantages. 
 
A series of empirical studies were undertaken, using data collected through the use of adverse-
event measures of quality in a British acute hospital, aimed at investigating the validity and 
reliability of those measures.    The results showed that the adverse-event measures being tested 
had moderate to good face, content and construct validity.  Although their validity was capable 
of improvement, it was still clear that they were measuring meaningful and important 
dimensions of the quality of healthcare.   However, the reliability of the measures being tested 
was more mixed.  While experimental studies of interrater and intrarater reliability indicated that 
they had moderate to good reliability (though, again, it was capable of improvement) 
observational studies suggested that the reliability in actual use might be lower than that found 
during testing.   
 
This research concludes that adverse-event measures of quality are important measures of the 
quality of healthcare, which should be used in healthcare quality assurance with two main 
provisos.  Firstly, the development of measures should be more rigorous, and should pay more 
attention to both validity and reliability issues.  Secondly, the routine use of such measures 
should incorporate some element of ongoing reliability testing, in order to ensure that good 
reliability is maintained. 
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Chapter 1 
 
Introduction 
 
 
 
1.1 Overview 
 
Adverse events can be loosely defined as “instances which indicate or may indicate that a patient 
has received poor quality care” (Walshe, Bennett and Ingram 1995).    They are events which 
exhibit three key characteristics - negativity, patient impact, and healthcare process causation.  
Firstly, they are circumstances or happenings which are, by their very nature, undesirable, and 
which we would prefer not to occur if that were possible.  Secondly, they are occurrences which 
have, or may have, some impact on the care that patients receive and so on their health status, and 
which could result in additional morbidity or mortality.   Thirdly, they are events which result not 
from the diseases or conditions of patients, nor from patients’ actions or behaviour, but from the 
healthcare process - the way that healthcare is organised, managed and delivered, the decisions that 
are taken by clinicians and others, and the acts of omission or commission of both the healthcare 
organisation and the individuals who make up that organisation. 
 
There is a wealth of evidence to suggest that adverse events are not infrequent occurrences in the 
modern healthcare systems of the developed world.  The incidence of adverse events found in 
empirical studies depends on the definition of the term which they adopt and the data sources and 
methods they use to identify adverse events.  However, even the most conservative studies, which 
limit themselves to the consideration of events in which patients have clearly suffered some 
significant harm as a direct result of the healthcare process, have estimated that about 1 in 25 
inpatients suffers such an adverse event during their stay in hospital (Mills 1978; Harvard Medical 
Practice Study 1990; and others).   Other evidence suggests that up to 5% of hospital admissions 
may actually be the result of previous adverse events, either during earlier admissions or in 
outpatient or community care, which would make adverse events perhaps the single most common 
reason for admission to hospital (Lakshmanan, Hershey and Breslau 1980). 
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Adverse events represent a substantial burden, in both financial and non-financial terms, for 
healthcare organisations and for patients.    The only published study which has followed up patients 
who have suffered adverse events found that while 76% of patients had returned to normal health 
status within 6 months and suffered little or no economic loss, a substantial minority of patients 
experienced longer term morbidity or reduced life expectancy with the usual economic 
consequences for them and their families (Harvard Medical Practice Study 1990).   Although it is 
difficult to unpick the effects of adverse events from the underlying disease processes which had 
cause patients to enter the healthcare system in the first place, it seems clear that adverse events 
resulted in substantial pain, suffering and financial loss for patients. 
 
The cost of adverse events for healthcare organisations is equally large but difficult to estimate.   If, 
as has been suggested above, 1 in 25 inpatients has an adverse event and up to 5% of inpatient 
admissions result from some form of earlier adverse event, then the costs of such events to 
healthcare organisations are huge, and might amount to billions of pounds across the British 
National Health Service, but such an estimate should be treated with considerable caution.  More 
specifically, the costs to the NHS of clinical negligence litigation can be argued to be a direct 
consequence of some adverse events.  In the NHS, these costs have been estimated at about £125 
million pa, though they are rising rapidly (Dingwall and Fenn 1995), while in the USA it has been 
suggested that negligence litigation costs the healthcare system about $5 billion pa (Relman 1989).  
Moreover, it has been demonstrated that since only a tiny proportion of adverse events result in 
clinical negligence litigation, the potential costs of such litigation are much higher than these actual 
costs  (Localio et al 1991). 
 
But perhaps the most persuasive evidence that adverse events in healthcare are worthy of study 
comes from a range of sources, both inside and outside healthcare, which suggest that many adverse 
events are avoidable and so could be prevented (Craddick 1979; Goldman and Walder 1992; and 
others), and that adverse events offer an invaluable insight into the strengths and weaknesses of 
healthcare processes (Deming 1986; Reason 1995; and others).  In short, adverse events both 
indicate that the quality of care is capable of improvement, and provide information and 
understanding crucial to making such improvements happen. 
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Improving quality has become a central concern in healthcare systems throughout the developed 
world over recent years, through changes in patient and user expectations, shifts in attitudes to 
professionals and public services, pressure on the mechanisms and levels of funding for healthcare, 
and the pace of technological advance in medicine.   As many healthcare systems have developed 
systems for attempting to measure, monitor and improve the quality of care, adverse events have 
often been used in those approaches to measurement.    But while the use of adverse-event measures 
of the quality of healthcare has become increasingly widespread, their worth as measures has not 
been widely researched, and some commentators have expressed fundamental concerns about their 
validity, reliability and utility in quality measurement and improvement (Goldman 1989; Sanazaro 
and Mills 1991). 
 
 
1.2 Objectives of this research 
 
Although there is an extensive literature on quality measurement in healthcare, and  a substantial 
body of published work related to the characteristics of adverse events in healthcare, it was noted 
above that the scientific worth of measures of quality which are based on adverse events has not 
been much researched.    While a whole range of aspects or characteristics of such measures clearly 
need to be studied (as the evaluation framework set out in chapter 3 makes evident), it was felt from 
the review of the literature reported in chapter 4 that the most fundamental and urgent concerns 
related to the validity and reliability of adverse-event measures of the quality of care.  There were, 
therefore, two main research questions or hypotheses which the research was intended to address: 
 
a) Can information about adverse events in healthcare be used to provide valid measures of the 
quality of care?    The meaning of validity in this context  is discussed in more detail in 
chapter 2, but in broad terms the concern was to establish whether such measures had 
meaning for those who might use them, offered insight into and understanding of the 
healthcare processes they measured, and provided a basis for subsequent quality 
improvement activities. 
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b) Can adverse-event measures of the quality of healthcare be developed which are sufficiently 
reliable for wider use?   Again, the meaning of reliability is discussed further in chapter 2, 
but here the main issue was the extent to which these measures could be used in “real-
world” settings with the usual constraints of time and resources, and provide data which was 
appropriately consistent across different users, applications and subjects of the measures. 
 
With these objectives in mind, a number of separate but related studies were designed and 
undertaken, each focused on different aspects of validity and reliability: 
 
a) The face and content validity of an adverse-event measure were assessed through a 
questionnaire study of clinician opinion, drawing on both practising clinicians and public 
health physicians, and through an interview study involving a small group of clinicians 
involved in directing clinical audit activities in healthcare organisations. 
 
b) The construct validity of some adverse-event measures of quality was explored by testing 
whether a number of constructs or theories about the incidence and characteristics of adverse 
events (some of which had been previously tested in studies published in the literature) were 
supported by data drawn from the use of these measures in a British acute hospital. 
 
c) The reliability of some adverse-event measures of quality was assessed through a series of 
experimental studies in which the measures were applied repeatedly to a sample of patient 
admissions in order to measure interrater and intrarater reliability, and through a further 
analysis of the data drawn from a British acute hospital which used a number of adverse-
event measures, in which the extent to which variations in the data could be attributed to the 
staff applying the measures was assessed. 
 
The overall purpose of this research was to improve our understanding of the validity and reliability 
of adverse-event measures of quality, in ways that would facilitate the development of such 
measures in ways that maximised validity and reliability and that would aid the interpretation of the 
results from such measures. 
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1.3 Structure of thesis 
 
This thesis first explores the science of quality measurement, with a particular focus on the 
evaluation of quality measures, and then reviews the development and testing of adverse-event 
measures of quality.    It then reports on a series of research studies designed to test out the validity 
and reliability of some adverse-event measures of quality.  It concludes by drawing together 
findings from the literature with the results from these studies, and identifying a number of areas for 
further research.    
 
The thesis falls into three main parts.  The first part (chapters 2 and 3) is intended to set the context 
for the research, through a review of the relevant literature on three main themes - quality 
measurement, adverse events in healthcare, and testing the validity and reliability of measures.  The 
second part (chapters 4, 5 and 6) report on the research studies which were undertaken to address the 
objectives of the research set out above.  Each chapter presents a separate study or a related set of 
studies, and so each separately details the aims of the research, the methods used, the results, and the 
conclusions for the study or studies it describes.   The third and final part of the thesis (chapter 7) 
brings together the key findings and conclusions from the research (reported in chapters 4, 5 and 6) 
with the findings from the wider literature (reported in chapters 2 and 3).  It suggests how these 
findings might be interpreted and applied, and  identifies areas for further research.     
 
In order to make the thesis more accessible to the reader, each chapter commences with its own 
introduction, which sets out a short overview of the areas and issues covered by the chapter itself.  
In addition, two tables of contents are provided - an outline table, intended as a general guide to the 
structure of the thesis, and a detailed table of contents, which lists the content of each chapter down 
to section, subsection and unnumbered headings levels.  Both tables of contents contain page 
numbers.   In addition, a brief overview of the contents of the thesis is given below. 
 
Chapter 2 presents an overview of the science of quality measurement and its application in 
managing and improving quality in healthcare.   It explores the definition of quality and some 
common models of quality, and concludes that deconstructing the concept of quality is essential to 
meaningful measurement.  With this in mind, the construction of measures of quality is discussed, 
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using a framework for defining and assessing measures of quality, and the use of quality 
measurement in healthcare is briefly reviewed.  Finally, the chapter turns to the business of 
evaluating quality measures, and uses a framework for such evaluations to set out a number of 
dimensions on which the performance of such measures could be assessed.  It focuses particularly 
on the issues involved in assessing the validity and reliability of quality measures. 
 
Chapter 3 presents a comprehensive review of the place of adverse events in healthcare, and the use 
of adverse events in quality measurement.  It begins by examining the development of interest in 
adverse events in healthcare from a number of perspectives, and goes on to explore the definition 
and classification of adverse events in measures of healthcare quality.   It reviews the use of such 
measures, with a particular focus on the epidemiology of adverse events and the experience of using 
such measures in healthcare quality assurance.  Finally, it presents an analysis of the rather limited 
published literature on the validity and reliability of such measures, which highlights the need for 
further research in this area. 
 
The next three chapters present the empirical research which was undertaken to address the research 
questions set out in section 1.2 above.  As was noted earlier, each chapter reports on the findings 
from a separate study or series of studies, and contains details of the aims, methods, results and 
conclusions from that study or studies. 
 
Chapter 4 describes two studies undertaken to assess the face and content validity of one adverse-
event measure.    It reports on a questionnaire study and interview study of clinician opinion, which 
explored both quantitatively and qualitatively clinicians’ assessments of the validity of a generic 
adverse-event measure of quality. 
 
Chapter 5 explores the construct validity of adverse-event measures through an analysis of data 
collected from a British acute hospital at which adverse-event measures were used.     That extensive 
database is used to test out a number of constructs about the behaviour of such measures, some of 
which have been tested elsewhere and reported in the literature. 
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Chapter 6 examines the interrater and intrarater reliability of some adverse-event measures of 
quality.  It reports on a series of experimental studies which were undertaken to assess both the 
interrater and intrarater reliability of several measures, in different specialties.   It also uses a further 
analysis of part of the large database referred to above to explore the variations in that data, and the 
extent to which they are associated with differences in the raters or screeners who collected the data. 
 
Finally, chapter 7 draws together the findings from the studies reported in chapters 4, 5 and 6, and 
the results of the review of the literature in chapters 2 and 3.   It presents an overview of the research 
findings, suggests how they might be interpreted and applied, identifies some limitations which 
ought to be noted, and suggests some areas for further research. 
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Chapter 2 
 
Measuring quality in healthcare 
 
 
2.1 Introduction 
 
This chapter presents an overview of the science of quality measurement and its application in 
managing and improving quality in healthcare.   It begins by exploring the definition of quality 
itself, through some example definitions and a discussion of their common characteristics, and a 
brief critique of two commonly cited models of quality.   It is concluded that no single definition is 
generally accepted, and that the concept of quality is more likely to be measurable when it is 
deconstructed into a number of constituent dimensions or parts concerned with particular features or 
characteristics of the healthcare process. 
 
With this in mind, the construction of quality measures is then discussed.   A distinction is drawn 
between the data used in measurement and the valuations or meanings which are attached to that 
data.   Some sources of data are reviewed, and the development of the valuations or meanings which 
underlie all quality measures (either implicitly or explicitly) is explored.   The chapter then turns 
from theory to practice, with a brief overview of some practical examples of measures of healthcare 
quality.   A selection of systems or instruments are described and compared, using a framework 
based on the earlier work in the chapter.   The potential for confusion inherent in the lack of any 
agreed definitions or standardised terminology is highlighted, and a number of areas of overlap and 
duplication between approaches to quality measurement are noted.   It is argued that a framework 
for developing and assessing quality measures is an important tool for those involved in using such 
measures in practice.   
 
Next, the application of quality measurement in healthcare quality assurance is reviewed.    A brief 
historical account of the development of quality assurance in healthcare is presented, and the role of 
quality measurement in the wider context of health policy and healthcare systems is discussed. 
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Finally, the chapter turns to the business of evaluating quality measures.   After considering the 
potential objectives of quality measurement and quality assurance, a framework developed for the 
purpose of evaluating quality measures is used to explore a series of dimensions on which the 
performance of quality measures could be assessed.  The task of assessing the worth of quality 
measures is set in its wider context, as part of the process of evaluating the quality assurance or 
improvement activities in which quality measures are used.   The assessment of the validity and 
reliability of quality measures is discussed in some detail. 
 
2.2 Concepts and models of quality 
 
2.2.1 Defining quality in healthcare 
 
In order to measure something, we must define it.  If we are to measure the quality of healthcare, we 
first have to decide what is meant by quality in healthcare.  Our definition needs to be objective and 
robust enough to support the measurement process, and should be shared by those involved in 
measurement and in using the results of measurement in clinical practice, healthcare management, 
health services research or whatever. 
 
The British Standards Institute, in defining the terminology of quality assurance and quality 
management for industry and commerce, sets out three alternative senses or meanings for the 
concept of quality (British Standards Institute 1979, p3): 
 
a) Comparative sense - degree of excellence, in which products may be ranked relative to each 
other. 
 
b) Quantitative sense - the degree of conformity of a product with its quantitative specification. 
 
c) Fitness for purpose sense - relating the ability of a product or service to satisfy a given need. 
 
In common with most industrial quality theorists, the BSI defines quality in the third of these senses, 
as “the totality of features and characteristics of a product or service which bear on its ability to 
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satisfy a given need” (British Standards Institute 1979, p3).   More succinctly, but to the same effect, 
Juran (1979) defines quality as “fitness for purpose or use”.  
 
The central theme in these definitions of quality, and the common thread throughout industrial 
quality assurance and quality management, is a definition of quality which is squarely founded on 
“meeting the true requirements of the customer” (Oakland 1989, p7).  In this milieu, the process of 
measuring, assessing and improving quality is predicated on knowing who the customers are; 
knowing what their true requirements are (or how to find out what they are); knowing how to 
measure one's ability to meet those requirements; knowing whether one has the capability to meet 
the requirements (or how to change to acquire the capability); knowing whether one actually and 
continually meets those requirements; and knowing when the customers' requirements change. 
 
In healthcare, however, things seem less clear-cut.  To begin with, despite four decades of extensive 
research and development activity in healthcare quality assurance in which many possible 
definitions of quality in the context of healthcare have been advanced, none has become universally 
accepted (Steffen 1988).  Walter Deming, one of the foremost writers on industrial quality 
management, observed: 
 
“A suitable definition for quality of medical care is a perennial problem among 
administrators of medical care and people doing research in the subject.  It seems 
simple to anyone that has not tried it.”  (Deming 1986, p171) 
 
Donabedian, who has laid much of the conceptual and terminological framework for healthcare 
quality assurance, expressed similar reservations: 
 
“The quality of care is a remarkably difficult notion to define ... The criteria of 
quality are nothing more than value judgements that are applied to several aspects ... 
of a process called medical care.  As such, the definition of quality may be almost 
anything anyone wishes it to be, although it is, ordinarily, a reflection of values and 
goals current in the medical care system and in the larger society of which it is a 
part.”  (Donabedian 1966) 
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Defining quality in the context of healthcare (as opposed to in the context of an industrial or 
commercial setting) may be more problematic for four reasons: the complexity of healthcare itself; 
the way that healthcare organisations work; the problems involved in identifying customers and 
defining customer requirements; and the existence of additional non-commercial dimensions in 
healthcare which are not present in most commercial contexts (Pollitt 1996). 
 
Firstly, it can be argued with some justification that healthcare is a uniquely complex business.  The 
products and services provided can be both highly technical and highly heterogeneous, they are 
often more personal and intimate than those provided in other service or manufacturing sectors, and 
they interact with a multitude of external factors (such as patient behaviour and socioeconomic 
conditions) in intricate and dimly understood ways.  The complexity of healthcare activity makes 
defining and understanding quality more difficult for all these reasons (Øvretveit 1994). 
 
Secondly, healthcare organisations are, in some ways, less straightforward in their structure and 
management than equivalent industrial organisations.   They contain large numbers of professionals 
whose culture and attitudes are not sympathetic to managerialism; they are structured into many 
separate departments which have their own aims and microcultures and often have considerable 
autonomy;  and they are often functionally very diverse. This means that establishing a shared view 
of what is meant by quality in healthcare - across these different professional groups and services, 
through negotiation and persuasion rather than by directive, is a challenging task (Norman and 
Redfern 1995). 
 
Thirdly, it is harder to identify customers' requirements in the healthcare arena than in industry or 
commerce.  There are many different and competing groups which can claim to be customers - such 
as individual patients, patient groups, society, government, purchasers, and so on - with potentially 
conflicting requirements and frequently different perspectives on the quality of healthcare services.  
In many ways, healthcare professionals or healthcare organisations act as customers in their own 
right or on behalf of patients as well.   It can be argued that there is far more potential for dissonance 
between these various stakeholders in the healthcare process than there is in the more 
straightforward relationships found in a commercial or industrial setting.  Moreover, even when the  
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customers of the healthcare process are identified, some will be unable, because of the nature of 
healthcare, to specify, comprehend or monitor the important technical elements of their 
requirements for healthcare.   This makes the industrial definition of quality outlined above less 
suitable, or less workable, in healthcare (Morgan and Murgatroyd 1994, p168). 
 
Finally, the social, moral, ethical and political dimensions of healthcare (concepts such as the right 
to healthcare, differences between need and demand, equity of access, and so on) have no parallel in 
industry and commerce, but may be judged to be essential components of a definition of quality.   
Healthcare is more than simply another economic product, and the definition of quality of healthcare 
has to give these other considerations due weight (Pollitt 1996). 
 
However, the difficulties involved in defining quality in the healthcare setting have not discouraged 
people from trying.  Perhaps the best known definition of the quality of medical care is that offered 
by Donabedian himself: 
 
“The extent to which the care provided is expected to achieve the most favourable 
balance of risks and benefits.”  (Donabedian 1980, p5) 
 
Donabedian calls this an absolutist definition - other factors such as monetary costs and patient 
expectations and valuations are not a part of it.   When “the judgement of quality takes into account 
the patient's wishes, expectations, valuations and means” he terms the definition individualised.  If 
“the aggregate net benefit for an entire population [and] the social distribution of that benefit” are 
added, he terms the result a social definition of quality. 
 
Echoing Donabedian, but placing greater emphasis on the process of healthcare, Brook and 
Kosecoff (1988) offer a definition which is modelled around the medical processes of diagnosis and 
treatment: 
 
“Quality of care consists of two components: the selection of the right activity or 
task or combination of activities, and the performance of those activities in a manner 
that produces the best outcome.”  (Brook and Kosecoff 1988) 
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Alternatively, the American Medical Association (1986) defines quality healthcare much more 
widely, in terms of a list of its desired characteristics - it should produce optimal improvement in the 
patient's health, emphasise the promotion of health and the prevention of disease, be provided in a 
timely manner, seek to achieve the patient’s informed cooperation and participation, be based on 
accepted principles of medical science, be provided with sensitivity and concern for the patient's 
welfare, make efficient use of technology, and be sufficiently documented to allow for continuity of 
care and peer evaluation. 
 
A fourth (and, yet again, different) definition is that offered by the Institute of Medicine: 
 
“Quality of care is the degree to which health services for individuals and 
populations increase the likelihood of desired health outcomes and are consistent 
with current professional knowledge.” (Institute of Medicine 1990, p21). 
  
The Institute of Medicine reviewed over a hundred definitions of quality from the literature before 
producing this definition.   In doing so, it found there were eighteen common elements or themes 
each of which appeared in some of the definitions examined (table 2.1).   
 
Scale of quality stated. 
Nature of entity being evaluated specified. 
Goal-orientation of definition. 
Aspects of outcome specified. 
Acceptability of service. 
Type of recipient of healthcare. 
Role and responsibility of recipient. 
Continuity, management and coordination of service. 
Professional standards of service. 
Technical competency of provider. 
 
Interpersonal skills of provider. 
Acceptability of provider. 
Statements about use of service. 
Constraint of resources. 
Constraint of consumer and patient circumstances. 
Constraint of  technology and state of scientific  
 knowledge. 
Risk versus benefit tradeoff. 
Documentation requirements. 
 
 Table 2.1.  Elements in definitions of quality. 
 Institute of Medicine (1990). 
 
It seems from these quite different definitions that there are four properties or characteristics of 
definitions of quality which might be used to understand the similarities and differences between 
them. 
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a) Specificity.    
Some definitions of quality are highly specific, listing long series of elements which go to 
make up good quality care.  Others are highly non-specific, simply stating that quality 
consists of meeting the goals or objectives of care without predefining those objectives in 
any way (Steffen 1988). 
 
b) Scope.    
Some definitions of quality are of very limited scope - focused solely on the individual 
patient-practitioner interaction - whereas others are much broader in scope, encompassing 
wider issues such as resource usage, equity, access, etc.  It is possible, though perhaps of 
questionable value, to draw the boundaries of quality so widely that they include almost all 
properties and characteristics of healthcare.  The breadth and inclusivity of the preferred 
definition may reflect the cultural or social values and the structure of the healthcare system 
(Black 1990). 
 
c) Perspective.    
All definitions of quality might be viewed as subjective, in that they implicitly or explicitly 
contain value judgements about what constitutes the quality of care.  They differ in the 
perspective from which these subjective judgements are made (provider, patient, society, or 
a combination of these) and the extent to which they acknowledge the subjectivity of their 
perspective. 
 
d) Derivation.    
Most definitions are the fruit of intellectual thought or of some kind of professional 
consensus rather than practical fieldwork, but some are based on (or draw on) empirical 
evidence from studies of what clients, clinicians, managers and policymakers think 
constitutes quality (Donabedian 1980, p35). 
 
Much  research into the quality of healthcare proceeds with little reference to or apparent need for a 
definition of quality, and it might be suggested that the process of definition outlined above is of 
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theoretical interest rather than of real practical benefit.   However, a definition and its theoretical 
infrastructure are essential guides for both researchers and clinicians (Reerink 1990).  Firstly, a 
definition provides a common frame of reference and a common language which researchers and 
clinicians concerned with healthcare quality can use to communicate.  Secondly, a definition 
provides the basis for a theoretical framework within which hypotheses can be framed and tested, 
and knowledge accumulated and linked.  Thirdly, a definition is essential as the foundation for the 
development and validation of measures of the concept.   Lastly, without a theoretical structure it is 
difficult to generalise the results of empirical research.   It is true that much research into the quality 
of healthcare seems to proceed without much reference to definitions, theories or models of quality - 
but this focus on the study of practice, to the detriment of attention to theory, may be a factor in the 
perceived inability of such research to date to produce measures of the quality of healthcare which 
gain widespread acceptance, whose validity and reliability are universally acknowledged, and which 
are well described and used (Berwick 1988). 
 
2.2.2 Models of quality in healthcare 
 
Deming (1986, p279) wrote that “meaning starts with the concept, which is in someone's mind and 
only there: it is ineffable ... An operational definition puts communicable meaning into a concept.”  
Having developed or selected a definition of the concept of quality in the context of healthcare, the 
next step is to operationalise it - commonly through developing a model of quality which can be 
used to structure and guide research. 
 
Inherent in all definitions of quality is an acknowledgement of the multidimensionality of the 
concept - that it consists of a “heterogeneous assortment of attributes, gathered into a bundle” 
(Donabedian 1980, p3).  Models of quality work by organising these attributes into logically 
coherent or conceptually meaningful groupings or dimensions.  In so doing, they can act as the 
interface between the abstract definition of quality and the real world of measurement. 
 
The most widely used and influential quality model is that which was first articulated by 
Donabedian (1966), though it owes much to preceding work both within and outside healthcare.  It 
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divides the attributes of quality into three dimensions - structure, process and outcome.  Donabedian 
defines these three dimensions as follows (Donabedian 1990, p14): 
 
a) “Structure denotes the attributes of the settings in which care occurs.  This includes the 
attributes of material resources, of human resources, and of organisational structure.” 
 
b) “Process denotes what is actually done in giving and receiving care.  It includes the patient's 
activities in seeking care and carrying it out as well as the practitioner's activities in making 
a diagnosis and recommending or implementing treatment.” 
 
c) “Outcome denotes the effects of care on the health status of patients and populations.   
Improvements in the patient's knowledge and salutary changes in the patient's behaviour are 
included under a broad definition of health status, and so is the degree of the patient's 
satisfaction with care.” 
 
Donabedian's model has been extensively used by researchers and clinicians as a frame of reference 
for their work on quality measurement, assurance and improvement, almost to the exclusion of other 
theoretical viewpoints.  The predominance of the model may reflect its conceptual strength, though 
it may also indicate a preference amongst researchers for applied research rather than theory and 
model building.  Donabedian's model has also engendered longrunning debates over two issues - the 
relative merits and demerits of each dimension, and the existence of links or correlations between 
measures of the different dimensions. 
 
It is sometimes assumed that structure, process and outcome are, in that order, increasingly difficult 
to measure but increasingly important and valid as measures of quality - what Berwick (1988) has 
critically termed a “hierarchy of validity”.  Indeed, as Berwick and Knapp (1990) report, some 
researchers have treated structure and process as of value only to the extent that they act as proxies 
for outcome, arguing that since healthcare exists to improve or maintain people's health, outcome 
measures offer the most direct and inherently valid measure of their success (Frater 1992; Frater and 
Costain 1992; Shanks and Frater 1993).  Other researchers have suggested that outcome 
measurement is really the province of clinical research rather than quality measurement and quality 
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assurance, and that process measures are more feasible in practice, and provide information which is 
more directly applicable in making changes to systems or processes to improve quality (Sanazaro 
1974; Mant and Hicks 1995).   Donabedian (1980, p119) finds there are significant advantages and 
disadvantages to measures in each dimension, and argues that we should distrust generalities about 
methods of assessment, preferring to judge each situation on the setting and particular objectives 
concerned.  However, to gain a full picture of the quality of care, he advocates the use of 
multidimensional assessment methods, which include elements from each dimension of quality. 
 
The relationships between the three dimensions of Donabedian's model have also been examined - 
often in the course of the debate of their relative validity, since if structure and process measures are 
valid only as proxies for outcomes, the establishment of a relationship between measures of 
structure and process and measures of outcome becomes vitally important.  In practice, it has proved 
difficult to detect meaningful relationships between measures in different dimensions and the 
literature abounds with studies which have demonstrated little or no significant correlation 
(Komaroff 1978; Murphy and Jacobson 1984), a fact which some outcomes advocates have taken as 
evidence of the weakness of process and structure measures (Vuori 1989), while others have 
criticised the rigour and conceptual oversimplicity of the process-outcome studies themselves 
(McAuliffe 1978).  Berwick (1988) contends that the search for relationships amongst the different 
dimensions betokens a mistakenly unidimensional view of quality, and a misplaced conviction that 
there is a single latent property called quality.  In fact, he asserts, while the various aspects of quality 
may cluster in certain providers, “it is very unlikely that all of these and other valued attributes of 
care march strictly to a single underlying drummer we would call quality” (Berwick 1988). 
 
An alternative model of quality, based on a much broader definition of the concept of quality and 
structured much more specifically around healthcare, was propounded by Maxwell (1984), who 
suggested that there were six dimensions each of which should be recognised separately, and each 
of which required different measures and different assessment skills: 
 
a) Access to services - issues such as waiting times and referral patterns, geographic variations 
in service availability, or physical proximity and availability of services. 
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b) Relevance to need of the community - issues such as the pertinence of services provided to 
the actual needs of people, assessed through health needs studies or surveys. 
 
c) Effectiveness for individual patients - aspects such as the technical effectiveness of treatment 
and the outcome for the patient. 
 
d) Equity or fairness - the equitability of the distribution or provision of services across 
different social groups or sections of society. 
 
e) Social acceptability - aspects of care relating to whether care is provided in the way people 
want, and meets their expectations. 
 
f) Efficiency and economy - considerations such as the cost of services provided, both in 
absolute terms and relative to other providers. 
 
This model of quality might be fairly accused of encompassing almost every conceivable attribute of 
healthcare, and so expanding the definition of quality as to make it ultimately less meaningful.  
Maxwell's model has not been widely used in practice outside the UK to develop or support 
approaches to quality measurement, though it is often cited, particularly by researchers who 
approach quality assurance with an epidemiological or public health perspective, to demonstrate the 
dangers of adopting too narrow a definition of quality (Black 1990). 
 
Many other researchers have developed and published models of quality or structures which might 
be employed as models (Freeborn and Greenlick 1973; Williamson 1978; Merry 1987; Kitson 1989; 
and others).   Often, these models are largely derived from Donabedian's seminal work, though 
sometimes they categorise or group the attributes of quality slightly differently.   However, none has 
been anywhere near as widely used or applied.    
 
These models of quality seem to serve one important purpose.   They break down or deconstruct 
what is a complex, subjective concept which seems to defy adequate definition into a number of 
constituent dimensions or parts, each of which is rather more capable of being defined, understood, 
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measured and analysed.  There is no generally accepted single definition of quality in healthcare, 
perhaps because the concept defies sensible definition.  Models of quality, such as the structure-
process-outcome paradigm first advanced by Donabedian three decades ago, serve a useful purpose 
in breaking down the complex portmanteau concept of quality into an ordered hierarchy or 
framework of  simpler and more measurable concepts. 
 
 
2.3 The measurement of quality 
 
2.3.1 The theory of quality measurement 
 
The problems of measurement in healthcare are almost self-evident.  Kind (1988) contrasts 
measurement in the physical sciences which “conveys the impression of a precise operation based 
on well-established procedures, carried out in controlled laboratory settings and producing results 
which are expressed in terms of standardised units of measure” with the measurement of aspects of 
healthcare “where not only is the phenomenon under investigation defined in many different ways, 
but there are varying opinions as to how it might be represented, and on whether it could or should 
be quantified”.    The latter description neatly sets out the problems which face those who would 
design and develop measures of the quality of healthcare. 
 
To measure quality, the concepts and constructs used to define and model quality must be translated 
into unambiguous and concrete representations.  These will always consist of: 
 
a) Actual items of data, representing characteristics of the healthcare system, processes, or 
results.  These are often termed elements or parameters.  
 
b) Valuations, giving meaning to the data elements by providing some general rule about what 
represents goodness (or good quality) in respect of individual data items or groups of data 
items.  These are often termed criteria or standards. 
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Every measure of healthcare quality can be reduced to these component parts - data elements and 
valuations - though the manner in which they are selected, derived, defined, collected and used in 
individual measures varies tremendously.     
 
Nature and source of data elements 
The nature of the data elements used in measures of quality is so heterogeneous it is almost 
impossible to generalise about them.  They represent characteristics or properties of almost every 
conceivable part, process and effect of the healthcare system. They may be quantitative or 
qualitative; categorical, nominal, ordinal or ratio scaled; parametric or non-parametric; dimensioned 
or dimensionless. 
 
The sources of the data elements used in measures of quality are easier to categorise.  First and 
foremost, data elements are commonly drawn from the clinical record of care.  The clinical record is 
used as the primary data source for the many quality measures, sometimes supplemented by other 
data sources.  The importance of the clinical record to quality measurement makes its completeness 
and accuracy (which are often questioned) fundamental issues for the developers and users of 
quality measures.  In using clinical records, measures should take account of the acknowledged 
problems of completeness and veracity, and the risk that the development of measures is shaped by 
the availability (or nonavailability) of data in the clinical record.   Secondly, some measures require 
the completion of some additional record above and beyond that normally kept in the clinical record, 
with data elements collected or recorded specifically for the purpose of quality measurement.  While 
this frees the developer from the restrictions of the clinical record content, it imposes a new set of 
problems in ensuring that complete and accurate data is collected.   A third source of data, less 
frequently used because of its cost, is direct observation of practice or the situations or 
circumstances in which care is provided.  The fourth main source of data elements is the participants 
in the healthcare process (providers and consumers) who, through questionnaires, surveys or 
interviews, provide some data elements which might also be obtained from other sources and others 
which could only be collected from the participants themselves. 
 
Nature and source of valuations or criteria 
  
 
 
21
The valuations which are attached to data elements are used to interpret them, identifying what 
constitutes goodness (or good quality) and what does not.   In many quality measures it can be 
difficult to separate these valuations from the data elements themselves, and the derivation of the 
valuations or criteria can be far from clear.   
 
Donabedian (1982) developed a useful classification of the nature and source of the valuations or 
criteria used in the measurement of healthcare quality.  He defines the nature of the criteria in terms 
of: 
 
a) Specification.   
In some measures, the criteria are explicitly stated - usually in written form - in 
unambiguous terminology which leaves little room for differences in interpretation.  
However in others, the criteria are implicit, often unstated or stated in terms which allow 
ample latitude for professional differences of opinion or interpretation.  These latter 
measures often rely on individual professional judgements made by the users of the measure. 
 
b) Referent.    
The topic, subject, patient group or whatever to which the criteria are to be applied is termed 
the referent.  Again, some measures make their intended referent very clear, while others do 
not.  It is not unknown for quality measures designed for one referent to be used in a quite 
different setting with another referent. 
 
c) Monotony versus inflection.   
Some criteria are what Donabedian has termed monotonic - it can always be said that “the 
more the better” or “the less the better” (an example might be postoperative mortality rates).  
Other criteria are inflected, which means that there is an optimum value or range, below or 
above which quality decreases.   In practice, few criteria are likely to be wholly monotonic.  
The certainty with which the optimum value or range can be specified for inflected criteria 
varies considerably. 
 
d) Stringency.   
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The level of quality envisaged in a criterion or set of criteria is called its stringency.  The 
more stringent the criteria used in a measure, the harder it might be for providers to achieve 
those criteria. 
 
e) Importance.   
Clearly, all criteria are not of the same importance, since some will relate to aspects of 
healthcare that are more crucial than others.  There may, therefore, need to be some 
weighting process, which assigns greater weight to those criteria judged to be more 
important. 
 
The source of the criteria used in quality measures is clearly crucial to their validity.   If a measure 
were based on criteria which were not supported by available evidence from relevant clinical 
research, were not accepted by key stakeholders such as clinicians and service users, and did not 
match the context or setting in which the measure was to be used, then its validity would be very 
much open to question.  Donabedian categorises the source of the criteria used in measures of 
quality on these three axes: 
 
a) Normative versus empirical derivation.    
Criteria may be derived from the opinions of participants or developers about what 
constitutes good quality care (normative criteria), or they may result from actual research 
into the healthcare process and its outcomes (empirical criteria).   In the past, many measures 
made extensive use of normatively derived criteria, drawing on expert opinion either 
informally through consultation or discussion, or more formally through consensus building 
approaches like the Delphi technique.  However, it has been increasingly recognised that 
such criteria may be misleading, representing a skewed, partial or simply misplaced 
professional consensus which is not supported by available empirical evidence.  For that 
reason, there is now a much greater focus on grounding criteria more firmly in the evidence 
from well designed and rigorously conducted empirical research (using qualitative, 
quantitative, experimental and observational methods). 
 
b) Exogenous, endogenous and autogenous criteria.   
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When the criteria are developed by one group of practitioners or developers for use on or by 
others, they are said to be exogenous.  Endogenous criteria are those developed by the group 
of practitioners whose performance they will be used to measure.  Autogenous criteria are 
those that an individual practitioner develops and uses to assess his or her individual 
performance. 
 
c) Representative versus elitist criteria.   
Criteria which are derived from or based on the performance of practitioners or providers 
who are perceived to be of above average performance or who practice in atypical 
circumstances (such as leading academic clinicians, tertiary service specialists or 
professional opinion-formers) are termed elitist, while those which are based on the 
experience and practice of all providers or practitioners are termed representative. 
 
While all measures of quality are made up of data elements and valuations or criteria, as described 
above, there are important differences in the way measures use data elements or criteria.   Some 
measures give primacy to the data elements - focusing on defining and collecting those data 
elements for analysis, with little attention to the valuations which will be placed on those data 
elements.  These approaches can be said to be data-driven.    Other measures give primacy to the 
valuations or criteria - focusing on elucidating and defining those valuations very carefully, and only 
then using them to determine what data elements are required.   These approaches can be said to be 
criterion driven.   The distinction is not simply bipolar - there is a continuum of variation from one 
extreme to the other.  
 
The process through which measures of quality are developed, applied, tested and evaluated is far 
from well defined.  In theory, at least, seven distinct stages in the process can be distinguished - 
conceptualisation, definition, development, testing, evaluation, application and revision.   In 
practice, many measures are inadequately developed, with scant attention being given to aspects 
such as conceptualisation (the theoretical background or framework within which the measure fits, 
the theoretical concept which the measure is intended to measure) and evaluation (testing the 
reliability and validity of the measure, and formally assessing other aspects of its utility).   Such 
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inadequately developed and tested instruments have often then been widely and improperly used in 
quality assessment (Sanazaro and Mills 1991). 
 
There is no accepted classification of the bewildering variety of quality measures which have been 
developed and used in healthcare over the last four decades.   However, Donabedian's model and the 
preceding discussion of the theory of quality measurement offer one approach to grouping and 
ordering actual measures.   We can categorise measures according to two principal characteristics: 
 
a) Dimension measured - structure, process or outcome.   Whether the measure is primarily 
focused on issues of structure, process or outcome quality. 
 
b) Data-driven versus criterion-driven - whether the measure gives primacy to the data 
elements on which it is based or the valuations placed on those data elements. 
 
In the following sections, this approach to classification will be used to present an overview and 
brief critique of some of the measures of quality which have been developed and used in healthcare.  
For the purposes of clarity, the methods and measures to be reviewed are summarised in table 2.2, 
which also uses the same classification matrix. 
 
Of course, the boundaries between measures and dimensions are not clearcut, and so the 
classification must be to some degree imperfect.  Some measures address both structure and process, 
or combine some data-driven elements with some criterion-driven elements.  In classifying them 
below, their primary or principal orientations have been used. 
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Criterion-driven measures Data-driven measures 
Structure quality measures Accreditation 
Organisational audit 
Performance indicators 
Process quality measures Criterion audit 
Standard setting 
Practice guidelines 
Adverse events 
Large clinical databases 
Clinical indicators 
Patient satisfaction 
Outcome quality measures Avoidable deaths Patient satisfaction 
Mortality indicators 
Health status measures 
 
 Table 2.2.  Summary of measures of quality reviewed. 
 
 
2.3.2 Measures of structure quality 
 
Criterion-driven measures 
Criterion-driven measures of structural quality are largely based on sets of valuations or criteria 
which specify the desirable or preferable elements in the structure of a healthcare organisation such 
as a hospital.  These criteria may simply specify the presence or absence of some elements in the 
structure (such as the availability of certain equipment), or may outline preferred arrangements or 
procedures (such as the preferred management structure). 
 
Criterion-driven measures of structural quality have been widely used, particularly in the United 
States, Canada, Australia and (latterly) the United Kingdom in a process which is frequently termed 
accreditation (because the measures have been used to accredit or licence institutions).  In several 
countries, these measures of quality have been an important component of the process of monitoring 
and reviewing institutions' adherence to commonly accepted standards of service provision 
(Scrivens 1995). 
 
Accreditation has been used in the USA since the establishment of the Hospital Standardisation 
Programme by the American College of Surgeons in 1918, which set out to assess hospitals with 
more than 100 beds against a simple one-page statement of minimum requirements, through on-site 
visits.  The independent, nongovernmental Joint Commission on Accreditation of Healthcare 
Organisations (JCAHO) was set up in 1951 to take forward the programme, which by then was 
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accrediting over 3,000 hospitals.  It currently assesses over 80% of US hospitals.  Although 
accreditation is voluntary, many public and private payors impose an accreditation requirement 
which gives the JCAHO considerable authority over individual provider institutions (Couch 1989). 
 
The JCAHO standards are developed through a series of expert panels and committees, and are 
published annually in the Accreditation Manual for Hospitals (Joint Commission on Accreditation 
of Healthcare Organisations 1988).   They consist of a series of statements of structural and 
procedural attributes of healthcare organisations which are deemed to be associated with high 
quality care.  Compliance with the standards does not demonstrate that good quality care is being 
provided, but is claimed to show the potential for the provision of good quality care exists.  The 
measures are applied through site visits by survey teams, whose assessment of compliance with the 
standards is the basis for the decision whether or not to accredit the institution. 
 
In the UK, the King's Fund has sponsored the development of an accreditation programme for 
hospitals, modelled on the work of accreditation agencies in the USA, Canada and Australia (King's 
Fund 1996).   Accreditation has also long been used by the Royal Colleges to assess the suitability 
of hospitals for medical staff training (Hopkins 1990, p13).  In 1979, the British Standards Institute 
(BSI) developed a set of quality standards against which the quality management systems of 
industrial and commercial organisations could be assessed (British Standards Institute 1987).  The 
BS5750 accreditation system was subsequently adopted by the International Standards Organisation 
and, as ISO9000, is now widely used throughout the world (Department of Trade and Industry 
1995).  These standards have been adapted for use within the health service (Rooney 1988) and a 
number of NHS organisations have sought and achieved BS5750 or ISO9000 accreditation 
(McDonald 1991). 
 
Data-driven measures 
By gathering a wide range of information about the resources and facilities for healthcare across a 
large number of institutions, comparisons can highlight those providers with substantially different 
arrangements from their peers, and may be the starting point for more detailed analyses of the 
effects of those differences in structure. 
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Perhaps the best known large-scale application of this approach in the UK is the development of 
performance indicators led by Yates and colleagues which led to the longstanding Department of 
Health sponsored system of Health Service Indicators (Sanderson 1987).  In the 1970s, Yates and 
colleagues demonstrated that the comparative analysis of readily available structural information 
about long-stay mental handicap hospitals could be used to identify those institutions where the 
quality of care was unacceptably low (Yates and Vickerstaff 1982).  Yates and others went on to use 
the same approach in the acute hospital sector to considerable effect (Yates and Davidge 1984; Ham 
1985), and it formed the foundation of the current national system of Health Service Indicators 
(Department of Health 1989a), which present a range of comparative information from providers 
throughout the NHS, much of it relating to structure (though some indicators are focused on 
process).  
 
Merits and demerits of structure quality measures 
The advantages of structural measures of quality are that they are relatively easy to define and use, 
and the costs of collecting the data they require are relatively low.  Because structures tend to 
change quite slowly, measurement can be relatively infrequent and thus less costly.   In addition, it 
has been claimed that their clear factual base in the presence or absence of facilities or procedures 
makes them relatively objective (Rosenberg 1990).  However, measures of the quality of structure 
have often been criticised for being “a rather blunt instrument in quality assessment” (Donabedian 
1990, p21) with little demonstrable relationship to process and outcome measures.  Their validity is 
also frequently questioned by practising clinicians, who see little relation between such measures 
and the realities of providing good quality care.   Indeed, most of the structural quality measures 
described  above are normatively rather than empirically derived, and so doubts about their validity 
may be quite justifiable (Longo, Wilt and Laubenthal 1986).  On the other hand,, it may be argued 
that many elements of high structural quality - such as adequate staffing, equipment and training - 
should be an end in themselves, regardless of any hypothetical relationship to other dimensions of 
quality.  While the presence of good structural quality does not guarantee good process and outcome 
quality, it seems probable that poor structural quality will make the provision of good process and 
outcome quality much less likely - so good structural quality is a necessary but not sufficient 
condition for good quality on other dimensions. 
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2.3.3 Measures of process quality 
 
Criterion-driven measures 
The development and application of sets of criteria which define the constituent parts, elements or 
stages in a high quality process of care has played a large and continuing role in quality 
measurement.   Usually, these criteria map processes such as the diagnosis, investigation and 
treatment of conditions, defining the appropriate decisions, actions and recordkeeping of the health 
professionals involved. 
 
Lembcke (1956) first described the development of process criteria, which he termed “medical 
auditing by scientific methods”, and he set out a method for developing the criteria and for 
measuring performance against them.  He also demonstrated the effectiveness of the method in 
changing physicians' practice patterns.   The approach was adopted and promulgated by the JCAHO, 
and became the basis for mandatory quality assurance activities throughout the USA in the early 
1970s (Sanazaro 1974).  A tremendous investment was made in developing criterion-based 
measures of quality for a large number of conditions and patient groups and using them in medical 
audits (Brook 1977). 
 
However, a number of major studies demonstrated that criterion-based process measures were 
neither as valid nor as reliable as Lembcke (1967) had suggested.  Brook and Appel (1973) found 
that the results of such measures depended crucially on how the criteria used were derived and how 
the measures were actually applied.  Hulka (1978) found that nonadherence to criteria often resulted 
from patient heterogeneity rather than poor quality practice.  Sanazaro and Worth (1978) showed 
that the use of criterion-based measures had minimal effects on actual practice, and Nobrega et al 
(1977) and others found no significant relationship between criterion-based process measures and 
the quality of clinical outcomes.   Komaroff (1978) concluded that many criterion-based measures 
were too complex, overambitious and poorly tested and should be simplified.  Nevertheless, 
criterion-based measures continue to be widely used in a variety of settings (Mayer, Clinton and 
Newhall 1988) and form an important part of current quality measurement efforts in the USA 
(Agency for Health Care Policy and Research 1995). 
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Criterion-based measures of process quality have also been widely used in the UK, particularly over 
the last decade.  Clinical guidelines for a range of conditions and treatments, from asthma to 
electroconvulsive therapy, have been promulgated and used as a basis for  measurement 
(Department of Health 1993).   However, a similar set of concerns has been voiced about the 
validity of these measures  (Grimshaw et al 1995) and their utility in both quality measurement and 
improvement (Hopkins 1995). 
 
Traditional criterion-based measures of process quality have been developed by attempting to define 
what constitutes a good process of care.  The heterogeneity of patients and the complexity of the 
disease process and treatment modalities make this very difficult, and the resulting criterion-based 
measures are often complex and unwieldy.   An alternative approach has been to develop criterion-
based measures focused on poor quality care - in which the valuations or criteria define instances or 
events which are indicative of poor quality care rather than defining the constituents of good quality 
care.  These instances of poor quality care (or “disquality”) are often called adverse events.  A range 
of quality measures and quality assurance systems using this approach have been developed and 
widely used in the USA (Craddick 1979; Craddick and Bader 1983; Goldman 1989), and the 
concept has also been applied in Australia (Wolff 1992) and the UK (Bennett and Walshe 1990; 
Walshe, Bennett and Ingram 1995).  However, such adverse-event measures of quality have been 
criticised, on grounds of their relative inefficiency, high error rates (especially false positives), 
emphasis on patient safety, and poor validity as quality measures (Sanazaro and Mills 1991).  The 
theoretical background, development and testing, practical application, and evaluation of these 
measurement techniques is discussed in more detail in chapter 3. 
 
Data-driven measures 
Data-driven approaches to measuring process quality largely centre around the collection and 
analysis of large databases of information about the process of care.  The nature of modern 
healthcare organisations is such that relatively detailed computerised databases of information are 
often readily available.  Though the data sets they contain - defined by operational need rather than 
the requirements of quality measurement - may be restrictive, the opportunity offered by these 
databases has been widely used in quality measurement. 
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The earliest developer of such a database was the Commission on Professional Hospital Activities 
(CPHA), which first began to gather a uniform data set on each patient from hospitals in the United 
States in the 1950s (Commission on Professional Hospital Activities 1990).  CPHA established a 
database which at one point gathered data from over 2,300 acute hospitals in the USA, and now 
contains data on over 200 million patient admissions.  Many other organisations and researchers, 
including federal agencies such as the Health Care Financing Administration, have followed suit, 
using data from payor databases (Dubois et al 1987), billing systems (Mendenhall 1987a; 1987b), 
and other sources to develop measures of quality.  In 1989, the JCAHO, recognising the weaknesses 
of its largely structural quality measures, established an extensive programme to develop and collect 
clinical indicator information from accredited hospitals to provide new measures of process quality 
(Robinson 1988; O'Leary et al 1989). 
 
In the UK, routine data about the healthcare process has been available for some years for some 
areas of care (for example, acute inpatient services) but very little data has been routinely collected 
in other areas (such as mental health, or community services).  Some information from these sources 
has been used in the Health Service Indicators discussed earlier to provide process measures such as 
length of stay, admission and readmission rates, and so on.   More recently, an independent UK 
organisation linked to CPHA has established a similar comparative database providing a range of 
process quality measures largely but not exclusively oriented around resource usage (CHKS 1995). 
 
Another major data-driven approach to both process and outcome quality measurement is the 
monitoring of patient satisfaction and patient opinions about the care they receive - either 
proactively through patient surveys and other mechanisms for understanding patients’ views 
(Kelson 1996) or reactively through patient complaints (Allsop and Mulcahy 1996).  Patients' 
opinions can be viewed solely as an outcome (of their interaction with the healthcare process or 
healthcare system) but it is perhaps more meaningful to view patients' opinions as a data source for 
information on all three dimensions of quality - structure, process and outcome.  After all, patients 
have valid views on the quality of the physical environment (structure), the quality of 
communication from staff (process), and the improvement in their health status (outcome) and it 
would seem perverse to label all these views as outcomes. 
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Though the orthodox professional view is that patients lack the knowledge to make valid 
judgements of the quality of process and outcome, research has shown that patients can distinguish 
between interpersonal and technical aspects of process and outcome quality, and can make valid 
assessments in both domains (Kaplan and Ware 1989).  Patient satisfaction measures have been 
widely used both in the USA and the UK (Fitzpatrick 1990).  Patient satisfaction may be termed 
either a process measure or an outcome measure, depending on whether satisfaction with the 
processes or the results of care are being assessed. 
 
Merits and demerits of process quality measures 
Process measures of quality have many advantages.  In particular, they provide information which is 
focused on process performance and so is readily used in changing systems or practices, since the 
need for and direction of change are often clearly indicated by the process measures.  Indeed, 
advocates of continuous quality improvement (CQI) would argue that without a comprehensive 
understanding of healthcare systems and processes (which can only be gained through process 
quality measurement) opportunities for quality improvement cannot be identified and realised (Plsek 
1997).  In addition, process quality measures are often relatively inexpensive to apply (certainly 
compared to many measures of outcome) since all measurement takes place within the healthcare 
organisation, at or around the time of treatment.  Their primary weakness is the frequent lack of 
evidence that what is deemed to represent a good process of care is related to the achievement of 
good outcomes.   In some cases, this represents a failure on the part of those developing the 
measure, who have not made proper use of available research findings, but more commonly it 
indicates that the evidence to link processes and outcomes is not available for a variety of reasons.  
This results at least in part from the nature of clinical science, in which there is limited evidence for 
the efficacy of much of accepted custom and practice (Smith 1991) and it is, perhaps, unrealistic to 
expect the developers of quality measures to establish process-outcome correlations where clinical 
research has not done so. 
 
 
  
 
 
32
2.3.4 Measures of outcome quality 
 
Criterion-driven measures 
Most outcome quality assessment tools are data rather than criterion-driven - they rely on the 
collection of data about the outcomes of healthcare which is then interpreted in analysis, when 
valuations are placed on it.   However, there are some examples of criterion-driven measures of 
outcome which have been developed and used, in a process akin to that described above for process 
quality criteria.   Rutstein and colleagues, for example, established a set of criteria defining causes of 
mortality which they considered avoidable and therefore indicators of poor quality (Rutstein et al 
1976).   Charlton and colleagues applied a variant of these outcome criteria in the UK and 
internationally (Charlton et al 1983; Charlton and Velez 1986). 
 
Data-driven measures 
The most fundamental data-driven measures of outcome quality are those concerned with mortality, 
which assess quality through comparisons of various general or disease-specific mortality rates.  
Mortality measures are of limited validity, for while the aim of healthcare is usually to postpone 
death, this objective is often not the primary one, and almost never the only one.   Because mortality 
is rare, especially in some services and specialties, measures based on mortality are founded on the 
care provided to a very small proportion of patients.  In addition, even for those patients there are a 
number of causes and contributory factors involved in mortality which make the interpretation of 
general mortality rates difficult at best (Kahn et al 1988).   Nevertheless, mortality statistics have 
been widely used in the USA to compare quality at different institutions, and similar mortality 
indicators have been proposed by the Department of Health for use in the UK (Walshe 1997).  The 
validity of mortality rates as indicators of outcome quality has been widely questioned, especially by 
healthcare providers (Berwick and Wald 1990), but Dubois et al (1987) have demonstrated that 
hospitals with high outlier mortality statistics had a greater proportion of preventable deaths, 
suggesting that there is some relationship with quality of care. 
 
The weakness of mortality as an outcome measure has led some researchers to attempt to develop 
more sophisticated measures which are risk-adjusted - in other words, take account of differences in 
patient populations such as severity (DesHarnais et al 1990).   It has also led researchers to broaden 
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their interest to other relatively readily available outcome data, such as the incidence of hospital 
readmissions and post-discharge complications (Roos et al 1985; Roos, et al 1988; DesHarnais et al 
1990) though the validity of these data as measures of quality has also been challenged (Milne and 
Clarke 1990). 
 
The paucity of routinely available data on healthcare outcomes has led some to establish new data-
driven outcome measures drawing on information which is specifically collected for the purpose, 
often using the growing library of health status measures developed both for specific diagnoses or 
patient groups and for global or generic use (McDowell and Newell 1991; Hopkins 1990, p44).  The 
practicality of gathering such information (given that it involves data collection before and/or after 
the healthcare process) has been demonstrated (Tarlov et al 1989; Coles 1990; Bardsley and Coles 
1992), and they have been increasingly widely used in the UK (UK Clearing House on Health 
Outcomes 1996) despite some criticism of their validity and utility (Mant and Hicks 1995; Sheldon 
1994) 
 
Merits and demerits of outcome quality measures 
The single greatest advantage of outcome quality measures is the almost universal acceptance of 
their validity - they can be said to be intrinsically “self-validating” (Rosenberg 1990).  Proponents of 
outcome quality measures argue that, since healthcare services exist to improve peoples' health, 
direct measures of the outcomes of healthcare (in terms of peoples' health) are the best way to assess 
healthcare quality.   However, there are both theoretical and practical disadvantages to take into 
consideration.  Firstly, outcome measurement often reveals little about why good or poor quality 
outcomes occur (in other words, the processes that lead to those good or poor outcomes).  This can 
make the data of little practical value in making quality improvements, since the causes of poor 
quality and the workings of the healthcare processes involved have not been explored and are not 
understood.  Secondly, the attribution of health outcomes to healthcare interventions (as opposed to 
other factors or life events) is problematic and methodologically complex, and becomes more so, the 
more distant those outcomes are from the healthcare processes being studied.  Even with quite short 
term outcomes, the confounding effect of variables outside the control of the healthcare process 
(such as community support, patient behaviour, housing, and other economic and social factors) can 
be considerable.   Thirdly, since outcome measurement reaches out beyond the period of the 
  
 
 
34
healthcare intervention (both before it and after it) data collection is almost inevitably expensive and 
involved.  Fourthly, the low prevalence of some outcomes means that unfeasibly large numbers of 
cases or amounts of data may need to be collected to support a sound statistical analysis (Mant and 
Hicks 1995).  Arguing cogently against basing quality measurement around outcomes, Berwick and 
Knapp (1990) describe it as “a formula for paralysis”.  They point out that it burdens quality 
measurement with the agenda of almost all clinical and health services research, and suggest that we 
simply know too little about what in healthcare produces health to make outcome central to the 
definition of quality.  
 
 
2.4 Applying quality measurement in healthcare 
 
2.4.1 From quality measurement to quality assurance 
 
Quality assurance is an umbrella term, widely used to describe all sorts of programmes, activities 
and systems designed to monitor and improve the quality of healthcare.  It is commonly defined as 
“the measurement of the actual quality of care against preestablished standards, followed by the 
implementation of corrective actions to achieve those standards” (Vuori 1989).   Essentially, quality 
assurance consists of two interconnected activities (Walshe et al 1991): 
 
a) Quality measurement, in which a variety of tools and techniques (some of which are 
described above) are used to measure the quality of healthcare. 
 
b) Quality improvement, in which information about the quality of healthcare and about the 
workings of the healthcare system is used to make changes to individual or organisational 
practices which are designed to improve the quality of healthcare. 
 
These two activities are often visualised as part of a cycle of activity - which has been termed the 
audit cycle - in which measurement and changes to practice alternate to produce continuing 
improvements in quality (Fowkes 1982).   This rather simplistic cycle of activity can be (and has 
been) further subdivided to break down the processes of measurement and improvement into a 
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number of separate but interlinked steps, and to illustrate the processes involved, such as objective 
setting, planning, data collection, reporting, change management and ongoing monitoring (Lang and 
Clinton 1984; Crombie et al 1993, p27; and others). 
 
There are a number of other terms commonly (and confusingly) used to describe this process - 
medical audit, clinical audit, continuous quality improvement, total quality management, and so on. 
Shaw (1980a) suggests 96 possible combinations of words, and while there are certainly some 
important distinctions to be drawn between them, there are far more similarities than differences in 
the processes they describe.   What terminology is current seems to depend more on fashion than 
any more secure foundation, and the absence of clear demarcations between these terms means they 
are often used interchangeably.   In this thesis, for the sake of simplicity and consistency, the terms 
quality assurance, quality measurement and quality improvement will be used as described above.  
 
Quality measurement is an essential part of the quality assurance process, and it is almost impossible 
to conceive of a successful quality assurance programme being established without good 
measurement tools to serve it.   By the same token, quality measurement by itself would be a sterile 
occupation of little value, since it would involve data collection and analysis to no actual purpose.   
This recognition of the importance of quality measurement to quality assurance and vice versa must 
contribute to our ideas about what constitutes a good measure of quality.  Not only must measures 
be valid, reliable, and all the things measurement systems are meant to be, they must satisfy the 
needs of the quality assurance process, which means they must be practical, workable, affordable, 
applicable, and meaningful for the business of quality improvement.    
 
Berwick, Godfrey, and Roessner (1990) argue that research in the area of healthcare quality 
assurance has focused too much on the issues surrounding quality assessment, and has given too 
little attention to the problems of quality improvement - treating the subject as a science rather than 
an applied technology, and being directed towards “unveiling the fact of flaw, not its cause” 
(Berwick, Godfrey, and Roessner 1990, p11).  Two decades ago Jessee (1977) and Brook (1977) 
made the same point, noting that while quality measurement techniques were far from perfect, they 
had been able to identify important deficiencies in the quality of care.  However, remedying those 
deficiencies had proved to be a much more complex task than simply identifying them. 
  
 
 
36
 
 
2.4.2 Quality measurement in historical perspective 
 
Professional and public concern over the quality of care is not new.  In 1518, when the Royal 
College of Physicians was founded, its charter explicitly committed it to uphold the standards of 
medicine “both for their own honour and the public benefit” (Shaw 1989).  However, healthcare 
quality assurance has only become a part of everyday practice in recent years, as a result of modern 
social, financial and technological pressures. 
 
Perhaps the first documented quality assessment studies were undertaken by Florence Nightingale, 
who used data such as mortality rates for diagnostic categories to highlight unsafe conditions in 
Crimean British Army hospitals, by showing that soldiers in the Crimean hospitals were much more 
likely to die of common medical conditions like pneumonia than civilians in the UK.   She also 
developed a system of hospital statistics designed to monitor the outcomes of surgical operations 
and the efficiency and effectiveness of bed usage (Wilkin and McColl 1987).  Her interest in 
surgical mortality was pursued by Groves (1908) who surveyed operative mortality rates in 50 UK 
hospitals and published the results.  Codman, a Bostonian surgeon of the same era, undertook a 
systematic assessment of every patient he treated which included a classification of the outcome of 
all surgery - an approach he named his end results system (Codman 1914).  These pioneers were all 
unusual individuals whose interest in healthcare quality was not shared by most of their colleagues, 
and their innovations were not widely adopted or applied. 
 
The first systematic quality assurance programme was established in the USA 1918, by the then 
recently formed American College of Surgeons.   The Hospital Standardisation Programme, as it 
was called, set out to regularly review hospital facilities and practices against a set of minimum 
standards.  While the first annual inspections revealed that only 89 of 692 hospitals visited met the 
very basic standards, the programme grew and expanded rapidly (Couch 1989).  In 1951, 
responsibility for the programme was passed to the new Joint Commission on Accreditation of 
Hospitals (JCAH), which was founded to provide an independent, nongovernmental centre for 
quality assurance in US healthcare. 
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In the 1950s and 1960s, interest in the quality of healthcare flourished in the USA.  Research into 
the development of quality assessment techniques grew, and the academic foundations of quality 
assurance were laid (Donabedian 1966).   The growing costs of medical care and the problems of 
controlling the highly fragmented US healthcare system led to the establishment in 1974 of a 
mandatory, externally managed quality assurance programme throughout the USA - the Professional 
Standards Review Organisations (Sanazaro 1974).  The PSRO programme made extensive use of 
process criteria to assess the quality of care, but its effectiveness was widely questioned (Komaroff 
1978).  During the 1970s, an explosion in clinical negligence litigation brought a further focus on 
quality improvement, and the development of risk management in US hospitals (Mills and Von 
Bolschwing 1995).  In the 1980s, new legislation replaced the PSRO programme with a system of 
state-based Peer Review Organisations (PROs), with a similar mandate but a different methodology, 
based largely on generic occurrence screening (Jost 1989).  In the late 1980s, interest in industrial 
approaches to quality measurement and improvement grew, and a strong and influential continuous 
quality improvement (CQI) movement developed (Berwick Godfrey and Roessner 1990; Berwick 
1996).    With the growth of managed care in the 1990s came a number of new approaches to quality 
measurement, including the growing use of so-called balanced scorecards of performance measures, 
and the development of a new organisation,  the National Committee on Quality Assurance, to 
monitor and accredit managed care plans (National Committee for Quality Assurance 1996). 
 
In the USA today, the sheer extent and depth of quality assessment and monitoring is striking.  All 
hospitals have substantial internal quality assurance programmes, with quality review staff who use 
a variety of techniques to monitor the quality  of care and to intervene when problems are identified.  
These programmes are managed and directed by a complex arrangement of committees, with high 
level medical and managerial participation, and are often linked to physician credentialling and risk 
management (King and Jones 1989; Chassin 1996).   
 
Almost all hospitals have to satisfy the Joint Commission's quality standards to gain accreditation, 
which means undergoing periodic inspections by external survey assessors and making changes to 
practice where required (Couch 1989).  All hospitals receiving payments from the federal Medicare 
programme (which pays for care for all elderly people) have to submit a sample of cases to their 
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local Peer Review Organisation for detailed case reviews and quality assessments, and many other 
healthcare funding agencies (such as large health insurers) impose a similar requirement (Jost 1989).  
Detailed comparative information on hospital performance, based on a range of clinical data, is 
widely used by both providers and funders of healthcare to address quality issues, and such 
information is even available to the general public (Dubois et al 1987). 
 
Almost all care provided in the US healthcare system is subject to some form of quality review - and 
much is often reviewed more than once by different bodies.  Despite these extensive (and expensive) 
programmes, there is widespread dissatisfaction with the effectiveness of quality assurance in US 
healthcare, and a common perception that much current activity has little or no worth in terms of its 
effect in improving quality or controlling costs (Berwick 1989; Welch and Grover 1991; Angell and 
Kassirer 1996). 
 
In the UK, quality assurance in healthcare has developed much more slowly than in the USA, and 
has tended to consist of separate initiatives addressing individual issues rather than integrated 
quality assurance programmes.  For example, a confidential enquiry into maternal deaths was 
established in the 1930s (and still exists, in modified form, today) to undertake a confidential 
investigation of all instances of maternal mortality in childbirth (Department of Health 1991a).   A 
national quality control scheme for pathology laboratories was established in 1969, and continues to  
monitor the quality of laboratory test results through a programme of sampled retesting (Whitehead 
and Woodford 1981).   The Health Advisory Service was established in 1969, to deal with the 
quality problems of many long-stay hospitals for the mentally handicapped and mentally ill (Lancet 
1984).   The National Confidential Enquiry into Perioperative Deaths (NCEPOD) was set up in 
1986 to examine instances of postoperative mortality and to identify avoidable causes and factors in 
these cases (NCEPOD 1989). 
 
In the 1970s and 1980s there were a number of calls for the development of more comprehensive 
mechanisms for quality assurance than the isolated initiatives described above.  In 1979, the Royal 
Commission on the NHS reported: 
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“...We are not convinced that the professions generally regard the introduction of 
audit or peer review of standards of care and treatment with a proper sense of 
urgency.  We recommend that a planned programme for the introduction of such 
procedures should be set up for the health professions by their professional bodies 
and progress monitored by the health departments.” (Merrison 1979) 
 
A few years later, Griffiths levelled a similar criticism in his highly influential Management Inquiry 
report: 
 
“Clinical evaluation of particular practices is by no means common, and economic 
evaluation of those practices extremely rare.  Nor can the NHS display a ready 
assessment of the effectiveness with which it is meeting the needs and expectations 
of the people it serves ... Whether the NHS is meeting the needs of the patient and 
the community, and can prove that it is doing so, is open to question.” (Griffiths 
1983) 
 
The professions - especially medicine - showed remarkably little interest in or enthusiasm for 
quality assurance.  Editorials in the British Medical Journal asserted that “motives for audit in other 
countries had little relevance to the NHS”, and that if audit had to be introduced it must be voluntary 
and totally under the control of the profession (British Medical Journal 1974).  They also asked, 
rhetorically, “could we not rely on the innate sensitivity of the profession to the need to maintain 
standards rather than constantly thrust the minutiae of performance under the noses of those who are 
at the sharp end of clinical practice” (British Medical Journal 1976).   Others offered more direct 
opposition, writing of the “chopping block of audit”, asking why medicine should be singled out 
from other professions for this unwelcome attention, claiming that the best qualities of medical 
practice could not be audited, and asserting that “medical audit, if it set one doctor to assess or judge 
another, would be impracticable and even distasteful” (Practitioner 1980).  Understandably, 
Maxwell (1984) wrote that the medical profession seemed “collectively allergic to rational 
examination of the case for medical audit in any form”. 
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Interest in quality assurance in the UK grew during the 1980s, as the series of changes in managerial 
arrangements initiated by Griffiths took effect, and a number of local quality assurance programmes 
developed (National Audit Office 1988; Gruer, Gunn, Gordon et al 1986; Walshe, Lyons, Coles et al 
1991).  Indeed, in many public services - not just healthcare - there was an increasing recognition of 
the importance of service quality and client satisfaction (Pollitt 1990).   In the health service, the 
climate of professional opinion was gradually transformed, so that when a major NHS reform 
programme was launched in 1989 with comprehensive medical audit as a key constituent 
(Department of Health 1989b), that aspect of the proposed reforms was generally accepted and 
welcomed by the medical profession.  Medical audit was described as “an important professional 
obligation” which met the “need for a more systematic evaluation of the quality and effectiveness of 
doctor's work” (Royal College of Physicians 1989) and participation in medical audit became a 
requirement for the accreditation of training posts (Royal College of Surgeons 1989).  Far from 
being voluntary, it was made clear by the leaders of the medical profession that all doctors should 
participate, and that nonparticipation would not be accepted (Standing Medical Advisory Committee 
1990).   Editorial comment in the British Medical Journal, in tones distinctly different from those of 
a decade earlier, declared that “the whole profession needs to claim ownership of audit and see a 
constant search for improvement as a central part of being a doctor” (Moss and Smith 1991). 
 
The Department of Health issued guidance on the requirements for medical audit (Department of 
Health 1991b) and allotted substantial ringfenced financing to the programme - a total of £221 
millions between 1989/90 and 1994/95 - with the result that the level of activity in quality 
assessment and quality assurance in the NHS expanded rapidly (Department of Health 1993b; 
Buttery et al 1994).   At the same time a Patient’s Charter, setting out some national quality 
standards was established, and national league tables of performance were produced and published 
(Bagust 1996).   Some UK healthcare providers experimented with total quality management (Joss 
and Kogan 1995), and many professional organisations like the Royal Colleges became involved in 
leading or coordinating audit or quality assurance activities in their areas (Amess et al 1995) 
 
Currently, almost all UK healthcare providers have well established medical audit, clinical audit or 
quality assurance departments, with some staff and other resources allocated to supporting quality 
measurement and improvement.   While the nature of those activities varies very widely, and there is 
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evidence to suggest that the effectiveness of those activities is rather mixed the scale and substance 
of healthcare quality assurance activities in the UK today is very different from the position just a 
decade ago (Walshe 1995). 
 
In other European countries, there has been a similar upsurge of interest in quality in healthcare over 
recent years, with mandatory quality assurance introduced in Germany, Belgium, France, Sweden 
and the Netherlands (Jost 1990; Øvretveit 1997).  All European members of the World Health 
Organisation signed a declaration in 1985 that they would establish effective mechanisms for quality 
assurance in their healthcare systems by 1990 (World Health Organisation 1985). 
  
 
2.4.3 Objectives of quality assurance 
 
From this brief review of approaches to quality assurance in healthcare it is clear that the objectives 
of quality measurement and quality assurance are framed by their environment: the structure, 
financing and organisation of the healthcare system; the social and economic characteristics of the 
society it serves; and the culture and attitudes of the people who provide and use healthcare services.  
It is also evident that the objectives of these quality measurement and quality improvement 
programmes are often not well defined, which makes their evaluation rather difficult (Walshe and 
Coles 1993b).  However, in almost any setting, some common principal objectives of quality 
measurement and assurance programmes can be identified: 
 
 
a) Improvement of quality.   
It is almost axiomatic that quality assurance programmes are designed to improve the quality 
of healthcare, though this is not necessarily their sole or even their primary objective.   The 
aim of quality improvement may be expressed through goals such as the identification of 
substandard providers; the correction of substandard practices; the improvement of average 
performance (sometimes referred to as shifting the curve); and the identification and reward 
of superior performance (Institute of Medicine 1990, p46). 
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b) Control of costs.   
Rising costs have been a perennial feature of most healthcare systems (especially over the 
last two decades).   In the USA, healthcare costs amounted to 11% of GNP, or $600 billion 
in 1989 (Berwick, Godfrey and Roessner 1990, p5) and have consistently grown in real 
terms despite a range of measures designed to cap spending.   Fuchs (1979) argues that 
quality assurance in the USA has been principally driven by the need to control costs, 
through more efficient, appropriate and consistent healthcare. 
 
c) Regulation of practice.   
Though self-regulation is traditionally part of the definition of a profession, growing 
demands for professional accountability in many spheres and accumulating evidence of 
confirmed poor professional practices which have not been rectified by the profession itself 
have increased the need for objective mechanisms for monitoring and regulating 
professional practice (Graham 1990).   Quality assurance has been used to provide those 
mechanisms. 
 
d) Management of innovation and new technology 
The uncontrolled adoption of new technology in healthcare has been both a cause of 
spiralling healthcare costs and a source of controversy over the real benefits and harms 
associated with new services, treatments and procedures.  Equally, the tardy uptake by 
clinicians and healthcare organisations of new practices of demonstrated effectiveness has 
also been a cause for concern (Appleby, Walshe and Ham 1995). Quality measurement and 
assurance programmes have a part to play in managing the dissemination of innovation. 
 
e) Control of clinical negligence litigation.   
The costs of litigation from patients over the quality of the healthcare services they have 
received have risen consistently over recent years, both in the USA and the UK.  In 1989 the 
costs of malpractice insurance in the USA were estimated at $5 billion a year (Relman 
1989), while in the UK litigation costs rose at 17% per annum over the 1980s (Tribe and 
Korgaonkar 1989; Dingwall and Fenn 1995).  The presumed capability of quality assurance 
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to detect and prevent potential quality problems, reducing litigation costs, has often been an 
important factor in the development and direction of quality assurance programmes. 
 
f) Assuring and informing consumers.   
Consumers or users of healthcare have become increasingly willing to question the quality 
of service they encounter, and to make discriminating choices where possible between 
different providers.  This trend has been evident both in the USA and the UK (where it can 
be seen as part of a larger trend towards greater consumer sovereignty in both public and 
private services)  (Hopkins, Gabbay and Neuberger 1994).   Quality assurance programmes 
can provide information to assure consumers and to allow them to make informed choices 
about the healthcare services they use. 
 
g) Assuring and informing purchasers.   
In the highly fragmented and decentralised healthcare system of the USA, quality assurance 
has been an important source of information on which purchasers of healthcare - state and 
federal agencies, insurers, health maintenance organisations, and so on - have made 
purchasing decisions.  Indeed, it may be contended that this demand for information has 
been the most important single cause of the development of the extensive quality assurance 
industry in US healthcare.   By contrast, the absence of a healthcare marketplace in the UK's 
centrally planned NHS until 1989 was accompanied by a marked dearth of significant 
quality assurance programmes.   The development of the internal market in healthcare within 
the NHS over recent years was accompanied by a growth in quality assurance activities, at 
least in part to provide information to healthcare purchasers (Gill 1993). 
   
In practice, the objectives of quality assurance programmes are rarely spelt out, and expressed in 
terms which make their evaluation against those aims possible.  This lack of clarity about the 
objectives of quality assurance is an important problem.  It hampers programme implementation, 
makes monitoring and progress assessment more difficult, and hamstrings any proper programme 
evaluation. 
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2.4.4 Effectiveness of quality assurance 
 
There is extensive evidence, through reports from participants and observers of quality assurance 
programmes, that they can be effective in achieving at least some of the objectives set out above, in 
some circumstances.   However, the available evidence from publications is really only able to 
demonstrate their efficacy (that they can work in some circumstances), and not their effectiveness 
(that they do work, generally) - an important distinction, which Brook and Kosecoff (1988) defined 
in relation to healthcare interventions in general.   A brief review of this literature demonstrates the 
striking absence of consensus about the effectiveness of quality assurance. 
 
For example, Shaw (1989, p11) cites several examples of successful programmes improving 
resource usage and producing better outcomes for patients. Gruer et al (1986) report statistically 
significant improvements in reoperation and operative mortality rates resulting from a five year 
surgical audit programme.  Sellu (1986) describes significant improvements in postoperative 
infection rates and cost savings resulting from a similar audit programme.   On a larger scale, the 
Confidential Enquiry into Maternal Deaths has been claimed to have improved maternity care in the 
UK (Department of Health 1991a).  Craddick (1979) cites a series of examples of important 
individual quality improvements resulting from an occurrence screening programme. Kleefield, 
Churchill and Laffel (1991) report real improvements in pharmacy services resulting from a 
continuous quality improvement (CQI) programme.  Gabbay et al (1990) found significant 
improvements in recordkeeping resulting from a year-long criterion audit programme, and Reynolds 
(1995) showed that a CQI programme in obstetrics reduced episiotomy rates significantly.  
O’Connor et al (1996) demonstrate the effectiveness of multi-institutional comparisons of practice 
in reducing mortality following cardiac surgery.   Walshe and Buttery (1995) highlight the 
complexities of measuring the impact of quality assurance programmes and Palmer et al (1996) 
report the results of an experiment intended to identify the factors which affect the impact of quality 
assurance. 
 
At the same time, there are many reports in the literature of quality assurance programmes which 
have not met the expectations of participants, observers or funding agencies.  Twenty years ago, 
Nelson (1976) argued that criterion-based process audits were ineffective, and simply produced 
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“vast amounts of unusable data”.  Escovitz et al (1978), reviewing the effects of quality assurance in 
17 US hospitals, found that extensive criterion-based audits had resulted in little or no action to 
address quality problems.  Sanazaro and Worth (1978) studied the effects of concurrent quality 
assurance across 50 hospitals in the United States, and found virtually no evidence that it was 
effective in making any improvements.    Sanazaro and Mills (1991), reviewing the widespread use 
of generic occurrence screening in the USA, conclude that it provides information which is of 
limited use and minimal relevance to quality assessment.   Lohr (1990), reviewing the results of an 
extensive evaluation of the Medicare Peer Review Organisations' work in quality assurance, 
observes that the $300 million pa programme is “in general, not very effective, and may have 
serious unintended consequences”. Within the UK, Krukowski and Matheson (1988), relating the 
experience of a decade of surgical audit, question the value of the “onerous and obsessional 
collection of data .. together with its time-consuming analysis” which their study involved, and with 
some understatement observe that “in terms of improved patient care, the benefit of this audit lacks 
tangibility”. Walshe (1995b) suggests that while some quality assurance activities in the UK have 
been effective and worthwhile, others have not, indicating that effectiveness is very variable.  
Hopkins (1996) criticises the absence of tangible benefits from the investment in clinical audit in the 
UK, and suggests that much quality measurement and improvement activity lacks methodological 
rigour, while others argue that it is not possible to tell what either the benefits or the costs of clinical 
audit in the UK have been (Lord and Littlejohn 1997). 
 
Reviews of the literature produce a similarly mixed message. Mitchell and Fowkes (1985) reviewed 
the use of a variety of approaches to using information to change performance, and concluded that 
the evidence for their effectiveness was poor.  Mugford, Banfield and O'Hanlon (1991) examined 36 
studies of the effect of audit in a wide range of settings, using a variety of feedback mechanisms, 
and found that in 24 (67%) there was evidence of lasting practice changes and quality 
improvements.   A systematic review of experimental, quantitative studies of the use of audit and 
feedback to change clinical practice is being prepared for the Cochrane Library by the Cochrane 
Collaboration on Effective Professional Practice (Thompson et al 1997) and is expected to conclude, 
like the two reviews that have preceded it, that the evidence for the effectiveness of quality 
assurance is rather limited and inconclusive. 
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Bearing in mind the acknowledged bias of published literature in favour of positive results, it is 
notable that the literature yields perhaps as many accounts of unsuccessful quality assurance 
programmes as of demonstrably successful ones - and it is unfortunate that in most reports, the 
impact of quality assurance activities on the objectives set out above is not assessed.   
 
It seems, however, that the main obstacles for quality assurance lie more in the domain of quality 
improvement than in quality measurement. Brook (1977) and Jessee (1977) both highlight this issue, 
arguing that quality measurement techniques have been able to identify the need for change, but 
quality improvement techniques have not been able to ensure that change then takes place.  Brook 
observed: 
 
“The central failing of quality assessment is that it has rarely been used to change 
behaviour and hence has not contributed much to the goal of improving the health of 
the American people.   The literature on quality of care is replete with studies 
showing deficiencies in medical care no matter what standard or method is used.”  
(Brook 1977) 
 
 
Shaw (1980b), surveying the available evidence for the effectiveness of audit, admits it is “not 
overwhelming” and acknowledges that there is conflicting evidence on the ability of audit to bring 
about change.  
 
The absence of conclusive evidence of the effectiveness (or, indeed, the ineffectiveness) of 
healthcare quality assurance is partly a result of the complexity of the mechanisms and behaviours 
involved.   Quality measurement is complicated by a range of definitional and methodological 
hurdles; quality improvement faces similar organisational and behavioural obstacles.   There have 
been many calls for clearer objective setting and better evaluation in the field of quality 
measurement and quality assurance.  For example, Phelps wrote candidly: 
 
“The evidence used to justify these various regulations of quality has been, to be 
generous, sparse.  The primary justification for many of these programs is that the 
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present state of affairs is scandalous, so that change must lead to improvement.  
While not necessarily quarrelling with the premise, the conclusion is unwarranted.  It 
therefore seems appropriate to begin to evaluate the evaluators, to develop a 
framework with which one could assess the gains … from undertaking a quality 
assurance program of one type or another.”  (Phelps 1976). 
 
More recently, Carr-Hill and Dalley (1992), reporting on a survey of quality assurance activity in 
the UK, wrote: 
 
“In the NHS our knowledge about our own quality assurance activities is abysmal.  
The vast majority of [quality assurance] procedures are not costed; more than half 
are not evaluated, and where they are, the procedures used do not appear to be a 
model of rigour. ...  What is missing is accurate description and monitoring of what 
goes on … Without this, management and quality assurance is a nonsense.” (Carr-
Hill and Dalley 1992) 
 
The need for quality assurance activities - including both quality measurement and quality 
improvement - to be properly evaluated is clear.    
 
 
2.5 Evaluating quality measurement 
 
2.5.1 Theory, concepts and dimensions in evaluating quality measures 
 
St Leger, Schneiden and Walsworth-Bell (1992, p1) define evaluation as “the critical assessment, on 
as objective a basis as possible, of the degree to which entire services or their component parts fulfil 
stated goals”.  This places the goals or objectives of the programme to be evaluated at the centre of 
its evaluation - which presents problems when those goals are unstated or implicit, or are 
inadequately defined, as is often the case in quality measurement and quality assurance. 
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However, an alternative approach to the evaluation of quality measurement or quality assurance 
programmes is to consider the core objectives that most or all programmes would (or should) share 
(Walshe and Coles 1993).   While each quality measurement technique or quality assurance 
programme should have its own, specific goals, to which evaluation must be tailored to some extent, 
it is possible to draw up a list of desired attributes, components or characteristics of most or all 
techniques or programmes.  Although few researchers have addressed the issues of evaluation in any 
detail (Walshe and Coles 1993), the Institute of Medicine (1990), in its extensive review of the 
working of the Medicare quality assurance programme, established generic frameworks for 
evaluation which are certainly of wider relevance. 
 
Quality measurement techniques evaluation 
The Institute of Medicine (1990, p312) suggests that quality measurement techniques should be 
assessed against a set of structural attributes or dimensions - to do with the inherent characteristics 
of the tool itself - and a set of process attributes - to do with the way in which the tool is applied.   
The somewhat daunting list of proposed structural attributes is shown in table 2.3.    
 
Four main clusters or groupings of attributes can be determined.  Certain attributes concern the 
scientific grounding of the instrument (issues such as its reliability and validity, and the quality of its 
documentation).   Others concern the latitude the instrument provides for variations in patient 
characteristics and clinical circumstances - such as its flexibility, appealability, patient 
responsiveness, clinical adaptability and inclusiveness.   A third group of attributes concerns the 
instruments general design - issues such as its clarity, the concordance of professionals, its 
acceptability and its appropriateness.  The last group of attributes concern its efficiency - 
specifically, its sensitivity and specificity. 
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Sensitivity  High true positive rate in detecting deficient or inappropriate care. 
 
Specificity  High true negative rate in passing over cases of adequate care. 
 
Reliability  Known to produce the same decisions or evaluations when applied by the user groups 
   for which the tool is intended. 
 
Validity   Based on outcome studies or other scientific evidence of validity. 
 
Documentation  Documents methods of development and cites literature. 
 
Patient responsiveness Allows for eliciting or taking account of patient preferences. 
 
Flexibility  Respects the role of clinical judgement, with clinical judgement explicable 
 
Clinical adaptability Allows for or takes into consideration clinically relevant differences among different  
   classes of patients; population to which tool applies is specified. 
 
Inclusiveness  Covers all major foreseeable clinical situations and full range of clinical problems. 
 
Concordance  Reflects consensus of professionals with extensive experience in field, with input 
from  
   academic and nonacademic practitioners, specialists and generalists. 
 
Acceptability  Acceptable to the majority of professionals. 
 
Clarity   Written in unambiguous language; terms, populations, data elements, and collection  
   approach clearly defined. 
 
Appropriateness  Specifies appropriate, inappropriate, and equivocal indications (procedure and  
   technology appropriateness guidelines). 
 
 Table 2.3.  Structural attributes for evaluation of quality measurement techniques. 
 Institute of Medicine (1990). 
 
The slightly shorter list of proposed process attributes of quality measurement techniques is shown 
in table 2.4.   Again, four major groups of attributes can be discerned.  The ease of use of the 
instrument is addressed by the attributes of comprehendability, manageability and nonintrusiveness.  
The ease of implementation of the instrument is the focus of issues such as its feasibility, 
computerisation and executability.   The latitude for discretion offered by the instrument is 
addressed by issues such as flexibility and appealability.   Finally the progressive refinement of the 
instrument is addressed by its pretesting, its dynamism and its evaluation. 
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Pretesting  Tool is tested before implementation. 
 
Dynamism  Mechanism and commitment exists for reviewing and updating tool to incorporate  
   new information and cover new situations. 
 
Evaluation  Mechanism exists to review and evaluate outcome or impact of tool. 
 
Comprehendability Format of tool easily understood by nonphysician reviewers, by practitioners, and by  
   patients and consumers. 
 
Manageability  Not unduly burdensome for nonphysician reviewers to apply, for physician reviewers  
   to apply, or for professionals to follow. 
 
Nonintrusiveness  Minimises inappropriate direct interaction with treating physicians. 
 
Appealability  Allows for appeals process for professionals and patients. 
 
Feasibility  Ease of obtaining information. 
 
Computerisation  Has been or could easily be computerised. 
 
Executability  Includes instructions for implementation. 
 
 Table 2.4.  Process attributes for evaluation of quality measurement techniques. 
 Institute of Medicine (1990). 
 
While there is clearly some overlap between different attributes, these checklists of desirable 
attributes of quality measurement techniques are undoubtedly potentially useful.   The Institute of 
Medicine made some efforts to weight the attributes (or at least to identify the more important ones) 
through the use of an expert panel, which rated each attribute in terms of its relative importance.  
Clarity, validity and sensitivity emerged as the most important structural characteristics, while 
appealability was the most critical process attribute.  These weighting perhaps reflect the healthcare 
environment of the US, and its emphasis on inspection. 
 
Quality assurance programme evaluation 
Similarly, the Institute of Medicine (1990, p50) suggests an ambitious list of fifteen attributes 
against which quality assurance programmes (as opposed to quality measurement techniques) might 
be evaluated.  These attributes are listed in table 2.5. 
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Range   Ability to address a full range of quality problems, including poor technical  
   quality, overuse and underuse. 
 
Intrusion Intrudes minimally into the patient-provider relationship, and does not  
   jeopardise trust, clinician best judgement or patient autonomy. 
 
Acceptability  Acceptable to professionals and providers - seen as supportive to practitioner's  
   goals. 
 
Improvement focus Fosters improvement through the healthcare system - is focused on improving  
   processes of delivery of care. 
 
Outliers   Able to identify and ameliorate outlier practice - individual practitioners or  
   institutions with problematic patterns of care. 
 
Incentives  Can invoke positive and negative incentives for change and improvement in 
performance. 
 
Information  Provides practitioners and providers with timely and relevant information which  
   they can use to compare and to improve their practice. 
 
Face validity  Has face validity to the public and professionals - must be understandable and 
reasonable to both. 
 
Scientific worth  Individual elements meet requirements for reliability, validity and  
   generalisability - programme must demonstrate scientific rigour. 
 
Outcome focus  Improves patient outcomes.  Ultimately, a quality assurance programme should  
   affect patient outcomes.  When outcomes cannot be measured directly, there  
   should be a demonstrated link between healthcare processes and expected patient  
   outcomes. 
 
Individual/population Can address both individual patient and population based outcomes. 
 
Documentation  Documents improvements in quality and progress towards excellence. 
 
Ease of use  Easily implemented and administered.  Excessively costly, complex and labour  
   intensive programmes may detract from quality themselves. 
 
Cost   Is affordable and cost-effective. 
 
Public participation Includes patients and the public. 
 
 Table 2.5.  Attributes for the evaluation of quality assurance programmes. 
 Institute of Medicine (1990). 
 
Again, while the length of the list of attributes is perhaps a little offputting, its comprehensiveness 
and conceptual clarity make the Institute of Medicine's framework potentially valuable in evaluating 
quality assurance programmes.   Like almost any other checklist, it is possible to identify areas of 
overlap (such as between ease of implementation and use and affordability/cost effectiveness) and 
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potential conflicts (such as between minimal intrusion into practitioners' best judgement and the 
ability to change outlier practice and invoke sanctions for change).  Nevertheless, these frameworks 
developed by the Institute of Medicine are of worth, if only because few (if any) other researchers 
have developed similar tools.   Some of the dimensions of evaluation identified and discussed above 
are more amenable to assessment than others, but their inclusion is still important, if only to ensure 
that we do not fall into the trap of measuring only what is measurable and failing to take account of 
important but less assessable dimensions of performance. 
 
Since the focus of this thesis is the reliability and validity of some quality measures based on 
adverse events in healthcare, it is appropriate to examine the meaning of these concepts in more 
detail.   They are important components in the structural attributes set out for evaluation by the 
Institute of Medicine in table 2.3, but it should be recognised that the other attributes described there 
also deserve consideration. 
 
 
2.5.2 Validity of quality measurement 
 
In all measurement, there exists both random and non-random error.  A simple mathematical 
definition of the validity of a measure is that it is inversely related to the extent of non-random error.  
By the same token, the reliability of a measure is inversely related to the extent of random error 
(Carmines and Zeller 1979, p13). 
 
More usefully, validity is commonly defined as “the extent to which a measuring instrument 
measures what it is intended to measure” (Carmines and Zeller 1979, p17).  However, this definition 
has been criticised because it places too much emphasis on the measure itself, and too little 
emphasis on the environment in which it is used or the phenomena it is used to measure.  “One 
validates not the measuring instrument itself, but the measuring instrument in relation to the purpose 
for which it is being used” (Carmines and Zeller 1979, p17).  In the context of healthcare quality 
measurement, it is important to validate an instrument in the healthcare environment it which it is 
intended for use. 
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There are a number of different approaches to assessing validity, each of which measures different 
aspects of the extent to which a measure is appropriate for use in a given set of circumstances.  It is 
often recommended that validation studies use a variety of approaches rather than depending on a 
single type of validation procedure (McDowell and Newell 1991, p31). 
 
Criterion-related validity 
Criterion-related validity is concerned with the relationship between a measure and some external 
variable (the criterion) with which it is expected to correlate.  The degree of correlation between the 
measure and the external variable or criterion (which is also often termed the gold standard) 
indicates how well the measure represents the criterion, and is frequently referred to as the validity 
coefficient.   
 
For example, one might assess the criterion-related validity of a physical health status measure by 
correlating it with objective measurements of patients' physical health such as certain laboratory 
tests.  The scientific tests would constitute the gold standard for physical health, and the degree of 
correlation would indicate the validity of the measure. 
 
Criterion-related validity is also often termed concurrent validity or predictive validity (where the 
criterion is measured at some future point).  It has been observed that, of all the types of validity, 
criterion-related validity has the greatest intuitive meaning and closest relationship with the 
everyday usage of the term validity (Carmines and Zeller 1991, p17).  Its main disadvantage is that 
in many circumstances, no obvious criterion variable exists.  For example, in measuring certain 
dimensions of healthcare quality, such as patient satisfaction, it may be difficult to identify any 
objective criterion.  There may be a temptation to use as a criterion some measure of another 
dimension of quality, such as clinician compliance with treatment protocols, but this involves 
making unfounded and precarious assumptions about the relationship between different dimensions 
or attributes of quality. 
 
Criterion-related validity is measured empirically by correlating the results of the measure with the 
criterion variable.  The selection of appropriate statistical tests to measure this correlation depends 
on the nature of the two variables (Dick and Hegarty 1971).  However, where true or forced 
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dichotomous data is available, the concepts of sensitivity and specificity are frequently used in 
assessing validity.   The sensitivity of the measure is the proportion of cases positive on the criterion 
variable which are assessed as positive on the test variable while the specificity is the proportion of 
cases negative on the criterion variable which are assessed as negative on the test variable.   The 
sensitivity can be construed as the positive accuracy of the measure - the higher it is, the more 
successful the measure is at identifying accurately those cases where the criterion variable is 
positive.  Similarly, the specificity can be construed as a measure of the negative accuracy of the 
test.   The acceptability of the sensitivity and specificity statistics for a measure depend crucially on 
the use to which the measure is to be put.  For example, a high sensitivity but low specificity 
measure will successfully identify almost all positive cases, but will also throw up a considerable 
number of false positives.  This may be quite acceptable in a measure designed to identify possible 
drug prescribing problems for subsequent review by a pharmacist, since the false positive cases will 
be discarded at that review.  By contrast, it would be quite unacceptable in a measure used in a 
population screening programme to assess the risk of bowel cancer, since it would entail large 
numbers of healthy people being subjected to expensive, unpleasant and unnecessary further 
diagnostic tests, not to mention considerable temporary anxiety. 
 
Content validity 
Content validity refers to how adequately the items within a measure reflect the conceptual 
definition of its scope.  (McDowell and Newell 1991, p27).  For example, in a patient satisfaction 
measure, the content validity would be assessed by considering whether the individual items 
appeared relevant to the concept of satisfaction, and whether all aspects of the concept of 
satisfaction were covered.   
 
Content validity is assessed by studying the measure itself, rather than data produced by using the 
measure.  It is generally assessed through the use of expert panels or through a review of the 
measure against available literature or other evidence as to what makes up the concept.  It has been 
pointed out that content validity is harder to assess for more abstract concepts (such as quality of 
healthcare) than for simpler, more concrete concepts (such as driving proficiency), since it is 
generally easier with more concrete concepts to define their scope. 
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Construct validity 
Construct validity is concerned with the extent to which a particular measure supports or conforms 
with a given theory or construct, and begins with the theoretical definition of the construct, its 
relationship to other constructs, and its relationships with observable behaviours or phenomena 
(Ghiselli, Campbell and Zedeck 1981, p284).   It is particularly important when the measurement of 
criterion validity is difficult or impossible, because of the lack of an appropriate criterion variable - a 
situation which arises more frequently when the concept or construct being measured is complex or 
abstract. 
 
For example, if a theory suggests that patients' satisfaction with their care is related to a number of 
cultural and demographic factors - such as their ethnic background, social class, and age - then the 
construct validity of a patient satisfaction measure might be tested by examining whether it did 
indeed demonstrate differences in satisfaction as the theory predicts.   Construct validation has been 
called “part science, but to a large extent an art form” (McDowell and Newell 1991, p31), perhaps 
because it sits at the interface between theory testing and theory building, but it is generally regarded 
as a valuable addition to the developer's armoury of testing mechanisms. 
 
Construct validity is usually measured empirically, by examining the results of the measure being 
studied alongside other data which can be used to test whether the relationships predicted by theory 
actually exist. 
 
Face validity 
The face validity of a measure refers to whether users or potential users of the instrument report that, 
on the face of it, the measure seems reasonable and produces reasonable data (Horn and Horn 1986).  
As its definition makes clear, face validity is an inherently subjective concept, and it is not difficult 
to imagine circumstances where the production of unexpected but valid results from a study might 
lead to an unwarranted low estimate of the face validity of the measures used.  Conversely, it is 
possible for a measure to seem reasonable and to produce apparently reasonable data because of our 
incomplete understanding of the phenomena it measures, while in fact the measure is not valid. 
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Assessments of face validity, especially in areas of measurement which are incompletely understood 
or explored, deserve to be treated with some caution.  
 
Like content validity, face validity is not measured empirically.  Instead, surveys of users of the 
measure are employed to assess its face validity. 
 
Other concepts in validity 
The discriminant validity of a measure is its ability to differentiate between different categories or 
groups of respondents or cases.  It is often investigated when such discriminatory ability is the crux 
of the measure's worth.   For example, the validity of a measure of psychiatric well-being, which is 
intended to identify people at risk of psychiatric illness, might be tested by assessing its ability to 
distinguish between samples of people who have (or have not) been users of psychiatric services. 
 
Some researchers have used factor analysis to investigate the factorial validity of measures - a 
concept which is closely related to that of content validity.  Essentially, factor analysis can show 
how far the various items in a test accord in measuring one or more common themes.  When a 
measure deliberately sets out to yield separate scores on several dimensions (such as a measure of 
general health status such as the Nottingham Health Profile) factorial validity can be assessed by 
identifying whether the items belonging to each dimension actually measure a common theme.   
 
Finally, Dick and Hegarty (1971) coined the appealing (though perhaps not very scientific) term 
cash validity to describe the validity a measure acquires simply from being widely used and applied. 
Though they offer no empirical measure of the concept, it is undoubtedly true that measures do 
acquire some validity simply from widespread use. 
 
 
 
2.5.3 Reliability of quality measurement 
 
Reliability is concerned with  the random errors which occur in all forms of measurement (non-
random errors constitute bias, and are the province of validity assessment).   The reliability of a 
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measure is an indicator of the degree to which it can be replicated (McDowell and Newell 1991, 
p31).    
 
There are three forms of reliability which are commonly assessed: interrater reliability (also termed 
observer variation); intrarater reliability (also termed stability or repeatability); and internal 
consistency.  All are important to the developers of measures of healthcare quality. 
 
Interrater reliability 
Interrater reliability measures whether, when the same test is applied to the same respondent or 
subject by different raters or observers, the same results are produced.  In other words, it assesses the 
extent of random variation which results from the use of different raters to apply the measure. There 
may be logistical problems associated with having two applications of the measure, depending on its 
nature (for example, reinterviewing a subject) which distort the results. 
 
For example, the interrater reliability of a measure based on a set of treatment standards might be 
tested by using different raters to apply the measure to the same sets of casenotes, and comparing 
their results.   Both interrater and intrarater reliability are fundamentally affected by the 
arrangements which are made for rater training and guidance - few measures are wholly self-
explanatory, and a rater with no training or experience in using an instrument will certainly be less 
reliable than one who has been properly trained in how to apply the measure.  While the developers 
of instruments usually cite results of interrater and intrarater reliability tests, it must be borne in 
mind that instrument developers may be able to train raters more thoroughly than ordinary users of 
the instrument, and may also be able to use raters of different levels of ability and commitment. 
 
Interrater reliability is measured empirically by measuring the correlation between the scores of the 
two (or more) raters.  The nature of the correlation statistic used depends on the type of data yielded 
by the measure, and the number of raters. 
 
Intrarater reliability 
Intrarater reliability (also known as test-retest reliability, stability or consistency) measures whether, 
when the same test is applied twice by the same rater or observer to the same respondent or subject, 
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the same results are produced.   It assesses the extent of random variation which results from 
reapplication of the measure.  It suffers from two main logistical problems - that the time interval 
between test must be brief enough to prevent changes in the characteristic being measured affecting 
the results, and that carryover effects from the first to the second application, such as practice or 
learned responses, may distort the results. 
 
For example, the intrarater reliability of an adverse-event measure of healthcare quality might be 
tested by arranging for a rater to apply the instrument to the same sets of casenotes on two 
occasions, sufficiently far apart to minimise the effects of memory. 
 
Intrarater reliability is measured empirically by measuring the correlation between the scores of the 
two applications of the measure.  As for interrater reliability, the nature of the correlation statistic 
used depends on the type of data yielded by the measure, and the number of raters. 
 
Internal consistency 
Internal consistency measures how well the items within a measure which is designed to measure a 
particular characteristic correlate with each other.  If the measure is measuring a single trait, then a 
reliable measure should show high inter-item correlations.   If inter-item correlations are low, then it 
suggests that the measure may actually be measuring different traits or characteristics, and factor 
analysis might then be used to identify these separate themes. 
 
For example, internal consistency tests might be used to examine the performance of a functional 
disability scoring system used in assessing the improvements in functional disability resulting from 
orthopaedic surgery.   By testing the inter-item correlations within the measure, using data from its 
application to sets of cases, the ability of the measure to focus on the trait of functional disability 
could be assessed. 
 
Internal consistency is usually measured through the use of Cronbach's alpha statistic, a generalised 
form of the split-halves approach to reliability testing which effectively calculates the mean 
correlation of each item in the instrument with every other item (Ghiselli, Campbell and Zedeck 
1981, p256). 
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Other issues in reliability measurement 
There are two alternative theoretical models of reliability, which offer different conceptual 
approaches to assessing the reliability of measures.  The classical theory school postulates that 
observed scores are made up of two components - the true score and the error score.  It assumes that 
the subject of the test possesses stable characteristics or traits which can be measured and 
remeasured, and that all error scores are wholly random.  Approaches to measuring reliability are 
founded on assessing correlations between parallel tests of various forms.  The assumptions of the 
classical school are clearly open to challenge.  In particular, the error components of scores may not 
be randomly distributed, since different raters or cases may have different distributions of error 
scores.  However, it can be demonstrated statistically that this stringent assumption can be relaxed 
without invalidating the mathematical logic which leads to classical school formulae for reliability 
coefficients (Ghiselli, Campbell and Zedeck 1981, p208). 
 
By contrast, the domain sampling (or generalisability theory) school of thought suggests that the 
true score/error score model on which classical theory is based is too simplistic, especially for 
behavioural and social sciences where traits may frequently not be stable and where error scores 
may not always be wholly random.  It suggests instead that, through some complex statistics, the 
reliability of a measure can be assessed by correlating it with hypothetical parallel tests in the same 
domain (Ghiselli, Campbell and Zedeck 1981, p195).   While the statistical formulae for reliability 
produced by the two theoretical approaches are identical, their differing assumptions produce 
different assessments of the value of the empirical approaches to reliability testing discussed above. 
The concepts of interrater and intrarater reliability testing are founded in the ideas of the classical 
school, and are in many ways incompatible with domain sampling theory, which places greater 
weight on tests of internal consistency. 
 
Finally, the reliability of a measure is also related to its validity.  It can be demonstrated 
mathematically that the reliability of a measure places an effective limit on its criterion-related 
validity, and that the lower the reliability coefficient is, the lower the maximum achievable validity 
coefficient can be.  However, adjustment formulae allow validity coefficients to be corrected for this 
attenuation, so that the hypothetical validity (assuming perfect reliability) can be calculated 
(Carmines and Zeller 1979, p48). 
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2.6 Conclusions 
 
The quality of healthcare is a difficult concept to define in simple terms.  There is no single 
generally accepted definition, and the content of the concept varies considerably depending on the 
perspectives of those using it and the setting in which it is used.   When drawn widely, the concept 
of quality seems to embrace almost everything which is germane to performance and evaluation in 
healthcare.   It is, perhaps, more usefully deconstructed into a number of constituent parts or 
dimensions which are more capable of being conceptualised and defined and therefore more 
amenable to measurement. 
 
Quality measurement involves both the collection of data describing the structure, process or 
outcome of the healthcare system and the development and application of valuations which give 
meaning to that data by defining what represents good quality.    A wide variety of quality measures 
have been developed and are in use, and they form an important part of quality assurance activities 
in healthcare in the UK and abroad.   The need for quality assurance in healthcare, long established 
in some countries like the USA, has been increasingly recognised in other countries in Europe and 
the developed world, and investment in quality measurement and improvement has grown apace.   
However, there are important unanswered questions about the worth of these quality assurance 
systems.  There is a need to evaluate them more rigorously, both during their development and when 
they are applied in practice. 
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Chapter 3 
 
Adverse events and the quality of healthcare  
 
 
 
3.1 Introduction 
 
This chapter presents a comprehensive review of the place of adverse events in healthcare.   It 
begins by examining the development of interest in adverse events from a number of different 
perspectives, concerned with epidemiology, health services research, and quality improvement.  In 
each, the need to be able to identify, measure, analyse and understand adverse events, and to have 
some form of definition and classification or typology as a basis for measurement, is established. 
 
Next, the definition and classification of adverse events in healthcare is explored.   A number of 
alternative definitions from the literature are compared and contrasted, and a single definition is 
proposed.  Then, some of the frameworks proposed in chapter 2 are used to develop some criteria on 
which adverse events could be classified.   Some issues involved in measurement - such as the 
sources of data, arrangements for its collection, and construction of quantitative measures - are 
considered. 
 
The chapter then reviews the use of adverse event measures of quality in healthcare.  Firstly, a 
number of different measures which have been proposed or used are presented and discussed. Then, 
the epidemiology of adverse events in healthcare is explored, through a review of studies which 
have examined empirically the incidence, characteristics and causation of adverse events. The 
diversity of definitions and approaches evident from the studies highlights the need for rigour in 
defining the approach to measurement discussed earlier.   Nevertheless, some common themes and 
issues raised by these empirical studies are identified and discussed. 
 
Next, the chapter turns to explore the experience of using adverse-event measures of quality in 
healthcare quality assurance activities.   Experience from healthcare organisations in a range of 
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countries and settings is presented and discussed, and the importance of adverse-event measures of 
quality (in terms of their widespread application) is highlighted. 
 
Finally, the chapter explores the relatively limited literature on the validity and reliability of 
adverse-event measures.   A number of studies which have attempted to assess validity, reliability or 
both are presented and critiqued.   It is noted that there are methodological problems associated with 
measuring some dimensions of validity and reliability, and that the absence of published literature 
on some aspects of validity and reliability is of some concern. 
 
 
3.2 The concept of adverse events in healthcare 
 
3.2.1 The origins of the adverse event  
 
Adverse events in healthcare can be loosely defined as “instances which indicate or may indicate 
that a patient has received poor quality care” (Walshe, Bennett and Ingram 1995).   The idea that it 
would be useful or important to study the incidence, circumstances or causes of adverse events in 
healthcare arises from a number of different but related schools of thought.  For example, 
researchers concerned with various forms of iatrogenic disease, those interested in organisational 
performance, others investigating medical malpractice, clinical negligence and litigation, those 
concerned with quality measurement and improvement - all have developed approaches to studying 
adverse events in healthcare which, though they reflect the different interests of their developers 
have much in common.   Below, each is briefly reviewed and discussed in turn, before some 
common themes and concerns are identified. 
 
Iatrogenesis 
While the term iatrogenesis was not coined by Ivan Illich, his influential writings are probably 
responsible for its widespread use today.  Illich defines clinical iatrogenesis as: 
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“the adverse or undesirable effects of healthcare on patients...  Clinical iatrogenic 
disease comprises all clinical conditions for which remedies, physicians or hospitals 
are the sickening agents” (Illich 1975, p22). 
 
In one of the first comprehensive reviews of iatrogenic disease, Moser (1956) drew on over 140 
research studies to highlight the causation of a wide range of clinical conditions which he labelled 
“diseases of medical progress”.  He argued that “the history of medicine is replete with examples of 
illness resulting from sound therapeutic endeavour... However, in recent years the development of 
potent new therapeutic agents, improved surgical procedure and more efficient equipment has 
forced this facet of medicine into unprecedented prominence”.    Writing around the same time, Barr 
(1955) was one of the first researchers to attempt to quantify the impact of iatrogenic disease on 
patients and healthcare organisations.  He estimated that about 5% of hospital admissions resulted in 
or were caused by some form of iatrogenesis which qualified “iatrogenic disease [as] one of the 
commonest conditions encountered”. 
 
Since Moser's review, an enormous and ever-growing literature on the iatrogenic effects of 
individual therapies and healthcare interventions has developed.  Sartwell (1974) surveyed 
iatrogenesis from an epidemiologist's perspective and catalogued an alarming series of “iatrogenic 
epidemics”.   Kane (1980) classified iatrogenic diseases in four categories - those resulting from 
known risks of therapy; those arising from unknown or unexpected risks; instances of inept care 
(lack of skill, errors of judgement, inadequate knowledge, process failures, etc); and those resulting 
from unnecessary therapies or what he termed overzealous care.   There are 6,138 studies catalogued 
on Index Medicus under the MeSH term “iatrogenic disease” (from 1966 to 1997), with 241 reports 
in 1996 alone, covering issues as diverse as iatrogenic damage to the facial nerve during surgery 
(Prass 1996), iatrogenic cardiac tamponade (Yim, Lam and Haines 1996) and iatrogenic congestive 
heart failure (Rich et al 1996).  But while most of these reports concern the iatrogenic effects of an 
individual drug, or a particular surgical intervention, a limited number have focused on the 
incidence, causation and prevention of iatrogenesis in operational settings, such as ordinary acute 
hospitals serving a general population.  It is these investigations which provide the greatest insight 
into the importance of iatrogenesis for healthcare organisations.  As long ago as the 1960s, 
Schimmel (1964) found that 16% of inpatients in general medicine suffered some form of iatrogenic 
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disease during their stay, and McLamb and Huntley (1967) found similarly that about 20% of 
inpatients in their general medical service had some form of iatrogenic disease while in hospital.  
These and a number of other studies of the epidemiology of iatrogenic disease are reviewed later in 
this chapter.  Research into iatrogenesis seems to suggest that the rapid pace of technological 
advance in healthcare has its costs, in the growing risk of iatrogenic effects from increasingly 
complex and potentially toxic therapies (Friedman 1982). 
 
Using adverse events as measures of performance 
David Rutstein, an American public health physician, was one of the first people to recognise the 
importance of adverse events to healthcare quality measurement.  He designed, with colleagues, a 
system for measuring the incidence of sentinel health events which he defined as “unnecessary 
disease, disability or untimely death” (Rutstein et al 1976).  Writing about the theoretical 
background to this methodology, Rutstein and colleagues observed: 
 
“Most previous efforts to measure quality have failed because of the almost 
insurmountable difficulty of establishing objective criteria for the measurement of 
increasing gradations of positive health.  Our proposed system overcomes this 
difficulty by establishing quantitative negative indexes of health.  Cases of 
unnecessary disease, and unnecessary disability, and unnecessary untimely deaths 
can be counted.  Their occurrence is a warning signal, a sentinel health event, that 
the quality of care may need to be improved.” (Rutstein et al 1976). 
 
Rutstein argued that quality control systems based on negative indexes were able, through the study 
of undesirable health events, to yield crucial information on the causes of those events which could 
be used to make improvements, and that to focus on such events was a much more productive way 
of using resources than to attempt to measure global characteristics of all patients. 
 
Rutstein's method was based around an inventory of conditions, tabulated in the standard 
International Classification of Diseases, which a working group of physicians and epidemiologists 
had deemed partially or wholly preventable or treatable.   With his public health perspective, 
Rutstein included a whole range of diseases resulting from non-healthcare preventable causes (such 
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as cancers resulting from unnecessary exposure to carcinogens, and diseases resulting from poor diet 
or housing).  Rutstein applied his own techniques in studying occupational diseases (Rutstein et al 
1983), while others have used it to examine geographical variations in avoidable mortality (Charlton 
et al 1983) and to explore levels of unmet need for healthcare in the population (Carr et al 1989). 
 
Measures of the quality of healthcare based on the detection and classification of adverse events 
were first developed and used in the USA in the 1970s.  In the light of four years experience of 
mandatory quality assurance in the USA which had largely been based on the development of 
standards based audits of the process of care, Komaroff (1978) wrote of the growing awareness that 
these efforts had made little or no progress in establishing meaningful measures or in improving the 
quality of care.  He argued for the simplification of programmes, and for a focus on areas in which 
experience suggested there were “deficiencies in care”.   Other commentators also urged less 
emphasis on complex, standards based measures of process and a greater attention to adverse events, 
critical incidents, or instances of what Fifer termed disquality (Craddick and Bader 1983, p3).    
During the 1980s, a growing number of adverse-event measures of quality were developed and 
applied in the USA (Craddick and Bader 1983; Goldman 1989; Sanazaro and Mills 1991; and 
others),  Australia (Burr 1990; Wilson et al 1995; Wolff 1995), Canada (Carlow 1988; Nordal and 
Ang 1988),  the UK (Bennett and Walshe 1990; Walshe, Bennett and Ingram 1995; and others) and 
Holland (Bomhof, Arends and van der Beek 1993; Bomhof, Nieman and Reerink 1993).   These and 
other studies are reviewed in some detail later in this chapter. 
 
The critical incident technique 
Flanagan (1954) described the critical incident technique as “a set of procedures for collecting direct 
observations of human behaviour in such a way as to facilitate their potential usefulness in solving 
practical problems and developing broad psychological principles”.  It is a tool for “collecting 
observed incidents having special significance and meeting systematically defined criteria”.     
Flanagan cites as examples of the early application of the critical incident technique its use in 
understanding near-miss accidents in flying, errors in reading and interpreting aircraft instruments, 
army personnel failures in highly stressful emergency or combat situations, and the study of 
motivation and leadership in the armed forces.   In each case the approach involves identifying 
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critical incidents (which might often be thought of as adverse events) and exploring their causes and 
impacts in order to develop a wider understanding of the area being studied. 
 
The critical incident technique has been used widely in many areas of research related to healthcare.  
For example, it has been employed to explore what causes clinicians to change their practice 
(Allery, Owen and Robling 1997),  and what factors influence general practitioners’ prescribing 
decisions (Bradley 1992).   Norman et al (1992) applied it to develop indicators of quality in nursing 
care from the critical incidents identified by patients and their nurses. 
 
The focus of most critical incident studies is a set of events which are particularly significant to 
participants because they represent either instances of good or poor performance from which lessons 
can be learned.  Sometimes, the definition of those events is left to the participants in the study, but 
broad indicative areas of interest are often suggested.   There is clearly a link to other approaches 
concerned with adverse events.  Though critical incidents are not necessarily adverse in nature, and 
can represent exemplars of good practice or performance, they are more usually instances of some 
concern.  
 
The critical incident technique has been used to study adverse events in healthcare, where it has 
sometimes been called “significant event auditing” (Robinson, Stacy and Spencer 1995; Pringle et al 
1995).  For example, Berlin, Spencer and Bhopal (1992) employed it to audit deaths in general 
practice, and identified a series of avoidable factors in the cases studied which led to changes in 
clinical practices and organisational arrangements.     Diamond, Kamien and Sim (1995) used it to 
study the learning experiences of trainees in general practice and found that many incidents 
concerned participants’ communication and interpersonal skills, and knowing when and how to 
obtain support in difficult or complex clinical decisions.    Some studies of the quality of care, such 
as the various confidential enquiries into perioperative deaths, maternal deaths and neonatal deaths 
(NCEPOD 1989; Department of Health 1991a) can be seen as using the critical incident technique 
implicitly, both in their approach to identifying significant events and in the way in which those 
events are analysed and used to develop an understanding of causation and prevention. 
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It is notable that studies of adverse events in healthcare which use the critical incident technique 
place considerable emphasis on the importance of a deep understanding of the circumstances 
surrounding the event, often based on a detailed discussion with participants.  Although these 
studies may involve the analysis of large numbers of adverse events, they are usually qualitative in 
nature, focused on the common themes identified in the investigation of events rather than on the 
use of these data in developing quantitative measures. 
 
Negligence and malpractice in healthcare 
Medical malpractice is “negligent care by a health services provider that causes injury to a patient” 
(Morlock, Lindgren and Mills 1989).   Malpractice has attracted the attention of researchers because 
of its considerable and growing importance to healthcare organisations.  It is shown below that there 
is strong evidence that malpractice is a relatively frequent occurrence; that it is costly to both 
providers and consumers of healthcare; that the costs of malpractice have risen consistently for two 
decades and are continuing to rise; and that recourse to the law provides patients with very little 
remedy for malpractice.   
 
Researchers studying the incidence of malpractice have examined both the frequency with which 
claims arise and the incidence of instances of negligent care which could result in a successful claim 
if they were pursued.    For the latter, adverse events have been an important research tool.   Three 
major studies have established that negligent care is alarming common, and that in comparison, the 
numbers of claims made by patients are very low  (California Medical Association 1977; Mills 
1978; Harvard Medical Practice Study 1990; Wilson et al 1995).  Overall, these studies suggest that 
about 1% of inpatients suffer a negligent adverse event, and that only 1.5% of such negligent 
adverse event actually result in a malpractice claim.   These studies are reviewed in detail later in 
this chapter. 
 
While no epidemiological studies of malpractice performed in the UK were found, there is some 
research on the causation and nature of malpractice.  For example, Woodyard (1990) surveyed 
British orthopaedic consultant surgeons and found that 377 surgeons (58% of respondents, as the 
survey had a 50% response rate) had been or were at the time of the survey the subject of a 
malpractice action, and 185 (27%) had had one or more malpractice claims awarded against them.  
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Of the 236 successful claims that the respondents reported, 67 (28%) resulted from technical 
surgical errors on the part of the consultant surgeon, and 33 (14%) from the actions of junior 
medical staff.   Asked to name the causes of the errors which led to litigation, the commonest factors 
cited were communication failures, clinical inexperience, and inadequate help or supervision. 
Drawing conclusions about the prevalence of malpractice in the UK is difficult in the absence of 
epidemiological evidence.  However, the similarities in practice between the UK and the USA, and 
the strong evidence for widespread unrecognised malpractice in the USA support the tentative 
conclusion that there may be substantial unrecognised malpractice in the UK. 
 
In the USA, the UK and most of Europe, medical malpractice is dealt with through the civil law.  
Patients who suffer malpractice seek redress by taking their doctors and hospitals to court, where the 
decision on whether to award damages hinges primarily on whether or not the doctor and/or hospital 
have been negligent, not on the nature of the harm suffered by the patient or its effects.  Doctors and 
hospitals generally insure themselves against the risk of an action for negligence - but the costs of 
malpractice insurance have risen explosively in recent decades (Morlock, Lindgren and Mills 1989).  
In 1955, the average New York physician paid annual insurance premiums of $123.  Three decades 
later, in 1985, the average premium was $38,000, a rise of 31,000%.  Even allowing for inflation, 
the 1985 costs of malpractice insurance were about 35 times the costs in 1955.   The causes are 
clear.  In 1955, there were 1.9 successful claims per 100 doctors per year, but in 1985 there were 8.4 
successful claims per 100 doctors per year.  The cost in damages of each successful claim was at 
least 8 times as much, in real terms, in 1985 as it was in 1955 (Harvard Medical Practice Study 
1990).    In the UK, by comparison, there were just 1.3 successful claims per 100 doctors in 1988 - 
though this was ten times the level of a decade earlier (Woodyard 1990).  The value of awards to 
plaintiffs has also been much lower in the UK (Jost 1990) though these too are rising - at about 17% 
per annum through the 1980s, according to some commentators (Tribe and Korgaonkar 1990).   
Dingwall and Fenn (1995) report that in 1992 there were about 6,000 malpractice claims a year 
against the NHS in England, and the costs of medical negligence litigation  to the NHS were 
estimated at around £125 million pa.    
 
Malpractice litigation has been less common in the UK than the USA for a number of reasons: 
contingency fee arrangements (in which lawyers take a percentage of the award instead of charging 
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a fee) were not permitted in the UK until recently, thus restricting access to the law to the very rich 
who could afford the costs involved and the very poor and children who receive Legal Aid; many 
costs which in the USA must be recovered from the doctor or hospital responsible through legal 
action are met in the UK through the social insurance and welfare system; some aspects of the law 
make it harder to win cases for negligence in the UK; and it may be argued that Britain is simply a 
less litigious society (Jost 1990, p52). 
 
However, in both the UK and the USA it seems that malpractice litigation provides a poor and 
ineffective remedy for most of the problems of malpractice and its effects (Tancredi and Bovbjerg 
1992).   When the results of the Harvard Medical Practice Study (1990) review of 30,121 patient 
admissions were compared with the New York malpractice claims records, it was found that 47 
patients had made malpractice claims relating to their admissions.  Of these 47 patients, 18 (38%) 
had been judged by the study team to have suffered an adverse event, and only 8 (17%) had been 
rated as a negligent adverse event.  Thus, only 1.5% of negligent adverse events actually led to a 
malpractice claim, and 83% of malpractice claims filed related to care that had been judged to be 
adequate (Localio, Lawthers, Brennan et al 1991).  In view of these results, it is unsurprising that the 
study concluded that there was no evidence that the threat of malpractice litigation had any effect on 
the incidence of adverse events or negligent adverse events.   It seems that most negligent injuries 
are never brought to court, and so those patients are never compensated.  Many patients who have 
not suffered malpractice do bring actions, which are sometimes successful.  The legal process is 
laborious and expensive to administer, and rarely compensates people in a timely fashion.  Court 
decisions often seem haphazard, both in the way liability is assessed and in the size of damages 
awarded.  Finally, the legal process encourages an adversarial battle between plaintiff and defendant 
rather than a careful, joint examination of the facts. 
 
Human factors in medical accidents 
In a number of other industries, particularly those where accidents or errors might be dangerous or 
even disastrous (like aviation and nuclear power), there is an established record of research into the 
factors involved in accidents and the way that future accidents can be prevented.    Reason (1995) 
sets out a widely used classification of the human causes of accidents, which highlights the need to 
look beyond the immediate circumstances of the error in order to understand its causes.   He argues 
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that the way organisations are structured and make decisions, and the way that processes are 
designed create latent failures - circumstances which make eventual accidents more likely or even 
certain when certain conditions occur or circumstances coincide.    He suggests that studies of 
medical accidents have been too much concerned with classifying their consequences, and too little 
concerned with their causes.  
 
To date, the human factors approach has not been widely employed in investigating adverse events 
in healthcare, though there are some examples of its use in anaesthetics (Gaba 1989; Runciman et al 
1993; and others).  Leape (1994) argues that it requires a change of paradigm in healthcare, from 
regarding adverse events as the responsibility of individuals to be corrected and even punished after 
the event.  Instead, he believes we should learn from other industries and adopt an approach which 
is more focused on error prevention, on designing systems and processes of care to be able to absorb 
errors, and by creating a culture which is more tolerant of individual slips and lapses but less tolerant 
of organisational failures.   
 
Conclusions from a  diversity of approaches 
The research reported above may describe itself as being focused on iatrogenic disease, critical 
incidents, medical malpractice, quality measurement, human factors in medical accidents or 
whatever, but it can all be seen as studying different facets of the same phenomenon - what might be 
called the epidemiology of adverse events in healthcare.  As the brief review above demonstrates, 
researchers in these different areas have defined the concept of an adverse event quite differently.   
They have also focused their attention on different aspects of the epidemiology of adverse events - 
their consequences for patients, the costs for healthcare organisations, the perceptions of clinicians 
and others involved in these events, the causes and factors which contribute to their occurrence, their 
preventability, their use in performance measurement, and so on.   
 
However, some common themes can be identified.  Researchers concur that adverse events are 
important and worthy of study and investigation because they are more prevalent than might be 
expected, have important impacts on healthcare organisations and patients, and are often 
preventable.   The case was neatly summarised by McIntyre and Popper, who wrote: 
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“Mutual criticism is not personal and pejorative, but ... springs from a mutual respect 
and a desire to improve the lot of patients. It then becomes important not only to 
acknowledge mistakes but to search for them, in order to correct them as quickly as 
possible.  When errors are due to lack of skill we will, we hope, try to improve our 
skill; and when, as is sometimes the case, our errors are due to carelessness, or our 
failure to do what we know we ought to do, then we will look for ways of improving 
our behaviour.”  (McIntyre and Popper 1983). 
 
They also seem to agree that the study of adverse events should look beyond the performance of the 
individual clinician, and recognise the importance of the wider process of care and the 
organisational context in which it takes place. 
 
Looking outside healthcare, other industries use adverse events extensively in quality measurement 
and quality improvement.  For example, Oakland (1989, p165) places error/defect detection and 
prevention at the centre of the process of quality monitoring, though he emphasises that constructive 
investigations focused on error prevention should not become destructive inquisitions aimed at 
placing blame.   Deming, whose influence on modern industrial quality assurance has been 
profound, reviewed the needs of quality measurement in healthcare from an outsider's perspective, 
and recommended a series of indicators of which two thirds were based on the incidence of errors or 
defects (Deming 1986, p203).    
 
In short, the proven importance of adverse events in healthcare, and their confirmed worth in quality 
measurement and quality assurance outside healthcare both suggest that adverse-event measures of 
quality may have an important role to play in healthcare quality assurance.   The rest of this chapter 
explores the definition, development and use of adverse events in healthcare quality measurement 
and quality improvement. 
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3.2.2 Concepts and theory of adverse-event measures of quality 
 
Those involved in developing adverse-event measures of quality have tended to place greater 
emphasis on developing and applying those instruments than on either defining the concepts they 
use or on evaluating the measures they develop and apply.  Goldman (1989), having reviewed the 
literature, remarked that “given the widespread use of occurrence screening programmes in hospital 
QA and external peer review programmes, it was striking how little scientific literature existed on 
the subject”.  As a result, a welter of different and sometimes conflicting definitions of adverse 
events, sets of screening criteria, and classifications of causation and standards of care have evolved.   
It is important, in order to understand how different studies or instruments relate and how they 
differ, that some of these concepts are explored and clearly delineated.  To develop this 
understanding, there are six principal areas which need to be considered: the definition of adverse 
events; the classification of actual instances of adverse events; the various sources of information on 
adverse events; the use of sampling in identifying adverse events; the timing of measurement; and 
the construction of quantitative measures based on information about adverse events. 
 
Defining adverse events 
A number of different researchers have developed definitions for the term adverse event, and some 
of the principal ones are listed in table 3.1. Craddick and Bader’s (1983) definition of an adverse 
event (which they termed an adverse patient occurrence) has probably been most widely cited and 
often adapted or modified by others. 
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McLamb and Huntley (1967) “Any response to medical care in the hospital that is unintended, undesirable 
and harmful to the patient.” 
 
Mills (1978) “A potentially compensable event is a disability caused by health care 
management: 
• disability - is a temporary or permanent impairment of physical or mental 
function (including disfigurement) or economic loss 
• causation - is established when the disability is more probably than not 
attributable to health care management 
• health care management - includes both actions and inactions of any 
healthcare provider or attendant.” 
 
Craddick and Bader (1983, p23). “Adverse patient occurrences ... refer to untoward patient events which, under 
optimal conditions, are not a natural consequence of the patient's disease or 
treatment.  The common thread of all APOs is that they are events which 
health professionals agree are not desirable outcomes of medical 
management.”   
 
Harvard Medical Practice Study 
(1990) 
“An unintended injury caused by medical management rather than by the 
disease process.  The injury is sufficiently serious to lead to prolongation of 
hospitalisation or temporary or permanent impairment or disability in the 
patient.” 
 
Wilson RM, Runciman WB, 
Gibberd RW (1995) 
“An unintended injury or complication which results in disability, death or 
prolonged hospital stay and is caused by health care management.” 
 
 
Table 3.1.  Some definitions of adverse events drawn from the literature. 
 
Reviewing the definitions offered by different researchers, it is clear that they largely agree that an 
adverse event is a happening, incident or set of circumstances which exhibits three key 
characteristics to some degree: 
 
a) Negativity.   
It must be an event which is, by its very nature, undesirable, untoward, or detrimental to the 
healthcare process or to the patient.  This is a theme which is common to all definitions. 
 
b) Patient involvement/impact.   
It must in some way involve or have some negative impact or potential impact on a patient 
or patients.  The wider definitions of adverse events include occurrences in which there is no 
actual effect on any patient, though there is the potential for harm.  More restrictive 
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definitions often only include events where the patient has suffered some definable and 
identifiable ill effect from the event.  
 
c) Causation.   
There must be some indication that the event is a result of some part of the healthcare 
process (either through commission or omission), rather than a result of events outside the 
healthcare process, such as the patient's own actions or the natural progression of the 
disease.  Again, definitions vary, with some accepting events as adverse events with little or 
no evidence of causation, while others insist on strong and direct evidence of causation. 
 
Combining these three key characteristics gives the following definition, which is used throughout 
this thesis: 
 
An adverse event is an untoward or undesirable occurrence in the healthcare process 
which has or potentially has some negative impact on a patient or patients and results 
or may result from some part of the healthcare process. 
 
Of course, having defined the term adverse event does not in itself provide a basis for identifying or 
measuring such events in practice.   Since adverse events can take so many different forms, from 
patient falls to drug errors, most researchers have developed some form of list or classification of 
adverse events which sets out the kind of occurrences, incidents or sets of circumstances which 
make up an adverse event.   A number of examples of these lists or classifications are described and 
compared later in this chapter, but one example, drawn from Craddick and Bader (1983) is given in 
table 3.2. 
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1. Admission for complications or adverse results of outpatient management. 
2. Admission for complications or incomplete management of problems on previous hospitalisation. 
3. Operative consent incomplete, missing, or otherwise incorrect. 
4. Unplanned removal, injury or repair of organ or structure during surgery, invasive procedure  
 or vaginal delivery. 
5. Unplanned return to operating room on this admission. 
6. Invasive procedure with tissue removed where pathology report does not match preoperative  
 diagnosis, or non-diagnostic or no tissue removed. 
7. Transfusion required for bleeding/anaemia/other iatrogenic reason, not clinically indicated,  
 or resulting in reaction. 
8. Nosocomial (hospital acquired) infection. 
9. Antibiotic or drug utilisation problems. 
10. Cardiac or respiratory arrest, or low Apgar score. 
11. Transfer from general care unit to special care unit. 
12. Other patient complications. 
13. Hospital-incurred patient incident, such as fall, IV problem, medication error, or skin problem. 
14. Abnormal laboratory, X-ray or other test results not addressed by physicians. 
15. Neurological deficit present at discharge which was not present on admission. 
16. Transfer to another acute care facility. 
17. Death. 
18. Subsequent visit to ER or OPD for complication or adverse results related to this hospitalisation. 
19. Length of stay above certain percentile or allotted days. 
20. Medical record review. 
21. Nursing record review. 
22. Departmental or other problems. 
23. Patient or family dissatisfaction. 
 
Table 3.2.  Generic screening criteria used to identify adverse events.   
Craddick and Bader (1983). 
 
The list of circumstances or occurrences which are deemed to be adverse events is sometimes called 
a set of screening criteria (since it is used to screen patients or admissions to find those who have 
suffered an adverse event).   Almost all adverse-event measures of quality consist of a set of 
screening criteria like those set out above in table 3.2, but they vary greatly both in their content (the 
type of occurrences which are deemed to be adverse events) and in their nature (the way in which 
those occurrences are defined in the measure).    The classification of the criteria used to give value 
or meaning to data in quality measurement which was developed by Donabedian (1982) and was 
discussed in chapter 2 can be adapted here to describe some of the characteristics of adverse-event 
measures of quality and the screening criteria of which they are constructed: 
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a) Specification.   
The adverse event definitions may be fully and explicitly stated in great detail, and in terms 
which allow any user with sufficient understanding of the terminology involved to decide 
whether or not an adverse event has occurred.  Alternatively, they can be relatively 
imprecise, and rely on the professional judgements made by a rater who has sufficient 
clinical knowledge and experience.  The former is more likely to be reliable in application 
than the latter, but it may also be rather inflexible and allow too little room for sensible 
discretion and clinical judgement, resulting in a less valid measure.    In other words, there 
may be a trade-off between validity and reliability.  Some adverse events may be quite 
heterogeneous and hard to define precisely.  For example, criterion 1 in table 3.2 (admission 
for complications or adverse results of outpatient management) clearly demands clinical 
expertise to assess the link, if any, between an admission and preceding outpatient care. 
 
b) Referent.   
The referent of the adverse event definitions is the patient group to which they refer.  In the 
case of some adverse events, this may be all patients.  For more specialist adverse events, it 
may be those patients in a certain specialty, undergoing a certain procedure, or whatever.  
For example, in table 3.2, criterion 3 (operative consent missing or incomplete) can clearly 
only refer to patients who have undergone some form of procedure which requires consent, 
and so this subgroup would form the obvious referent.   In practice, adverse-event measures 
often assume that any adverse event could occur to any patient, because defining the referent 
can be quite complex, or else they leave the referent undefined. 
 
c) Monotony.   
In the vocabulary of Donabedian, adverse events are almost always monotonic - in other 
words, it can generally be said that the less often they occur, the better.  It can, however, be 
argued that some adverse events represent accepted and desirable tradeoffs between 
complete patient safety and other aspects of quality - such as patient autonomy, or the 
potential benefits of interventions.  For example, criterion 13 in table 3.2 includes patient 
slips and falls, but it may be that reducing the rate of such accidents below a certain 
threshold would require unacceptable restrictions on patients’ freedom to, for example, sleep 
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in beds without bedrails and take themselves to the toilet if they wish.  Hence, this criterion 
is not wholly monotonic, and some level of adverse events will represent an optimal tradeoff 
between patient autonomy and patient safety. 
 
d) Importance.   
Clearly, not all adverse event definitions are of equal importance.  Their importance is 
primarily a factor of their expected impact or potential impact on patients, though other 
considerations such as the resulting cost and the organisational effects of the defined adverse 
event may also be considered.  For example, adverse events under criterion 10 in table 3.2 
(cardiac arrests and low Apgar scores) are presumably far more significant in terms of likely 
patient impact than those under criterion 20 (deficiencies in the medical record). 
 
e) Expected incidence.   
The observed incidence of adverse events may be used as the measure of the quality of care.  
However, different adverse events may have quite different expected incidences - some may 
be inherently quite frequent, while others may usually be very rare.  A relationship with the 
importance of the adverse event may exist (in that rare adverse events may be perceived as 
more important than common ones).  Clearly, the expected incidence of an adverse event is 
an important consideration for those using it in quality measurement, since very rare events 
will require large samples and much effort to identify even small numbers of cases.  
Conversely, if the expected incidence is very high, collecting information about every 
instance of the event may be expensive, and the event may be regarded as commonplace and 
trivial.  The concept of the expected incidence of adverse events is related to that of 
stringency in Donabedian's classification. 
 
f) Source.   
Donabedian terms criteria normative or empirical; exogenous, endogenous or autogenous; 
and representative or elitist.  Most adverse event definitions are part normative, part 
empirical - blending professional opinions on events with (usually limited) research 
findings.  They are often exogenous - developed by professionals elsewhere - though they 
usually have the approval of the professionals involved.  They are generally representative, 
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rather than elitist - defining events which would be deemed adverse by most practitioners, 
not just those who are specialists or professional leaders.  Patients are rarely involved in the 
process of definition. 
 
Investigating and classifying adverse events 
While adverse-event measures of quality are generally based on counts of the numbers of instances 
of adverse events, those events are also frequently categorised, classified or further subdivided in 
several ways as part of the process of investigation and analysis. 
 
a) Importance.   
Individual adverse events of the same type will vary in their importance (which was also 
identified above as a characteristic of the adverse event definition).  Importance is a complex 
concept, which implicitly combines some of the considerations detailed below (such as 
effect, causation and avoidability) with such factors as the opportunities for improvement 
highlighted by the event. 
 
b) Effect.    
Events are often assessed in terms of their effect on the patient's health.  Rating scales which 
combine the severity and the temporal persistence of effect are often used - ranging, for 
example, from a minor, temporary effect on health, to a major, permanent effect.   Other 
effects of adverse events are also sometimes considered, particularly the effect on continuing 
or future healthcare needs (such as extended stays in hospital).   The key problem in 
assessing the effect of adverse events, which is usually addressed (or sidestepped) by relying 
on implicit review by clinical professionals, is the separation of the effects of the event from 
the effects of the underlying disease process. 
 
c) Causation.    
The causative factors in an event are often analysed and categorised.  The most basic (and 
frequently used) distinction is that made between events caused by the healthcare process 
itself and events caused by factors outside the healthcare process - the rationale being that 
only those factors within the healthcare process are generally amenable to revision.   More 
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detailed assessments of causation (sometimes called attribution or association) may link the 
event to specific staff groups, individual clinical professionals, organisational processes, or 
other factors. 
 
e) Avoidability.    
Evaluations of the avoidability of individual adverse events are often made, categorising the 
event on a scale ranging from wholly avoidable, to wholly unavoidable.   The concept of 
avoidability is closely linked to that of causation (in that it is likely that only events caused 
by healthcare process factors may be deemed avoidable) and to the concepts of acceptability 
and negligence discussed below. 
 
f) Acceptability.   
The acceptability of an event is, by definition, a subjective assessment of the extent to which 
the clinical or organisational practices and actions which led to the event are judged to be in 
conformity with accepted professional standards.  This assessment is generally made by a 
clinical professional with acknowledged expertise in the area.  However, it is fraught with 
measurement problems, arising from the implicit nature of the review, and the lack of an 
adequate definition of accepted professional standards.    Nevertheless, as a measure of the 
extent to which practice leading to an event is deemed unacceptable by other clinical 
professionals, it can be useful. 
 
g) Existence of negligence.    
The existence of negligence requires a medicolegal rather than a clinical assessment.  
Legally, to demonstrate negligence requires evidence that on the balance of probabilities the 
patient suffered some harm which was a result of the negligent actions of those healthcare 
professionals caring for the patient.  Negligent actions are generally defined in the UK as 
those falling outside practices accepted at the time as proper by a responsible body of 
medical opinion.  Thus, determining the existence negligence is linked to the assessments of 
effect and acceptability outlined above. 
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The classification of adverse events in these ways is almost always performed through some form of 
professional review.   The rigour with which those reviews are carried out varies - from those which 
are simply based on a single professional's personal and implicit assessment of the circumstances, to 
those which use multiple professional assessments, made with explicit criteria and definitions of the 
concepts involved.  Investigations of the reliability and validity of this review process have indicated 
that consistent intrarater and interrater reliability are elusive, and that the achievement of reliable 
judgements may demand more multiple ratings than are practically feasible (Richardson 1972; 
Goldman 1992; Localio et al 1996).  It has also been elegantly demonstrated that reviewers' 
judgements can be biased by their knowledge of irrelevant case circumstances, which raises serious 
concerns about the validity of implicit peer reviews (Caplan, Posner and Cheney 1991). 
 
While some authors argue that the value of adverse event detection lies in these detailed analyses 
and assessments of individual adverse events (Sanazaro and Mills 1991), other suggest that the 
methodological weaknesses of the mechanisms available to make the judgements required means 
that the limited advantage gained by performing these analyses is outweighed by their considerable 
cost (Massanari 1992).  Certainly, the limited available literature suggests we should be cautious 
about using implicit reviews or assessments by clinicians in adverse-event measures of quality 
because of their low reliability and unproven validity. 
 
Sources of information 
By far the most frequently used approach to identifying adverse events in healthcare is to monitor or 
screen patients' clinical records either during or after the process of care.  Information is abstracted 
from the clinical records by raters or screeners, who use the records to decide whether or not adverse 
events have occurred and to document and classify those events.  There are two important 
weaknesses in this process.  Firstly, the clinical records may be deficient, and as a result adverse 
events might be missed.  Indeed, since the more deficient the medical records are, the harder it will 
be to identify adverse events, the paradoxical situation could occur in which good, comprehensive 
records produce a higher adverse event score (and so an indication of a lower quality of care) than 
sketchy, incomplete records.   Secondly, the clinical records are always a summary of events in the 
patient's care and treatment, rather than a record of every action, conversation and incident.  Some 
adverse events might concern circumstances which are not routinely recorded in the clinical record, 
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and so reliance on the clinical record as the sole source of information might produce a spuriously 
low indication of their incidence. 
 
Another source of information on adverse events is the self-reporting of incidents by clinical 
professionals.  Indeed, most hospitals have at least some reporting mechanisms for a range of 
adverse events such as medication errors, and patient accidents (Williamson and Mackay 1991; 
Hartwig, Denger and Schneider 1991; and others).   However, if the reliability of the clinical records 
is a concern, the reliability of reporting mechanisms which rely on many different professionals to 
report adverse events, all of whom may have different personal definitions of what constitutes an 
adverse event and different degrees of commitment to the self-reporting mechanism, must be even 
more in doubt.  In fact, Craddick and Bader (1983, p11) claim that only 5-10% of adverse events 
identified through screening the clinical records are identified by self-reporting systems.   Thompson 
and Prior (1992) report that when the results of screening were compared with self-reporting, only 
74% of significant adverse events found through screening had been reported.   Hartwig, Denger 
and Schneider (1991) assert that the rate of reporting for medication errors is “probably well below 
the actual error rate” and point out that this means that any variations in rate may be due as much to 
changes in the tendency to report them as to any change in the actual incidence of errors, which is 
certainly a drawback for any measure.  However, in another study (O’Neill et al 1993) where 
adverse events could be reported directly by clinicians via electronic mail, it was found that 
reporting identified virtually the same number of adverse events as screening, finding 89 versus 85 
events in a total of 3,128 admissions, though only 41 events were common to the two sets.  The 
authors argued that well-motivated clinicians were capable of reporting adverse events at least as 
reliably and validly as screening could detect them, that reporting was cheaper, and that it had the 
advantage of drawing clinicians into quality measurement rather than making them the passive 
subject of the process.   Nevertheless, the consensus of the literature seems to suggest that incident 
reporting is likely in most circumstances to miss a proportion of adverse events and to be less 
consistently and reliably applied than screening for adverse events. 
 
With the increasing availability of information technology in hospitals, some researchers have used 
available computer systems to identify fairly limited groups of adverse events.   For example, 
Mendenhall (1987a; 1987b) used readily available hospital databases to identify medication 
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prescribing errors and the overadministration of anaesthetic/analgesic agents.   Bates et al (1994) 
examined a series of 133 adverse events identified through manual reviews of 3,138 patient 
admission records to assess how many of them were identifiable from computer systems.  They 
found that even when computer systems held only basic demographic data along with test orders, 
test results and medication prescriptions, 53% of adverse events could be identified.    If all 
physician instructions were available on computer, the proportion identifiable rose to 58%, and if 
wholly computerised clinical records were in place, 89% of all adverse events could have been 
detected automatically. 
 
A final, though little used, source of information on adverse events is the direct observation of 
practice.   Though theoretically possible, direct observation is generally too expensive and too 
intrusive to yield useful information on the incidence of adverse events.  However, concurrent 
review procedures, which involve the periodic screening of patients' records during their hospital 
stay, inevitably include an element of observation, since the frequent screenings are carried out in 
the ward environment.  The review staff can hardly avoid observing some practice, and their regular 
contact with the clinical professionals involved in direct patient care often results in information 
from the clinical record being supplemented with information from observation and staff 
communication. 
 
Sample definition 
Craddick (1984, pV-1) argued that the review of all patient records (in other words, the entire 
patient population) for adverse events was worthwhile for two reasons.  Firstly, she suggested that 
single, serious adverse events - those which are rare but important - may be missed if only a sample 
of cases are reviewed.   Secondly, she pointed out that any sampling process is open to suggestions 
of bias, and using adverse event rates from sampled populations allows the validity of comparative 
analyses to be challenged, on the basis that the sample is not representative of the population of 
patients as a whole.  However, other researchers have used an assortment of sampling strategies to 
select samples of patients for adverse event review: 
 
a) Random sampling.    
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Random sampling is the simplest sampling strategy, though it may also be the least cost-
effective way to identify adverse events.   It involves selecting a subgroup of patients at 
random, whose cases are then reviewed for adverse events.  Perhaps its main advantage is 
that, if sampling is truly random, adverse event rates found in samples can, with appropriate 
confidence limits, be generalised to the population of all patients. 
 
b) Stratified sampling.    
Random sampling produces very small samples of groups which form a relatively small part 
of the whole population, such as minor specialties.  These samples may be too small for any 
useful calculations to be performed.   Stratified sampling involves dividing the population of 
patients into groups according to a set of characteristics (such as specialty, ward, age or 
whatever) and drawing samples from each group.  Thus, small specialties or patient groups 
can be oversampled (disproportionate stratified sampling) to ensure adequate sample sizes.  
Rates for the population as a whole can still be calculated, since the structure of the stratified 
sample and the structure of the population as a whole are known. 
 
c) Targeted sampling.   
Some researchers have deliberately targeted their sample selection on areas where empirical 
evidence or shows (or it is assumed) adverse events are more frequent.   This form of 
targeted sample might be made up of a sample of the population as a whole, plus all patients 
in certain defined high risk groups, such as readmitted patients, long stay patients, patients in 
particular Diagnosis Related Groups (DRGs), etc.  The main rationale for this approach is 
that it maximises the yield from the screening process - producing more adverse events than 
a random or stratified sample.   Its main disadvantage is that it makes the calculation of rates 
for comparative analyses or the derivation of population-based estimates of rates very 
difficult (Jost 1989; Stuart 1989). 
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d) Probability sampling.   
Probability sampling is an alternative approach to targeted sampling, which is designed to 
combine the latter's high yield from screening with the ability to generate population-based 
estimates of rates and figures for comparative analyses.  It involves building a model which 
uses cumulative records of adverse events to predict where adverse event rates are highest. 
These predictions are used to guide sampling, and the results of sampling are used to update 
the model (Ash, Shwartz, Payne et al 1990).  Since areas are targeted on the basis of 
empirical evidence from the model, rather than assumptions or conjecture, probability 
sampling should be more effective at maximising the yield from case review than targeted 
sampling.   Its main disadvantage is the statistical complexity of the methodology, which 
reduces the system's transparency to clinicians, and which requires appropriately skilled 
quality assurance staff to apply the methodology and interpret its results. 
 
In practice, the costs of screening cases for adverse events make the use of whole population 
screening too expensive for many healthcare organisations to support. 
 
Timing of measurement 
Ideally, a patient's care and treatment would be reviewed for adverse events once all elements of that 
care and treatment were complete, and all effects and results of care were known.  However, that 
delay in measurement conflicts with the need for timely information on adverse events, and with the 
practicalities of accessing patients' records for review.   Two main approaches to undertaking 
reviews for adverse events have developed: 
 
a) Concurrent review.   
In concurrent review, the patient's care and treatment is reviewed for adverse events whilst 
they are in hospital, with reviews taking place shortly after admission and then periodically 
during the hospital stay.  This produces very up-to-date information, and the repeated 
reviews may help to make the review more reliable.  However, it is also more expensive, 
since each case is reviewed not once but several times. 
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b) Retrospective review.   
This involves patients' care and treatment being reviewed for adverse events soon after its 
completion - usually on or shortly after the date of discharge.   This is less costly than 
concurrent review, and produces relatively up-to-date information.   However, since patients' 
stays in hospital are often very brief, some adverse events may not be observable or recorded 
until after this retrospective review has taken place. 
 
Construction of measures 
Simply detecting and classifying adverse events is not, by itself, enough to provide a useful measure 
of quality.   There are a number of important issues to be considered in converting these raw 
numbers of adverse events into functional measures of quality: 
 
a) Denominators.   
To calculate incidence rates of adverse events, some denominator variable is needed.  The 
two commonest denominators used are the number of patients or cases, and the number of 
inpatient days.  The former produces incidence rates will be lower for specialties or areas in 
which many short-stay patients are treated, but higher for areas in which long lengths of stay 
are the norm, whereas the latter has the opposite bias.   When making comparisons, it is 
important to recognise the influence of the choice of denominator variable. 
 
b) Risk adjustment.   
The principles of risk adjustment have already been rehearsed above.  Essentially, it 
involves considering not only whether an adverse event has happened, but whether it could 
have happened, and using the ratio of actual adverse events to potential adverse events in 
measures.  The main advantage is that it makes little sense to calculate incidence rates for 
adverse events in which the denominator includes patients who would never have had an 
adverse event of that type, since the incidence rate will be artificially low as a result.  
However, deciding whether individual patients were at risk from adverse events is a difficult 
and unreliable process, and this second layer of rating makes it harder to achieve adequate 
reliability for these measures (Richards et al 1988). 
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c) Multiple classifications of single events.   
Some adverse events may be classifiable as more than one type of event.  For example, a 
missing entry on a drug chart might be classified as either a medical record deficiency or a 
drug administration error.  Clear adverse event definitions can certainly help to reduce the 
potential for such overlaps, but it can be difficult to remove them altogether.   Therefore, 
adverse-event measures, if they are to be reliably applied, need to define how such potential 
multiple classifications should be handled. 
 
d) Multiple adverse events of the same type.    
During a single patient episode, the same type of adverse event can happen more than once 
(for example, two quite separate medication errors could take place).   There are two basic 
approaches to incorporating such events into a measure: either each individual event is 
counted (which means that theoretically there is no limit to how many adverse events a 
single patient might have) or each event type is counted (which means that one or more than 
one adverse events of a particular type are counted as a single event, and the maximum 
number of event types for a single patient is the number of different adverse events for 
which screening takes place).   
 
e) Multiple adverse events of different types.   
During a single patient episode, a number of different adverse events may be causally or 
conceptually linked.  For example, a hospital acquired infection could lead to a return to 
theatre for wound debridement.  In some adverse-event measures, each causal chain of 
events would be treated as a single event - usually the initial event in the chain.  In other 
measures, each event would be counted separately.  The former approach may understate the 
incidence of adverse events, but the latter method can lead to apparent double-counting of 
events which artificially inflates the numbers of events recorded. 
 
f) Aggregation.   
Many adverse-event measures, having identified the adverse events which occurred during a 
patient's stay in hospital, then aggregate the results, yielding a single integer (the number of 
adverse events the patient suffered) or a dichotomous variable (whether or not the patient 
  
 
 
87
suffered any adverse events).  This process of aggregation tends to eliminate the distinctions 
between different types of adverse events, and in some circumstances this may be clinically 
inappropriate and relatively meaningless. 
 
Conclusions 
The framework set out above provides a useful structure against which a wide range of different 
adverse-event measures can be set in order to compare and contrast them.  In practice, many of the 
issues outlined above have often not been addressed by the developers of adverse-event measures of 
quality, leaving considerable room for ambiguity and confusion in the way in which those measures 
are then used.   For example, although the definition of denominators or the approach to classifying 
multiple events are both important issues which have to be faced in defining a quantitative measure 
based on adverse events, both issues are generally ignored, which does not help to assure the 
validity and reliability of the resulting measures. 
 
 
3.3 Using adverse events in quality measurement and improvement 
 
3.3.1 Defining adverse-event measures of the quality of care 
 
Before exploring the findings of some of the studies which have examined the incidence of adverse 
events in healthcare, using a variety of approaches to measurement, it is important to understand 
how some of those measures have been developed.    It was noted earlier that the definitions of 
adverse events used by researchers and practitioners varied in two specific ways - the degree of 
impact on the patient required, and the strength of demonstrated causative relationship with the 
healthcare process needed - for something to “count” as an adverse event.    It will be seen from the 
examples of adverse-event measures reviewed below that they also differ in two further ways.  
Firstly, some are intended to be generic, that is they attempt to be applicable to all patients almost 
regardless of their condition or specialty, while others are more specific to particular patient groups, 
such as those in a given specialty, with a particular condition, or undergoing a particular 
intervention.    Secondly, some are defined explicitly and in some detail, while others are much less 
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clearly specified and rely far more on the judgement of the person applying the measure.  Some 
representative examples of adverse-event measures of quality are reviewed below. 
 
Medical Management Analysis 
Craddick, who had participated in the Californian Medical Insurance Feasibility Study reported 
earlier, used the definitions of adverse events developed for that research to design a systematic 
quality assurance programme based around the detection and analysis of adverse events and aimed 
at acute hospitals, which she dubbed Medical Management Analysis (Craddick 1979).  This 
programme was intended to be more than just a quality measurement system - it included 
mechanisms for utilisation review, risk management, and medical staff credentialling, as well as 
offering an organisational model for the structuring of quality assurance committees, the reporting 
of quality assurance information, and the staffing and resourcing of quality assurance departments. 
 
1. Admission for complications or adverse results of outpatient management. 
2. Admission for complications or incomplete management of problems on previous hospitalisation. 
3. Operative consent incomplete, missing, or otherwise incorrect. 
4. Unplanned removal, injury or repair of organ or structure during surgery, invasive procedure  
 or vaginal delivery. 
5. Unplanned return to operating room on this admission. 
6. Invasive procedure with tissue removed where pathology report does not match preoperative  
 diagnosis, or non-diagnostic or no tissue removed. 
7. Transfusion required for bleeding/anaemia/other iatrogenic reason, not clinically indicated,  
 or resulting in reaction. 
8. Nosocomial (hospital acquired) infection. 
9. Antibiotic or drug utilisation problems. 
10. Cardiac or respiratory arrest, or low Apgar score. 
11. Transfer from general care unit to special care unit. 
12. Other patient complications. 
13. Hospital-incurred patient incident, such as fall, IV problem, medication error, or skin problem. 
14. Abnormal laboratory, X-ray or other test results not addressed by physicians. 
15. Neurological deficit present at discharge which was not present on admission. 
16. Transfer to another acute care facility. 
17. Death. 
18. Subsequent visit to ER or OPD for complication or adverse results related to this hospitalisation. 
19. Length of stay above certain percentile or allotted days. 
20. Medical record review. 
21. Nursing record review. 
22. Departmental or other problems. 
23. Patient or family dissatisfaction. 
 
Table 3.3.  Generic screening criteria used in the Medical Management Analysis programme.  
Craddick and Bader (1983). 
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The MMA programme was based around a review of all patient records for adverse patient 
occurrences (APOs), carried out by quality assurance staff.  This review took place both 
concurrently (while the patient was in hospital) and retrospectively (after discharge).  Reviewers 
used a set of 23 generic screening criteria, designed to identify all important APOs in almost any 
specialty, to screen patients' records for APOs (see table 3.3).  For each criterion, more detailed and 
specific guidance was provided on its interpretation.  Information on APOs from other sources - 
such as incident reports - was also used, but the record screening was the primary source of 
information.   The MMA programme aimed to use this single comprehensive record review to serve 
a range of purposes, including quality assurance, risk management and utilisation review. 
 
While some of the set of 23 generic criteria were unambiguous indicators that an adverse occurrence 
had taken place (such the unplanned removal, injury or repair of organ during surgery), many were 
what Craddick termed clue criteria, merely indicating that a case was worthy of further attention 
(such as unexpected death).  The primary screening was not designed to yield a definitive adverse 
occurrence rate - its main purpose was to identify a limited subset of records which were worthy of 
further detailed review by a medical reviewer. 
 
When a record was flagged by one or more of the generic screening criteria on initial screening, it 
was passed to a medical peer reviewer, who would either confirm or refute the initial judgement that 
an APO had occurred.  If the reviewer confirmed that an APO had occurred, he or she would 
undertake a structured analysis of the event, assessing the standard of care provided, judging the 
attribution or involvement of different staff groups in the event, and rating the severity of the event 
for the patient.    
 
Information from the MMA programme was used in a number of ways.  Firstly, individual APOs 
were followed up, especially when they indicated a serious weakness in individual or organisational 
performance.  Secondly, trends over time in APO rates, often broken down by the severity of the 
occurrence or the standard of care assessment, were used to compare performance and to identify 
patterns of suboptimal care.   Data from the MMA programme was commonly used by quality 
assurance committees, risk management staff, and physician credentialling committees, and 
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overviews of the substantial database of information built up by the programme were presented to 
the hospital governing body. 
 
Craddick and Bader (1983, p46) asserted that the main advantages of the MMA programme over 
other approaches to quality assurance were its objectivity; its identification of meaningful patient 
care issues, including both individual APOs and APO trends; the involvement of physicians and 
their peers in both assessment and followup action; the emphasis on taking corrective action; and the 
ability to react and intervene speedily when problems were identified. 
 
Occurrence screening in the Veterans Administration healthcare system 
The Veterans Administration (VA) healthcare system runs 172 medical centres in the USA with 
about 90,000 beds in total.  It introduced an occurrence screening programme in 1988 (Goldman 
1989; Goldman and Walder 1992) which used a set of 9 generic occurrence criteria (see table 3.4), 
each of which could be identified through existing computer systems.  Cases flagged on one or more 
criteria were then reviewed by nurse reviewers, who decided whether an adverse event had in fact 
occurred.  A process of peer review was used to determine the causation and appropriate follow-up 
action for each adverse event.     
 
1. Readmission within 14 days of discharge 
2. Admission within 3 days following unscheduled ambulatory care visit. 
3. Admission within 3 days following ambulatory surgery procedure. 
4. Admission from nursing home within 14 days of discharge from acute care. 
5. Transfer from Intermediate Medicine within 14 days of transfer from acute care. 
6. Transfer to a special care unit within 72 hours of transfer from special care unit, or within 72 hours of a 
surgical procedure. 
7. Return to operating room in same admission. 
8. Cardiac or respiratory arrest. 
9. Death. 
 
Table 3.4.  Veterans Administration screening criteria.  Goldman (1989). 
 
The VA measure can be seen to rely more heavily on the implicit reviews of the quality of care 
undertaken by nurse and medical reviewers.   Indeed, the criteria set out in table 3.4 could be argued 
to be largely a mechanism for targeted sampling, intended to identify admissions where an adverse 
event is more likely to have occurred for further review.   In use, the automated screening of 
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discharges flagged 13.3% of all  cases for review (57,841 episodes out of a total of 435,000 during 
six months ending March 1990) of which only 19.5%, or 2.7% of all episodes were confirmed to 
have an adverse event (Goldman and Walder 1992).   
 
Medicare PRO occurrence screening 
While US hospitals make extensive use of adverse-event measures of quality, perhaps the largest 
single user of these techniques is the Medicare Peer Review Organisation (PRO) programme.   This 
programme is federally mandated to review the quality and cost of care delivered to 31 million 
Medicare beneficiaries in 7,000 hospitals across the United States.   A Peer Review Organisation 
(PRO) was established in each state to review a carefully defined sample of inpatients admitted to 
hospitals in the state whose care was being financed by Medicare.    The sampling strategy used to 
select those patients for review was intended to select cases where quality or utilisation problems 
were more likely to occur (table 3.5). 
 
3%  Random sample of all discharges. 
50%  Cases involving an interhospital transfer. 
10%  Cases involving a transfer to psychiatric care within same facility. 
25%  Cases involving a transfer from acute to nursing home care within same facility. 
25%  Cases of readmissions within 31 days of previous admission. 
25-100% Cases in certain “problem” DRGs 
25%  Cases with costs above usual DRG prepayment. 
 
 
Table 3.5.  Peer Review Organisation sampling strategy for retrospective review. 
 
The clinical records of all cases in the selected sample are retrieved, and reviewed by trained 
reviewers (usually with a background in nursing) who use a generic occurrence screening tool to 
identify potential adverse events.    They also undertake reviews of utilisation and appropriateness 
and data validation.  The generic occurrence screening tool used by all PROs is shown in table 3.6.  
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Adequacy of discharge planning. 
No documentation of discharge planning or appropriate follow-up care with consideration of physical, 
emotional and mental status needs at time of discharge. 
 
Medical stability of patient at discharge. 
BP within 24 hrs of discharge outside limits. 
Temperature within 34 hrs of discharge over limit. 
Pulse within 24 hrs of discharge outside limits. 
Abnormal diagnostic findings not addressed/resolved. 
IV fluids or drugs given on day of discharge. 
Purulent/bloody wound drainage within 24 hrs prior to discharge. 
 
Death  
During or following surgery 
Following a return to intensive care. 
In other unexpected circumstances. 
 
Nosocomial (hospital acquired) infection. 
 
Unscheduled return to surgery during same admission for same condition. 
 
Trauma suffered in hospital 
Unplanned surgery/surgical injury. 
Fall. 
Serious complications of anaesthesia. 
Transfusion error or serious transfusion reaction. 
Hospital acquired decubitus ulcer/deterioration. 
Medication error or serious adverse drug reaction. 
Care or lack of care resulting in serious complications. 
 
 
Table 3.6.  Medicare PRO generic screening criteria. 
 
Any adverse event identified by primary screening is then referred to a physician reviewer, 
independent of the hospital concerned.  If the physician confirms the adverse event, then a complex 
analysis and rectification process, called the quality intervention plan, commences.   The hospital 
and physician involved are notified of the problem, and can appeal against the PRO assessment of 
the problem.  An assessment of the severity of the adverse event is made, and this is used to build up 
a profile for both the hospital and the physician concerned.  The PRO may withhold payment for the 
case, may require the hospital or physician to undergo some form of education, may intensify its 
review of that hospital or physician's cases, may refer details to licensing bodies who allow the 
hospital to operate and the physician to practice, and ultimately can sanction the hospital and/or the 
physician by excluding them from the Medicare programme. 
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Specialty-specific adverse-event measures 
The use of a single, generic set of criteria in all acute specialties has been perceived by many 
developers as a weakness of the approaches.  Craddick developed some specialist screening criteria 
for use in specialties such as anaesthesia, obstetrics, paediatrics and radiology (Craddick 1984). 
Other researchers have addressed areas such as vascular surgery (Lawrence-Brown et al 1989), 
accident and emergency (Manning et al 1990), long term geriatric care (Nordal and Ang 1988), 
obstetrics, orthopaedics and ophthalmology (Walshe, Bennett and Ingram 1995) and others.  Shaw 
(1992) provides suggested adverse event quality indicators for a wide range of specialties. 
 
 
3.3.2 The epidemiology of adverse events 
 
There are many studies of what might be called the epidemiology of adverse events - their 
incidence, causation and consequences - but they approach the subject from three main perspectives: 
the study of iatrogenic disease, negligence and malpractice, and quality measurement.  Each of these 
three perspectives is explored below, before some common themes in their findings and conclusions 
are identified. 
  
Adverse events and iatrogenic disease 
Researchers have studied the incidence of specific kinds of iatrogenic disease - such as admissions, 
deaths, or drug errors - as well as examining the incidence of iatrogenesis more broadly.  
 
Lakshmanan, Hershey and Breslau (1986) studied all admissions to the medical services of a large 
teaching hospital over a two month period, to identify the incidence and causation of iatrogenic 
admissions.   Records were reviewed by the researchers, who “attempted to be very conservative, 
and did not include patients where the clinical picture could have been caused by the underlying 
disease”.   Among 834 admissions they found 45 (5.4%) which were iatrogenic in origin, resulting 
from 47 separate iatrogenic events, of which 23 (49%) were deemed to have been avoidable.   Most 
of the iatrogenic events involved drug therapies (35, 78%).  Lakshmanan et al’s study confirms the 
findings of earlier research, which suggested that between 3% and 5% of hospital admissions are 
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iatrogenic in origin, and that pharmaceutical agents are the commonest causative factor (Caranasos, 
Stewart and Cluff 1974). 
 
Within the acute setting, Trunet et al (1980) examined all admissions to an intensive care unit over a 
12 month period, again to assess the incidence of iatrogenic admissions, using a similar process of 
implicit record review, based on a set of five criteria defining the causation of adverse events.   They 
found that of 325 admissions, 41 (13%) were iatrogenic in origin, and 19 (46%) of these were 
judged to have been avoidable.  Adverse drug reactions and drug prescribing errors caused 23 (56%) 
of the admissions.    
 
In a ten year study of surgical mortality, McDonald et al (1991) reviewed 543 deaths among 23,557 
admissions, and found that 89 (16%) were avoidable.   By definition iatrogenic in nature, these 
deaths resulted most commonly from surgical errors (32 deaths, 36%).  The decision about the 
avoidability of each death was made by a meeting of the clinical team involved, a methodology that 
McDonald et al acknowledge has obvious weaknesses.  In a similar surgical setting, using a process 
of implicit record review by the researchers, Heywood, Wilson and Sinclair (1989) reviewed 80 
deaths from 10,592 admissions, and found that 33 (41%) were avoidable.   In the USA, Dubois and 
Brook (1988) carried out a more rigorous examination of 182 deaths drawn from 12 hospitals which 
were high or low outliers on the Health Care Financing Administration adjusted mortality statistics.  
Each death was independently reviewed by three physicians to assess its preventability.  Using a 
majority rule, the three physicians deemed 49 (27%) of the deaths to be preventable; using a 
unanimity rule, 25 (14%) were judged to be preventable.  A range of errors in both diagnosis and 
management were cited as the causes of the preventable deaths. 
 
There are a number of studies which explore the incidence of medication or drug errors, as a specific 
but relatively common cause of iatrogenic disease.  As long ago as 1964, Cluff, Thornton and Seidl 
(1964) argued that 5% of admissions resulted from the iatrogenic effects of pharmaceutical therapy, 
and 20% of patients suffered such effects during their admission to hospital.    In a comprehensive 
review of observational studies of medication errors, Allan and Barker (1990) conclude that there is 
about one drug error per patient day, though the majority are minor and insignificant deviations 
from the prescription, and they present a detailed classification of the different types of error.  Using 
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a more stringent definition of an adverse drug event, Bates, Cullen and Laird (1995) studied 4,031 
admissions to 11 medical and surgical units in two acute hospitals over a six month period. They 
found 247 adverse drug events (involving 6.1% of admissions), of which 1% were fatal, 12% life-
threatening for the patient, 30% serious and the remainder were less significant in terms of their 
impact.  About 28% of these adverse drug events were preventable.  They concluded that 
preventable adverse drug events were relatively common, and that serious events were more likely 
to be preventable. 
 
Barr (1955) reports in passing what is perhaps the first study of the prevalence of iatrogenic disease 
in hospital.   Over a period in which about 1,000 patients were admitted to a major US teaching 
hospital, he found more than 50 major “toxic reactions and accidents consequent to diagnostic or 
therapeutic measures”.  He concluded that, since it affected 5% of patients, “iatrogenic disease could 
be regarded as one of the commonest conditions encountered during the period [of the study]”. 
 
Schimmel (1964) undertook a more detailed study of the incidence and causation of iatrogenesis 
during hospital admissions to general medical services.  He reviewed 1,252 admissions over an 8 
month period to a teaching hospital medical department, and found that 198 patients (16%) suffered 
one or more iatrogenic events during their stay.  He categorised the 240 events found as reactions to 
diagnostic procedures (29, 12%), therapeutic drugs (49%), transfusions (31, 13%), or therapeutic 
procedures (24, 10%); acquired infections (23, 10%); and other hospital hazards (14, 6%).  
Interestingly, Schimmel deliberately omitted from his study iatrogenesis which resulted from 
clinical errors or from previous treatment.   McLamb and Huntley (1967) studied 240 patients 
admitted to the general medical department of a general hospital, and found 47 patients (20%) 
suffered one or more iatrogenic events during their admission - a total of 63 such events were found.  
Again, drug reactions were the commonest form of iatrogenic event (28, 44%).   Both Schimmel 
(1964) and McLamb and Huntley (1967) used self-reporting mechanisms to gather data on 
iatrogenic events, which they acknowledge may have underestimated their incidence since some 
iatrogenic events may not have been reported. 
 
More recently, Steel et al (1981) examined all patients admitted to a teaching hospital medical 
service over a five month period, using a structured review of all patients' records performed by the 
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researchers.  They found that of 815 admissions, 290 patients (36%) suffered one or more iatrogenic 
events during their hospitalisation.  Of the 497 iatrogenic events found, 208 (42%) resulted from 
drug therapy, 175 (35%) from diagnostic or therapeutic procedures, and 114 (23%) from other 
sources, particularly patient slips and falls.  In 15 patients (5% of those with iatrogenic events, and 
2% of all patients admitted) the iatrogenic event was believed to have contributed to the patients' 
death. 
 
Couch et al (1981) conducted a one year prospective study focused on serious errors in care in the 
general surgical service of a large teaching hospital - what the team termed surgical mishaps.   Over 
the period 5,612 admissions were screened for mishaps, with flagged cases being discussed by the 
clinical team.  Only those cases which involved “violation of basic surgical principles” were 
confirmed as surgical mishaps.  The study found 36 (0.6%) patients who suffered a total of 56 
serious errors, of which 9 (16%) were diagnostic errors and 47 (84%) were therapeutic.  That these 
cases represented only the most serious instances of avoidable iatrogenic disease can be seen from 
the poor outcomes for the patients involved - 20 (56%) died, and 5 (14%) were left with serious 
physical impairment.  Couch et al asserted that the errors they found had five main causes, all of 
which related to physician behaviour and performance: misplaced optimism about patients' state of 
health or physicians' own ability; unwarranted urgency in undertaking procedures; the urge for 
perfection resulting in unnecessary surgery; the use of vogue therapies of unproven effect; and 
insufficient restraint and deliberation before making diagnostic and therapeutic decisions. 
 
These studies of iatrogenic disease are summarised in table 3.7 below, which sets out the setting, 
methodology and results of each in a common format.   It can be seen that while there are major 
variations in the apparent incidence of iatrogenic events, reflecting the differences in definition 
discussed earlier, there is some consensus that a substantial proportion of these events (from a 
quarter to a half) were avoidable. 
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Study Setting Methodology Episodes 
examined 
All 
iatrogenic 
events 
Avoidable 
iatrogenic 
events 
Avoid-
ability 
(%) 
Lakshmanan 
Hershey and 
Breslau 
(1980) 
Admissions to 
medical service of 
teaching hospital 
Prospective implicit 
review of all records 
by researchers. 
834 
admissions 
45 (5.4%) 
of 
admissions 
22 (2.6%) 
of admissions 
49% 
Trunet, Le 
Gall, Lhoste 
et al (1980) 
Admissions to 
intensive care unit 
Prospective implicit 
review of all records 
by researchers. 
325 
admissions 
41 (13%) 
of 
admissions 
19 (5.8%) 
of 
admissions 
46% 
McDonald, 
Royle, 
Taylor et al 
(1991) 
Mortality in 
surgical unit 
Review of all deaths 
by clinical team 
involved to assess 
avoidability. 
543 
deaths 
n/a 89 (16%) 
 of deaths 
16% 
Heywood, 
Wilson and 
Sinclair 
(1989) 
Mortality in 
African surgical 
unit 
Review of all deaths 
by researchers. 
80 
deaths 
n/a 35 (44%) 
 of deaths 
44% 
Dubois and 
Brook 
(1988) 
Mortality in 12 
selected US 
hospitals 
Independent 
retrospective review 
of deaths by three 
physicians. 
182 
deaths 
n/a 25 (14%) to 
 49 (27%) 
deaths 
14% to 
27% 
Bates, 
Cullen, 
Laird et al 
(1995) 
Adverse drug 
events in 2 selected 
acute hospitals 
Prospective 
stimulated self-report 
followed by case 
review 
4,031 
admission 
247 (6.1%) 
of 
admissions 
69 (1.7%) of 
admissions 
28% 
Barr (1955) Inpatients in 
general medicine 
Methodology not 
reported. 
1000 
inpatients 
50 (5%) 
of 
inpatients 
n/a n/a 
Schimmel 
(1964) 
Inpatients in 
general medicine. 
Prospective self-
reporting of 
iatrogenic events by 
physicians. 
1252 
inpatients 
198 (16%) 
of 
inpatients 
n/a n/a 
McLamb 
and Huntley 
(1967) 
Inpatients in 
general medicine. 
Prospective self-
reporting of 
iatrogenic events by 
physicians. 
240 
inpatients 
47 (20%) 
of 
inpatients 
n/a n/a 
Steel, 
Gertman, 
Crescenzi et 
al (1981) 
Inpatients in 
general medicine. 
Prospective screening 
of all patients to 
identify iatrogenic 
events. 
815 
inpatients 
290 (36%) 
of 
inpatients 
n/a n/a 
Couch 
Tilney, 
Rayner et al 
(1981) 
Inpatients in 
general surgery. 
Prospective screening 
of all patients to 
identify iatrogenic 
events. 
5612 
inpatients 
n/a 36 (0.6%) 
of 
inpatients 
n/a 
 
Table 3.7.   Summary of studies of adverse events and iatrogenic disease. 
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Adverse events, negligence and malpractice 
Three major studies of the incidence of adverse events have been undertaken to explore the likely 
extent of negligence and the implications for those concerned with the rising levels of medical 
malpractice litigation. 
 
The first study of the epidemiology of malpractice in healthcare was undertaken in California in 
1974, in response to dramatic rises in malpractice litigation and a consequent crisis in the insurance 
market in the early 1970s.  The California Medical Insurance Feasibility Study (CMIFS) set out to 
examine the incidence and causation of malpractice, with a view to evaluating alternatives to a tort 
based system for patient compensation (California Medical Association 1977).    
 
A sample of 20,864 inpatient admissions to California hospitals were selected, designed to be 
representative of the 3 million patients admitted to Californian hospitals during that year.  Each 
patient's medical records were screened for potentially compensable events (PCEs), which the study 
defined as “a temporary or permanent impairment of physical or mental function (including 
disfigurement) or economic loss in the absence of such impairment, which is caused by healthcare 
management” (Mills 1978).  The screening was performed using a structured list of 20 generic PCE 
types, which were used to flag records for review by one of the research team.  Inconsequential 
events were not included, and all PCEs were categorised by their nature, severity, causation, and 
legal liability. 
 
The study found that 970 patients (4.6%) had a PCE, of which the majority (796, 82%) resulted 
from the adverse effects of treatments or procedures; 144 (15%) involved incomplete or delayed 
diagnosis or treatment; and 30 (3%) resulted from incomplete protection or prevention.  The severity 
and assessed liability for the PCEs is shown in table 3.8.  Overall, 94 patients (9.7% of those with 
PCEs) died as a result of their PCE, and 165 patients (17% of those with PCEs, and 0.79% of all 
patients in the study) suffered a PCE for which the researchers judged the healthcare provider was 
legally liable.   The majority of PCEs were caused by therapeutic procedures (641, 66%) or drug 
therapy (182, 19%), and most (696, 72%) occurred in or originated in the operating theatre (Mills 
1978). 
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Severity of PCE No of PCEs No of liable PCEs Liable PCEs as % of all 
PCEs 
Temporary 776 (80%) 92 (56%) 12% 
Minor permanent 63 (6.5%) 15 (9.1%) 24% 
Major Permanent 37 (3.8%) 18 (11%) 49% 
Death 94 (9.7%) 40 (24%) 43% 
All PCEs 970 (100%) 165 (100%) 17% 
 
Table 3.8.   Severity and assessed liability of potentially compensable events in the California 
Medical Insurance Feasibility Study.  Mills (1978). 
 
The findings of the California Medical Insurance Feasibility Study (CMIFS) provided the first 
strong evidence that malpractice was a not uncommon occurrence, affecting almost 1 patient in 100 
in the study sample - far more than the proportion of patients who subsequently made legal claims 
for malpractice. 
 
More recently, the Harvard Medical Practice Study (1990) was established to undertake a more 
detailed examination of the incidence and causation of malpractice, with a greater focus on the 
relationship with malpractice litigation.   The study had four main aims: to establish a population 
based measure of the incidence of adverse events and negligent adverse events; to assess the 
economic effects of these events on patients; to determine what proportion of these events actually 
lead to litigation; and to examine whether the threat of litigation has any value in deterring 
malpractice (Hiatt et al 1989; Brennan et al 1991b; Leape et al 1991). 
 
A sample of 30,121 admissions to 51 hospitals in New York State during 1984 was selected, 
structured to be representative of all patients admitted to hospitals in New York during that year.  
These records were screened using a generic instrument not dissimilar to that applied by Mills 
(1978), to identify adverse events - which the study team defined as “unintended injuries caused by 
medical management rather than by the disease process, and sufficiently serious to lead to 
prolongation of hospitalisation or temporary or permanent impairment or disability in the patient” 
(Harvard Medical Practice Study 1990).   Each adverse event discovered was reviewed by a team of 
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physicians using a structured analysis process designed to gather information about its nature, 
causation, and assessed liability. 
 
Of the 30,121 patient admissions, 1,278 (4.2%) suffered an adverse event during hospitalisation, of 
which 280 (22%) were judged to have resulted from negligence.  Adjusting these figures for the 
population of admissions to New York hospitals in 1984 indicates that 3.7% of all patients admitted 
to hospital suffered an adverse event, and that 27.6% of all adverse events were due to negligence.  
Thus, 1.0% of all patients suffered a negligent adverse event during their admission.   While most 
adverse events resulting in minimal or transient disability, 14% caused or were implicated in the 
patient's death (and 51% of these were judged to be negligent).  Almost half (48%) of adverse events 
resulted from an operation - including wound infections (14%) and technical complications (13%).  
The commonest nonoperative causes of adverse events were drug therapy (19%) and diagnostic 
errors (8.1%). 
 
The Harvard Medical Practice Study undertook a painstaking investigation of the economic costs to 
patients of the adverse events it discovered, which was complicated by the need to separate out the 
costs of the adverse event and the underlying illness.  They found that most patients (76%) suffering 
an adverse event returned to normal functioning within 6 months, and their economic losses were 
minimal.  However, for those patients who suffered the effects of the adverse event beyond 6 
months, the per capita costs were high, and while 86% of the consequent medical costs were met by 
health insurance, only 19% of the earnings loss was met by sick leave or disability insurance. 
 
When the results of the study review of 30,121 patient admissions were compared with the New 
York malpractice claims records, it was found that 47 patients had made malpractice claims relating 
to their admissions.  Of these 47 patients, 18 (38%) had been judged by the study team to have 
suffered an adverse event, and only 8 (17%) had been rated as a negligent adverse event.  Thus, only 
1.5% of negligent adverse events actually led to a malpractice claim, and 83% of malpractice claims 
filed related to care that had been judged to be adequate (Localio et al 1991).  In view of these 
results, it is unsurprising that the study concluded that there was no evidence that the threat of 
malpractice litigation had any effect on the incidence of adverse events or negligent adverse events. 
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Researchers in Australia used a very similar methodology to those described above to examine the 
quality of care and the incidence of adverse events in two states during 1992 (Wilson et al 1995).  
Although the study was not explicitly focused on levels of negligence and malpractice, it is 
reviewed here because it was so closely modelled on the Harvard Medical Practice Study (1990).  
The researchers reviewed 14,179 admissions to 28 hospitals in two Australian states using 
essentially the same definition and tool for identifying adverse events as the Harvard Medical 
Practice Study (1990).  Instead of using reviewers to judge whether adverse events were negligent, 
as both earlier studies had done, they instead sought an assessment of how preventable it was, and 
what disability it caused.  They found that 16.6% of patients suffered an adverse event, of whom 
46.6% suffered no or minimal disability, 48.8% suffered some moderate temporary or permanent 
disability, and 4.9% died.   Reviewers judged that 51% of adverse events had high preventability, 
29.8% had low preventability and 19.0% were not preventable at all.   
 
The three studies are summarised in table 3.9 below.  While the Californian and Harvard studies are 
broadly in consensus, about both the incidence of adverse events and the proportion of negligent 
adverse events, the Australian study has rather different findings.   It suggests that adverse events are 
almost four times as common in Australia as in the USA, and almost half are judged preventable.  
There is no obvious explanation for this discrepancy, which could reflect differences in the research 
design, cultural or other differences in the implicit review process on which all three studies are 
founded, or differences in the actual quality of care (Brennan 1995). 
Study Setting Methodology Episodes 
examined 
All adverse 
events 
Negligent 
adverse events 
Negligence 
(%) 
Mills (1978) 23 hospitals in 
California 
Initial screening for 
potentially 
compensable events 
followed by case 
review 
20,864 
admissions 
970 (4.6%) 
of 
admissions 
165 (0.79% of 
admissions) 
17% 
Harvard 
Medical 
Practice 
Study (1990) 
51 hospitals in 
New York State 
Initial screening 
using generic 
adverse-event 
measure followed by 
case review 
30,121 
admissions 
1,278 
(4.1%) of 
admissions 
280 (0.93% of 
admissions) 
22% 
 Wilson, 
Runciman, 
Gibberd et al 
1995 
28 hospitals in 2 
states in 
Australia 
Initial screening 
followed by case 
review using 
modified Harvard 
Study measure 
14,179 
admissions 
2,353 
(16.6%) of 
admissions 
8.3% of 
admissions 
(note - 
preventability 
used, not 
negligence) 
51.2% 
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Table 3.9.  Summary of studies of adverse events, negligence and malpractice. 
 
 
Adverse events and quality assurance 
There are many anecdotal reports of experience in using adverse-event measures of the quality of 
healthcare in quality assurance, some of which are reviewed later in this chapter in an assessment of 
what can be learned about them from their application.  However, despite the widespread use that 
has been made of these measures, there are rather fewer quantitative reports of their results. 
 
Goldman and Walder (1992) report on the experience of the Veterans Administration healthcare 
system in the USA in using the adverse-event measure of quality which was described earlier.  Over 
a six month period in 1989-90, computerised screening using 9 criteria identified 57,841 admissions 
out of a total of 435,000 to be reviewed.   On review by quality assurance staff, 10,698 admissions 
were referred for peer review by medical staff.  The quality of care was judged to be acceptable in 
80.3% of cases, but 14.5% of cases “might have been handled differently” by experienced and 
competent practitioners, and 5.2% “should have been handled differently”.   No separate assessment 
of the avoidability of these adverse events was made. 
 
Bomhof, Arends and van der Beek (1993) report on a study of adverse events in the ENT 
department of an acute hospital.  Using an adverse-event measure developed with clinicians in the 
specialty, all admissions during 1989 were screened both by specialists within the department and 
separately by an external medical reviewer.  They found that 16-20% of admissions had one or more 
adverse events, and that the ENT specialists were much more likely than the external reviewer to 
identify adverse events which were specific to the specialty.   No assessment of the effects or 
avoidability of the adverse events was made. 
 
Walshe, Bennett and Ingram (1995) used a part-generic and part-specialty specific adverse-event 
measure to review 1,088 admissions in ophthalmology.  They found that while 64.2% of patients 
had no adverse events, 25.4% had one adverse event, and 10.5% had two or more adverse events.  
“Clinically relevant” adverse events constituted 37.2% of all events found, and included a variety of 
surgical complications.   Of the 31% of adverse events which were sent to a clinician for peer 
review, 41.3% were assessed to have had no effect on the patient, 33.9% had a minor effect, and 
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10.5% had a major effect (some could not be assessed).  About 21% of adverse events subjected to 
peer review were judged to have been avoidable.   
 
Wolff (1996) used a set of 8 generic screening criteria to review all inpatients admitted to a small 
acute hospital between 1991 and 1994.   A total of 15,912 admissions were reviewed, of which 
1,465 (9.1%) were found to have one or more adverse events according to the criteria in use.  
However, all these cases were then subject to peer review by medical staff, and only 155 (0.97% of 
all admissions and 10.6% of those initially identified by the criteria) were confirmed as adverse 
events.    A range of actions were initiated as a result for the 43.2% of adverse events which were 
judged to have been preventable in some way. 
 
These studies are summarised in table 3.10 below.  It can be seen that comparisons are difficult, 
particularly between the incidence rates of adverse events, because of the very different definitions 
of adverse events which were adopted. 
 
Study Setting Methodology Episodes 
examined 
Proportion 
with at least 
one adverse 
event 
Avoidable or 
preventable 
adverse events 
Avoidability 
 (%) 
Walshe, 
Bennett 
and Ingram 
(1995) 
Admissions in 
ophthalmology  
Prospective 
screening of 
patient records 
using an adverse-
event measure 
1,088 
admission 
35.8% Not all 
reviewed. 
21% 
(of those 
reviewed) 
Wolff 
(1996) 
Admissions to 
small acute 
hospital 
Prospective 
screening using 
adverse-event 
measure 
15,912 
admissions 
9.2% on 
screening; 
0.97% on 
peer review 
43.2% of 
confirmed 
adverse events 
43.2% 
Goldman 
(1992) 
Admissions to 
VA healthcare 
system 
Prospective 
automated 
screening using 
basic criteria, 
followed by QA 
staff review and 
peer review 
435,000 10,698 
(2.5%) of 
admissions 
485 (0.1%) 
“should have 
been managed 
differently” 
4.5% 
Bomhof, 
Arends and 
van der 
Beek 
(1993) 
Admissions in 
ENT in acute 
hospital 
Prospective 
screening of 
patient records by 
both specialists in 
ENT department 
and external 
medical reviewer 
921 
admissions 
(not all seen 
by both 
reviewers) 
16% 
(specialists 
review) 
20% 
(external 
reviewer) 
n/a n/a 
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Table 3.10.  Summary of studies of adverse events and quality measurement. 
 
Conclusions 
It must be acknowledged that some of the studies outlined above (summarised in tables 3.7, 3.9 and 
3.10) have serious methodological flaws, which limit the generalisability and power of their 
individual findings.   It is also clear that the adoption of different definitions and methods in 
identifying adverse events influences the results of the studies, and so comparisons, even among 
those which appear to be methodologically compatible, are invidious.  However, three common 
themes emerge. 
 
a) Causation.    
While a minority of adverse events can be clearly identified as having resulted from the 
healthcare process,  establishing causation is often complex.  While most of the studies cited 
paid attention to the causation of the adverse events they recorded, some sought stronger and 
more immediate evidence than others.  Most made use of implicit review by clinicians to 
determine causation, a process which is of unproven reliability and validity. Most viewed 
causation rather simplistically, focusing largely on determining whether or not the healthcare 
system was “at fault” rather than exploring the underlying causes and predisposing factors 
which caused or enabled the event to occur. 
 
b) Severity.   
All the studies are focused on adverse events which involve (or may involve) some harm to 
patients, but the severity of these events varies.  For example, Steel et al (1981) studied any 
illness resulting from a diagnostic or therapeutic intervention, however minor, while Couch 
et al (1981) focused on instances of serious harm.  Unsurprisingly, less severe events tend to 
be commoner, with the result that the severity threshold used in the study has a critical effect 
on the incidence of adverse events found.   The wide variation in the reported incidence of 
adverse events in the studies reviewed is thought to be largely a result of this definitional 
variation rather than of any underlying differences in the quality of care. 
 
c) Avoidability.    
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The concepts of avoidability, preventability and (sometimes) culpability are mentioned in 
many studies, and addressed in different ways.  Not all adverse events are avoidable, and 
some studies approach the problem by trying to identify all events and then separate out 
those which are avoidable, while others try to exclude unavoidable adverse events and focus 
solely on those events which are avoidable.  In most studies, the avoidability of events is 
assessed through implicit reviews - again, these are, at best, of unproven reliability. 
 
These studies concur in one key respect. They suggest that adverse events are an important 
and potentially preventable component of the demand for healthcare. Of all admissions to 
hospital, the research implies that around 5% result from adverse events, and half of those 
are preventable.   While patients are in hospital, around 20% suffer some form of adverse 
event, up to half of which are preventable, and a proportion of which involve major or life-
threatening illness.  It is clear from the research that these patients stay longer in hospital and 
cost more to treat.  Other studies show that about 20% of the deaths which occur in hospital 
are preventable, and result in part from adverse events.  In short, there is ample proof that 
adverse events are important both in terms of the resources they consume and their impact 
on the quality of care. 
 
Unsurprisingly, most studies call for more attention to be paid to the incidence, causation and 
prevention of adverse events.  Couch et al (1981) argue that “all hospitals should continuously 
survey final results ... to determine the prevalence of avoidable misadventure, and evolve 
surveillance and educational machinery that can minimise them”.    Steel et al (1981) concur, calling 
for “new methods of monitoring untoward occurrences in hospitalised patients, especially on 
medical services”.  However, most studies pay far more attention to describing and delineating the 
incidence and nature of adverse events than they do to developing or testing strategies for their 
prevention.  Most simply attribute the preventable or avoidable component of adverse events to the 
medical staff involved - writing of the “errors and lack of attention” on the part of physicians 
(Lakshmanan et al 1986), and calling for educational programmes to improve doctors' performance 
(Trunet et al 1980; Steel et al 1981).    In fact, the adverse events identified and documented in the 
studies reviewed above should be seen in the context of the wider literature on errors and the human 
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and organisational factors that cause them (Reason 1995) and the strategies for quality improvement 
which are needed to prevent them (Berwick 1996). 
 
 
3.3.3 Using adverse events in quality improvement 
 
It could be reasonably argued that, despite the relatively limited scientific literature on their 
development, adverse-event measures of the quality of care have been among the most widely used 
techniques in healthcare quality assurance.   In the terminology of Dick and Hegarty (1971), they 
have a high “cash validity”.   Some examples of the use of adverse events in quality assurance are 
presented below. 
 
Occurrence screening programmes in US healthcare 
While there are no definitive statistics available, the vast majority of US healthcare providers make 
some use of adverse-event measures in their quality assurance, risk management and associated 
activities.   The remarkable size and scope of quality assurance programmes in the USA healthcare 
system has already been discussed in chapter 2.  Methodologies based around the detection and 
analysis of adverse events play a central role in those programmes. The examples outlined below 
illustrate the approaches to using adverse event information in two hospital quality assurance 
programmes and a major hospital chain, and also describe an archetypal quality assurance 
programme used as a model by many hospitals and published by the American Hospital 
Association. 
 
The Medical Management Analysis (MMA) programme which was outlined earlier has been 
applied in at least two hundred US hospitals.  The Good Samaritan Medical Center in Phoenix, 
Arizona was one of the earliest users of the programme, in 1981.   It used six full-time screening 
staff, with nursing backgrounds, to perform concurrent reviews of all patients admitted to the 770 
bedded hospital.   About 15% of patients were found to have an adverse event, and about one third 
of these events were passed on to physician reviewers to assess severity, attribution and the standard 
of care.  There were close links between the programme and the risk management department of the 
hospital.   The programme is claimed to have identified a series of important quality problems, 
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through trends in adverse events, including defective medical supplies, technical problems relating 
to a particular surgeon's ability, and a series of avoidable obstetric complications resulting from a 
lack of staff training and supervision.   Other hospitals using the MMA programme have reported 
that it has assisted in identifying and rectifying quality problems related to physician behaviour and 
knowledge, medical records documentation, pharmacy practice, and excessive departmental 
workloads (Craddick and Bader 1983, p41).  
 
The Johns Hopkins Health System is a large healthcare provider based around the tertiary teaching 
hospital of Johns Hopkins in Baltimore, Maryland.  It has an extensive and detailed quality 
assurance programme, which is centred around concurrent quality monitoring for adverse events, 
carried out by quality assurance staff with a nursing background.  These staff visit patients on a daily 
basis, reviewing both resource utilisation and the quality of care.   In each review they use a total of 
49 adverse event definitions, subdivided into events concerned with admission, documentation, 
medical care, surgical care, drug usage, nonclinical events, discharge and, other miscellaneous 
events.   When problems are identified, they are taken up by a physician quality reviewer, who is 
responsible for taking follow-up action to resolve the issue.  Information on the incidence of adverse 
events is used by hospital quality assurance committees and the governing Board to monitor the 
quality of care (King and Jones 1989). 
 
The Veterans Administration (VA) healthcare system’s extensive use of an adverse-event measure 
of quality has already been discussed.   There have been mixed reports of the effectiveness of the 
approach in improving the quality of care (Goldman and Walder 1992).  For example, the VA 
Medical Center in Pennsylvania, reporting in positive terms on the process of establishing its 
successful occurrence screening programme, argued that the planning and implementation of the 
programme were very important in ensuring its acceptance (Citro et al 1988).  They suggested that 
occurrence screening had brought about timely corrective action through early problem 
identification, better problem resolution, better use of quality assurance resources, more effective 
use of clinicians' time, and greater integration of physicians into the quality assurance process.  
However, in contrast the VA Medical Center in Milwaukee suggested that their occurrence 
screening programme revealed few significant quality problems and was expensive to undertake 
(Erdmann 1990). 
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Integrated Quality Assessment (IQA) programme 
The Integrated Quality Assessment (IQA) programme was developed by Longo and colleagues 
(Longo, Ciccone and Lord 1989).  It is, in many ways, an updated equivalent of the MMA 
programme originated by Craddick and colleagues.   The programme is designed to integrate four 
key US hospital functions - quality assurance, risk management, infection control and utilisation 
review.   At the heart of the programme is a process of concurrent review, in which patients' care 
and treatment is screened on admission, periodically during their stay, and after discharge.  This 
screening process combines the abstraction of information on adverse events with the assessment of 
care against predefined quality standards, the measurement of illness severity and resource 
utilisation, the detection of infection, and focused reviews of other issues. 
 
The IQA programme uses occurrence screening alongside other quality measurement 
methodologies, rather than relying solely on a single technique.  It also allows for greater flexibility 
in determining the types of adverse events which are screened for, and the way in which the 
screening process is managed.  The authors of the IQA programme argue that its key benefits are the 
synergies and resource savings of integrating the four functions it contains, and its ability to identify 
and rectify quality problems while patients are still in hospital.   
 
Occurrence screening in the Medicare PRO programme 
The Medicare PRO programme’s use of occurrence screening, based on a generic adverse-event 
measure of quality, was discussed earlier.  Over the 1986-88 period, PROs performed over 6.6 
million case reviews.  Payment to the provider was denied in 4.2% of cases, though this figure 
ranged from 1.2% in one PRO to 25.5% in another.   PROs identified over 87,000 physicians during 
this period with some level of quality problem, and undertook over 70,000 specific quality 
interventions.   However, very few cases result in serious sanctions - just 83 physicians and one 
hospital over this period were excluded from the Medicare programme (Institute of Medicine 1990).   
The PRO programme has been monitored and evaluated continually since its inception, though this 
evaluation has focused on the timeliness and procedural correctness of the process, rather than its 
effectiveness in measuring and improving quality (Institute of Medicine 1990, p182).  In general, 
the programme has been criticised for being overfocused on utilisation issues, to the detriment of 
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quality concerns, for its centralised and inflexible review strategies and systems, and for the 
ambiguity and conflicts between its two roles - helping providers to improve the quality of care, and 
sanctioning or excluding poor providers.  The generic quality screens used by PROs have been 
widely criticised as both unreliable (in that different PROs yield quite different results, because they 
interpret and apply the generic screening tool differently) and insufficiently focused on genuine 
quality problems.  In particular, they have produced high rates of false positives (cases which fail the 
generic screen but actually have no quality problem) which has resulted in many costly and 
unnecessary physician reviews.   Having co-ordinated an Institute of Medicine evaluation of the 
programme (Institute of Medicine 1990), Lohr (1990) concluded that “the current system to assess 
and ensure quality is in general not very effective, and may have serious unintended consequences”. 
Although the PRO programme has since been revised, case review using an adverse event measure 
of quality remains an important component of its approach (Jencks and Wilensky 1992) 
 
Use of adverse events in risk management 
As a result of the high levels of malpractice litigation discussed earlier, most American hospitals 
have established risk management programmes, designed to minimise the hospital's exposure to 
risk, by detecting instances of malpractice and acting both to minimise their cost to the hospital and 
to prevent recurrence (Mills  and von Bolschwing 1995).   Generally, these use either an occurrence 
reporting system or some form of occurrence screening to identify adverse events in which there 
may be an element of malpractice.   These events are managed proactively, to try to settle them 
simply through communication with the patient or by making a small compensatory payment, with 
the aim of avoiding litigation.   Cases which do involve litigation are also managed proactively with 
the twin aims of minimising legal costs and securing a favourable legal outcome.   Perhaps most 
importantly, the information about adverse events is used to plan and implement prevention 
strategies, which may involve making organisational or individual changes in practice.   There is 
empirical evidence from a US study that hospitals with risk management programmes are subject to 
fewer successful legal claims and have lower total awards against them than those which do not use 
risk management, though it is difficult or even impossible to determine the causes of this 
relationship (Morlock and Malitz 1991).  Recently, most UK healthcare providers have also 
established risk management programmes, in the face of growing levels of malpractice litigation and 
changes in their legal liability (Bowden 1990; Clements 1995).  While there are few, if any, 
  
 
 
110
examples of UK healthcare providers screening for adverse events as part of their approach to risk 
management, almost all have established new reporting systems under which clinicians are expected 
to report adverse events. 
 
Canada 
While adverse event measures of quality have not been as widely used in Canada as in the USA, a 
survey of practice in one province suggested that 25% of healthcare providers had occurrence 
screening programmes in place (Barrable 1992), and their are a number of anecdotal accounts of the 
use of such approaches (Carlow 1988)   For example, Nordal and Ang (1988) describe the 
development of an occurrence screening programme at the Queen Elizabeth Hospital in Toronto 
where, they claim, it has had “tremendous value as a tool for reducing our exposure to risk 
situations, ensuring appropriate utilisation of hospital resources, and, most importantly, improving 
the quality of patient care”. 
 
Australia 
The first Australian institution to establish a quality assurance programme based on adverse event 
analysis was the Royal North Shore Hospital in Sydney.   Initially, the hospital adopted the MMA 
programme outlined earlier almost in its entirety.  However, dissatisfaction with the costs involved 
and antagonism from the hospital's medical staff towards the programme soon led to its redesign.  A 
much smaller team of screening staff was established, to undertake screening of a targeted sample of 
patients in certain groups with a higher risk of adverse events.  The mechanisms for peer review in 
specialties adopted from the MMA programme had not worked well, and a smaller central team of 
medical assessors was established.  With these revisions, the programme has became more effective 
and efficient (Stuart 1989).  Other Australian hospitals have also experimented with occurrence 
screening, albeit on a smaller scale than the Royal North Shore Hospital project.   The Royal Perth 
Hospital has undertaken a series of occurrence screening studies in individual specialties 
(Lawrence-Brown and Manning 1989; Manning and Lawrence-Brown 1990) which have concluded 
that the approach is “worthwhile, productive and rewarding” (Lawrence-Brown and Manning 1989).   
At the Royal Adelaide Hospital, a comprehensive screening instrument covering both adverse 
events and other issues was developed and piloted, but the project lacked the cooperation and 
involvement of many medical staff, and unsurprisingly its findings were inconclusive (Burr 1990).  
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In a rather different setting, the 200-bed Wimmera Base Hospital established an occurrence 
screening programme in 1988, and reported that it had identified a series of important quality 
problems, resulting in changes to protocols for transfusion, better preoperative assessment of fitness 
for anaesthesia, and reduced misprescribing of diuretics (Wolff 1992; Wolff 1995).  Wolff 
concluded: 
 
“Occurrence screening provides an efficient, integrated and coordinated approach to 
quality assurance in hospitals.   Occurrence screening using a limited number of 
criteria and retrospective review has the potential to provide a simple, inexpensive 
and effective medical quality control system suitable for medium size hospitals.” 
(Wolff 1992) 
 
United Kingdom 
Systems based on the detection and analysis of adverse events in healthcare have existed in the 
National Health Service (NHS) for some time.  The longstanding Confidential Enquiry into 
Maternal Deaths (Department of Health 1991a) and the more recent National Confidential Enquiry 
into Perioperative Deaths (NCEPOD 1989) are both studies of a single type of adverse event - 
unexpected or potentially avoidable deaths.   Most hospitals have systems for recording certain sorts 
of adverse events, such as patient accidents and medication errors.  Many pharmacy departments 
routinely review patient records to identify drug prescribing or administration problems and 
intervene to change practice.  However, these systems have been fragmented, isolated, and often 
little used in quality measurement or improvement. 
 
The first trial of an adverse event based quality measure took place at Hove Hospital, a small acute 
hospital in Sussex (Stevens and Bennett 1989).   A sample of 250 cases were screened 
retrospectively for adverse events, using a set of generic screening criteria based on those developed 
by Craddick.   The trial, which was primarily directed at testing the methodology, found that over 
90% of cases in the sample, which was drawn from three specialties, could be screened for adverse 
events in less than 10 minutes, and that 20% of cases in the sample had one or more adverse events.  
It concluded that the approach “could be practically applied in a British hospital” (Stevens and 
Bennett 1989). 
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Other British hospitals have also made some use of occurrence screening, in their growing clinical 
audit and quality assurance programmes.  For example, Bromley Health Authority established an 
extensive system of occurrence screening, based closely on the MMA model (Lyall 1990).   Using 
11 nursing staff to perform concurrent reviews of all patients throughout the district's acute services.  
Writing shortly after the system's introduction, Lyall (1990) reported that improved recordkeeping 
and fewer patient complaints had resulted from the occurrence screening programme.   In a smaller 
study in Bath, Lewis and Charny (1992) developed and used specialty-specific adverse-event 
screening criteria, and outside the hospital setting, Smith (1992) reported the small scale application 
of an adverse-event measure in general practice.     
 
A research project was established at the Royal Sussex County Hospital in Brighton in 1989 to test 
the use of adverse events in healthcare quality assurance in the UK (Walshe, Bennett and Ingram 
1995).  It had four main aims: 
 
a) To investigate the reliability and validity of adverse-event measures in the measurement of 
the quality of healthcare in acute services. 
 
b) To establish whether the information produced by adverse-event measures of quality could 
be analysed and fed back to clinicians in a timely and relevant format which they found 
useful in medical audit and quality assurance activities. 
 
c) To assess whether the provision of information about adverse events, through adverse-event 
measures of quality, identifies areas where quality improvements are needed, and whether 
those quality improvements are made. 
 
d) To identify the costs involved in applying adverse-event measures of quality in the setting of 
a British district general hospital. 
 
The development of adverse-event measures commenced in January 1990, and screening for 
adverse events began in February 1990.   Screening for adverse events continued until the end of the 
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project in April 1992.   During that 26 month period, adverse-event measures were developed and 
applied in a total of 12 different specialties, for periods ranging from 4 months to 26 months.  In 
aggregate, over 13,000 patient episodes were screened for adverse events during the project's life, 
involving 12 specialties (Walshe, Bennett and Ingram 1995). The research reported in later chapters 
of this thesis was carried out as part of this project. 
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3.4. Evaluation of adverse-event measures of quality 
 
 
3.4.1 Merits and demerits of adverse-event measures 
 
Philosophical and conceptual issues 
Our attitudes to approaches to quality measurement are shaped by a combination of theoretical and 
methodological innovation, practical experience and empirical findings, and developments within 
the healthcare system itself.  At times, certain methodologies and theories become in vogue, then 
lose popularity as the collective consensus about their value shifts.   For example, in the USA 
criterion-based quality assessment methodologies were very widely used in the early and mid-
1970s, then fell into disrepute as concerns about their reliability and effectiveness grew, and then 
returned to favour again in the late 1980s and 1990s.  In the late 1970s and early 1980s, problem-
focused approaches to quality became widely preferred, and adverse-event measures of quality came 
to predominate in quality assurance activities.   
 
However, in the late 1980s, they too began to be criticised for a number of reasons by both 
researchers and practitioners in the field - especially by those espousing the ideas and methods of 
continuous quality improvement (O'Leary 1991; Laffel and Blumenthal 1989).  In particular, it was 
suggested that adverse-event measures focus attention on inspection for quality problems (after the 
event), rather than on the prevention of quality problems.  It was argued that they promote a view of 
healthcare workers which sees them as potentially deficient and incompetent rather than as generally 
committed to high quality, and that these measures tend to present quality problems as the result of 
individual practitioners' behaviour rather than as the result of system or process mechanisms.  It was 
also asserted that adverse-event measures focus attention on bringing outliers - cases or practitioners 
different from the norm - into the mainstream, rather than making the quality of care in the 
mainstream improve (in the language of CQI, shifting the distribution), and that the resulting quality 
assurance activities address individual cases rather than aggregate trends 
 
There is certainly some justification for these arguments, and they are explored further below.  
However, it also seems that they confuse the properties of adverse-event measures of quality with 
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the characteristics of their application in a particular setting - the US healthcare system of the 1980s.  
It is undoubtedly true that adverse-event measures of quality have been used as described above, in 
an adversarial and inspection-based quality paradigm of the sort that Berwick (1989) and others 
regard as unhelpful.   However, the measures themselves are not inherently so directed - it has been 
the application of the information they yield in monitoring physicians and hospitals that perhaps 
deserves criticism, rather than the measures themselves. 
 
It can also be argued that the concept of using adverse event information is actually central to CQI.  
The oft-quoted maxim “every defect is a treasure” (Berwick 1989) embodies the cardinal concept of 
CQI, that quality problems represent opportunities for quality improvement, and so their discovery 
should be valued and prioritised.  The pioneers of CQI outside healthcare, use adverse event 
information extensively in measuring systems' performance and identifying avenues for process 
improvement.  Deming (1986, p203), offers a series of potential quality indicators in healthcare, of 
which two thirds are adverse event based.   Kritchevsky and Simmons (1991) make the importance 
of adverse event information in CQI very clear.  They maintain that to improve quality, an 
understanding of the nature of quality problems within a system must be matched by monitoring of 
the incidence of those problems, study of their causes, and evaluation of the efficacy of changes to 
the system in reducing their incidence. 
 
In conclusion, adverse-event measures are an important (and, arguably, a crucial) part of quality 
assessment.  Like any measure, they can be misused and misapplied, but their value to healthcare 
quality assurance should be assessed on their genuine merits and demerits (discussed below) rather 
than on instances of their misapplication. 
 
Merits of adverse-event measures 
Developers and users of adverse-event measures of quality have cited a wide range of perceived 
merits (Craddick 1979; Craddick and Bader 1983; Bennett and Walshe 1990; Wolff 1992; and 
others): 
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a) Systematism.   
The occurrence screening process outlined in previous sections of this chapter is highly 
systematic.  The centralised process of case review by screening staff provides a controllable 
and manageable mechanism for data collection in which sample selection, data collection 
methods, and other aspects can all be systematically determined and varied as required.   It 
also facilitates rigorous training and regular monitoring of screening staff (since relatively 
small numbers of staff are involved) which should help to establish and maintain high 
standards of reliability. 
 
b) Integration.   
Since occurrence screening can combine data collection for infection control, utilisation 
review, quality assurance and risk management, it is often perceived or presented as an 
efficient and integrated methodology, able to serve multiple separate but related data needs. 
 
c) Flexibility.   
Despite the centralisation of the data collection mechanism, occurrence screening can make 
use of a wide range of different adverse event definitions, tailored for specific specialties or 
patient groups.  Detailed studies on specific sorts of adverse events can be performed, and 
new adverse-event measures can easily be incorporated.  This flexibility allows occurrence 
screening systems to respond rapidly to new data needs or to clinician requirements. 
 
d) Objectivity.   
Since adverse-event measures are designed to detect incidents which are generally agreed to 
represent or indicate a poor quality of care, the resulting information is often claimed to be 
more objective than that gathered by less clearly defined and explicit methodologies. 
 
e) Use of clinician time.   
When adverse-event measures are used, clinicians are generally not involved in the process 
of primary review.  Usually, clinicians are involved in deciding what adverse-event 
measures will be used, and then in the subsequent review of those cases where adverse 
events are found - in assessing the individual incidents, and in planning and implementing 
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quality improvements.  This, it can be argued, minimises the amount of clinician time which 
must be devoted to quality assurance, and makes the most effective use of that time in 
activities which genuinely require the clinician's expertise. 
 
f) Timeliness.   
Both concurrent and retrospective review for adverse events produce information close to 
the time when events actually occurred which, it is argued, makes review processes more 
effective and the alteration of practice more attainable.  Indeed, proponents of concurrent 
review assert that through the real-time detection of adverse events, their effects on patients 
can be minimised and potential subsequent adverse events can be prevented. 
 
g) Patient focus.   
Adverse-event measures of quality are patient focused, gathering data about all aspects of 
the care provided to patients.  Some authors suggest that many adverse events result from 
interdepartment or interprofession rather than intradepartment or intraprofession problems.  
A profession or department centred quality measure might miss those quality problems, 
because they lie on the periphery of each individual department's or profession's concerns.   
By contrast, a patient focused measure can identify these interdepartment or interprofession 
issues.   It is also suggested that adverse-event measures, since they are centred on 
undesirable events which impact (or potentially impact) on patients themselves may provide 
a more valid measure of quality than other measures which are more driven by clinicians' 
interests or provider concerns and activities. 
 
h) Causation focus.   
Most adverse-event measures of quality make some use of an investigation of the causes of 
adverse events.  It is contended that this attention to the processes and circumstances which 
cause events makes it easier to identify suitable improvements to systems or processes to 
prevent similar events in the future. 
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i) Corrective action focus.   
Quality assurance programmes using adverse-event measures of quality generally have 
formal mechanisms for recording the causes of adverse events and the action taken to rectify 
or prevent them.  It has been claimed that this focus on taking and recording corrective 
action makes these programmes more likely to succeed in producing and maintaining quality 
improvements. 
 
j) Liability limitation.   
There is frequently a link between adverse-event measures of quality and parallel risk 
management programmes, which are aimed at reducing medical negligence liability.  Thus 
the liability implications of adverse events are actively considered, and potential liability is a 
factor in planning and implementing quality improvements.  Even where such a link does 
not exist, it is argued that the focus on adverse events (and their causation and prevention) is 
likely to have some limiting effect on levels of liability. 
 
k) Trend identification.   
The ability to link together series of adverse events and thereby to discover significant trends 
or patterns (sometimes called trending) is often cited by users and developers of adverse-
event measures of quality as an important advantage, in that it can reveal quality problems 
which might otherwise remain undetected.  In particular, it is argued that systematic 
screening for adverse events across many departments or specialties can highlight causal 
links between isolated events in different areas, or can reveal a series of less serious adverse 
events in time to allow action to be taken to prevent a potentially much more serious event. 
 
l) Cost savings.   
If adverse-event focused quality programmes are successful in preventing future adverse 
events, they are likely to reduce overall healthcare costs.  Within the healthcare organisation, 
many adverse events will be followed by reworking or remedial action, which is costly (for 
example, the return to theatre of a patient where the first operation was not successful).  
Moreover, the liability limitation effects described above should also reduce the healthcare 
organisation's insurance or litigation costs. 
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Demerits of adverse-event measures 
While the developers and users of adverse-event measures of quality have asserted they offer many 
advantages, their critics have suggested that there are important deficiencies in such measures which 
limit their usefulness (Sanazaro and Mills 1991; O'Leary 1991; Laffel and Berwick 1992; and 
others): 
 
a) Negativity.   
Perhaps the most common criticism of adverse-event measures is that they focus attention 
and quality improvement efforts on the negative (what has been labelled disquality), to the 
exclusion of other important facets of quality.  This may bias our assessment of quality in a 
number of ways - for example, towards technical quality and away from interpersonal or art-
of-care quality issues.  It is also argued that the negativity of adverse-event measures arouses 
defensiveness and self-justification, and leads, almost inevitably, to a quality assurance 
process which is negative, punitive, and adversarial in its orientation. 
 
b) Outlier bias.   
It has been argued that adverse-event measures tend to focus attention on outliers - patients 
or clinicians whose care lies outside the patterns of the majority - rather than on quality 
issues concerning the practices and treatment of all practitioners.   This may mean that poor 
quality is tolerated simply because it is endemic or part of accepted practice.  Critics contend 
that this overattention to the periphery (rather than the centre) of practice reduces the ability 
of quality assurance to bring about meaningful quality improvements.  
 
c) Infrequent events.   
Serious adverse events are usually relatively infrequent occurrences.  This means that 
detecting them may require the screening of many patient records where no event is found - 
so the cost of each actual event detected is quite high.  The value for quality assessment of 
the negative information yielded by screening (that most patients do not have a serious 
adverse event) may be relatively limited.   It also means that, even when a number of events 
are found, the small numbers involved make statistical comparative analysis practically 
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impossible.  This infrequency of significant events is sometime referred to as the small-n 
problem. 
 
d) Difficulty defining events.   
Adverse-event measures are relatively easy to design for areas of healthcare in which 
patients with single pathologies are treated with clearly defined interventions to achieve 
explicit and measurable goals - examples might include obstetrics, or elective surgery.  They 
are much harder to define for areas in which patients have multiple pathologies some of 
which may be chronic in nature, and receive many overlapping interventions - examples 
might include general medicine or psychiatry.  In these areas, it may be very difficult to 
define meaningful adverse events in terms sufficiently explicit to permit screening.  It may 
also be much more difficult, once adverse events are identified, to establish their causes. 
 
e) Patient safety bias.    
Adverse-event measures are sometime characterised as defining quality solely or primarily 
in terms of patient safety, to the exclusion of other important facets of quality, particularly 
appropriateness.  It is argued that this overemphasis on safety may discourage worthwhile, 
desirable but risky interventions, and may stifle innovations in practice which would be to 
the long-term good of patients. 
 
f) Individual case bias.   
Although the advocates of adverse-event measures suggest that rates and trends in events 
can and should be used to detect and address quality issues, critics assert that they are not so 
used.  They argue that too much attention is given to assessing the causation of and 
assigning responsibility for individual adverse events, drawing attention away from 
underlying systemic quality problems. 
 
g) Low reliability.   
Although the reliability of adverse-event measures has not been well researched, a number 
of authors have suggested that they are not particularly reliable, especially when definitions 
of adverse events are vague or non-specific, and much is left to the rater's discretion or 
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professional judgement.  The evidence for the reliability of adverse-event measures is 
reviewed in detail below. 
 
h) Low validity.    
Some critics simply contend that there is little or no inherent relationship between the 
incidence of adverse events and the quality of care (though this depends on what is meant by 
quality of care).   They argue that adverse-event measures may be able to evaluate levels of 
iatrogenic risk, or potential liabilities, but they are not good indicators of quality.  The issues 
surrounding validity, and the available evidence, is reviewed in detail below.  
 
h) Reliance on implicit reviews.   
Many adverse-event measures make extensive use of professional review, frequently with 
no explicit criteria to guide those professional judgements.  These implicit reviews are used 
to assess causation, to assign responsibility, to plan further action, and so on.  However, 
these multitiered review systems can be very expensive to implement (especially if the 
primary review produces large numbers of cases for professional review, or if multiple 
reviews are required).  There is also a well-established body of evidence that such reviews 
are, even in the best of circumstances, not necessarily reliable or valid.  Hence the 
information they yield, at some considerable cost, may be of little value. 
 
i) Cost.   
The costs of using adverse-event measures of quality are dependent on the method and 
circumstances of their application.  However, since some proponents of these measures have 
advocated concurrent review of the whole population of patients it is not surprising that 
some critics have labelled the process as unduly expensive.  The limited empirical evidence 
available as to the costs of adverse-event measures is reviewed in more detail below, and the 
costs must be balanced against the potential costs savings outlined above. 
 
Many of the advantages and disadvantages of adverse-event measures of quality outlined above are 
highly subjective, and open to the different interpretations of the proponents and critics of such 
measures.   However, the validity and reliability of these measures do permit a more scientific, 
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objective and quantitative evaluation, and the available evidence on these important aspects of the 
measures' worth is outlined in the following sections. 
 
 
3.4.2 Validity of adverse-event measures of quality 
 
In chapter 2, the concept of validity was defined and explored, and a number of approaches to 
instrument validation were discussed.  The importance of validating a measure in the context or 
environment in which it is to be used, and the desirability of using a number of validation techniques 
rather than a single approach were both highlighted.  In this section, the relatively limited empirical 
evidence available for the face and content validity, criterion-related validity and construct validity 
of adverse-event measures is critically reviewed. 
 
Face and content validity 
Face validity is a measure of whether an instrument seems reasonable, and produces reasonable 
data, from the viewpoint of its users.  Content validity is a measure of whether the items within an 
instrument adequately reflect the conceptual definition of its scope.  Neither face nor content 
validity can be assessed empirically.  Instead, the opinions of expert panels or user groups are 
sought, and this information is used to explore the face and content validity. In this relatively 
subjective form of validity analysis, it is important that a broad and representative range of opinion 
is sought; that the instruments used to gather opinions are themselves carefully designed and 
applied; and that a number of approaches (rather than a single approach) to assessing face and 
content validity are employed, so that the results of different approaches can be compared. 
 
Disappointingly, the literature yields no substantial published studies of the face or content validity 
of any adverse-event measures of healthcare quality.   Panniers and Newlander (1986) report briefly 
that they tested the content validity of the APO inventory (an adverse-event measure which was 
discussed in earlier), using an expert panel consisting of one doctor and three nurses.  Regrettably, 
they do not offer any specific results from this exercise.  Richards et al (1988) used a panel of three 
doctors to rate the “adversity” of each element of the APO inventory, and reported that “all of the 
weights obtained were negative, and the physicians generally agreed with one another in their 
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evaluations”.   The small size of the expert panels used and the brevity with which their findings are 
reported severely limit the usefulness of these two studies. 
 
Criterion-related validity 
Criterion-related validity is a measure of the relationship between measurements made using an 
instrument and an external variable (the criterion, sometimes called the gold standard) with which it 
is expected to correlate.  In assessing the criterion-related validity of an adverse-event measure of 
healthcare quality, the most important and difficult issue is the selection of an appropriate criterion.  
The few researchers who have studied the criterion-related validity of adverse-event measures have 
mostly used some form of implicit professional assessment of the quality of care as their criterion.  
While this is obviously simpler to perform than identifying a separate explicit measure of the quality 
of care as the criterion, the acknowledged low validity and reliability of implicit professional 
judgements (Brook and Appel 1973; Hulka 1979; Goldman 1992; Caplan, Posner and Cheney 1991) 
present serious methodological difficulties, and must be considered in interpreting the results of 
these studies. 
 
Barnes and Moynihan (1988) used data from the SuperPRO project, which rereviews a sample of 
records from each Peer Review Organisation (PRO), in an attempt to “assess both the accuracy and 
the efficiency of the generic screens in identifying deficiencies”.  They compared the results of the 
primary screening for adverse events with the professional opinion of a physician reviewer on 
whether a quality problem existed (see table 3.11), and found the primary screening had a sensitivity 
of 48.5% and a specificity of 72.8%.  They also found that the adverse events missed by the primary 
screening tended to be the less important ones, and that some adverse event definitions in the PRO 
generic screens were much more effective at identifying genuine quality problems than others.  
Barnes and Moynihan (1988) concluded that while “generic screens perform well in identifying the 
most serious quality problems”, modifying some of the generic screens and providing more specific 
guidelines on their interpretation would improve their validity.   
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 Professional assessment by physician reviewer Totals 
 Quality problem(s) 
identified 
No quality problems 
identified 
 
 
Primary 
screening by 
nurse 
reviewer 
Adverse 
event(s) found 
162 
(5.0%) 
792 
(24.4%) 
954 
(29.3%) 
 No adverse 
events found 
172 
(5.3%) 
2,126 
(65.4%) 
2,298 
(70.7%) 
Totals 
 
334 
(10.3%) 
2,918 
(89.7%) 
3,252 
(100.0%) 
 
Table 3.11.  Comparison of the results of primary screening and physician assessment. 
Barnes and Moynihan (1988) 
 
The study is interesting, but methodologically weak.  Firstly, the range of adverse events identified 
by the PRO generic screens is collapsed to a single dichotomous variable - the presence or absence 
of an adverse event or events, both for the primary screening and the secondary review.  This means 
that the identification of quite different adverse events by primary screening and secondary review 
would falsely suggest agreement, and so the quantitative measures of validity may be inaccurate.  
Secondly, there is a complete absence of rigour in defining and measuring the criterion variable to 
which primary screening was compared - that is, the professional assessment of “whether a quality 
problem existed” (Barnes and Moynihan 1988).  Moreover, since physician reviewers were aware of 
the findings of the primary screening, the two can hardly be said to be independent.  These flaws 
mean Barnes and Moynihan's conclusions, though a useful contribution to the specific debate about 
the value of the PRO programme, must be treated with some caution. 
 
The Institute of Medicine (1990, p185) presented further evidence of the relationship between 
primary screening and the presence of confirmed quality problems in the PRO programme, for a 
sample of 6.3 million cases reviewed by PROs up to June 1989.  For those cases where an adverse 
event was identified in primary screening, between 7.5% and 71.3% were subsequently shown 
through the PRO professional review mechanisms to have a confirmed quality problem (see table 
3.12).  These findings provide some support for Barnes and Moynihan's conclusions - particularly 
their finding that different adverse event definitions have different degrees of validity. 
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Generic screen Percent with adverse event 
identified at primary 
screening 
Percent of primary 
screening adverse events 
confirmed as quality 
problem 
Adequacy of discharge planning 3.1% 71.3% 
Medical stability of patient on discharge 12.5% 10.6% 
Deaths 1.5% 7.5% 
Nosocomial infections 7.8% 35.7% 
Unscheduled return to surgery 1.0% 7.6% 
Trauma suffered in hospital 4.9% 20.8% 
 
Table 3.12.  Rates of adverse events and confirmed quality problems in the PRO programme 
Base for table: 6,309,839 cases reviewed up to June 1989 by PROs. 
Institute of Medicine (1990, p185). 
 
 
Brennan, Localio and Laird (1989) examined the validity of an adverse-event measure of quality 
which they had themselves developed for use in the Harvard Medical Practice Study.  They 
performed multiple reviews of 360 cases, each of which was reviewed separately by two medical 
records administrators and by a senior physician.  A total of 672 pairs of reviews were performed, 
and the results are shown in table 3.13.  For the 360 cases (which were deliberately selected to 
include many cases with adverse events) the sensitivity was 84.5% and the specificity was 71.8%.  
However, adjusting for the estimated incidence of adverse events in the population of patients from 
which the sample had been drawn, the estimated sensitivity was 21% and the estimated specificity 
was 99.5%.   Brennan, Localio and Laird (1989) argued that “the careful completion of the 
screening process by senior physicians was the best approximation to a gold standard that we could 
develop”, and concluded that despite the very high false positive rate signalled by a sensitivity of 
21%, their adverse-event measure was valid for wider use in the Harvard Medical Practice Study. 
 
Like Barnes and Moynihan (1988), Brennan, Localio and Laird (1989) collapsed the range of 
adverse events in their measure to a single dichotomous variable for validity assessment, and used a 
single physician review as the criterion variable, and so there must be some concern about the 
generalisability of their results. 
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 Senior physician review Totals 
 Criteria present Criteria not present  
Medical records 
administrator 
review 
Criteria present 403 
(60.0%) 
55 
(8.2%) 
458 
(68.1%) 
 Criteria not 
present 
74 
(11.0%) 
140 
(20.8%) 
214 
(31.8%) 
Totals 
 
334 
(49.7%) 
195 
(29.0%) 
672 
(100.0%) 
 
Table 3.13.  Comparison of the results of medical record administrator  
and senior physician reviews.  Brennan, Localio and Laird (1989). 
 
Bates et al (1995) reviewed 3,137 admissions to an acute hospital, using a generic adverse-event 
measure applied by medical records staff.  Records which they identified as containing an adverse 
event were they reviewed by a medical reviewer, who determined whether an adverse event had 
occurred or not, whether it was preventable and how serious it was using his or her professional 
judgement in an implicit review.   Unlike the other studies detailed above, Bates et al (1995) did not 
collapse the results of screening to a single variable, but presented sensitivity and specificity data 
separately for each criterion in their adverse-event measure.  In table 3.14, these results are 
presented alongside odds ratios derived from a logistic regression with the presence or absence of an 
adverse event as the dependent variable and the various screening criteria as the independent 
variables. 
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Criterion Sensitivity Specificity Odds ratio (95% 
CI) 
 
Prior hospitalisation 68 56 2.5 (1.9 - 3.2) 
Readmission to any hospital 28 80 1.5 (1.1 - 2.0) 
Hospital incurred trauma 16 97 3.6 (2.3 - 5.5) 
Transfer to special care unit 12 98 2.8 (1.7 - 4.6) 
Adverse drug reaction 10 99 6.7 (3.9 - 12.0) 
Death 9 97 1.8 (1.1 - 3.0) 
Cardiorespiratory arrest 7 98 not reported 
Return to operating room 7 99 2.7 (1.2 - 6.1) 
New neurologic deficit at discharge 6 99 2.5 (1.2 - 5.4) 
MI, CVA or PE during or after an invasive procedure 5 99 2.8 (1.3 - 5.8) 
Treatment or operation because of damage subsequent to an 
invasive procedure 
4 99 not reported 
Transfer to another hospital 4 98 not reported 
Other 12 96 2.1 (1.3 - 3.3) 
 
Table 3.14.  The sensitivity and specificity of screening criteria in detecting adverse events 
identified through physician reviews. Bates, O’Neil, Petersen et al (1995). 
 
These results suggest that most criteria had poor sensitivity, and would produce large numbers of 
false positive results, though it should be noted that most were significantly correlated with the 
presence of adverse events in the logistic regression.   Again, the reliance of the study on implicit 
professional review by a single clinician as the criterion against which validity is assessed is a 
serious weakness.   In addition, since the clinician reviewers only reviewed those cases where an 
adverse event was found in screening, they were not truly blinded to the results of the first 
screening.   In order to allow sensitivity and specificity calculations, a clinician reviewer did review 
a random sample of 25% of screen negative cases, and this was used to extrapolate to the 75% of 
screen negative cases that had not been reviewed, but again the absence of blinding to the results of 
screening is unfortunate. 
 
The only published research into the validity of adverse-event measures which does not use implicit 
professional reviews as the criterion variable was carried out as part of a much larger examination of 
the differences between teaching and non-teaching hospitals (Richards et al 1988).   Richards and 
colleagues applied an adverse-event measure (the APO inventory), a severity of illness measure (the 
Severity of Illness Index) and a number of condition-specific criterion-based quality measures for 
myocardial infarctions, gallbladder disease, benign prostatic hypertrophy, and a series of other 
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conditions.  These criterion-based measures worked by applying a set of standards for the 
management of the given condition to each case, and scoring the case on the degree of compliance 
with the standard found.  The instruments were applied to a sample of about 25,000 patients from 45 
hospitals.   Correlation coefficients between the APO inventory and the criterion-based quality 
measures ranged from 0.03 to 0.65 (see table 3.15).  Richards et al (1988) suggested that stronger 
correlations were observed for the more serious conditions because the APO inventory was made up 
of relatively serious and clinically significant adverse events, which were very unlikely to occur in 
some diseases, and which only occurred to a small minority of patients. 
 
Condition-specific criterion-based quality of 
care measure 
No of cases in sample Correlation with APO inventory 
score (weighted) 
Myocardial infarction 680 0.63 
Gallbladder disease 678 0.22 
Benign prostatic hypertrophy 618 0.16 
Asthma 616 0.06 
Gastroenteritis 553 0.03 
Upper gastrointestinal haemorrhage 619 0.65 
 
Table 3.15.  Correlations between condition-specific criterion-based quality of care measures 
and APO inventory scores.  Richards, Lurie, Rogers et al (1988). 
 
 
There is surprisingly little published evidence for the criterion-related validity of adverse-event 
measures of healthcare quality.  Of the few existing studies, all but one are marred by their 
dependence for the criterion variable on implicit reviews performed by individual physicians with 
few or no guidelines and little attention to review reliability.   Nevertheless, three important points 
can be drawn from this research.  Firstly, four of the studies cited above suggest that adverse-event 
measures may suffer from high false positive rates - identifying cases as having adverse events when 
in fact they contain no real quality problem.  Although the studies are not conceptually or 
methodologically clear about what a quality problem consists of, this apparent hair trigger effect is 
worthy of further investigation.   Secondly, some studies indicate that different individual adverse 
event definitions may have quite different validity characteristics.  This implies that the validity of 
adverse-event measures may be crucially dependent on the mixture of adverse events they contain, 
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and that attempts to develop or test adverse-event measures should pay attention to the individual 
items included within the instrument rather than relying on aggregate scores.   Thirdly, it seems 
from one study that adverse-event measures of quality may exhibit a floor effect, providing a valid 
measure of quality only for those patients whose illness is relatively severe.  With these provisos, the 
existing research supports the cautious conclusion that adverse-event measures can be valid 
indicators of the quality of care.  
 
Construct validity  
Construct validity is a measure of how well an instrument supports or conforms with theories or 
constructs.   Exploring the construct validity of adverse-event measures of quality is difficult, 
because there are few established theories and constructs about the distribution and effects of 
adverse events for researchers to test.   In fact, three theoretical constructs have been examined by 
researchers: 
 
a) Length of stay and resource usage.   
It can reasonably be expected that a correlation should exist between adverse-event 
measures of quality and measures of resource usage such as patients' length of stay in 
hospital or costs of treatment.  Patients who suffer adverse events are likely to require further 
treatment for the effects of those events - increasing their stay in hospital, and increasing the 
costs of treatment.  Conversely, patients who stay longer in hospital have greater exposure to 
the risk of suffering adverse events, and so should have higher adverse event rates.  While 
the effects of these two relationships would be difficult to separate, both should result in a 
positive correlation between the incidence of adverse events and length of stay or costs of 
treatment. 
 
Panniers and Newlander (1986) applied an adverse-event measure, the APO inventory, to 
426 patients with myocardial infarctions, and demonstrated that patients who had suffered 
adverse events both stayed significantly longer in hospital and had significantly higher total 
treatment costs (for both p < 0.001).  In a second, related study of a further 354 patients with 
the same diagnosis, Panniers (1987) again found significant correlations between APO 
inventory scores and both length of stay and treatment costs.  Richards et al (1988), whose 
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extensive study is outlined above, also found a “mild correlation” between APO inventory 
scores and length of stay, and concluded that “longer lengths of stay are associated with 
more adverse occurrences” (Richards et al 1988).  Thus, the findings of three separate 
research studies all support the construct validity of the adverse-event measures they used. 
 
b) Severity of illness on admission.   
Patients who are more severely ill are generally more difficult to treat and complex to 
manage.  It seems likely that in this more complex treatment, the opportunities and risks of 
adverse events would also be higher, so a positive correlation between admission severity 
and adverse-event measures of quality might be expected. 
 
Panniers (1987) showed that for her sample of 354 patients with myocardial infarctions, 
there was a significant relationship between APO inventory scores and severity of illness on 
admission, as measured by the AS-SCORE severity of illness measure (p < 0.001). 
Schumacher, Parker, Kofie et al (1987) reviewed 752 cases drawn from 7 hospitals, using 
both the APO inventory and the Severity of Illness Index (SII).  They demonstrated that 
patients' adverse-event measure scores and their severity of illness scores were related (p < 
0.0001), and that more severely ill patients tended to have more adverse events.   Richards et 
al (1988) concurred, finding a significant correlation between APO inventory scores and 
Severity of Illness Index scores (Richards et al 1988).   Again, all three research studies 
support the construct validity of the adverse-event measures they tested.   However, both the 
severity of illness measures used (AS-SCORE and SII) include some hospital complications, 
which may result in these measures being influenced by adverse events which occur during 
an admission.  Thus, the positive correlations observed in these studies may be at least in 
part spurious. 
 
c) Hospital characteristics.   
There is widespread evidence that different types of hospital provide different levels of 
healthcare quality, and that factors such as the hospital's size, facilities, teaching status and 
location can be important predictors of quality.  It might reasonably be expected that 
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adverse-event measures of quality would show patterns of variation across institutions which 
echo those of other studies of healthcare quality. 
 
Richards et al (1988) found few significant differences in APO inventory scores across 
groups of teaching and non-teaching hospitals.  However, for some particular conditions, 
such as myocardial infarction and gastrointestinal haemorrhage, mild trends were observed, 
with more adverse events occurring in teaching hospitals.  Brennan et al (1991a) used the 
database of the Harvard Medical Practice Study (containing 31,000 patient records) to 
examine patterns in the incidence of adverse events across 51 hospitals in New York during 
1984.   A large variation in adverse event rates across hospitals was found (ranging from 
0.2% to 7.9%, mean 3.2%).   All adverse events had been reviewed to determine negligence, 
and the proportion of adverse events deemed negligent varied from 1% to 60% (mean 
24.9%).   They found that primary teaching hospitals had significantly higher adverse event 
rates, and rural hospitals had significantly lower rates.  They also observed that the 
proportion of adverse events due to negligence was lower in teaching hospitals and in 
proprietary hospitals, and higher in nonprofit and public hospitals.  Brennan et al (1991b) 
concluded that their measures of adverse event rates and negligent adverse event rates “may 
represent an important improvement on existing measures of quality”. 
 
In all three of the constructs outlined above, the available research evidence supports the construct 
validity of adverse-event measures as indicators of the quality of care. 
 
Conclusions of existing validity research 
The most striking feature of the literature on the validity of adverse-event measures is the absence of 
any substantial studies of face or content validity - a serious and important omission, which future 
research should endeavour to rectify.  The investigations of criterion-related and construct validity, 
though not especially numerous or rigorous, are generally encouraging, in that they suggest that 
adverse-event measures do provide a valid indication of the quality of healthcare.  However, they 
also identify a number of deficiencies in the measures that they test, which are deserving of further 
investigation. 
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This review of the validity literature also indicates that it is probably as difficult to make valid 
general statements about the validity of all adverse-event measures as it would be for all general 
health status measures, or for any other family of different instruments based on a particular 
methodology.  The findings of studies which demonstrate the adequacy (or inadequacy) of a specific 
adverse-event measure cannot simply be generalised to all such measures, because as the reports 
cited above demonstrate, different measures (and different items within measures) have different 
validity properties.  We can, however, draw conclusions from these studies about the potential 
validity of adverse-event measures.  In that respect, this review of the literature suggests that such 
measures can potentially provide a valid insight into the quality of healthcare. 
 
Table 3.16  summarises the methods, results and conclusions of the validity research referred to 
above. 
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Study Dimension 
of validity 
Methods Results and conclusions 
Panniers and 
Newlander 
(1986) 
Face/ 
content 
Consulted “expert panel” made up of 1 
doctor and 3 nurses. 
Results not reported. 
Panniers and 
Newlander 
(1986) 
Construct Applied APO inventory to sample of 
426 patients in DRGs 121 and 122 
(myocardial infarction) from one 
hospital, and collected details of length 
of stay and treatment costs. 
Significant correlation between APO 
inventory score and both length of stay 
(p < 0.001) and treatment costs (p < 
0.001). 
Panniers 
(1987) 
Construct Applied APO inventory and AS-
SCORE to sample of 354 patients in 
DRGs 121 and 122 (myocardial 
infarction) from one hospital, and also 
collected details of length of stay and 
treatment costs. 
Significant correlation between APO 
inventory score and AS-SCORE (p < 
0.001). 
Schumacher, 
Parker, 
Kofie et al 
(1987) 
Construct Applied APO inventory and Severity 
of Illness Index to 752 patients from 7 
hospitals. 
Significant correlation between APO 
inventory score and SII (p < 0.0001). 
Barnes and 
Moynihan 
(1988) 
Criterion-
related 
Used 3,252 records from SuperPRO 
project, drawn from PROs all over 
USA.  Applied PRO generic screens 
for primary review; used single 
physician assessment for secondary 
review. 
Primary screening had sensitivity of 
48.5%, specificity of 72.8%.  Missed 
adverse events tended to be less 
clinically significant ones.  Some 
adverse event definitions were more 
valid than others. 
Richards, 
Lurie, 
Rogers et al 
(1988) 
Face/ 
content  
Used panel of 3 doctors to rate 
“adversity” of each element of APO 
inventory. 
Results not specifically reported.  All 
ratings obtained were negative and 
“generally agreed”. 
 Criterion-
related 
Applied APO inventory, Severity of 
Illness Index, and condition-specific 
quality measures to 25,000 patients 
from 45 hospitals, and also collected 
administrative/demographic and 
clinical details of cases. 
APO inventory score correlated with 
criterion-based quality measures for 
more serious conditions. 
 Construct  APO inventory score correlated with 
length of stay and with SII.  Some 
variations in APO inventory score 
observed across different types of 
hospitals. 
 
Table 3.16.  Summary of research into the validity of adverse-event measures  
of healthcare quality (continued overleaf). 
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Study Dimension 
of validity 
Methods Results and conclusions 
Brennan, 
Localio and 
Laird (1989) 
Criterion-
related 
Applied own adverse-event measure 
twice each to 360 cases selected to 
contain a high proportion of cases with 
adverse events; undertook a separate 
single physician assessment of cases. 
For general population of cases, 
estimated measure had sensitivity of 
21% and specificity of 99.5%.  
Institute of 
Medicine 
(1990) 
Criterion-
related 
Used 6,309,839 cases reviewed by 
PROs up to June 1989 to compare 
percentages of cases with an adverse 
event identified at primary screening 
and percentage of those adverse events 
subsequently confirmed as quality 
problems. 
Between 7.5% and 71.3% of adverse 
events were confirmed as quality 
problems - rate varied by type of 
adverse event. 
Brennan, 
Hebert,  
Laird et 
al(1991) 
Construct Used 31,000 patient records drawn 
from 51 hospitals to compare adverse 
event rates and negligent adverse 
event rates across hospitals. 
adverse event rate and negligent 
adverse event rate varied substantially 
across hospitals.  Primary teaching 
hospitals had higher adverse event 
rates; rural hospitals had lower adverse 
event rates.  Proportion of adverse 
events due to negligence lower in 
teaching and proprietary hospitals; 
higher in nonprofit and governmental 
hospitals. 
Bates, 
O’Neil, 
Petersen et 
al (1995) 
Criterion-
related 
Applied adverse-event measure to 
3,137 admissions; undertook a 
separate clinician review of those 
screened positive to assess presence, 
seriousness and preventability of 
adverse event. 
Sensitivity of screening criteria ranged 
from 68% to 4%; specificity ranged 
from 56% to 99%.  No criteria had 
both high sensitivity and high 
specificity. 
 
Table 3.16.  Summary of research into the validity of adverse-event measures  
of healthcare quality (continued from previous page). 
 
 
3.4.3 Reliability of adverse-event measures of quality 
 
In chapter 2, the different approaches to defining and measuring the reliability of instruments were 
discussed, and the importance of careful reliability assessment was highlighted.  In an apposite 
comment, Richards et al (1988) observed that “although reliability analyses do not make for 
glamorous research, positive answers to the questions posed by these analyses are essential for 
confidence in results obtained from any subsequent work”.   The available empirical evidence on the 
reliability of adverse-event measures is outlined below. 
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Interrater reliability 
Interrater (or interobserver) reliability measures whether, when the same test is applied to the same 
respondent or subject by different raters, the same results are produced.  A number of researchers 
have examined the interrater reliability of adverse-event measures, generally by arranging for 
multiple reviews of patients' case records by different screening staff, and then comparing the results 
of screening. 
 
Panniers and Newlander (1986) used two reviewers, both qualified and experienced nurses, who 
separately applied a slightly modified form of the APO inventory (which has been described in 
section III.1.3) to a sample of 200 cases from 426 patients with myocardial infarctions.  The kappa 
statistic (Fleiss 1981, p146) was used to assess the extent to which observed agreement exceeded 
that which would be expected simply through chance.  Of the 15 adverse events in the APO 
inventory, 10 showed raw agreement levels of 99-100% on whether or not the event had occurred.  
For the remaining 5 items, raw agreement levels ranged from 72% to 96% (kappa from 0.29 to 
0.83).   Reliability data for judgements of whether a patient was at risk from an adverse event (the 
denominator section of the APO inventory) were not reported.  Panniers and Newlander concluded 
that the APO inventory was reliable. 
 
Schumacher et al (1987) used seven different raters to review 752 cases (each being reviewed two 
or three times) drawn from seven teaching hospitals, also using the APO inventory. The APO 
inventory is a risk adjusted score, composed of a numerator (the count of actual adverse events) and 
a denominator (the count of adverse events for which the patient was at risk).  Schumacher 
compared agreement for each pair of raters for the numerator, the denominator and the APO 
inventory score as a whole, using Pearson's correlation coefficient.  The mean correlation coefficient 
for the APO inventory score was 0.33, with individual rater pairs’ correlations ranging from -0.05 to 
0.58.  Correlations for denominator scores were higher than those for numerators or the APO 
inventory score itself.  Schumacher and colleagues concluded that the APO inventory was not 
reliable. 
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Unfortunately, Schumacher et al (1987) used the Pearson correlation coefficient alone to assess 
reliability - a measure which is really an indicator of linear association, not agreement, and which 
takes no account of deviations of scale and bias.  Brennan and Silman (1992) advise that the Pearson 
correlation coefficient “is not applicable as a measure of between observer variability”; Main and 
Pace (1991) concur, recommending the use of intraclass correlation methods to measure agreement 
for continuous variables instead.   In addition, by only citing the correlation coefficient on aggregate 
scores rather than on the individual items of the APO inventory, Schumacher and colleagues 
concealed the potentially different reliabilities of different items within the APO inventory.  In view 
of these flaws, it is questionable whether their conclusions can be justified on the basis of their 
published results. 
 
As part of a larger study described above, Richards et al (1988) applied the APO inventory to 516 
cases drawn from 5 hospitals, each of which was reviewed by a pair of raters.  Kappa statistics were 
calculated for each item within the APO inventory - both the adverse event items and the at risk 
items (indicators of whether a particular patient was at risk of a certain type of adverse event).  
Agreement for the at risk items ranged from 0.28 to 0.83 (mean 0.50), while agreement for the 
adverse event items ranged from -0.18 to 0.73 (mean 0.33).   Richards and colleagues also examined 
the reliability of the overall APO inventory score (in the form of a weighted sum of their own 
design).  They found that within-patient variability of this APO inventory score was substantially 
less than the overall variability of the sample (51.5% of cases had within-patient variability < 0.33 
SD; 77.8% had within-patient variability < 1 SD).   They also constructed an analysis of variance 
model, using diagnosis, hospital, patient and rater as the independent variables and the APO score as 
the dependent variable.  The model accounted for 91% of the variability of APO scores, and little of 
the variability was attributable to differences between raters (2%) while most was attributable to 
patient (63%), diagnosis (9%) and interactions of patient, diagnosis and hospital variables.   
Richards et al (1988) concluded that “reliability analyses for the APO as a whole suggest that it is at 
best only a moderately reliable measure”. 
 
The Harvard Medical Practice Study (1990, p5-26) investigated the reliability of the adverse-event 
measure developed and validated (Brennan, Localio and Laird 1989) for use in the project.  A 
randomly selected sample of 282 cases (about 1% of all cases reviewed for the study) was separately 
  
 
 
137
screened using the adverse-event measure by a medical records administrator (MRA) and the MRA 
supervisor.   When the decisions made by the medical records administrator and the MRA 
supervisor about whether or not a case had an adverse event were compared, a raw agreement rate 
of 93.6% was calculated, with a kappa statistic of 0.85.   This suggests a relatively high and 
acceptably reliable degree of agreement, though combination of raters decisions about a number of 
different adverse events into a single dichotomous variable (whether or not an adverse event 
occurred in a case) may overstate the level of agreement. 
 
While several studies of interrater reliability exist, all but one made use of the same adverse-event 
measure (the APO inventory).  Bearing in mind the unusual construction of this measure, it may be 
difficult to draw general conclusions about the interrater reliability of adverse-event measures from 
these studies.  It is also notable that a clear consensus about the interrater reliability of adverse-event 
measures does not emerge from the four studies: one suggests reliability is very high, two suggest it 
is moderately good, and one concludes that it is poor.   More extensive testing of the interrater 
reliability of adverse-event measures is certainly needed if a definitive conclusion is to be reached. 
 
Intrarater reliability 
Intrarater (or intraobserver) reliability measures whether, when the same test is applied twice by the 
same rater to the same subject, the same results are produced.  It is an important test of reliability, 
complementing information on interrater reliability.  Unfortunately, no studies of the intrarater 
reliability of adverse-event measures have been identified in the literature.  This is, therefore, an area 
which future studies of these measures should address. 
 
Internal consistency 
Measures of internal consistency show how well the individual items within a measure which are 
meant to be measuring a particular trait or characteristic are correlated.   High inter-item correlation 
suggests that the measure is indeed measuring a particular trait.  Low inter-item correlation suggests 
that the measure may actually be measuring different traits, and further analysis might be indicated 
to identify and separate these characteristics. 
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Adverse-event measures generally count or flag the occurrence of a number of different sorts or 
types of adverse event, with each item within the measure acting as a counter or flag for a particular 
type of adverse event.  In these circumstances, correlations between items in the measure would 
often not be expected to occur, unless there was some causal link between the different types of 
adverse event.  For most pairings of items within an adverse-event measure, such causal links will 
not exist, and so it is not appropriate to seek high interitem correlations or to use such correlations as 
a benchmark of reliability.  Measures of internal consistency are not very useful in assessing the 
reliability of adverse-event measures, and indeed no examples of studies addressing internal 
consistency were found. 
 
Conclusions of existing reliability research 
This review of existing investigations of the reliability of adverse-event measures of healthcare 
quality is brief, because of the scarcity of published studies.   The studies reviewed provide some 
indications of the reliability of the measures they tested, but no clear consensus emerges from their 
conclusions.   Considering the extensive use made of adverse-event measures in the US healthcare 
system, and their growing deployment in other countries such as the UK, it appears that there is a 
pressing need for further research in this area. 
 
Table 3.17 summarises the methods, results and conclusions of the reliability research referred to 
above. 
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Study Dimension 
of 
reliability 
Methods Results and conclusions 
Panniers and 
Newlander 
(1986 
Interrater 
reliability 
Used 2 raters to apply modified form 
of APO inventory to sample of 200 
cases from 426 patients with 
myocardial infarctions. 
Raw agreement of 99-100% for 10 
items of APO inventory; other 5 items 
ranged 72-96% (kappa 0.29 to 0.83).  
Concluded APO inventory was 
reliable. 
Schumacher, 
Parker, Kofie 
et al (1987) 
Interrater 
reliability 
Used 7 raters to apply APO inventory 
to 752 cases (each being reviewed 2 or 
3 times) drawn from 7 hospitals. 
Pearson correlation coefficients cited, 
measuring association between raters.  
Mean correlation for APO score was 
0.33 (ranged from -0.05 to 0.58).  
Concluded APO inventory 
insufficiently reliable. 
Richards, 
Lurie, Rogers 
et al (1988) 
Interrater 
reliability 
Used multiple raters to apply APO 
inventory to 516 cases drawn from 5 
hospitals, each reviewed by 2 raters. 
Kappa statistics for APO numerator 
items had mean of 0.33 (ranged -0.18 
to 0.73); for APO denominator items 
mean was 0.50 (ranged 0.28 to 0.83).  
For APO score, found within-patient 
variability much less than overall 
variability. ANOVA showed 
differences between raters responsible 
for 2% of APO score variability.  
Concluded APO inventory “at best 
moderately reliable”. 
Harvard 
Medical 
Practice 
Study (1990) 
Interrater 
reliability 
Used multiple raters to apply own 
adverse-event measure to 282 cases 
(random 1% sample of total study), 
each reviewed by 2 raters. 
Raw agreement on presence/absence of 
adverse event in each case of 93.6%, 
kappa of 0.85.  Concluded measure 
was sufficiently reliable for use in 
study. 
 
Table 3.17.  Summary of research into the reliability of adverse-event measures  
of healthcare quality. 
 
 
3.5 Conclusions 
 
While there is much anecdotal evidence of the value of adverse-event measures of quality, and of 
quality assurance programmes which use such measures, there is limited empirical research 
evidence to support many of the bold contentions of either their advocates or their critics which 
were described earlier. 
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The body of research on the validity of these measures is generally cautiously positive about their 
value as measures of the quality of healthcare, though important concerns about their behaviour do 
emerge.  The validity of these measures has not been adequately explored in any area, but particular 
aspects of validity where further research is especially necessary include the face and content 
validity of adverse-event measures, and their construct validity.  It is evident that examining the 
criterion-related validity of these measures presents methodological problems. 
 
The reliability research into adverse-event measures is equally disappointing in both its scope and 
quality.   Little consensus emerges from the few existing studies about the reliability of adverse-
event measures - indeed, different researchers seem to have achieved markedly different reliability 
results using identical instruments, which may point to the importance of rater training.   Both the 
interrater and intrarater reliability of adverse-event measures require further investigation. 
 
If the state of current knowledge about adverse-event measures of quality is mapped out against the 
framework for the structural evaluation of quality measurement techniques developed by the 
Institute of Medicine (1990, p312) and discussed earlier, the results are concerning.  The reliability, 
validity, sensitivity and specificity of these measures have been inadequately explored.  However, 
other attributes identified as important in any evaluation by the Institute of Medicine have barely 
been addressed by researchers concerned with adverse-event measures.  Characteristics such as 
appropriateness, clarity, acceptability, concordance, inclusiveness, clinical adaptability, flexibility, 
patient responsiveness and documentation have not been explicitly examined, though some 
anecdotal accounts of the use of adverse-event measures provide an imperfect understanding of 
certain attributes.    
 
Even less evidence is available for the key process evaluation attributes enumerated by the Institute 
of Medicine (1990) as important characteristics of the application of any quality measurement 
techniques - pretesting, dynamism, evaluation, comprehendability, manageability, nonintrusiveness, 
appealability, feasibility, computerisation, and executability.  Again, our limited knowledge 
provides some comprehension of the behaviour of adverse-event measures in these dimensions - but 
the areas of ignorance or supposition again outweigh those of empirically derived and tested, 
objective veracity. 
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Few could argue with Sanazaro and Mills (1991) who wrote: 
 
“The appeal [of occurrence screening] is clearcut: it purports to be a simple method 
of simultaneously serving the purposes of both quality assessment and risk 
management.  However, its use for this dual purpose is yet another instance of 
widespread adoption of inadequately tested technology in quality assessment.  Users 
of generic screening criteria tend to ignore the fact that the screens have never been 
shown to have any intrinsic value other than to identify charts that may or may not 
contain a clinical event attributable to care.  Consequently, use of such screens for 
quality assessment may have serious limitations.”  (Sanazaro and Mills 1991) 
 
The task for researchers and others interested in using and applying adverse-event measures in 
healthcare is clear.  Before these measures can be used with confidence, their validity, reliability and 
general utility must be properly evaluated, with particular attention being given to those areas in 
which there is little or no existing research.  Then, once those methodological foundations have been 
established, the behaviour and application of adverse-event measures in healthcare organisations 
should be examined, and their effectiveness within quality assurance programmes should be 
evaluated.     
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Chapter 4 
 
Content and face validity of  
adverse-event measures of quality 
 
 
 
 
4.1 Introduction 
 
In chapter 3, the available evidence for the validity of adverse-event measures of quality was 
presented.   When that relatively limited evidence is placed in context, against the very widespread 
use of these measures in healthcare quality assurance programmes in the USA, and their growing 
use in the UK and elsewhere, it is fair to conclude that no aspect of validity could be said to have 
been overresearched.  Indeed, some important aspects of validity have scarcely been examined at 
all, at least in the published literature.    
 
It was noted that no substantial studies of the face or content validity of any adverse-event measures 
of healthcare quality were found in the published literature.  This suggests that the face and content 
validity of adverse-event measures of quality is perhaps the most important single research need 
identified by the literature review.   Two research studies intended to address this research need are 
reported in this chapter. 
 
a) Survey of clinician opinion 
The primary aim of this study was to explore the face and content validity of a generic 
adverse-event measure of quality by gathering the opinions of clinical professionals who had 
the skills and experience necessary to provide an informed view of its validity, through a 
postal questionnaire survey.   The study also gathered other information from the clinicians 
surveyed on other secondary aspects not directly concerned with validity, such as the 
expected behaviour of the measure in practice, the practicability of collecting the data it 
required, and the potential for improvements in its design and specification.    
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b) Interviews with clinicians 
The primary aim of this study was to support and supplement the largely quantitative 
information gathered by the questionnaire study of clinician opinion with a more qualitative 
understanding of the issues of face and content validity, gained through individual 
interviews with a small number of clinicians.  It was particularly intended to identify themes 
or matters which might have been omitted or overlooked by the questionnaire study due to 
its prestructured format, and to explore the place of adverse-event measures of quality in the 
quality measurement and quality improvement process in healthcare. 
 
Both these studies drew on an adverse-event measure of quality which had been developed for use 
within the RSCH project.  The generic adverse-event measure used in both the studies of clinician 
opinion can be found in appendix 4.1.  This measure was developed by clinicians within the RSCH 
project, based on information collected on measures used elsewhere and developed by others and on 
the particular interests and views of the clinicians involved in the project.   Control over the 
development of the measure thus lay at least in part outside this study, and the clinicians involved 
did not see the maximisation of the measure’s validity and reliability as their primary goals, though 
these issues were discussed.  As a result, it can be argued that the studies using this measure provide 
a pragmatic and realistic test of the validity and reliability of such measures, which is likely to be 
generalisable to other similar settings, rather than an ideal or maximal estimate of validity and 
reliability which might be hard to replicate in practice.   
 
It should also be noted that the process of developing this and other measures continued over the life 
of the RSCH project, with small changes being made to definitions and interpretations quite 
frequently.  This could complicate the interpretation of the data drawn from the RSCH project itself 
and used as the basis of the study of construct validity, and particular caution should be exercised in 
assessing temporal trends. 
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4.2 Survey of clinician opinion 
 
4.2.1 Aims of survey 
 
The primary aim of the survey of clinician opinion was to assess the content and face validity of the 
adverse-event measure which was developed for use in the Royal Sussex County Hospital 
occurrence screening project (and which is contained in appendix 4.1).   
 
Content validity and face validity were both defined in chapter 2, and set in context among other 
dimensions of validity.    Content validity refers to how adequately the items within a measure 
reflect the conceptual definition of its scope.  Assessing the content validity of an adverse-event 
measure of quality thus involves ascertaining whether the criteria making up the measure are real 
indicators of quality, and particularly whether any important criteria are omitted (in other words, 
whether the measure adequately reflects the scope of adverse events).  It can be assessed through the 
use of some form of expert panel made up of people with an understanding of both the measure and 
the concept it is designed to measure.  Face validity refers to whether “on the face of it” the items 
making up a measure and the measure as a whole seem reasonable in the view of users or potential 
users of the measure.  Again, for an adverse-event measure of quality it can be assessed through the 
use of some form of expert panel as described above.  Face validity is, in essence, a measure of the 
acceptability of the measure under test by those who use it or might use it, and so it needs to be 
evaluated by seeking the opinions of users or potential users.     
 
Content and face validity are clearly related and overlapping concepts (for example, a measure 
which does not reflect the scope of the concept being measured is unlikely to be acceptable to users 
and so will have a low face validity).  They are both measured by gathering and analysing opinion.   
This study set out to assess both content and face validity by gathering the opinions of clinical 
professionals who had the skills and experience needed to assess content validity and who also, as 
potential users of the measure, were able to provide information on its face validity.  
 
The secondary aim of the survey of clinician opinion was to gather the opinions of clinical 
professionals on other important aspects of the adverse-event measure of interest - such as its 
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expected behaviour in use, and its practicability - and to improve the measure if the survey results 
indicated that improvements were necessary and feasible.  To these ends, the study set out to 
establish professionals’ opinions on the expected incidence of adverse events defined in the adverse-
event measure, the availability of information on these adverse events in patient records, the severity 
of effect of these adverse events on patients, and the potential for improvement in the design of the 
adverse-event measure.   Textual comments on all aspects of the measure were also sought, in an 
effort to ensure that any important issues or themes not specifically addressed in the questionnaire 
would be uncovered. 
 
 
4.2.2 Method 
 
Survey design 
It was not have been feasible to gather opinions from a relatively large number of clinical 
professionals on the validity and other properties of the adverse-event measure by any means apart 
from a postal questionnaire.   In any case, the structured nature of the data required for the 
assessment of face and content validity was well suited to a questionnaire-based methodology. 
Nevertheless, the potential disadvantages of self-completion questionnaire-based surveys were 
appreciated.  In particular, the risk that important issues, not specifically mentioned in the 
questionnaire, might be implicitly excluded from the study despite their importance was recognised.  
This consideration was addressed by the interview study which is described in section 4.3. 
 
Five issues were identified which the questionnaire needed to address for each screening criterion 
(and the associated adverse event definition) within the adverse-event measure to be tested. 
 
a) Relationship to the quality of care.    
The respondent’s assessment of the relationship between the criterion and the quality of care 
delivered to the patient needed to be assessed, either directly or indirectly.   
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b) Availability of information in patient records.   
The anticipated availability of information on adverse events in patient records is an 
important indicator of the practicability of each criterion in the adverse-event measure.  If 
the necessary information is not well documented in patient records, this may have 
important implications for the reliability of any measure based on that information (and 
hence may impose a practical limit on the measure's validity).  Therefore, the likely 
availability of the necessary information needed to be assessed. 
 
c) Expected incidence of adverse events.   
The costs of detecting very infrequent adverse events will be high (since most screenings 
will produce a negative result), and the reliability with which they can be identified may be 
lower (since screening for them may seem tedious and unrewarding to those involved).  For 
these reasons, it might in some circumstances be reasonable to exclude screening criteria 
which are focused on such infrequent events from an adverse-event measure, and so the 
expected incidence of the adverse events included in the measure to be tested needed to be 
investigated.   Of course, in deciding to include or exclude a certain type of adverse event, 
the frequency of that event would have to be considered alongside other factors - like the 
effect of that event on the patient, discussed below. 
 
d) Effect on patient.   
Different adverse events will inevitably have varying degrees of clinical significance for 
patients’ health status.  It is reasonable that adverse events with a greater impact on patients' 
health status might be regarded as more important.  If an aggregate score were to be derived 
from the adverse-event measure, some form of weighting based on the importance of 
different criteria would be required, and this might be based on an assessment of the effect 
on patients of these events.  In any case, the severity of effect of the events in the adverse-
event measure should be examined, since it might be argued that events with little or no 
effect on patients are not good indicators of the quality of care delivered to patients. 
 
 
e) Potential for improvement of the measure.    
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Another important indicator of the general adequacy or suitability of each criterion within 
the adverse-event measure would be the extent to which professionals perceived some 
potential for its improvement.   Criteria which are well specified and meet with 
professionals’ approval might be expected to be rated as having little improvement potential, 
while those with important perceived defects might be rated as having much more room for 
improvement (unless those defects were so severe as to render the criterion unimprovable in 
respondents' eyes).  Therefore, assessing the potential for improvement of each criterion 
would provide a further indication of its validity, and would also yield specific suggestions 
for the improvement of individual criteria within the measure and of the measure as a whole. 
 
The adverse-event measure to be tested in the questionnaire study contained 20 screening criteria.  
For each criterion, some details of its definition needed to be given, and a number of questions 
needed to be asked.  It was therefore clear from an early stage in the study that the questionnaire 
itself might necessarily be quite long and bulky, and that it might take quite some time for 
respondents to complete. 
 
Since it was anticipated that most British clinicians would be unfamiliar with the concepts of 
adverse events and quality measures based on adverse events, some explanation of the background 
and terminology would be necessary, as would an explanation of the purpose of the study itself.  
  
Pilot study 
The pilot questionnaire, accompanying letter and supporting information developed for the study is 
shown in Appendix 4.2.  A single page was used for each criterion in the adverse-event measure, 
with details of the criterion at the top of the page and seven questions beneath.  Four questions used 
linear visual analogue scales, two used three point multiple choice scales, and one sought a 
dichotomous (yes or no) response.  Respondents were also invited to write textual comments on any 
aspect of each criterion. 
 
A pilot study was undertaken in July 1990 using these materials.   Questionnaires were distributed to 
six subjects with a range of clinical and research skills who were not directly involved in the RSCH 
occurrence screening project.  Each questionnaire was accompanied by a letter and supporting 
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materials (including a paper on occurrence screening).  In addition, each pilot subject also received a 
single sheet questionnaire seeking information on the time taken to complete the questionnaire, 
details of particular difficulties encountered, views on the questionnaire design, and suggestions for 
improvements.   
 
The pilot study highlighted three main issues which required attention before the main study could 
commence: 
 
a) Questionnaire length.   
All respondents commented on the length of the pilot questionnaire, and suggested that it 
needed to be shorter if clinicians were to be expected to persist with its completion.  Some 
suggested that too much information about each criterion was given.  It was observed that 
the questionnaire design did not make it immediately clear that the same questions were 
being asked about each criterion, and that awareness of this might make completion quicker.  
The physical bulk of the questionnaire was also criticised.  Respondents had taken between 
30 and 70 minutes to complete the questionnaire. 
 
b) Question complexity/design.   
Three questions in the pilot questionnaire addressed the validity of each criterion.  Question 
1 asked directly for a scaled rating of the relationship between the criterion and the quality of 
care, while questions 4 and 5 duplicated question 1, asking about whether detailed case 
review would reveal lapses in the quality of care and would show a better or worse overall 
quality of care.  Several respondents found questions 4 and 5 particularly difficult to 
understand, and observed that they duplicated each other, and question 1.  The use of 
analogue scales was criticised by some respondents as making completion slower and 
adding nothing to the questionnaire's ease of use. 
 
 
c) Supporting materials/information.   
Respondents suggested that the amount of information in the questionnaire itself on each 
criterion was too great for subjects to assimilate unless they were particularly well motivated 
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to complete the questionnaire.  They also suggested that the letter and supporting 
information contained too much information.  The risk that the paper about occurrence 
screening which was included in the supporting materials might bias or predispose subjects 
towards adverse-event measures was highlighted.   
 
In the light of these important findings from the pilot study, the questionnaire was substantially 
redesigned.  Firstly, by condensing the descriptions of screening criteria and placing questions in a 
tabular format, the length of the questionnaire was reduced to four pages.  This allowed it to be 
produced in the form of a four-sided (two sheet) A4 sized leaflet.  The tabular question format also 
made it clearer that the same questions were being asked about each criterion, and made it easier for 
the respondent to compare his or her own answers for different criteria.   Secondly, questions four 
and five from the first questionnaire were eliminated, because of the problems outlined above.  
Finally, the supporting materials were reduced in length, the paper on occurrence screening was 
removed, and a single page background information leaflet was substituted. 
 
Having made these changes, the questionnaire was informally repiloted with the same subjects.  The 
revisions were wholly welcomed, and the questionnaire was judged suitable for use in the main 
study.  The revised questionnaire, accompanying letter and information, are shown in Appendix 4.3. 
 
Despite the substantial improvements made between the pilot and main study questionnaires, the 
length of the questionnaire (and the length of time it would take to complete) was still a matter of 
some concern to the researcher.  Seeking five items of data about each of 20 screening criteria 
inevitably involved 100 responses from each respondent, however the questionnaire was physically 
presented.  If, making rather optimistic assumptions, each question took a mere 15 seconds to 
complete, filling in the questionnaire would take 25 minutes.  Reading and assimilating the 
information needed to complete the questionnaire might take the same length of time again.  Thus, it 
would still require very good motivation on the subject's part to complete the questionnaire, and the 
response rate to the questionnaire might be poor. 
 
Because of these concerns, alternative study designs which would reduce the burden on the subject 
were considered.  Two main alternatives existed.  Either the number of items of data per criterion 
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could be reduced (by eliminating some questions) or the number of criteria on which data was 
sought could be reduced (by partitioning the measure and using questionnaires which only included 
some of the screening criteria).   The former solution was rejected for two reasons.  Firstly, the loss 
of information involved in eliminating some of the questions in the questionnaire was deemed 
unacceptable.  Secondly, it was believed that the actual time saving for the subject that would result 
would be relatively limited, since he or she would still need to read the information about each 
criterion before responding to the reduced set of questions about that criterion.   Answering fewer 
questions about each criterion would not produce a proportionate reduction in the time taken to 
complete the questionnaire. 
 
The latter solution was also rejected, because of its potential effect on the power of the study to 
demonstrate the validity of the measure being tested.  Any assessments of content validity which 
were derived from questionnaires which only included half of the measure being tested would 
inevitably be misleading.   To provide an informed view of the measure (and especially of its 
content validity), clinicians needed to be presented with the whole measure, rather than a part of it.  
The number of criteria in the adverse-event measure could not be reduced simply to suit the needs of 
validity testing, since that would itself reduce its validity.   
 
Therefore, it was decided that the main study should proceed using the revised questionnaire shown 
in appendix 4.3.  In order to encourage subjects to complete the questionnaire, it would be 
accompanied by a letter from a clinician with whom they could identify (if possible, a member of 
the same specialty), seeking their cooperation.  In addition, subjects would be offered a copy of the 
study report if they completed the questionnaire, as an incentive to completion.   Non-respondents 
would be identifiable (since the questionnaires would be numbered) and they would be contacted a 
second time to encourage them to respond.  Finally, response rates would be monitored 
prospectively throughout the study, in order to identify any difficulties with response rates as early 
as possible. 
 
Main study 
It was not feasible to attempt to draw a random sample which was statistically representative of all 
senior medical staff in the UK, or of all medical staff, or of all clinical professionals with an interest 
  
 
 
151
or involvement in the healthcare processes addressed by the adverse-event measure.  Nor, indeed, 
was it necessary to seek such a representative sample in order to undertake an adequate assessment 
of the face and content validity of the adverse-event measure.  As has already been noted (see 
chapter 2), face and content validity are commonly assessed through expert panels.  Having 
established the skills which an expert panel might be expected to hold, the primary concern should 
be that the sample group (and the subgroup of those who respond) should contain clinical 
professionals with those skills, and not that they should necessarily be representative of their 
profession as a whole. 
 
The sample of clinicians to be used in the main study was identified on the basis of five main 
considerations or requirements: clinical knowledge, training and experience; an understanding of the 
science of measurement and of quality assessment in healthcare; independence from the RSCH 
occurrence screening project; achieving a representative geographic and specialty spread; and the 
demand that the relatively complex questionnaire would place on subjects' time.   It was recognised 
that no single group of clinicians would possess all the desired attributes detailed above, and that the 
unavoidable size and length of the questionnaire might discourage its completion by many 
clinicians.  Therefore, three different groups were selected: 
 
a) Public health physicians.   
A group of 201 public health physicians, made up of all those holding posts as Directors of 
Public Health in Districts or Regions within England, was identified.  This group was 
chosen because public health physicians have skills and training in both clinical medicine 
and in epidemiology, statistics and the science of measurement.  They were therefore 
regarded as being particularly well suited to assessing the validity of the adverse-event 
measure.  They also provided a wide geographic spread, representing every area of England. 
 
b) Practising clinicians - Worcester Health Authority. 
A group of 59 consultants, made up of all those currently practising in clinical medicine 
within Worcester Health Authority in the West Midlands, was identified.  This group was 
chosen because it provided a diversity of clinical specialists from every major specialty, and 
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was sufficiently physically distant from the site of the RSCH occurrence screening project to 
ensure that the clinicians involved would have little or no previous knowledge of the project. 
 
c) Practising clinicians - leaders in clinical audit. 
A group of 22 consultants currently practising in clinical medicine and acting as medical 
leaders of clinical audit programmes within the South East Thames region was identified.  
The group was made up of all consultants who were either Chairs of the District Medical 
Audit Advisory Committee (DMAAC) in their own District or were members of the 
Regional Medical Audit Advisory Committee (RMAAC) for the South East Thames region.  
This group was chosen because it provided an additional diversity of clinical specialists 
from various major specialties, and because it also provided the opinions of clinicians with 
particular experience and skills in quality assessment in healthcare. 
 
Questionnaires, accompanied by the background information and supporting letters described 
above, were distributed to clinicians in group A by post in March 1991.  Non-respondents were 
contacted again by letter, with a further copy of the questionnaire, in May 1991.   For group B, 
questionnaires were distributed by post in January 1991, and non-respondents were contacted again 
shortly afterwards.   For group C, questionnaires were distributed in May 1991, and non-respondents 
were contacted again shortly afterwards. 
 
Returned questionnaires were immediately identified (through their questionnaire number) and the 
response was noted on the list of study subjects used to identify non-respondents.   The Statistical 
Package for the Social Sciences (SPSS-PC) was used to record the numerical and categorical 
responses from each questionnaire, and to produce the analyses and statistics detailed below. 
 
A wordprocessor was used to record, classify and tabulate the textual comments made by 
respondents to the questionnaire, and these are also discussed below.   The questionnaire was 
designed to encourage respondents to comment on the adverse-event measure, on individual 
screening criteria within the measure, and on the design and implementation of the questionnaire 
study itself.   Respondents' comments were sought both to enrich the quantitative data gathered by 
the questionnaire and to help identify themes or issues which the questionnaire had not addressed.  
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All comments from respondents were transcribed and categorised, and a full listing of these 
comments can be found in appendix 4.4. 
 
 
4.2.3 Results and discussion 
 
Response rates 
The final response rates to the questionnaire study, from each group and from the sample as a whole, 
are shown in table 4.1.  It can be seen that the response rate from public health physicians was 
substantially higher than the response rates from the two groups of practising clinicians.  Of the 
practising clinicians, the response rate of those with a known interest in clinical audit was higher 
than the response rate from ordinary practising clinicians in Worcester. 
 
 
Group Group size Number 
returned 
 
Response rate 
(%) 
Public health physicians 
 
201 132 65.7% 
Practising clinicians - Worcester Health Authority 
 
59 10 16.9% 
Practising clinicians - leaders in audit 
 
22 8 36.4% 
All groups 
 
282 150 53.2% 
 
Table 4.1.  Response rates to questionnaire study. 
 
 
The sample of clinicians used in the questionnaire was selected, as has already been noted earlier, 
because they were felt to have the skills and knowledge required of an expert panel commenting on 
the validity of an adverse-event measure of quality.  Since some of the sample did not respond to the 
questionnaire, it is necessary to examine the response rates and their causes, and to consider their 
potential effects on the representativeness and meaning of the responses received to the 
questionnaire.   The critical issue, in considering the effects of lowered response rates, is whether 
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there are differences between respondents and non-respondents which are germane to the purpose or 
aims of the study.  
 
Contact with many non-respondents from all three groups was established, through the process of 
mailing additional questionnaires to and receiving uncompleted returns from subjects who did not 
respond.  Subjects who did not wish to respond to the questionnaire were asked to return blank 
questionnaires so that they would not be troubled by reminders, and many of these blank returns 
were accompanied by notes or letters explaining their reasons for non-completion.  In addition, a 
few non-respondents were contacted by telephone during the study.  From these sources, it appeared 
that there were three main reasons for non-response: 
 
a) Time availability.   
Many non-respondents indicated that they could not spare the time required to complete the 
questionnaire.  As was discussed above, the questionnaire was a substantial one, and 
required a considerable investment of subjects' time if it was to be completed.   Senior 
medical staff with a clinical commitment often declined to complete the questionnaire for 
this reason. 
 
b) Interest in quality measurement.   
Some subjects indicated that the subject of quality measurement or clinical audit did not 
interest them, felt it did not involve them, or believed they knew too little about the subject 
to answer any questionnaire relating to it. 
 
c) Attitude to questionnaires.   
All subjects were clinicians working within the NHS.  A number of subjects observed that 
they received many questionnaires, from other clinicians, professional bodies, and outside 
organisations such as pharmaceutical companies.  In the face of the many questionnaires 
they received, some subjects indicated a reluctance to complete any questionnaires at all.   
 
The different response rates obtained from the three study groups provide some additional evidence 
that the reasons cited above for non-response are correct.   Public health physicians might be 
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expected to have more office-based time than their clinical colleagues because of the nature of their 
responsibilities; to be more interested in the measurement of quality than their clinical colleagues 
because of their training in epidemiology and the science of measurement and their involvement in 
areas such as needs assessment and quality specification where such measures would be useful; and 
to be better disposed towards questionnaires since they are often themselves involved in originating 
and managing questionnaire studies.   It is therefore unsurprising that the response rate for public 
health physicians (65.7%) was far higher than that for the other two groups. 
 
The third group - of practising clinicians who were leaders in clinical audit - might be expected to be 
similar to the second group - practising clinicians from Worcester Health Authority - in most 
respects.  However, they might be expected to have a greater than average interest in healthcare 
quality, since they were all involved in leading the clinical audit programme.   This supposition is 
supported by the fact that the response rate from these clinicians involved in audit (36.4%) was 
twice that of the clinicians from Worcester Health Authority (16.9%), though it was still much lower 
than that of the group of public health physicians. 
 
Response rates in the two smaller groups - both formed of practising clinicians - were particularly 
low, and therefore give some cause for concern about the potential for biases resulting from 
differences between the groups of respondents and non-respondents.  The reasons for non-response 
discussed above provide some reassurance, but it is still important that the nature of potential biases 
is explored and, where possible, the data from respondents is used to assess the extent of bias.  There 
are two main forms of systematic bias which might be introduced by the lowered response rates in 
the two smaller groups: 
 
a) Bias towards those favouring the measure.   
If clinicians who were favourably disposed towards the adverse-event measure were more 
likely to respond than those who were not, a misleadingly positive view of clinical opinion 
about the measure might be established.   Responses might not represent the full range of 
clinical opinion about the measure.  It is very difficult to assess the extent of this form of 
bias.  However, the reasons for non-response cited above provide some reassurance (since 
opposition to the measure was not featured among them).  In addition, the analysis of textual 
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comments from respondents can provide some evidence that respondents did at least 
represent a full spread of opinion about the measure. 
 
b) Bias towards clinicians not practising clinical medicine.    
The higher response rate from public health physician subjects than from practising clinician 
subjects means that while 71% of the sample were public health physicians, they made up 
88% of respondents.   Overall, the actual numbers of practising clinicians responding to the 
study were small (n=18).   It might be argued that public health physicians have less direct 
clinical experience and understanding, and might therefore rate the adverse-event measure 
differently.  Since the respondent group is undoubtedly biased towards public health 
physicians, the effect of this bias can best be examined by comparing the responses of public 
health physicians and practising clinicians to identify any significant differences. 
 
With the proviso that the effects of these two biases are examined in analysing and discussing the 
results of the questionnaire study, the overall response rate of 53.2% from the three groups outlined 
earlier provides a base of data with which the analysis and interpretation of the face and content 
validity of the adverse-event measure can be performed with a reasonable degree of confidence. 
 
Validity of adverse-event measure as a measure of quality 
Each respondent was asked to rate the validity of each screening criterion in the adverse-event 
measure on a scale of zero to ten, on which zero indicated that the events identified by the screening 
criterion were "not at all related to the quality of care that patients receive" while ten indicated that 
the events were "very closely related to the quality of care that patients receive". 
 
The results are summarised in table 4.2.  For each screening criterion, the mean, mode and median 
responses are given.   The table also shows the standard deviation of the distribution of responses to 
provide an indication of the spread of responses.    
 
The mean, modal and median responses for each criterion provide indicators of the consensus view 
of the validity of that criterion from the clinicians who participated in the study.  The standard 
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deviation provides an indication of the spread of the distribution of responses, and hence of the level 
of agreement among the clinicians involved in the study. 
 
 
Crit 
no 
 
Criterion title 
 
No of 
responses 
Validity ratings 
   Mean  Mode Median Standard 
deviation 
1 Adm for adv results o/p mgt 149 6.75 8 7 2.45 
2 Readmission for comp prev adm 150 7.34 8 8 1.97 
3 Error in operative consent 150 5.75 10 6 3.13 
4 Unpl rem/inj/repair in surg 149 7.78 10 8 2.51 
5 Unpl return to theatre 150 6.97 8 7 2.00 
6 Path/hist varies from diag 149 5.83 7 6 2.46 
7 Prob of transfusion 148 6.39 8 7 2.61 
8 Hosp acquired infection 150 6.33 8 7 2.33 
9 Medication error/reaction 149 8.03 10 8 1.88 
10 Cardiac/resp arrest in hosp 148 3.99 1 4 2.71 
11 CVA/MI/PE in hosp after surg 149 5.32 5 5 2.52 
12 Unexp transfer to spec care 150 5.27 7 6 2.70 
13 Pt related clinical complcn 147 7.15 8 8 2.39 
14 Non-clin problem/incident 146 7.24 8 8 2.07 
15 Neuro deficit devel in hosp 144 5.38 7 5 2.66 
16 Unexp patient death 148 5.50 5 5 2.72 
17 Medical record deficiency 149 6.77 7 7 2.26 
18 Nursing record deficiency 149 6.78 8 7 2.33 
19 Pt/family dissatisfaction 150 6.68 8 7 2.20 
20 Discharge related problems 150 6.60 8 7 2.16 
All criteria 2974 6.40 8 7 2.59 
 
Table 4.2.  Analysis of the ratings by all respondents of validity 
of all screening criteria in adverse-event measure. 
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Figure 4.1.  Distribution of validity ratings for all criteria by all respondents. 
 
The graph in figure 4.1 shows the distribution of validity ratings by all respondents for all criteria.  It 
is visually evident that the distribution is weighted towards the upper end of the validity rating scale, 
with a modal response of eight, and with 66.1% of all ratings being six or more.  This suggests that 
the adverse-event measure was, in general, considered valid by respondents, since responses to the 
upper end of the validity rating scale predominated. 
 
However, it is clear from table 4.2 that different criteria within the adverse-event measure received 
quite different ratings from respondents (means range from 3.99 to 8.03, modes range from one to 
ten).   Those differences, as well as informing us about the validity of the criteria relative to one 
another, can also be used to make a judgement about whether each criterion (and, indeed, the 
measure as a whole) can be deemed a valid measure of the quality of care. 
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For example, the criterion whose validity was rated highest by respondents was criterion nine - 
which identified incidents of medication errors and reactions.   It can be argued that this criterion has 
very strong face validity, since almost no-one would suggest that such adverse events are not 
important to the quality of care.  Its mean validity rating was 8.03 (with a modal response of ten - 
the maximum validity). 
 
In contrast, the criterion whose validity was rated lowest by respondents was criterion ten - which 
identified incidents of cardiac or respiratory arrest occurring during the patient's stay in hospital.  
Here, the face validity can be argued to be low, since many patients are admitted to hospitals for 
observation because of the risk of cardiac or respiratory arrest, and since most such arrests in 
hospital result from the progress of the patient's disease rather than from the effects of poor quality 
care.   Its mean validity rating was 3.99 (with a modal response of one - almost the lowest rating 
respondents could give). 
 
If we accept that criterion nine's rating of 8.03 (mode of ten) constitutes acceptable validity, and that 
criterion ten's rating of 3.99 (mode of one) constitutes unacceptable validity, the next step is to 
consider the distribution of other criteria across the range between these two values.  As can be seen 
from figure 3.2, criterion nine is a low outlier.  Most other criteria have mean validity ratings of 
above 5.0, and 13 out of 20 criteria have means above 6.0.  The mean rating for all criteria is 6.4. 
Similarly, table 4.2 shows that the modal validity rating for most criteria was seven or more, and that 
the modal rating across all criteria was seven.   These ratings provide reasonable evidence that the 
respondents to the questionnaire study considered most criteria within the adverse-event measure to 
be valid indicators of the quality of care. 
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Figure 4.2.  Distribution of mean validity ratings for all criteria. 
 
The level of agreement among respondents about each criterion can be measured by the standard 
deviation (shown in table 4.2).  Differences between the mean, median and modal responses for 
each criterion may also indicate disagreement about its validity.  Two criteria show particular 
disagreement: criterion ten (cardiac/respiratory arrest while in hospital) and criterion three (error in 
operative consent).  For the former, the low level of agreement seems to result from a minority of 
respondents rating its validity much more highly than the majority who gave it a low validity rating.  
For the latter, the low level of agreement seems to result from a genuinely wide spread of opinion 
among respondents about whether this essentially documentation-oriented criterion is a valid 
indicator of the quality of care.  
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Expected incidence of adverse events 
Each respondent was asked to rate the expected incidence of each screening criterion in the adverse-
event measure on a scale of zero to ten, on which zero indicated that the events identified by the 
screening criterion would be expected to happen to no patients, while ten indicated they would be 
expected to happen to all patients.   This information was sought in order to assess the yield of 
adverse events which the screening criteria within the adverse-event measure might be expected to 
produce.   It was also sought because, unlike other information gathered by the questionnaire, it 
could be compared with empirical evidence of actual incidence rates from the RSCH occurrence 
screening project.   If the clinician ratings corresponded to the empirical findings, this would support 
the use of the clinician ratings of other aspects of the measure which could not be tested empirically. 
 
The results are summarised in table 4.3.   For each screening criterion, the mean response is given, 
along with the associated ranking of the criterion (ranging from one for the highest expected 
incidence criterion to 20 for the lowest expected incidence).  Empirical incidence rates and 
associated rankings are also given, from a sample of 8,504 inpatients in several specialties who were 
screened using this adverse-event measure during the RSCH occurrence screening project. 
 
The mean ratings for each criterion given by respondents cannot be directly interpreted as simple 
incidence rates, because of the nature of the scale on which the ratings were made.  Although it was 
intended that zero represented a 0% incidence rate, and ten represented a 100% incidence rate, the 
rankings in between were used by respondents to record relative rather than literal incidence rates, 
because of the poor granularity offered by the scale.  For example, if the scale had been used 
literally, a response of one would have represented a 10% incidence, and respondents who expected 
incidences somewhere between 0% and 10% would have been forced to opt for either one or the 
other.  Since many adverse events are relatively rare occurrences, the scale used provided 
insufficient resolution for respondents to estimate literal rather than relative incidence rates, and in 
practice respondents used the scale to indicate relative expected incidence rates.  In retrospect, a 
different response scale for this question would have yielded additional useful information, although 
this issue was not raised by the participants in the pilot study.   For example, a simple percentage 
scale could have been used, on which respondents rated expected incidence on a scale of 0 to 100. 
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Crit 
no 
 
Criterion title 
Expected incidence ratings Actual incidence 
data 
 
Rank 
differ
-ence 
  No  of 
responses 
Mean 
response 
Relative 
ranking 
Incidence 
(%) 
Relative 
ranking 
 
1 Adm for adv results o/p mgt 136 1.87 11 1.28 12 -1 
2 Readmission for comp prev adm 136 2.13 10 3.62 4 6 
3 Error in operative consent 135 1.69 12 1.35 11 1 
4 Unpl rem/inj/repair in surg 135 1.39 18 2.18 9 9 
5 Unpl return to theatre 137 1.53 15 0.83 13 2 
6 Path/hist varies from diag 137 2.75 7 0.32 15 -8 
7 Prob of transfusion 135 1.56 13 0.47 14 -1 
8 Hosp acquired infection 139 2.84 5 2.25 8 -3 
9 Medication error/reaction 137 2.64 8 3.08 6 2 
10 Cardiac/resp arrest in hosp 136 1.41 17 0.27 17 0 
11 CVA/MI/PE in hosp after surg 136 1.55 14 0.24 18 -4 
12 Unexp transfer to spec care 137 1.47 16 0.31 16 0 
13 Pt related clinical complcn 135 2.87 4 2.85 7 -3 
14 Non-clin problem/incident 134 3.34 3 9.92 3 0 
15 Neuro deficit devel in hosp 133 1.29 19 0.14 20 -1 
16 Unexp patient death 137 1.18 20 0.19 19 1 
17 Medical record deficiency 137 5.37 1 14.81 2 -1 
18 Nursing record deficiency 135 4.32 2 26.70 1 1 
19 Pt/family dissatisfaction 136 2.61 9 1.95 10 -1 
20 Discharge related problems 137 2.80 6 3.35 5 1 
All criteria 2720 2.33 - - - - 
 
Table 4.3.  Analysis of the ratings by all respondents of expected incidence 
of all screening criteria in adverse-event measure, compared to empirical findings on 
actual incidence of all screening criteria in adverse-event measure from a sample of 
8,504 patients screened during the RSCH occurrence screening project. 
 
It is immediately evident from table 4.3 that the rankings provided by the respondents to the 
questionnaire study correspond quite closely with the empirically derived rankings from the RSCH 
occurrence screening project.   Indeed, if the expected and empirically derived incidence rankings 
are compared, using the Spearman rank correlation coefficient (Hays 1974, p788), rs = 0.826, which 
indicates a strong degree of correlation (p < 0.001).   An alternative statistical test which can also be 
employed to measure the correlation between the two sets of rankings is Kendall's Tau coefficient 
(Siegel and Castellan 1988, p245).  For the data in table 4.3, τ = 0.662, which indicates that a strong 
and statistically significant correlation exists (p < 0.0001).  This empirical confirmation of the 
clinician opinions sought in the questionnaire study is encouraging, and strengthens the validity of 
the clinician ratings of other aspects of the adverse-event measure which cannot be empirically 
verified. 
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Unsurprisingly, the adverse events which clinicians correctly expected to be most frequent were 
those which were also deemed least serious (see the discussion of severity of effect ratings below).   
Events such as medical and nursing record deficiencies and non-clinical problems and incidents 
(criteria 17, 18 and 14) were rightly thought to be the commonest adverse events included in the 
adverse-event measure. 
 
It is interesting to note the criteria for which expected and empirical incidence rankings diverge.  
Respondents overestimated the frequency of criterion six (pathology/histology results vary from 
diagnosis) and 11 (CVA, MI or PE after surgery).  However, they underestimated the relative 
frequency of criteria two (readmission resulting from previous care) and four (unplanned removal 
injury or repair during surgery). 
 
Availability of required information in records 
Each respondent was asked to rate the likely availability in patients' casenotes (including both 
medical and nursing records) of information about the events specified in each screening criterion in 
the adverse-event measure.  The scale used for rating availability ranged from zero (information 
never found in records) to ten (information always found).   This question aimed to identify potential 
practical difficulties which might emerge in applying the adverse-event measure, and to gauge the 
risk that an absence of information would produce results which showed an artificially low 
incidence rate for some criteria within the measure.   Clearly, if some criteria require information 
which is not routinely recorded in patients' records, the measure might be improved by removing or 
adjusting those criteria. 
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Crit 
no 
 
Criterion title 
 
No of 
responses 
Availability of information ratings 
   Mean 
response 
 
Modal 
response 
Median 
response 
Standard 
deviation 
1 Adm for adv results o/p mgt 149 5.55 5 5 2.57 
2 Readmission for comp prev adm 149 6.88 8 7 2.13 
3 Error in operative consent 150 7.10 10 8 3.08 
4 Unpl rem/inj/repair in surg 149 7.76 8 8 2.09 
5 Unpl return to theatre 150 8.02 9 9 1.99 
6 Path/hist varies from diag 149 7.66 9 8 2.05 
7 Prob of transfusion 148 7.12 8 8 2.20 
8 Hosp acquired infection 150 6.33 8 7 2.33 
9 Medication error/reaction 148 6.30 8 7 2.36 
10 Cardiac/resp arrest in hosp 149 8.39 10 9 2.33 
11 CVA/MI/PE in hosp after surg 149 8.00 10 9 2.18 
12 Unexp transfer to spec care 150 8.08 10 9 2.25 
13 Pt related clinical complcn 147 6.33 8 7 2.16 
14 Non-clin problem/incident 146 4.23 5 4 2.38 
15 Neuro deficit devel in hosp 146 6.86 8 7.5 2.41 
16 Unexp patient death 147 8.21 10 9 2.65 
17 Medical record deficiency 146 8.18 10 10 2.72 
18 Nursing record deficiency 147 8.06 10 10 2.81 
19 Pt/family dissatisfaction 150 3.11 2 2 2.42 
20 Discharge related problems 150 3.97 2 4 2.51 
All criteria 2969 6.81 10 8 2.82 
 
Table 4.4.  Analysis of the ratings by all respondents of the availability of information 
in medical and nursing records for all screening criteria in adverse-event measure. 
 
 
Table 4.4 shows the respondents' ratings of information availability for each criterion within the 
measure.   For each screening criterion, the mean, mode and median responses are given. The table 
also shows the standard deviation for each criterion. 
 
It is evident from the mean and modal responses shown in table 4.4, that for most screening criteria 
in the adverse-event measure, respondents believed that the necessary information would be 
available in the medical and nursing records.  Seven criteria have a modal response of ten (the 
maximum, denoting information always available), and 16 criteria have a modal value of eight or 
more. Indeed, as the graph in figure 4.3 shows, the modal response for all criteria was the maximum 
value of ten, and 52% of all ratings of the availability of information were eight or more. 
  
 
 
165
 
 
Figure 4.3.  Distribution of availability of information ratings for all criteria by all respondents. 
 
The lowest ratings of the likely availability of information were given to criteria one (admission for 
adverse results of outpatient management), 14 (non-clinical problems and incidents), 19 (patient or 
family dissatisfaction) and 20 (discharge related problems).  For these criteria, the mean ratings 
ranged from 3.11 to 5.55 (modal response two to five).   In each case, the probable reasons for 
respondents' lower ratings are fairly clear.  Either the criteria related to events which occur outside 
the hospital environment which may therefore not be documented in hospital records, or they related 
to events which though important may not be routinely recorded in patient records.  
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Severity of effect of adverse events 
Respondents were asked to rate the likely severity of effect of the adverse event defined in each 
screening criterion in the adverse-event measure, in terms of its impact on patients' health.   The 
rating scale ranged from zero (no effect on patient's health) to ten (very serious effect on patient's 
health).  The severity of effect of adverse events on patients' health is clearly important to the 
validity of the adverse-event measure (since events with little or no effect may not be good 
indicators of the quality of healthcare).  However, the information was also sought because 
aggregating the results of any adverse-event measure involves combining scores for different 
screening criteria (which identify quite different adverse events) into a single score.  It is simplistic 
to weight all adverse events equally, since some are clearly much more important than others.  To 
develop a weighting system requires some quantitative assessment of the relative importance of 
different screening criteria.    Clinicians' ratings of the severity of effect of adverse events on 
patients' health might form the basis for such a weighting system. 
 
Table 4.5 shows respondents' ratings of the severity of effect of each screening criterion within the 
measure.  For each screening criterion, the mean, mode and median responses are given.  The table 
also shows the standard deviation for each criterion. 
 
The mean clinician ratings shown in table 4.5 reflect clinicians' priorities and concerns.  The highest 
ratings were given to those adverse events which have direct and serious effects on patients' physical 
well-being, such as unexpected death, cardiac and respiratory arrest, and CVA/MI or PE after 
surgery (criteria 16, 10 and 11).  Non-clinical events, though they may be of great significance to 
patients, received generally lower ratings.  It is indicative of respondents' priorities that some 
documentation-related adverse events such as medical and nursing record deficiencies (criteria 17, 
and 18) are rated as having a more serious effect on patients' health than either patient or family 
dissatisfaction or discharge related problems (criteria 19 and 20). 
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Crit 
no 
 
Criterion title 
 
No of 
responses 
Rating of severity of effect on patients' health. 
   Mean 
response 
Modal 
response 
Median 
response 
Standard 
deviation 
1 Adm for adv results o/p mgt 138 5.61 5 6 2.14 
2 Readmission for comp prev 
adm 
142 6.22 8 7 2.14 
3 Error in operative consent 144 3.15 1 2 2.70 
4 Unpl rem/inj/repair in surg 142 6.93 5 7 2.20 
5 Unpl return to theatre 141 6.65 7 7 2.03 
6 Path/hist varies from diag 137 5.76 5 6 2.41 
7 Prob of transfusion 139 6.52 8 7 2.27 
8 Hosp acquired infection 138 5.80 5 6 1.76 
9 Medication error/reaction 141 6.23 5 6 2.22 
10 Cardiac/resp arrest in hosp 142 9.03 10 10 1.60 
11 CVA/MI/PE in hosp after surg 145 8.73 10 9 1.34 
12 Unexp transfer to spec care 139 7.64 8 8 1.88 
13 Pt related clinical complcn 135 6.33 5 6 1.90 
14 Non-clin problem/incident 132 4.54 5 5 2.05 
15 Neuro deficit devel in hosp 136 7.31 8 8 2.00 
16 Unexp patient death 136 9.55 10 10 1.68 
17 Medical record deficiency 140 4.51 5 5 2.24 
18 Nursing record deficiency 140 4.16 5 4 2.28 
19 Pt/family dissatisfaction 141 3.85 5 4 2.28 
20 Discharge related problems 141 4.06 2 4 2.27 
All criteria 2789 6.13 5 6 2.71 
 
Table 4.5.  Analysis of the ratings by all respondents of the severity of effect on the  
patients health of adverse events defined by screening criteria in adverse-event measure. 
 
 
Potential for improvement in the adverse-event measure 
Respondents were asked to indicate, for each screening criterion within the adverse event measure, 
whether or not they felt that the criterion could be "altered to make it related more closely to the 
quality of care that patients receive".    The purpose of this question was to gauge respondents' 
attitude towards the adverse-event measure as it stood, and to pinpoint particular screening criteria 
which consensus opinion indicated should be revised.   The question also sought textual comments 
from respondents on specific improvements, which are analysed later in this section.  
 
Table 4.6 shows respondents' opinions on the potential for improvement of each screening criterion.  
The table gives the number and proportion of respondents replying that the criterion could or could 
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not be improved for each criterion.   Of course, respondents might indicate that they saw no 
potential for improvement in a criterion for two reasons: either because they felt it was already very 
well defined, was a valid indicator of quality, and they were satisfied with it as it stood; or because 
they felt it was highly inappropriate, was not a valid indicator of quality, and should be removed 
altogether rather than modified.   It would therefore be unwise to interpret a high "could not be 
improved" rating as an indication of respondents' satisfaction with or approval of a criterion without 
also considering their ratings of its validity. 
 
 
Crit 
no 
 
Criterion title 
 
No of 
responses 
Could not be 
improved 
Could be improved 
   Number Percent Number Percent 
1 Adm for adv results o/p mgt 136 85 62.5 51 37.5 
2 Readmission for comp prev adm 134 93 69.4 41 30.6 
3 Error in operative consent 130 106 81.5 24 18.5 
4 Unpl rem/inj/repair in surg 135 96 71.1 39 28.9 
5 Unpl return to theatre 134 105 78.4 29 21.6 
6 Path/hist varies from diag 128 95 74.2 33 25.8 
7 Prob of transfusion 131 94 71.8 37 28.2 
8 Hosp acquired infection 127 96 75.6 31 24.4 
9 Medication error/reaction 130 89 68.5 41 31.5 
10 Cardiac/resp arrest in hosp 127 102 80.3 25 19.7 
11 CVA/MI/PE in hosp after surg 130 100 76.9 30 23.1 
12 Unexp transfer to spec care 129 107 82.9 22 17.1 
13 Pt related clinical complcn 123 90 73.2 33 26.8 
14 Non-clin problem/incident 122 92 75.4 30 24.6 
15 Neuro deficit devel in hosp 125 95 76.0 30 24.0 
16 Unexp patient death 122 102 83.6 20 16.4 
17 Medical record deficiency 125 98 78.4 27 21.6 
18 Nursing record deficiency 124 99 79.8 25 20.2 
19 Pt/family dissatisfaction 126 99 78.6 27 21.4 
20 Discharge related problems 123 97 78.9 26 21.1 
All criteria 2561 1940 75.8 621 24.2 
 
Table 4.6.  Analysis of the opinions of all respondents on the potential for improvement  
of screening criteria in adverse-event measure. 
 
Overall, respondents indicated that that there were no improvements they would wish to make to 
most criteria, replying in 75.8% of cases that they would leave the criterion as it was.  For most 
criteria, between 70% and 85% of respondents would leave the definition as it stood.  The criteria 
with the greatest perceived potential for improvement were those dealing with admissions and 
readmissions (criteria 1 and 2) and medication errors and reactions (criteria 9).  The improvements 
suggested in these cases are detailed below.    
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Comparing the opinions of different respondent groups 
In section 4.2.2, the potential biases arising from the different response rates from the three groups, 
and the preponderance of public health physicians among respondents, were discussed.   In 
particular, it was suggested that public health physicians might rate the adverse-event measure 
differently from practising clinicians, and so their overrepresentation among respondents might give 
a misleading impression of overall clinical opinion. 
 
In order to test this hypothesis, respondents to the questionnaire were divided into two groups: 
public health physicians (study group A described earlier), and practising clinicians (study groups B 
and C).  For each respondent, a mean response to each question on the questionnaire was calculated 
(by taking the mean of his or her responses to that question for all 20 criteria).   This mean response 
effectively represents the respondent's rating of the adverse-event measure as a whole on that 
question.   These respondent means were calculated for each of the four questions asked about each 
criterion - the relationship to quality, the expected incidence, the availability of information in 
records, and the severity of effect.   The distributions of respondent means for the two groups were 
then compared for each of the questions for which detailed analyses have already been described - 
the rating of validity, the estimate of expected incidence, the rating of likely availability of 
information, and the expected severity of effect. 
 
The results of this analysis are shown in table 4.7.   For each question, information about the 
distributions of respondent means for the two groups is given and compared.   Firstly, for each group 
the mean and standard deviation of the distribution of respondent means are given.   Then, two 
statistics which compare the two groups are cited.  The Wilcoxon-Mann-Whitney test is a non-
parametric test which shows whether two groups are drawn from the same population (Siegel and 
Castellan 1988, p128).   The Kolmogorov-Smirnov two sample test also tests whether two groups 
are drawn from the same population, but is sensitive to differences in central location, dispersion 
and skewness (Siegel and Castellan 1988, p144).  For each test, the probability that the two groups 
are drawn from different populations is cited. 
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Question Public health 
physicians 
(n = 132) 
Practising clinicians 
(n = 18) 
Wilcoxon  
Mann-
Whitney 
test 
p value 
Kolmogorov
-Smirnov 
2 sample test 
p value 
 Mean Standard 
deviation 
Mean Standard 
deviation 
  
Validity as measure of quality 6.48 1.29 5.85 1.52 0.059 0.011 
Expected incidence 2.34 1.02 2.46 1.25 0.869 0.651 
Availability of information 6.81 1.15 6.89 1.22 0.991 0.974 
Severity of effect 6.12 1.20 5.97 1.40 0.529 0.330 
 
Table 4.7.   Comparison of respondent mean distributions between groups of 
public health physicians and practising clinicians. 
 
 
Table 4.7 shows that for three of the four questions asked in the questionnaire - those relating to 
expected incidence, availability of information, and severity of effect - there was virtually no 
difference between the distributions of respondent means for the two groups.  This means that public 
health physicians and practising clinicians gave similar mean ratings to the adverse-event measure 
on these questions. 
 
However, the distribution of respondent means for ratings of the validity of the adverse-event 
measure as a measure of quality do show some significant differences.  On average, public health 
physicians rated the validity as a measure of quality of the measure slightly higher than the 
practising clinicians (6.48 versus 5.85) and both the Wilcoxon-Mann-Whitney and Kolmogorov-
Smirnov two sample test suggest the difference between the two distributions may be significant (p 
= 0.059 and p = 0.011 respectively). 
 
Of course, the respondent means used in the above analysis could hide important differences in the 
way public health physicians and practising clinicians rated individual screening criteria within the 
adverse-event measure.   Such differences can be examined by repeating the analysis of table 4.7 for 
each criterion individually.    
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Crit 
no 
 
Criterion title 
Public health physicians 
(n = 132) 
Practising clinicians 
(n = 18) 
Wilconxon 
Mann-
Whitney 
test 
p-value 
Kolmogor
ov-
Smirnov 
2 sample 
test 
p-value 
  Mean Rel 
rank 
Std 
dev'n 
Mean Rel rank Std 
dev'n 
  
1 Adm for adv results o/p mgt 6.57 13 2.46 8.06 2 1.98 0.008 0.113 
2 Readmission for comp prev adm 7.34 4 1.92 7.39 3* 2.40 0.528 0.787 
3 Error in operative consent 6.05 14 2.95 3.61 20 3.63 0.005 0.014 
4 Unpl rem/inj/repair in surg 7.84 2 2.46 7.33 5 2.87 0.472 0.977 
5 Unpl return to theatre 6.91 8 2.02 7.39 3* 1.82 0.4683 0.998 
6 Path/hist varies from diag 5.77 15 2.44 6.28 8 2.63 0.406 0.970 
7 Prob of transfusion 6.58 12 2.43 4.94 14* 3.49 0.059 0.070 
8 Hosp acquired infection 6.60 11 2.07 4.78 16* 2.69 0.004 0.009 
9 Medication error/reaction 8.00 1 1.92 8.28 1 1.60 0.680 0.991 
10 Cardiac/resp arrest in hosp 3.86 20 2.57 4.94 14* 3.54 0.330 0.287 
11 CVA/MI/PE in hosp after surg 5.34 18 2.45 5.17 12* 3.02 0.769 0.833 
12 Unexp transfer to spec care 5.26 19 2.60 5.39 11 3.47 0.773 0.554 
13 Pt related clinical complcn 7.19 5 2.34 6.83 6 2.79 0.722 0.756 
14 Non-clin problem/incident 7.35 3 1.97 6.44 7 2.60 0.179 0.192 
15 Neuro deficit devel in hosp 5.50 17 2.59 4.41 18 2.98 0.129 0.226 
16 Unexp patient death 5.66 16 2.62 4.33 19 3.18 0.067 0.134 
17 Medical record deficiency 6.99 7 2.04 5.17 12* 3.03 0.014 0.019 
18 Nursing record deficiency 7.05 6 2.09 4.78 16* 2.98 0.002 0.010 
19 Pt/family dissatisfaction 6.83 9 1.93 5.61 10 3.50 0.352 0.032 
20 Discharge related problems 6.71 10 2.07 5.78 9 2.65 0.216 0.886 
 * denotes tied rankings. 
 
Table 4.8.   Comparison of respondent ratings of the validity  
of screening criteria within the adverse-event measure. 
 
 
Since the ratings of validity obtained from respondents were the primary aim of the questionnaire, 
and since it was only in the ratings of validity that some differences seemed to exist between public 
health physicians and practising clinicians, it is appropriate to examine these ratings in more detail.  
To this end, table 4.8 shows an analysis of validity ratings for each screening criterion by the two 
groups.  For each criterion, the mean rating, relative ranking and standard deviation of the 
distribution of ratings for the two groups is given.  The same two statistical tests (Wilcoxon-Mann-
Whitney test and Kolmogorov-Smirnov two sample test) are used to compare the two groups. 
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Table 4.8 shows that, while there are some differences in the validity ratings given to individual 
criteria by the two groups of respondents, in most cases the ratings are fairly similar.   Indeed, 
although the value of the mean validity ratings of the two groups for particular criteria may differ, it 
is clear from table 4.8 that in most cases the relative rankings of the criteria (where 1 is the most 
valid and 20 is the least valid indicator of the quality of care) are similar.  If the relative rankings are 
compared using the Spearman rank correlation coefficient adjusted for ties (Siegel and Castellan 
1988, p239), rs = 0.602 (p < 0.01).  If Kendall's Tau coefficient adjusted for ties is calculated (Siegel 
and Castellan 1988, p249) using the ranking data in table 4.8, τ = 0.399 (p = 0.007).  These results 
suggest that there is a strongly significant correlation between the validity rankings provided by the 
two groups. 
 
It is interesting to note the screening criteria on which the public health physicians' and practising 
clinicians' opinions of validity diverge.  The main area of contention is the validity of adverse events 
which are essentially documentation-related (criteria three, 17 and 18).  Public health physicians 
saw these adverse events as more valid indicators of the quality of care than their clinical colleagues.  
Perhaps because of their epidemiological training and responsibilities, public health physicians also 
regarded hospital acquired infections (criterion eight) as more valid indicators of quality than did the 
practising clinicians.  More puzzlingly, practising clinicians gave a higher validity rating to 
admissions resulting from the effects of outpatient management (criterion one) than the public health 
physicians. 
 
Respondents' comments on the validity of the adverse-event measure 
Many respondents' commented on the validity of the adverse-event measure as an indicator of 
quality (and, often, about the validity of adverse-event measures in general).  The range and variety 
of comments received indicated that a broad spectrum of opinion existed, and comments were 
neither overwhelmingly in favour of such measures nor overwhelmingly against them.  For 
example, some respondents praised the measure: 
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"As screening criteria I think most of the twenty are very useful". 
"Most of the clinical indicators are valid in terms of quality of care ... I thought the 
measures were well derived." 
 
However, others clearly had doubts about the practicality of the measure, its relevance, and the 
attitudes to quality improvement which it might encourage: 
 
"The whole approach horrifies me - bad apples versus continuous quality 
improvement.  Too much emphasis on outliers - it hasn't worked in US." 
"Nearly all the criteria are too loosely defined at the present.  They need to be much 
more specific." 
"This questionnaire convinces me even more that this type of audit is costly, has a 
low payback rate, and is threatening and about blame.  90% of the clinical issues will 
have a perfectly rational explanation.  Let us learn from the American experience." 
 
The main areas of concern about the use of adverse-event measures in general which were raised by 
respondents generally reiterated some of the potential problems with such measures which were 
enumerated and described in chapter 2.   The primary themes which emerged from respondents' 
comments were: 
 
a) Negativity.   
A number of respondents expressed concern that the focus on negative events inherent in 
any adverse-event measure would skew the medical or clinical audit process towards the 
detection of errors and mishaps, and produce an atmosphere of blame and recrimination 
among clinical staff.   Several respondents cited the American experience with such 
measures as evidence that this might happen.    
 
 
 
 
b) Cost.   
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Some respondents questioned the cost of gathering adverse-event data across large numbers 
of patients, especially when some events would be very rare and so individual instances of 
those events would be expensive to detect.    
 
c) Accuracy.    
While the ability of the measure to identify instances of poor quality care was generally 
accepted, several respondents felt that many adverse events identified by the measure would, 
on examination, turn out to be normal variations in clinical practice or patient outcomes.  
Some saw the adverse-event measure as being primarily of use in identifying cases for 
subsequent review by clinicians rather than as a measure in itself. 
 
d) Generic nature.    
The adverse-event measure which respondents were given was generic in nature, designed 
to be applicable to acute inpatient care in a wide range of specialties or settings.  A number 
of respondents identified this as a potential problem, suggesting that patient factors (such as 
age, sex, general health, etc) and diagnosis or procedure-specific factors (such as the nature 
and severity of disease and the complexity of procedures or treatments) were so important in 
determining whether or not adverse events had occurred that they needed to be explicitly 
taken into account in the definition of such measures. 
 
e) Availability of information.   
Some respondents suggested that the adverse-event measure was heavily reliant on good 
quality medical records, and that some of the screening criteria it contained defined adverse 
events which might not be routinely documented in patients' medical records. 
 
Respondents also made some specific criticisms of the adverse-event measure itself (in other words, 
comments which were specific to this measure rather than being directed at adverse-event measures 
in general), relating to how it had been constructed and defined.   Two main points were raised: 
 
 
a) Inappropriate groupings.   
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The most frequently occurring criticism was that the individual screening criteria grouped 
together adverse events which were dissimilar in causation, in their nature, and in the effect 
they might have on patients.   This made rating their validity, effect on patients' health and 
other aspects more difficult, and might reduce the validity of the measure as a whole.  Some 
specific examples are outlined  below.  It was suggested that subdividing some screening 
criteria into two or more separate criteria would be the best way to deal with this problem. 
 
b) Inadequate definition.   
A number of respondents suggested that criteria needed to be more clearly defined, and that 
the terms used in existing definitions were vague or were open to more than one 
interpretation.   It was suggested that greater precision and less subjectivity would be 
achieved if more examples were given, and if definitions were stated in more detail.   Of 
course, each criterion within the measure did have a much more detailed definition, which 
was not given to the clinicians participating in the survey because it would have presented 
them with much more information to read and comprehend before filling in what was 
already a very time-consuming questionnaire. 
 
It was, to some degree, reassuring that no wholly new criticisms of adverse-event measures emerged 
from respondents' comments.  The issues raised were all ones which had been considered and raised 
during the development of the adverse-event measure, or which had been identified by other 
developers and users of such measures.   
 
Respondents' comments on the validity of individual criteria 
The questionnaire sought comments from respondents on the criteria which made up the adverse-
event measure.  In particular, respondents were asked to suggest ways in which the criteria could be 
improved.   Respondents provided a number of suggestions for improvements to individual 
screening criteria within the adverse-event measure, and a range of comments on their individual 
validity and suitability.  All these comments are listed in full in Appendix 4.4.  Below, for each 
screening criterion, a brief summary of the main comments, criticisms and proposed improvements 
is given: 
a) Admission for adverse results of outpatient management. 
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This criterion was generally seen as very broad, covering a wide range of different sorts of 
adverse events, and liable to pick up false positives.  More definition of the concepts 
involved was recommended, with particular attention to the issue of causation. 
 
b) Readmission for complications relating to previous admission. 
Comments were similar to those for criterion one above, with respondents identifying 
problems in defining the events concerned and their causation as the main limitation to the 
use and validity of this criterion.   Suggestions included better definition of the factors 
involved in readmission, particularly its timing and causation.  It was pointed out that in 
some specialties, such as elderly medicine, discharge home and subsequent unplanned 
readmission if necessary may actually represent better quality of care than the retention of 
the patient in hospital. 
 
c) Error in obtaining consent to operative procedure. 
This criterion was seen as a useful proxy for quality in other areas (in that poor 
documentation of a legal requirement such as operative consent may suggest a lack of 
attention to detail in other areas), though many respondents raised what they saw as the more 
important issue of patients' understanding of procedures and their informed consent.  Of 
course, current documentation does not provide the information needed to assess whether 
patients' understand the treatments to which they are consenting. 
 
d) Unplanned removal/injury/repair of organ/structure during surgery. 
Many respondents pointed out that unplanned actions might be taken because of the findings 
of exploratory surgery (though in fact the definition of this criterion explicitly excluded that 
kind of unplanned action).  However, replacing the word unplanned with unintended or 
accidental might make the meaning clearer.  Some respondents suggested this was a rare 
event, and that some technical errors of this sort were very difficult to avoid. 
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e) Unplanned return to theatre. 
This criterion attracted relatively little criticism, though the suggestions for improvements 
tended to echo those set out for criterion four above.  Some modification to make the causal 
relationship between the first and second procedure clearer was suggested. 
 
 
f) Pathology/histology varies from diagnosis. 
Many respondents commented on this criterion, and suggested that the two main groups of 
adverse events - one concerned with pathology or histology results, and the other with 
postmortem results - should be separated into two criteria.  It was pointed out that 
postmortems often produce a different diagnosis of the cause of death from the antemortem 
diagnosis (which may suggest that this is a valuable criterion to include).  Some respondents 
identified a need to define more clearly the effect of this variation on treatment or clinical 
management, and to focus attention on those cases where a significant difference existed. 
 
g) Transfusion problems: reactions, complications, usage. 
This criterion was one of those criticised by many respondents as incorporating three 
distinctly different types of adverse event, which are only linked by the fact that they involve 
the use of blood and blood products.  Some respondents suggested trying to omit adverse 
events which are probably unavoidable (such as reactions to transfusions) and focusing on 
avoidable complications and misuse of the service.  it was also suggested that misuse needed 
to be more clearly defined. 
 
h) Hospital acquired infection. 
The main concern raised by respondents in relation to this criterion was the issue of 
definition.   Hospital acquired infections were recognised as clinically important, relatively 
common and often preventable.  Respondents suggested trying to define more clearly the 
separation between hospital acquired and pre-existing infections, and classifying infections 
according to their site or type.  Some respondents pointed out that many less serious hospital 
acquired infections may not be actively treated or even recorded. 
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i) Antibiotic/drug utilisation problems. 
This criterion grouped together medication reactions, and prescribing and administration 
errors.  Like criterion seven above, it was mainly criticised because it grouped adverse 
events which were really quite different from each other together.  Also like criterion seven, 
it was suggested that most drug reactions are probably unavoidable, while prescribing or 
administration errors were preventable.  Many respondents suggested separating the 
criterion into two or more criteria. 
 
j) Cardiac or respiratory arrest in hospital. 
The primary criticism voiced by some respondents of this criterion was that they believed 
most hospital cardiac and respiratory arrests to be unavoidable, resulting primarily from the 
progress of the patients' disease.   However, others suggested that avoidable factors did exist, 
and might be incorporated into the criterion.  Some respondents indicated that the 
management of such arrests was a more appropriate focus for the criterion. 
 
k) CVA or MI or PE following surgery. 
Some respondents suggested that the three events linked together in this criterion would be 
better separated into different criteria.  In particular, pulmonary embolus was seen as largely 
avoidable, while cerebrovascular accidents and myocardial infarctions were seen as resulting 
from the patients' pathology or disease process. 
 
l) Unexpected transfer to special care/higher dependency unit. 
This criterion is designed to identify sudden transfers to high dependency or intensive care 
units which might result from an unexpected deterioration in a patient's condition.  Some 
respondents wanted more attention to be given to the reasons for the transfer in the 
definition, while others pointed out that a transfer at an appropriate point in a patient's stay 
might actually represent timely detection of problems and a high quality of care. 
 
 
 
m) Patient related clinical complications occurred. 
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This criterion, which links together a number of quite diverse clinical complications, was 
criticised by some respondents for that diversity.  Some suggested splitting it into several 
criteria, or limiting it to a much smaller set of complications.  The complications included in 
the criterion were generally recognised as being valid attributes of the quality of care. 
 
n) Patient-related non-clinical problems/incidents occurred. 
Respondents made similar comments about the diversity of this criterion as were described 
above for criterion 13.   Interestingly, some respondents saw the events grouped together in 
this criterion as more avoidable than the clinical issues detailed in criterion 13. 
 
o) Neurological deficit on discharge not present on admission. 
In this case, many respondents felt that the criterion needed to be more specific about the 
nature of the neurological deficits involved, and their causes. 
 
p) Unexpected death. 
The primary problems with this criterion identified by respondents were the absence of a 
clear definition of unexpected, and the potential for overlap with many other criteria.  
Respondents wanted to adjust the definition to focus it more closely on avoidable deaths. 
 
q) Medical record deficiency. 
Most respondents combined their comments on this criterion and criterion 18 (below).  
Many suggested that a clearer definition of what the medical record should contain was 
needed if inadequacies were to be reliably identified, and proposed checklists of items which 
should be present.   Respondents seemed to view medical and nursing record quality as 
important issues in themselves as well as being proxies for more clinical quality attributes.  
Some suggested that there was a need to distinguish between minor and more severe record 
deficiencies. 
 
r) Nursing record deficiency. 
 See comments above for criterion 17 (point (q)). 
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s) Evidence of patient and/or family dissatisfaction. 
It was interesting to note that respondents - who were all consultant medical staff - did not 
generally regard patient dissatisfaction as an important attribute of quality.  Some suggested 
that adverse events identified by this criterion could be trivial and that non-clinical 
dissatisfaction was not especially relevant.   Respondents also pointed out that most 
dissatisfaction is not documented in patient records, and so could not be identified by the 
adverse-event measure. 
 
t) Discharge related problems. 
Respondents generally felt that this criterion was a useful indicator of quality, though they 
highlighted the fact that it combined problems caused by hospital care (such as poor 
discharge planning) with those resulting from poor community care (such as shortage of 
nursing home provision) and suggested that these items might be separated. 
 
 
Respondents' comments on the questionnaire design and completion 
Respondents were largely complimentary about the actual questionnaire design and layout, and 
seemed to have found it and the accompanying letter comprehensible and relatively user-friendly.  
The only design issue which a few respondents raised was the placing of screening criteria 
definitions on the back page of the four page questionnaire booklet.  A few respondents observed 
that they had not realised that these definitions were there until they were part or all of the way 
through completing the questionnaire. 
 
Quite a number of respondents felt that they lacked some or all of the knowledge needed to fill in 
the questionnaire - particularly the ratings of availability of information, expected incidence of 
adverse events, and effect on patients' health which were sought for each screening criterion.  Some 
felt uncomfortable that their answers were subjective and questioned how repeatable the study 
would be.   It is interesting that although the question about the expected incidence of adverse events 
probably aroused the most concern and self-doubt in respondents, as has already been shown, their 
ratings on this question were actually well matched to the actual incidence of adverse events in a 
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relatively large sample of actual patients.   This empirical confirmation of the accuracy of clinicians' 
ratings on one question may support their accuracy on other questions. 
 
The use of zero to ten rating scales throughout the questionnaire attracted little comment, and 
seemed to be well accepted, except on the question about the expected incidence of adverse events.  
Here a number of respondents drew attention to the problems of rating on this scale, and indicated 
that they had interpreted the scale as an ordinal rather than a ratio scale.  The need for a different 
scale on this question has already been discussed. 
 
The length of time it would take to complete the questionnaire was expected to deter some potential 
respondents.  This was confirmed by the comments of some respondents who did complete the 
questionnaire.  They observed that it needed some determination to complete it, that it took longer 
than they had expected (and, indeed, than our estimate had suggested it would take), and it required 
good motivation to complete. 
 
 
4.2.4 Conclusions 
 
The aim of the questionnaire study of clinician opinion, set out in section 4.2.1, was to assess the 
content and face validity of the adverse-event measure, and to gather the opinions of clinical 
professionals on other aspects of the measure which were relevant to its validity. 
 
Despite the relatively low response rate to the questionnaire study, the causes of non-completion do 
not in general detract from the ability of respondents to act as an expert panel in assessing the 
validity of the measure, or from the value of their comments on other aspects of the measure 
relevant to its validity.    
 
The study found that the adverse-event measure was generally regarded as a valid measure of the 
quality of care given to acute hospital inpatients.   Some individual criteria within the measure were 
regarded as more or less valid than others, and the measure could be made more valid in the opinion 
of some respondents by omitting some criteria, and restructuring or adding some others.  However, 
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overall respondents indicated a generally high level of confidence in the validity of the measure.  In 
their quantitative ratings and in their written comments they generally confirmed the face and 
content validity of the measure. 
 
The study also found that respondents were able to predict, with reasonable accuracy, the relative 
incidence of adverse events found empirically with a sample of 8,504 patients screened using the 
adverse-event measure.  This empirical confirmation of respondents' ratings provided some 
reassurance that respondents' ratings in other areas were also meaningful.    
 
In addition, the study showed that respondents believed that, for most criteria within the adverse-
event measure, the information needed to determine whether events had happened or not would be 
available in the patients' medical and nursing records.   Although respondents to the study came 
from two distinct clinical professional groups - practising clinicians and public health physicians - 
the ratings of these two groups on all aspects of the measure were generally consistent with each 
other. 
 
Respondents suggested a wide range of alterations to the adverse-event measure which might 
improve it, but overall they endorsed the measure as a valid measure of the quality of care. 
 
 
4.3 Interviews with clinicians 
 
4.3.1 Aims of interview study 
 
Qualitative enquiry, using data collected through interviews, observation, or document analysis, 
allows the researcher to study issues in depth and detail, without being constrained or limited by 
predetermined categories of analysis  (Patton 1990, p14).  While quantitative methods facilitate the 
comparison and statistical aggregation of data, qualitative methods can produce detailed and 
insightful information about the subject of the research. Though its results may be less generalisable 
(and indeed generalisability is not one of its aims), qualitative research can identify themes or issues 
which quantitative enquiry, by its prestructured nature, excludes. 
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The primary aim of the interview study of clinician opinion on the use of adverse-event measures of 
quality was to support and supplement the largely quantitative information on the validity of 
adverse-event measures gathered and analysed by the parallel questionnaire study (reported in 
section 4.2).  The interview study was designed to provide a more qualitative understanding of 
clinicians' perceptions of adverse-event measures of quality and their application in quality 
measurement and quality improvement, and to enable clinicians participating in the study to raise 
issues or themes which had not been addressed by the questionnaire study.   It has been suggested 
that the simultaneous or sequential use of qualitative and quantitative research methods and the 
integration of their results, known as triangulation, provides stronger and more valid research results 
and conclusions than using one or other method by itself (Field and Morse 1985, p16). 
 
While the broad aim of the interview study was to provide a qualitative understanding of clinicians' 
perceptions of adverse-event measures of quality and their application in quality measurement and 
quality improvement, it was undertaken with two main objectives in mind: 
 
a) To identify themes or issues omitted by the questionnaire study. 
The questionnaire study was focused on a series of issues related to the validity of the 
adverse-event measure being tested.  In particular, it gathered clinicians' ratings of the 
validity of criteria within the measure, the expected incidence of adverse events and the 
severity of their effect on patients, the availability of information about adverse events in 
patients' records, and clinicians' suggestions for improvements in individual criteria or in the 
measure as a whole.  While respondents' views on other aspects of adverse-event measures 
in general were solicited, it is in the nature of a postal questionnaire study, especially one as 
long and complex to complete as this one, that it provides little encouragement for 
respondents to address themes or issues outside its existing boundaries.   Therefore, one 
objective of the interview study was to identify any themes or issues relating to the general 
validity and utility of adverse-event measures which did not emerge from the questionnaire 
study. 
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b) To explore the place of adverse-event measures of quality in the quality measurement and 
quality improvement process in healthcare. 
It was noted in chapter 2 that one does not simply validate a measuring instrument.  Rather, 
one validates a measuring instrument in relation to the purpose for which it is being used, 
and in the context or environment in which it is being deployed.   While the questionnaire 
study was designed to validate the adverse-event measure, it was not intended to yield much 
information about the potential application of such measures, and their place in quality 
measurement and quality improvement.   Therefore, a second objective of the interview 
study was to gather clinicians' opinions on the place of adverse-event measures in the current 
British healthcare environment, their relationship to other quality measures, and their 
application. 
  
 
4.3.2 Method 
 
In quantitative research, sampling strategies are generally driven by the objective of producing 
generalisable results, which can be used and applied by other people in a range of contexts or 
situations.  As a result, they often use relatively large, random samples.  By contrast, qualitative 
research is driven by the need to develop a deep understanding of the phenomenon under study 
within its own context.  As a result, it typically focuses on relatively small samples, selected 
purposefully.  The intention of such purposeful sampling is to select information-rich cases or 
subjects, which are judged likely to provide sufficient information about the phenomenon or issue 
under study (Patton 1990, p168). 
 
For this interview study a purposeful sampling strategy was chosen.  It was felt that information-rich 
subjects were likely to have a clinical background and experience in the practice of clinical 
medicine, an interest in quality assessment in healthcare, and some understanding of the use of 
adverse-event measures.  In addition, they would need to be willing to commit time to being 
interviewed for the study.  On this basis, it was decided to ask members of the Regional Medical 
Audit Advisory Committee (RMAAC) for the South East Thames region to participate in the study.  
This group contained a total of 10 senior medical staff, all of whom held senior posts in clinical 
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medicine, and who were (by virtue of their voluntary membership of this committee) interested and 
involved in quality assessment and quality improvement in healthcare.  Small sample sizes of this 
kind are common in qualitative research, where the main criteria used to determine the sample size 
are its appropriateness (whether it fits the needs of the research study) and its adequacy (whether the 
data obtained is sufficient, and whether saturation is achieved in data collection) (Morse 1991).   
 
A number of general themes were chosen to be explored with each interviewee, using the 
preliminary analysis of the textual responses in the questionnaire study and information from the 
literature review.  These themes were then used to form the basis of a semi-structured interview 
schedule (a copy of which can be found in appendix 4.5).   It was not intended that this schedule 
would be rigidly adhered to, but it was designed to guide the interviewer and to be used as the main 
contemporaneous record of the interview.    
 
The open structure of the questions put to interviewees and the broad nature of the themes identified 
for discussion during interviews were both intended to encourage interviewees to raise issues which 
were of concern or interest to them, and to enable issues relating to the design or application of 
adverse-event measures of quality which might not have previously been encountered to be raised.   
After all, the primary aim of the interview study was not to confirm the findings of the questionnaire 
study or the existing literature - it was to identify any issues which might have been overlooked in 
those findings. 
 
The six themes chosen for discussion in each interview were: 
 
a) The general advantages and disadvantages of adverse-event measures. 
This theme was used at the start of each interview to initiate a general discussion of the 
merits and demerits of adverse-event measures of quality, in which interviewees could raise 
any perceived advantages or disadvantages of these measures, without their opinions being 
directed or structured by the interviewer in any way.  It was the most general and least 
specific of the six themes, since the remaining five themes addressed during the interview all 
focused on particular aspects of these measures. 
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b) The similarities and differences between adverse-event measures and more traditional audit 
or quality assurance mechanisms. 
This theme was felt to be worthy of exploration because both the literature review and 
informal opinion from clinicians suggested that some important methodological similarities 
existed between adverse-event measures of quality and traditional audit mechanisms such as 
mortality and morbidity meetings or death and complication reviews.  These similarities 
might be important aids in explaining adverse-event measures to clinicians and in 
influencing them to use such measures in quality assurance.  It was therefore important to 
seek interviewees' views of any similarities or differences, without directing them to 
particular examples or instances. 
 
c) The utility of adverse-event information in measuring quality for individual patients or for 
groups of patients. 
In order to encourage interviewees to consider how useful they would find adverse-event 
information, this theme was raised during each interview.   The term utility was used 
because it emphasised the practical issues in measurement and because the broad meaning of 
utility allowed interviewees to raise issues relating to validity, reliability, costs and almost 
any other aspect of the measure. 
 
d) The utility of adverse-event information in creating or promoting changes in practice and 
the quality of care. 
This theme was discussed with each interviewee, in combination with (c) above, in order to 
examine what interviewees felt would be the results of using adverse-event information.     It 
was included in order to encourage interviewees to look beyond the process of measurement 
and to consider how adverse-event information might actually be put to use in producing 
changes in the quality of care.   Again the term utility was used because its broad and 
relatively unspecific meaning allowed interviewees to raise a wide range of issues around 
the effects of adverse-event information on practice. 
 
e) The suitability of adverse-event measures of quality for different areas or specialties in 
inpatient care. 
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It has been suggested, both in the literature review and in responses to the questionnaire 
study, that adverse-event measures of quality are less well suited to areas of healthcare 
where patients may have multiple problems and undergo multiple concurrent interventions 
(such as geriatrics or general medicine) and are more suited to areas where patients are 
generally healthy apart from a single problem which is treated by a single intervention (such 
as some surgical specialties).   This theme aimed to explore any differences in the suitability 
of such measures without directing interviewees to the reasoning outlined above. 
 
f) Factors which might either facilitate or obstruct the application of adverse-event measures 
of quality. 
This last, broad theme sought interviewees' opinions on the organisational, structural and 
managerial factors which might either help the introduction of a quality assurance system 
based on adverse-event measures of quality or might hinder it.   The theme aimed to explore 
interviewees' perceptions of the role of such measures in healthcare organisations in the 
NHS, and to seek their views of the way such measures would fit into the culture and ethos 
of such organisations. 
 
A letter explaining the purpose of the interview was sent to all members of the Regional Medical 
Audit Advisory Committee (RMAAC) for the South East Thames region.  It sought their agreement 
to be interviewed, and identified the general themes that the interview would seek to address.  This 
letter was designed to give potential interviewees the opportunity to think about the issues involved 
before being interviewed.   All interviews were conducted by telephone, because of the logistic 
difficulties of arranging meetings with interviewees who were geographically located across south 
east England.  Interviews varied in length from 20 minutes to over an hour.   All members of the 
group agreed to be interviewed, but in practice establishing times when they were able to make 
themselves available for the interview proved difficult in some cases.  As a result, interviews were 
only conducted with 6 of the 10 members of the group.    These interviews were conducted between 
November 1991 and March 1992.  
 
Each interview commenced with a brief explanation of the aims of the interview.   Then the themes 
identified on the interview schedule were explored in turn, allowing the interviewee to determine the 
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direction and subject of the interview.   During each interview the interviewer made notes on a copy 
of the interview schedule, and these notes were then written up immediately the interview ended.  
Contemporaneous notes were used as the interview record, rather than tape recording and 
transcription, because the use of telephone interviewing made the keeping of such detailed notes 
relatively easy, and it was judged that verbatim transcripts would not add significantly to the value 
of the interview record as a data source in the context of the study aims. 
 
The concepts of validity and reliability in quantitative research are paralleled by the concepts of 
credibility and replicability in qualitative research.   Credibility is concerned with the intellectual 
rigour with which the study is undertaken, the qualifications and experience of the researcher, and 
the adherence to key concepts in qualitative research like naturalistic inquiry.  Replicability is 
concerned with the extent to which a study is adequately documented and recorded, so that 
decisions and judgements made by the researcher are made explicit and the study could be 
reproduced by another researcher using the report of the study (Patton 1990, p460).   For this 
interview study, the information given here is intended to provide the evidence of its credibility and 
replicability that a reader might require. 
 
The notes from all the interviews were analysed manually.  First, each interview was numbered and 
the notes of each interview were read through and coded to identify sections of the notes which 
related to particular themes, concepts or issues.   These themes, concepts or issues were in part 
derived from the interview schedule, but were supplemented by some themes which emerged from 
the interview notes themselves.  Then notes relating to specific themes, concepts or issues were 
grouped together, to facilitate the description of interviewees' attitudes and beliefs on each theme 
and the development of a coherent or common view where that was possible.   In the analysis which 
follows, these themes and issues are reported and discussed.  All quotations from interview notes are 
followed by the number of that interview. 
 
 
 
4.3.3 Results and discussion 
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General advantages and disadvantages of adverse-event measures 
In all, the interviewees mentioned seven different advantages and seven different disadvantages of 
adverse-event measures, which are summarised in table 4.9 below. The most frequently mentioned 
advantages of adverse-event measures of quality were their systematic nature and their focus on 
taking action and preventing future adverse events (each of which was cited twice), while the most 
frequently mentioned disadvantage was the potential for bias in adverse-event measures (cited by 
four interviewees).   These advantages and disadvantages are discussed in more detail below. 
 
 
Advantages Disadvantages 
Action/problem focus 
Systematic nature 
Objective nature 
Validity 
Efficiency 
Provides aggregate data 
Done by additional staff 
Potential for bias 
Difficulty of attribution/causation 
Timing of measurement 
Indirect measure of quality 
Clinician motivation problems 
Poor quality documentation 
Needs additional staff 
 
Table 4.9   Advantages and disadvantages of adverse-event measures of quality  
cited by interviewees.   
 
 
The advantages of adverse-event measures of quality which were cited by interviewees are 
described in their own words in table 4.10.  
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Systematism "..advantages of occurrence screening are mainly its systematisation of events audit - which 
is a long-standing part of audit in most specialties.  ...[it] would satisfy a need for a 
systematic approach to audit." [4] 
 "Huge advantage of occurrence screening is that it picks up events systematically.." [6] 
Objectivity "..it is clear cut, with readily recognisable sources of information.." [1] 
Validity "..if criteria are good, the information is directly related to quality of care." [2] 
Efficiency “It can obtain a much better pickup rate of adverse events at reduced cost." [5] 
Action focus "..it is easy to identify the action that needs to be taken from the information gathered." [1] 
 "..it picks up events systematically and can be used to stop them happening again - 
prevention." [6] 
Aggregate data "..you build up a picture of near misses - minor incidents that no-one knows how frequently 
they occur.  Particularly in [specialty] which is a sharp-end specialty where lots happens in 
a short space of time need a way to monitor minor incidents." [3] 
Staffing "One advantage of occurrence screening is that data is collected by an audit assistant - data 
needs to be collected by audit assistants as clinicians haven't got enough time." [2] 
 
Table 4.10.  Advantages of adverse-event measures of quality cited by interviewees 
 
 
Several of the advantages cited by interviewees were clustered around what might be termed the 
technical worth of adverse-event measures of quality - aspects such as their systematism, objectivity, 
validity, and efficiency.  Other perceived advantages included the action or problem focus of 
adverse-event measures (in other words, the fact that having detected an adverse event, it provides a 
natural focus for action to prevent future such events and so to improve the quality of care). 
 
The aggregate information about rates of adverse events which adverse-event measures provide was 
seen as a particular advantage by one interviewee, since that kind of information was not available 
elsewhere. When adverse-event measures of quality are employed, the data is generally gathered by 
specifically designated staff rather than by clinicians themselves.  This means that little additional 
workload is placed on clinical staff - which one interviewee saw as another advantage. 
 
The disadvantages of adverse-event measures of quality which interviewees described are detailed 
in table 4.11.   
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Potential bias "..the focus on adverse aspects of care, and only on those criteria selected by clinicians (so if 
not selected, then not picked up - perhaps bias in the criteria?)." [2] 
"Bias towards the things on the list. Also a danger that list is subjective and reflects value 
judgements on what is or is not adverse or appropriate."  [4] 
"..Occurrence screening is not going to audit everything - in particular, just because an event 
is not listed in the criteria does not mean it doesn't matter.  There would be some danger in 
relying on occurrence screening as the only method of audit." [5] 
"..audit is about more than just adverse events (just because no adverse events does not 
mean perfect care)." [6] 
Indirect measure "..these things are an indirect measure - a proxy - for real quality of care (need a test - serum 
quality!)." [3] 
Timing "Problems are picked up after they have happened (horse has bolted) though it depends on 
at what position/time screening takes place." [6] 
Causation "..doing it without attributing blame could be difficult." [1] 
Poor documentation "...these incidents are not always documented (often not), so a self-reporting system would 
be needed.   Problems with reliability and honest reporting would be a problem especially if 
not confidential." [3] 
Motivation "Occurrence screening is not enough for audit by itself - it would get boring.  Have had 
some contact with [clinicians] in [district where occurrence screening being used] and they 
don't like it!  With a centralised system there is the danger that you lose the sense of clinical 
ownership." [2] 
Staffing "..it needs an external agent to collect data (eg the nurse screener or whoever) which would 
not be available in [specialty].  Could use [existing member of staff] perhaps to perform this 
function for a limited number of cases." [1] 
 
Table 4.11.  Disadvantages of adverse-event measures of quality cited by interviewees 
 
 
The most frequently mentioned single disadvantage cited by interviewees was the potential for bias 
in adverse-event measures of quality.  Several interviewees suggested that because a measure might 
include certain adverse events but not include others, it might solely represent clinicians' judgements 
of what is or is not adverse.  The omission of important adverse events from the measure, and the 
resultant lack of attention to instances of those events, was seen as a problem. 
 
It was interesting to note, however, that the negative focus of adverse-event measures (their 
attention to what are, essentially, instances of poor quality) was not mentioned as a disadvantage by 
interviewees (except, in passing, by interviewee 2 above).  Although this perceived disadvantage is 
given prominence in the literature and was raised by a number of respondents to the questionnaire 
study, it did not seem to be as important to this group of interviewees.   One interviewee suggested 
that adverse-event measures were essentially indirect rather than direct measures of the quality of 
healthcare.   
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While the action or problem focus of adverse-event measures had been cited by some interviewees 
as an advantage, one interviewee felt that the timing of data collection meant that adverse events 
would be noted after the event rather than prevented, and another believed that deciding on the 
causation of adverse events without seeming to be allocating blame would be difficult.  Another 
interviewee suggested that the poor quality of medical record documentation made the application 
of adverse-event measures practically difficult.   Interestingly, only one interviewee suggested that 
clinicians might not want to use adverse event information to review the quality of care they deliver 
(or might at least want other sorts of information as well). 
 
Although one interviewee (cited above) had seen the fact that adverse-event measures are usually 
applied by specially designated staff rather than by clinicians themselves as an advantage, another 
perceived it as a disadvantage, because such staff would not be available. 
 
Similarities to and differences from traditional quality assurance methods 
It has been commonplace for medical staff to review individual cases or groups of cases in mortality 
and morbidity meetings or death and complication reviews.  The cases chosen for such review have 
often been selected because they involve some sort of potentially avoidable adverse event.  Case 
presentations have generally been followed by some form of discussion, in which senior clinicians 
provide informal guidance on the future management of similar circumstances. 
 
All interviewees perceived strong parallels between these traditional medical approaches to quality 
assurance and adverse-event measures of quality, and regarded adverse-event measures of quality as 
a kind of continuation of more informal current practices.   For example: 
 
"In [specialty] we already have anecdotal information on adverse events - which 
gets discussed at [specialty] meetings, coffee, etc." [1] 
"Occurrence screening is like traditional audit in that it is notes-based and some of 
the criteria pick up common traditional audit issues..." [2] 
 "[Specialty] have been using adverse events for years in audit.." [3] 
 "Strong similarities with traditional case audits in [specialty]." [4] 
"Occurrence screening is very similar to some traditional audit methods - M&M 
meetings etc." [5] 
 "There are obvious parallels with traditional M&M meetings..." [6] 
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Interviewees described five main differences between adverse-event measures and the traditional 
methods of quality assurance - the degree of systematism and formality in the method, the 
objectivity of the method, the range of events included, the inclusion of an outside view, and the 
potential to delegate data collection.  In each case the difference seemed to be regarded as a positive 
one by the interviewees (in other words, the adverse-event measures were seen as better than 
traditional methods because of it).  Interestingly, none of the interviewees raised differences 
between adverse-event measures and traditional audit methods in which the latter were seen as 
superior.   These differences are described in more detail in table 4.12 
 
Systematism "The main difference with occurrence screening would be that the data collected would be 
more formal and more systematic." [1] 
"Main difference .. is the systematic nature of occurrence screening." [4] 
"The difference is that occurrence screening is more systematic and sophisticated.." [6] 
Objectivity "It is different from traditional approaches to audit in that there are much clearer definitions 
of things - they are less subjective." [5] 
Range "The range of definitions of occurrence screening is much wider, encompassing far more 
than the strictly clinical matters." [5] 
Sensitivity "It is important to know about near misses, which occurrence screening does and other 
approaches do not." [5] 
Outside view "M&M meetings take place within the profession - occurrence screening brings in a healthy 
outside view." [6] 
Clerical support "You can define occurrences to a degree that delegating initial screening to clerical support 
becomes feasible." [5] 
 
Table 4.12.   Differences between adverse-event measures and  
traditional methods of quality assurance identified by interviewees 
 
The links between adverse-event measures of quality and some traditional quality assurance 
methods seemed to be used by interviewees to conceptualise the former's use and application, and 
the similarities appeared to help in gaining their acceptance of adverse-event measures.  While the 
interviewees did see some important differences between adverse-event measures and traditional 
quality assurance methods, those differences were advantages rather than disadvantages. 
 
Utility in measuring quality for individual patients or groups of patients 
All interviewees were asked how the information from adverse-event measures of quality might be 
used to assess the quality of care for individual patients and for groups of patients. Adverse event 
information on both individual patients and groups of patients was seen as valuable and helpful, 
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though most interviewees believed that aggregate information about the rates of adverse events in 
groups of patients would be more useful because it would be more reliable: 
 
"Feel occurrence information is useful in aggregate to pinpoint problem areas.  
Useful in individual cases for case discussion and for prevention.  Both sorts of data 
are needed." [2] 
"Rates of occurrences would be main useful indicator rather than individual events - 
eg how often an incident occurred (5 reports and start to do investigation)." [3] 
"Data from individual events might be misleading and might be prematurely 
interpreted.  Group data - rates of adverse events - would be much more useful in 
comparing practice and identifying problems." [4] 
"Aggregate data would be useful for saying how often x happened, unless there is a 
specific single problem would tend to look at how often things happened - whether 
acceptable.  Need aggregate data to argue for more resources." [5] 
 
However, one interviewee raised some of the difficulties involved in interpreting rates of adverse 
events, and pointed out that the review of individual cases and groups of cases had some 
advantages: 
 
"Most useful part of occurrence screening would be the review of individual events 
or groups of events.  Rates and so on would be less useful.  There is a risk that 
patients have unrealistic expectations of care and some adverse events are 
unavoidable - so rates less meaningful than study of individual cases.  Problems is 
that some events would happen very rarely - low incidence - and the nature of the 
events affects their importance clinically." [6] 
 
 
Utility in creating or promoting changes in practice and the quality of care 
Interviewees had a variety of ideas of how they might use information about individual adverse 
events or about groups or rates of adverse events to create and promote changes in practice or the 
quality of care.   Some believed that the simple availability of information would have a beneficial 
influence on individual practitioners' patterns of practice and behaviour, and this would bring about 
improvements in the quality of care: 
 
"I believe that this information would create a heightened self-awareness which 
would reduce event rates (self-knowledge makes people change)." [3] 
"Suggest that constant repetition of information - drip drip effect - would be 
effective." [4] 
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Other interviewees saw the process of changing individuals' behaviour as more complex and 
challenging than this, and suggested that to change practice required more than simply the provision 
of information: 
 
"For occurrence screening to bring about change, very important to bring people 
who need to change into the setting of criteria initially - get people to define adverse 
occurrences in advance, and set target percentages for each occurrence.  Important 
that the system is not just used to criticise but also to praise." [5] 
 
Some saw adverse-event information as a starting point for investigations which would focus on 
changing the way processes or systems were organised and managed.  From their viewpoint, the 
information would be used to change systems or processes rather than to alter any individual's 
behaviour: 
 
"I recently found [an adverse event] which when investigated turned out to result 
from a string of organisational problems ... we have now changed the way things are 
organised.  The point is that it was not a problem of individual behaviour, it was an 
organisational problem." [1] 
 
 
Suitability for different areas or specialties in inpatient care 
When asked about the appropriateness of adverse-event measures for particular specialties or areas, 
interviewees were divided on whether they were equally appropriate in all areas of inpatient care.  
Some interviewees felt they might be developed and applied in any specialty: 
 
"Occurrence screening is well suited to most specialties..." [3] 
"I think occurrence screening could work across the board in most specialties ..." 
[5] 
"I think that occurrence screening could be applied equally to every specialty - there 
are adverse events in all specialties worthy of screening." [6] 
 
In contrast, other interviewees argued that adverse-event measures were better suited to the more 
acute inpatient areas: 
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"Occurrence screening is best used in monotonal disease areas, surgery (especially 
for the under 75's), for younger patients in general, and is good for clinical audit as 
well.  It is not well suited to ... specialties where multiple problems/pathologies are 
common, because it is harder to separate disease process and effects of care." [2] 
"Occurrence screening is better suited to the acute areas ... less well suited to the 
long term chronic care work." [4]  
"... it would be less suitable for long stay patients because of the lower numbers and 
the difficulties of setting standards." [5] 
 
Interestingly, all interviewees said that they would (or did) use adverse-event measures in their own 
specialties, although they represented a full spread of specialties including both surgical and medical 
and acute and non-acute areas: 
 
"Can see ways of using occurrence screening in [specialty].  Think it is a good idea, 
worth trying out.  Suggest some possible criteria for use in [specialty] [list of 
suggestions followed]." [1] 
"I would use occurrence screening in audit, but only in combination with other audit 
tools.  Suggest one third occurrence screening and two thirds outcomes work (in 
[specialty] at least).   Occurrence screening would be useful for some big issues we 
are not currently doing enough about which prolong hospitalisation - such as 
pressure sores, constipation." [2] 
"I would certainly use occurrence screening in own specialty/hospital ...  Currently 
am working out a pilot system based on a standard checklist ... Occurrence 
screening is very like the things we have already been doing - in favour of it." [3] 
"I would like to use occurrence screening as one of the main planks of audit in my 
own department, though I would want to retain the element of 'unstructured'  free 
discussion which currently exists." [4] 
"We are currently doing it!  Clerk pulling notes of patients in outpatients clinic to 
check for failures to record height and weight, non-availability of results.  We would 
use (do use) occurrence screening as part of our audit, included with other 
techniques." [5] 
"At present we only use adverse events in audit as a 'trigger' for further 
investigations or studies - not routinely.   I believe we should use occurrence 
screening more - gathering data and feeding it back through our medical audit 
assistant.  Proper feedback when events happen is essential, to get people to start to 
work out strategies for avoiding/preventing adverse occurrences.  Occurrence 
screening certainly has a defined place in medical audit, though it is not all that is 
needed - it might make up only 20% of audit activity/studies." [6] 
 
While the interviewees were all clinicians with some interest and involvement in clinical audit, it 
was interesting to note that they showed considerable enthusiasm for using adverse-event measures 
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in their own audit or quality assurance activities, in combination with other approaches to 
measurement and monitoring. 
 
 
Factors which might facilitate or obstruct application of measures 
Interviewees identified a number of factors which might facilitate or assist the introduction of 
adverse-event monitoring in a department or specialty, including the atmosphere and relationships, 
the leadership provided by senior clinicians, the extent of participation in the process, and the degree 
to which it could be made interesting to those involved.   These factors, and others which might 
obstruct such an introduction, are set out in table 4.13 below. 
 
Atmosphere: "To set it up needs a good rapport in the department - and a level of interest in knowing 
about every adverse occurrence. " [6] 
Leadership "Need to convince the consultants to participate then juniors would follow." [3] 
"In getting occurrence screening to work the key thing would be to motivate and secure 
conviction of consultants to do it." [4] 
Participation "To get occurrence screening to work well it would be important to involve people in setting 
standards/criteria themselves, to review the standards/criteria regularly, and to ensure it is 
not just criticism." [5] 
Interest "Occurrence screening would be best accepted if it was [part of] a rotating audit - covering 
different topics each month rather than looking at the same things again and again." [2] 
Lack of interest "Problems in occurrence screening include getting people excited (essential part of audit) 
and establishing ownership." [2] 
"Problems might result from high occurrence rates (get used to it) or low occurrence rates 
(not enough to sustain interest)." [6] 
Punitive use "Very important that no aspect of blame/punitive nature/disciplinary factors/etc attached to 
occurrence screening or events wouldn't be reported." [3] 
Restrictiveness "This approach might be too 'disciplined' for some - though it might usefully encourage 
focus on smaller areas, better defined." [4] 
 
Table 4.13.  Factors which might facilitate or obstruct the  
application of adverse-event measures of quality identified by interviewees. 
 
Some of the factors identified by interviewees which might obstruct the introduction of adverse-
event monitoring were essentially the reverse of those factors identified above.  For example, the 
difficulties of sustaining interest were seen as an obstacle by some.  However, two new factors 
which might impede adverse-event monitoring were identified - the risk that the process might be 
used punitively to assign blame and even to take disciplinary action against clinicians, and the 
possibility that the structured nature of adverse-event monitoring might seem restrictive to clinicians 
who are used to a more unstructured and less methodical approach: 
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4.3.4 Conclusions 
 
The interview study set out to identify any themes or issues relating to the validity of adverse-event 
measures in general which might have been overlooked by the questionnaire study.   The structure 
of the interviews gave interviewees the opportunity to raise almost any aspect of adverse-event 
measures and their application in healthcare, including (but not restricted to) aspects of their 
validity. 
 
Interviewees generally regarded adverse-event measures as valid indicators of the quality of care, 
and cited a number of merits of such measures which directly impinged on their validity and their 
wider utility.   However, they also expressed concerns about the potential for bias in adverse-event 
measurement, especially if adverse-event measures were the only indicators of quality to be used.  
The validity issues raised by interviewees (both positive and negative) closely matched those raised 
by respondents to the questionnaire study, suggesting that the two studies support and confirm each 
others' findings.    Perhaps the clearest signal that interviewees regarded adverse-event measures as 
valid and useful indicators of the quality of care was that they all, without exception, indicated that 
they would wish to use, planned to use or were using these measures themselves in their own 
clinical practice. 
 
The interview study afforded the opportunity to explore other aspects of adverse-event measures, 
beyond their validity.  It was clear that interviewees regarded these measures as having much in 
common with traditional medical approaches to quality assurance, but saw them as superior to the 
latter for a number of reasons.   Interviewees felt that the aggregate data which results from adverse-
event measurement, giving rates and trends in adverse events, would be particularly useful in 
identifying quality problems and comparing practice.  Interviewees had differing ideas of how they 
might use adverse-event data to influence and change clinical practice, and while some thought that 
the simple availability of data would bring about change others believed that a more proactive and 
interventionist application of the data would be needed.  Interviewees saw adverse-event 
measurement as relevant to the whole range of inpatient care, though most interviewees perceived it 
  
 
 
199
as being easier to apply in areas of medical care where the effects of the disease process and of the 
healthcare interventions can be separated.   A number of factors important to the introduction of 
adverse-event measurement were identified, such as the support of clinical leaders, the existence of 
good working relationships, the participation of clinical staff in designing or applying the measure, 
and the stimulation of clinicians' interest in the process. 
 
All the clinicians interviewed for this study were already involved in clinical audit or quality 
assurance, and so might be thought to be predisposed towards the general idea of healthcare quality 
measurement, but there was no predisposition towards this particular form of quality measurement, 
using adverse events.  It was, therefore, significant that all interviewees wanted to use adverse-event 
measures in the quality assessment of their own clinical practice, often in combination with other 
forms of quality measures. 
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Chapter 5 
 
Construct validity of  
adverse-event measures of quality  
 
 
 
5.1 Introduction 
 
The concepts of construct validity were discussed in chapter 2, where it was noted that the 
examination of construct validity can be of particular benefit in situations where the criterion-related 
validity of a measure is difficult to test because a suitable criterion variable is not available.   It has 
already been demonstrated in chapter 3 that studies of the criterion-related validity of adverse-event 
measures have struggled to identify suitable criterion variables, with which those measures should 
be expected to correlate if they are valid.   Most studies have relied upon some form of implicit, 
professional assessment of quality as their gold standard, although there is evidence that such 
assessments are themselves low in validity and reliability.  A few studies have used other quality 
measures (such as standards-based quality assessment tools for given patient groups) as their 
criterion variable, but it can be argued in these cases that the criterion measure and the measure 
under test actually measure different dimensions of the quality of care, and that a correlation 
between them would not necessarily be expected.   
 
In these circumstances, an examination of the construct validity of an adverse-event measure is both 
methodologically more correct and appropriate and more likely to provide an insight into the 
behaviour of the measure being studied than an attempt to measure criterion-related validity. The 
aim of the analysis of adverse-event measure data from the RSCH project was to examine whether 
or not the data supported or was consistent with a number of constructs or theories about adverse 
events and the quality of care in hospitals.   If the data supported these constructs, it would provide 
some further evidence that the measures themselves were valid. 
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Three main constructs have been examined by previous research studies - namely that patients with 
adverse events would stay longer in hospital and use more resources; that patients who are more 
severely ill would be more likely to have adverse events; and that the incidence of adverse events 
would vary from hospital to hospital.    Each of these constructs has been explored by more than one 
research study.   However, there are many other potential constructs which could be used to assess 
the construct validity of adverse-event measures, so there is a need for research to confirm construct 
validity for those constructs which have already been tested and to extend the evidence for construct 
validity by identifying and testing new constructs.   
 
This chapter presents a study of the construct validity of the adverse-event measures of quality used 
in the RSCH occurrence screening project.   Firstly, a number of constructs or theories to be tested 
are defined.  Then, a number of univariate, bivariate and multivariate statistical techniques are used 
to test whether the data collected during the RSCH project supports these constructs. 
 
 
5.2 Method 
 
5.2.1 Constructs to be tested 
 
The first step in testing the construct validity of a measure is to identify the constructs or hypotheses 
about the measure’s behaviour which are to be tested.   In the case of adverse-event measures, there 
is little existing direct empirical evidence relating to their behaviour, and few established theories 
about them, though a small number of constructs have been tested in past research studies.   For this 
study, the following constructs were chosen, and the rationale for the selection of each construct is 
stated below: 
 
a) Rates of different types of adverse event, and aggregate adverse-event rates for a generic 
adverse-event measure, will vary across specialties.    
 Patients in different specialties have different diseases and illnesses, and undergo different 
diagnostic and therapeutic processes.   While they may have certain types of adverse event 
in common, it is likely that the incidence of adverse events will vary from specialty to 
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specialty, as will the number of adverse events per patient.  For example, hospital acquired 
infections might be expected to be more common in general surgery than in ophthalmology, 
because of the nature of the surgical procedures each specialty involves, and so the rates of 
this adverse event in these specialties would be expected to differ. 
 
b) Patients who have adverse events will  stay longer in hospital than those with no adverse 
events, and patients who have multiple adverse events will stay longer than those with a 
single adverse event.    
 When an adverse event results in some additional morbidity for patients and consequently 
requires some additional diagnostic and therapeutic actions over and above the needs of the 
patient on admission, it is likely to result in an increased length of stay.    Alternatively, 
patients with longer lengths of stay may be exposed to the risk of certain adverse events for 
longer, and may consequently be more likely to have adverse events.  For both these 
reasons, patients with adverse events are likely to stay longer in hospital and those with 
multiple adverse events are likely to stay longer still.   For example, a patient who suffers an 
adverse event like a slip or fall while in hospital may require further diagnostic tests and 
examinations to check for injuries, and those injuries may require treatment in their own 
right, hence prolonging the patient’s admission. 
 
c) Different types of adverse event will result in different degrees of prolongation of the 
hospital length of stay.    
 It was argued above that patients with adverse events are likely to stay longer in hospital 
because of the diagnostic and therapeutic consequences of the adverse event.  Different 
types of adverse event will have quite different consequences, and are so likely to have 
different effects on patients’ length of stay. For example, adverse events like medical record 
deficiencies would be unlikely to result in a longer length of stay, while an adverse event 
such as a postoperative pulmonary embolism would almost certainly extend the length of 
stay.  If this construct were confirmed, it would support the contention that adverse events 
cause prolonged hospital stays rather than the converse (that prolonged hospital stays result 
in a higher level of adverse events through greater exposure to risk). 
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d) Patients who die in hospital will have had more adverse events during their stay than those 
who are discharged alive.   
 Patients who die in hospital will commonly have been more severely ill, and their care will 
often have been more complex to manage.   Certain adverse events will be more common in 
patients whose illnesses are severe and complex, and so patients who die in hospital are 
likely to have had more adverse events than those who do not.  Alternatively, some adverse 
events may be so serious that they contribute to or cause the patient’s mortality, with the 
same result that patients who die in hospital are likely to have had more adverse events than 
those who do not. 
 
e) Patients who are admitted as emergencies will have more adverse events than those 
admitted electively.    
 Emergency admissions are commonly more complex to manage than elective admissions, 
because they present less predictable health problems which require faster diagnosis and 
treatment and make immediate and unscheduled demands on healthcare services.   As was 
argued above, certain adverse events will be more common in patients whose management 
is more complex, and so emergency admissions are likely to have more adverse events than 
elective admissions. 
 
f) Elderly patients will have more adverse events than younger patients.   
 Like patients who die in hospital and patients who are admitted as emergencies, patients 
who are elderly are commonly more complex to manage than younger patients because they 
have more comorbidities and are less able to tolerate the effects of treatment.  As argued 
above, certain adverse events will therefore be more common among elderly patients. 
 
It should be noted that some of these constructs have already been explored in some of the research 
studies reviewed in chapter 3.  Specifically, a relationship has already been identified between 
adverse-event measures and length of stay, and between adverse-event measures and severity of 
illness (a concept related to the constructs listed under d-f above).   However the other constructs 
listed have not been examined previously in the published literature. 
5.2.2 Sources and nature of data from the RSCH project 
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The data analysed and presented in this chapter was collected for the RSCH occurrence screening 
project, which was described in chapter 3.   In that project, 14,815 inpatient admissions from 12 
different specialties were screened using a number of different adverse-event measures over the 
period from February 1990 to April 1992.   Each adverse-event measure consisted of a number of 
screening criteria, as shown by the example in Appendix 4.1. 
 
For each inpatient admission, a set of demographic and administrative data was collected from the 
hospital’s Patient Administration System (PAS).   Soon after the patient was discharged, their 
medical and nursing casenotes were screened by one of the project staff.   Using an adverse-event 
measure, the screener checked the notes to see whether the adverse events contained within the 
measure had occurred during the admission.   For each screening criterion within the adverse-event 
measure, the screener recorded whether or not that type of adverse event had occurred.  If it had 
occurred, the screener went on to record a further data set describing the adverse event (the contents 
of that data set are not used or detailed here).  Table 5.1 lists the data set collected for each patient, 
including some data items which were derived from other data within the set.  The data set outlined 
in table 5.1 forms the basis for the analyses reported in this chapter. 
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Data item Description Source 
Unit number Unique patient identifier code PAS 
Surname Patient’s surname PAS 
Forename Patient’s forename PAS 
Sex Patient’s sex, coded as 1 (male) or 2 (female) PAS 
Date of birth Patient’s date of birth PAS 
Date of admission Date on which patient was admitted to hospital PAS 
Date of discharge Date on which patient was discharged from hospital PAS 
Admission method How patient was admitted (range of codes for admissions from waiting list, 
A&E, via GP etc) 
PAS 
Admission category Whether patient was an NHS  or private patient PAS 
Discharge method How patient was discharged (range of codes for died, discharged 
with/against medical advice, etc) 
PAS 
Discharge 
destination 
Where patient was discharged to (home, another hospital, nursing home, 
etc) 
PAS 
Consultant Code for consultant responsible for admission PAS 
Specialty Code for specialty of consultant admitting patient PAS 
Ward(s) Code(s) for ward(s) on which patient stayed PAS 
Screener Code for member of project staff who screened the admission Screening 
Screening data A series of dichotomous variables, one for each screening criterion in the 
adverse-event measure being used, for each of which 0 represented no 
adverse event and 1 represented an adverse event.  Different adverse-event 
measures were used with different specialties, and so the number and 
meaning of these dichotomous variables varied from admission to 
admission. 
Screening 
Age on admission Age in years on date of admission Derived 
Admission type Type of admission, categorised simply as emergency or elective Derived 
Discharge type Type of discharge, categorised simply as alive or dead Derived 
Length of stay Length of stay in days Derived 
Number of 
screenings 
Number of screening criteria against which the admission was screened Derived 
Number of positive 
screenings 
Number of positive screenings (eg number of criteria for which an adverse 
event was found) 
Derived 
Number of negative 
screenings 
Number of negative screenings (eg number of criteria for which no adverse 
event found) 
Derived 
Screening percentage 
score 
Number of positive screenings expressed as a percentage of number of 
screenings 
Derived 
Age range Age on admission, categorised into three groups (0-50 years, >50 to 70 
years, >70 years) 
Derived 
Length of stay range Length of stay, categorised into four groups (0 days, 1-5 days, 6-10 days, 
11+ days) 
Derived 
 
Table 5.1.  Data set collected for each inpatient admission in the RSCH project. 
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In the analyses of construct validity presented in this chapter, data from the RSCH project on all 
admissions in eight specialties was used.   The data for these eight specialties represented a total of 
12,676 admissions (or 86% of the 14,815 admissions screened during the project and held on the 
project database).  The remaining 2,139 admissions were excluded from the analysis because they 
involved a range of other specialties or groups for which there were insufficient admissions to 
support analysis at the specialty level. 
 
The resulting data set is described in table 5.2.   It can be seen that the total of 12,676 screened 
admissions was not spread evenly across the eight specialties studied.  The data set contained more 
admissions for some specialties, notably obstetrics, ophthalmology and trauma and orthopaedics, 
than for others, largely because screening in those specialties took place over a longer time span 
during the project or because these specialties admitted higher volumes of patients.   In six of the 
eight specialties being studied, the generic adverse-event measure described in chapter 4 and 
appended in Appendix 4.1 was used.  These specialties therefore formed an important subgroup for 
analysis, consisting of a total of 7,633 admissions from six specialties all screened with the same 
adverse-event measure.  In the other two specialties (obstetrics and accident and emergency) 
adverse event measures developed specifically for those specialties had been used. 
 
Specialty No of  
admissions 
screened 
Adverse-event measure used in screening 
Accident and emergency 1,031 Special measure designed for A&E short stay admissions 
ENT 800 Generic adverse-event measure plus specialty addition. 
General surgery 549 Generic adverse-event measure plus specialty addition 
Gynaecology 566 Generic adverse-event measure plus specialty addition 
Obstetrics 4,012 Special measure designed for obstetrics 
Ophthalmology 2,252 Generic adverse-event measure plus specialty addition 
Trauma and orthopaedics 2,945 Generic adverse-event measure plus specialty addition 
Urology 521 Generic adverse-event measure plus specialty addition 
 
Table 5.2.  Data set from RSCH project used in analyses of construct validity. 
 
5.2.3 Statistical techniques used 
  
 
 
207
 
It is evident from tables 5.1 and 5.2 that the RSCH project provided a rich but complex data set for 
analysis.  The data contains a large number of variables, including categorical, ordinal, interval and 
ratio data items.   None of the data items could be expected to be parametrically distributed and 
some categorical data items would be expected to be very unevenly distributed, with low relative 
frequencies for some categories. 
 
In order to test the constructs described in section 5.1 using the RSCH project data a combination of 
univariate, bivariate and multivariate statistical techniques was used.   Firstly, each construct was 
tested using appropriate univariate and bivariate techniques, including both parametric and non-
parametric methods.  Secondly, a multiway frequency analysis using a loglinear model was 
performed, to examine the relationships between a number of key variables in the RSCH data set.  A 
summary of the univariate and bivariate analytical techniques and data sets used to test each 
construct is given in table 5.3 below. 
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 Construct 
 
Data set used Analytical techniques 
a) Adverse event rates will 
vary between specialties. 
Sample of 7,633 admissions 
in 6 specialties all screened 
using the same generic 
adverse-event measure. 
χ2 tests used for each criterion within the 
measure, to establish whether significant 
differences in rates existed between 
specialties.  Overall adverse event rates 
compared by Kruskal-Wallis analysis of 
variance by ranks and one way analysis of 
variance (ANOVA). 
b) Adverse event rates will 
correlate with length of 
stay. 
Whole sample of 12,676 
admissions in 8 specialties 
For each specialty, t-test and Mann-Whitney 
test used to compare length of stay for 
patients with and without adverse events; also 
Spearman rank correlation coefficient used to 
measure association between adverse event 
rate and length of stay. 
c) Different types of adverse 
events will have different 
effect on length of stay. 
Sample of 4,012 admissions 
in obstetrics all screened 
using an obstetric adverse-
event measure. 
For each criterion within the obstetric 
adverse-event measure, t-test and Mann-
Whitney test used to compare length of stay 
for patients with and without that adverse 
event. 
d) Patients who die will 
have had more adverse 
events than those who do 
not. 
Whole sample of 12,676 
admissions in 8 specialties 
For each specialty, t-test and Mann-Whitney 
test used to compare the numbers of adverse 
events among patients who died and those 
who were discharged alive. 
e) Emergency patients will 
have more adverse events 
than elective patients. 
Whole sample of 12,676 
admissions in 8 specialties 
For each specialty, t-test and Mann-Whitney 
test used to compare the numbers of adverse 
events among patients who were admitted 
electively and patients who were admitted as 
emergencies. 
f) Elderly patients will have 
more adverse events than 
younger patients. 
Whole sample of 12,676 
admissions in 8 specialties 
For each specialty, age on admission was 
compared for patients with 0, 1 and 2 or more 
adverse events using Kruskal-Wallis analysis 
of variance by ranks and one way analysis of 
variance (ANOVA). 
 
Table 5.3.  Summary of analytical techniques and data sets used to test construct validity. 
 
The statistical techniques used varied from construct to construct, so in the presentation of results in 
section 5.3.1 below the testing of each construct is reported separately, along with those details of 
the statistical methods used which are specific to that construct.   The results of the multiway 
frequency analysis are reported separately and subsequently in section 5.3.2, to allow the discussion 
to compare and contrast those results with the findings of earlier univariate and bivariate testing for 
individual constructs. 
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5.3 Results and discussion 
 
5.3.1 Univariate and bivariate analyses of construct validity 
 
Analysis of rates of adverse events across specialties 
In section 5.1 it was proposed that the rates of different types of adverse event and aggregate 
adverse-event rates for a generic adverse-event measure would be found to vary across specialties.  
The rationale for this construct was that patients in different specialties have different diseases and 
illnesses, and undergo different diagnostic and therapeutic processes.   While they may have certain 
types of adverse event in common, it is likely that the incidence of adverse events will vary from 
specialty to specialty, as will the number of adverse events per patient.   
 
To test this construct, the sample of 7,633 admissions in 6 specialties, which were screened using 
the same generic adverse-event measure, was examined.   For each of the 20 screening criteria 
within that measure (which can be found in Appendix 4.1), χ2 tests were used to establish whether 
significant differences in incidence rates existed between different specialties. Because some 
adverse events were quite rare, in many of the χ2 tests expected frequencies for some cells fell 
below 5, which is sometimes cited in statistics texts as a threshold below which the χ2 should not be 
used because assumptions made in approximating the statistic to the χ2 distribution are violated.  
However Everitt (1992, p39) and others argue that this restriction is arbitrary, and not based in 
mathematical or empirical evidence.  They suggest that 2 x c tables (such as these) can always be 
tested if no expected frequency falls below 1, and can usually be used if no expected value is below 
0.5.  In none of the χ2 tables did any expected values fall below 0.5, and only in one table (for 
criterion 16) were any expected values below 1.0.    
 
Where significant differences in incidence rates of adverse events across specialties were found, the 
standardised adjusted residuals were used to identify the specialty groups which were significantly 
different from the others.    These statistics are approximately normally distributed with a mean of 0 
and standard deviation of 1.0, so standardised adjusted residuals of  ±2.58 or greater are significant 
at the 0.01 level (Everitt 1992, p47). 
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The results of testing are presented in table 5.4 below.  Each row in the table contains a summary of 
the crosstabulation (and associated statistics) of specialty by screening result for a single criterion 
within the generic adverse-event measure.  For each specialty, the incidence rate of that type of 
adverse event is given (shown as a percentage of patients who had that adverse event during their 
hospital stay), along with the standardised adjusted residual.  The incidence rate for all specialties is 
also given, for the purposes of comparison.  The last two columns in the table contain the χ2 statistic 
for that crosstabulation and its significance level. 
 
Crit 
no 
Criterion title Specialty adverse event incidence rates (%) and standardised adjusted 
residuals (in square brackets) 
χ2 statistics 
  ENT Gynae-
cology 
Ophth-
almlgy 
T & O Gen 
surger
y 
Urolo
gy 
All specs χ2 P value 
1 Adm for adv results 
o/p mgt 
1.75 
[1.1] 
3.56 
[4.8] 
2.70 
[-5.2] 
1.57 
[1.5] 
1.28 
[-0.1] 
1.54 
[0.4] 
1.33 43.29 < .0001 
2 Readmission for 
comp prev adm 
4.25 
[0.7] 
13.88 
[12.9] 
2.49 
[-3.9] 
2.63 
[-4.3] 
4.93 
[1.4] 
3.65 
[-0.2] 
3.82 179.12 < .0001 
3 Error in operative 
consent 
2.63 
[3.5] 
0.71 
[-1.3] 
1.11 
[-0.9] 
1.06 
[-1.5] 
1.82 
[1.1] 
1.54 
[0.5] 
1.30 15.81 .0074 
4 Unpl rem/inj/repair 
in surg 
1.50 
[-1.4] 
1.25 
[-1.6] 
4.53 
[9.1] 
0.92 
[-6.0] 
1.28 
[-1.5] 
2.11 
[-.01] 
2.18 86.23 < .0001 
5 Unpl return to 
theatre 
0.13 
[-2.4] 
0.36 
[-1.3] 
1.02 
[1.0] 
0.61 
[-1.8] 
2.73 
[5.0] 
0.15 
[0.8] 
0.85 32.83 < .0001 
6 Path/hist varies from 
diag 
0.13 
[-1.1] 
0.71 
[1.6] 
0.00 
[-3.3] 
0.34 
[0.0] 
1.82 
[6.2] 
0.19 
[-0.6] 
0.34 46.84 < .0001 
7 Prob of transfusion 0.13 
[-1.6] 
0.18 
[-1.2] 
0.00 
[-4.1] 
1.02 
[4.9] 
0.55 
[0.1] 
0.77 
[0.8] 
0.51 30.90 < .0001 
8 Hosp acquired 
infection 
0.25 
[-4.1] 
0.53 
[-2.9] 
0.49 
[-6.9] 
4.47 
[9.8] 
4.20 
[3.0] 
1.34 
[-1.5] 
2.32 126.55 < .0001 
9 Medication 
error/reaction 
2.13 
[-1.8] 
1.25 
[-2.7] 
1.60 
[-5.1] 
5.05 
[7.4] 
4.93 
[2.4] 
1.34 
[-2.5] 
3.18 72.39 < .0001 
10 Cardiac/resp arrest 
in hosp 
0.00 
[-1.3] 
0.00 
[-1.1] 
0.09 
[-1.3] 
0.34 
[2.5] 
0.00 
[-1.0] 
0.38 
[1.1] 
0.18 9.72 .0837 
11 CVA/MI/PE in hosp 
after surg 
0.00 
[-1.5] 
0.00 
[-1.2] 
0.04 
[-2.3] 
0.51 
[3.6] 
0.36 
[0.6] 
0.19 
[-0.3] 
0.25 15.68 .0078 
12 Unexp transfer to 
spec care 
0.13 
[-0.9] 
0.18 
[-0.5] 
0.09 
[-2.0] 
0.14 
[-1.8] 
2.01 
[8.0] 
0.38 
[-0.5] 
0.28 65.72 < .0001 
13 Pt related clinical 
complcn 
1.00 
[-3.6] 
0.00 
[-4.4] 
0.22 
[-9.4] 
6.25 
[12.6] 
6.20 
[4.4] 
0.96 
[-2.9] 
3.09 214.69 < .0001 
14 Non-clin 
problem/incident 
6.38 
[-4.0] 
6.41 
[-3.3] 
4.18 
[-11.6] 
17.47 
[15.9] 
8.94 
[-1.2] 
10.17 
[-.02] 
10.44 274.53 < .0001 
15 Neuro deficit devel 
in hosp 
0.00 
[-1.2] 
0.00 
[-1.0] 
0.00 
[-2.2] 
0.38 
[3.8] 
0.00 
[-1.0] 
0.19 
[0.2] 
0.16 15.44 .0086 
16 Unexp patient death 0.00 
[-1.0] 
0.00 
[-0.8] 
0.00 
[-1.9] 
0.27 
[3.1] 
0.18 
[-.05] 
0.00 
[-.08] 
0.12 11.03 .0508 
17 Medical record 
deficiency 
18.50 
[3.3] 
4.98 
[-6.7] 
11.90 
[-4.3] 
14.44 
[-.04] 
34.06 
[13.4] 
11.32 
[-2.2] 
14.62 235.70 < .0001 
18 Nursing record 
deficiency 
43.13 
[14.3] 
26.87 
[2.2] 
5.02 
[-24.2] 
33.82 
[17.7] 
17.67 
[-3.1] 
10.94 
[-6.8] 
23.04 842.96 < .0001 
19 Pt/family 
dissatisfaction 
1.38 
[-1.4] 
2.31 
[0.5] 
1.51 
[-2.0] 
2.59 
[2.9] 
2.01 
[0.0] 
1.54 
[-0.8] 
2.01 10.41 0.064 
20 Discharge related 
problems 
1.00 
[-4.3] 
1.07 
[-3.5] 
1.16 
[-7.7] 
6.65 
[10.7] 
6.20 
[3.2] 
2.69 
[-1.3] 
3.72 150.41 < .0001 
 
Table 5.4.  Variation in rates of adverse events across specialties 
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It is clear that the results in table 5.4 support the construct that adverse event rates vary across 
specialties.   For 17 of the 20 criteria in the generic adverse event measure, significant differences 
existed in the incidence rates found in different specialties (p < 0.01).   Though the purpose of this 
analysis is to test the construct, rather than to seek to explain the variations in rates across specialties 
which were observed, for many of the criteria within the generic adverse-event measure the 
information presented in the table conforms with the known characteristics of the specialties 
involved.  For example, higher rates of discharge related problems (criterion 20) were observed in 
trauma and orthopaedics and general surgery than in ENT or ophthalmology, which probably 
reflects the nature of the patients and disease processes involved.  The former specialties deal with 
elderly patients admitted more frequently as emergencies with major health problems which change 
their ability to cope at home either progressively or more immediately.  It would therefore be 
expected that discharging these patients would be more complex and difficult, and that a higher 
frequency of discharge-related problems would be observed, as was indeed the case. 
 
The construct under examination suggested not only that individual adverse event rates for single 
criteria within the adverse-event measure would vary across specialties, but also that the aggregate 
adverse-event rates for the generic adverse-event measure as a whole would vary across specialties.  
In order to test this, two analyses were undertaken on the same sample of 7,633 admissions in 6 
specialties.  The generic adverse-event rate was calculated for each admission, by counting the 
number of screening criteria within the generic adverse-event measure for which an adverse event 
had been recorded for that admission.  The rate therefore had a minimum of 0 and a theoretical 
maximum of 20 (since there were 20 screening criteria in the generic adverse-event measure).  For a 
small number of admissions, data was missing for one or more of the criteria in the generic adverse-
event measure.  These cases were excluded from the analysis and so the actual sample used 
consisted of  7,210 admissions 
 
Firstly, a non-parametric Kruskal-Wallis analysis of variance by ranks was undertaken.   This tests 
whether a number of samples (in this case, the admissions in each of 6 specialties) have the same 
median adverse-event rate (or, more exactly, are drawn from populations with identical median 
adverse-event rates) (Siegel and Castellan 1988, p206).   Secondly, a one way analysis of variance 
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(ANOVA) was used to test whether the mean adverse event rates in the 6 specialties differed 
significantly from each other.   Both tests were used because, while the data certainly violates the 
parametric assumptions underlying the one-way ANOVA test, the power of the Kruskal-Wallis 
analysis of variance by ranks is more limited.    
 
The Kruskal-Wallis analysis of variance by ranks indicated that significant differences in adverse-
event rates between specialties existed (χ2 = 532.52, χ2 = 641.89 when corrected for ties; in both 
cases p < 0.0001).   Similarly, the one-way ANOVA test also indicated that the mean adverse-event 
rates in specialties were significantly different (F = 139.38, p < 0.0001).   Some descriptive statistics 
illustrating the differences in adverse event rates between specialties are presented in table 5.5 
below. 
 
Specialty Adverse event rate 
 
 No of 
admissions 
Mean Standard 
deviation 
Minimum Maximum 
ENT 800 0.844 0.866 0 5 
Gynaecology 562 0.642 0.745 0 5 
Ophthalmology 2249 0.357 0.611 0 4 
T & O 2930 1.004 1.160 0 8 
General surgery 548 1.005 1.134 0 7 
Urology 521 0.524 0.713 0 3 
 
Table 5.5.  Descriptive statistics illustrating differences in adverse-event rates  
between specialties. 
 
Both the Kruskal-Wallis analysis of variance by ranks and the ANOVA test provide procedures for 
identifying the source of any statistically significant difference found, by examining the significance 
of differences between pairs of groups within the analysis.  In the Kruskal-Wallis test, the absolute 
difference between the mean rankings of groups is normally distributed for large samples, and can 
be tested using the standard normal distribution as long as adjustments are made to take account of 
the multiple comparisons being made (Siegel and Castellan 1988, p213).  For the ANOVA test, the 
Scheffé method allows a similar multiple pairwise comparison of means.    These procedures were 
each used to test for significant differences (at the p < 0.05 level) between all combinations of pairs 
of groups in the sample, and the results are shown in table 5.6 below 
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 ENT Gynae- 
cology 
Ophth- 
almology 
T & O Gen surgery Urology 
ENT  § ‡ § ‡ §  § ‡ 
Gynaecology   § ‡ § ‡ § ‡  
Ophthalmology    § ‡ § ‡ § ‡ 
T & O      § ‡ 
Gen surgery      § ‡ 
Urology       
‡ indicates Kruskal-Wallis test shows significant difference between two groups (p < 0.05) 
§ indicates Scheffe method shows significant difference between two groups (p < 0.05) 
 
Table 5.6.  Pairwise comparison of group means/medians for  
significant differences in adverse-event rates between specialties. 
 
Interestingly, there is a high level of agreement between the two statistical methods.   Significant 
differences in adverse event rates exist between most pairs of specialties.  Only in three pairs - 
general surgery and ENT; general surgery and trauma and orthopaedics; and urology and 
gynaecology - was no significant difference found.    
 
In conclusion, the evidence from these analyses strongly supports the construct that rates of different 
types of adverse event and aggregate adverse-event rates vary across specialties. 
 
Analysis of the relationship between adverse event rates and length of stay 
The second construct to be examined proposed that patients who have adverse events would stay 
longer in hospital than those who do not, and that patients with multiple adverse events would stay 
longer in hospital again than those with a single adverse event.   Two rationales for this construct 
were put forward.  Firstly, when an  adverse event results in some morbidity for the patient, the 
additional diagnostic and therapeutic actions required may require an extension to their stay in 
hospital.  Secondly, patients who stay longer in hospital will be more exposed to the risks of some 
types of adverse event and so more likely to have them. 
 
To test this construct, the whole sample of 12,676 admissions in 8 specialties was used, and two 
analyses were undertaken.  Firstly, to examine whether patients with adverse events stayed in 
hospital longer than those with no adverse events, the length of stay of patients in these two groups 
was examined and compared using both t-tests and Mann-Whitney tests.  The results are presented 
in table 5.7 below. 
  
 
 
214
 
Specialty No of 
admissions 
Patients with 0 
adverse events 
Patients with 1 or 
more adverse events 
t-test Mann-
Whitney 
test 
  No Mean 
length of 
stay 
No Mean 
length of 
stay 
  
Accident and emergency 1031 613 1.07 418 1.01 0.755 0.448 
ENT 800 253 2.40 547 2.98 0.002 0.008 
General surgery 549 168 6.42 381 9.36 0.137 < 0.001 
Gynaecology 566 204 1.49 362 1.72 0.051 0.130 
Obstetrics 3960 1721 2.18 2239 4.04 < 0.001 <0.001 
Ophthalmology 2252 1386 2.61 866 3.10 < 0.001 < 0.001 
Trauma and orthopaedics 2945 1202 7.19 1743 14.46 < 0.001 < 0.001 
Urology 521 251 6.23 270 7.61 0.073 0.680 
 
Table 5.7.   Comparison of length of stay for patients with and without adverse events. 
 
Secondly, to examine whether patients with multiple adverse events staying in hospital longer than 
those with a single adverse event, the length of stay of patients in these two groups was examined 
and compared using both t-tests and Mann-Whitney tests. The results are presented in table 5.8 
below.   
 
Specialty No of 
admissions 
Patients with 1 
adverse events 
Patients with 2 or 
more adverse events 
t-test Mann-
Whitney 
test 
  No Mean 
length of 
stay 
No Mean 
length 
of stay 
  
Accident and emergency 1031 352 0.92 66 1.56 0.200 0.332 
ENT 800 282 2.74 265 3.23 0.091 0.056 
General surgery 549 214 6.14 167 13.50 < 0.001 < 0.001 
Gynaecology 566 258 1.70 104 1.75 0.833 0.286 
Obstetrics 3960 1370 3.35 869 5.11 < 0.001 < 0.001 
Ophthalmology 2252 642 2.86 224 3.80 < 0.001 < 0.001 
Trauma and orthopaedics 2945 940 10.93 803 18.58 < 0.001 < 0.001 
Urology 521 194 6.21 76 11.18 0.004 0.004 
 
Table 5.8.   Comparison of length of stay for patients with single and multiple adverse events. 
 
It is evident from the two tables that patients with adverse events have significantly longer lengths 
of stay than those who have no adverse events, and that multiple adverse events are associated with 
a further prolongation of the hospital stay.   Only in two specialties - gynaecology and accident and 
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emergency - was no association found.   In others, such as obstetrics, trauma and orthopaedics, 
ophthalmology and general surgery there was a marked increase in length of stay in patients with 
adverse events. 
 
The differences between specialties which are shown in tables 5.7 and 5.8 warrant some discussion.  
Firstly, the much larger sample size available in some specialties (such as obstetrics, orthopaedics 
and ophthalmology) makes it easier to demonstrate statistical significance, even for numerically 
small differences in mean lengths of stay.  Secondly, some specialties such as accident and 
emergency and gynaecology have short lengths of stay for most or all cases and so the impact of 
adverse events may be less detectable. Length of stay is measured in whole days, and so the 
prolongation of length of stay by an adverse event has to be proportionately greater in a specialty 
with short lengths of stay than it would in a specialty with longer lengths of stay for that 
prolongation to be recorded. However, it may also be that the differences in presenting diseases and 
diagnostic and therapeutic processes between specialties, already referred to above, account for the 
different degrees of association between adverse events and length of stay that were observed. 
 
In conclusion, these two analyses both support the construct that patients who have adverse events 
stay longer in hospital than those who do not, and that patients with multiple adverse events stay 
longer in hospital again than those with a single adverse event.   However, they also indicate that 
conformance with the construct varies across specialties. 
 
Analysis of relationship between different types of adverse event and length of stay 
The third construct to be tested also related to the relationship between length of stay and adverse 
events.  It proposed that patients who had undergone different types of adverse events would have 
different degrees of prolongation of their hospital stay, because some adverse events had more 
serious consequences for patients’ health than others.   If this construct were confirmed it would 
support the contention that adverse events cause increased length of stay (or that both are caused by 
some third factor, such as severity), rather than that increased length of stay exposes patients to 
greater risk of adverse events and so may result in higher scores on adverse event measures. 
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In order to examine the effect of an individual adverse event on lengths of stay, it is necessary to 
separate out that effect from the effects of any other adverse events which may have also occurred 
during a patient’s admission.   Since patients quite commonly have multiple adverse events, this 
may be difficult to do without undertaking a multivariate analysis capable of identifying separately 
the contributions that each type of adverse event makes to the patient’s length of stay.    However, 
such an analysis would be problematic because of the large number of variables to be included (one 
for each criterion in the adverse-event measure being used). 
 
However, if a relatively large sample of admissions is available for analysis, an alternative approach 
can be adopted which permits the continued use of bivariate statistical approaches.   The analysis 
can be restricted to patients who had either no adverse events or a single adverse event under a 
single criterion.  In other words, their score on the adverse-event measure would be either 0 or 1.  
Using this approach, bivariate statistical techniques can be used to compare the lengths of stay of 
patients with no adverse events at all with the lengths of stay of patients who had a single adverse 
event under a given criterion.  Effectively, this involves comparing a single base group of all 
patients with no adverse events with a series of subgroups of patients with one and only one adverse 
event, of a particular type.  Of course, this approach has the disadvantage that if some adverse 
events rarely or never occur alone, the subgroup of patients with one and only one adverse event of 
that type may be very small or might not exist.  There is also some risk of bias, since patients with 
single adverse events may not be typical of all patients with adverse events (and may particularly be 
those patients with less severe adverse events).  Both these limitations need to be borne in mind in 
interpreting the results of such an analysis. 
 
To test this construct, the sample of 4,012 admissions in obstetrics was examined, and as described 
above the analysis was restricted to those admissions with either 0 or 1 adverse events.   For each of 
the 14 criteria within the adverse-event measure that was used in obstetrics (which can be found in 
Appendix 5.1), the lengths of stay of patients with and without an adverse event under that criterion 
were compared using the parametric t-test and the non-parametric Mann-Whitney test. Because the 
patients with an adverse event under that criterion were known to have had only that adverse event 
(and no others), any difference in lengths of stay could be said to be associated with that type of 
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adverse event alone, rather than being confounded by other adverse events which might also have 
occurred during that admission. 
 
The results are presented in table 5.9 below.  For each criterion within the obstetric adverse-event 
measure, the table shows the number of admissions with no adverse events and their mean length of 
stay, and the number of admissions with a single adverse event under that criterion, and their mean 
length of stay.  The number of admissions with no adverse events and their mean length of stay 
remains the same, since this base group is constant in each analysis, while the number of admissions 
with a single adverse event under the criterion and their mean length of stay obviously varies from 
criterion to criterion.  The table shows the significance of differences in the lengths of stay between 
these two groups, using the t-test and the Mann-Whitney test.   It also shows the 95% confidence 
intervals for the estimate of the mean length of stay of patients in the group with a single adverse 
event.  This allows the significance of differences in the lengths of stay of patients with single 
adverse events of different types to be explored. 
 
Crit 
no 
Criterion title Patients with 
no adverse 
event 
 
Patients with adverse event 
 
t-test Mann-
Whitney 
test 
  No Mean 
LoS 
No Mean 
LoS 
Lower 
95% CI 
Upper 
95% CI 
p value p value 
1 SROM 1721 2.18 62 2.40 1.98 2.82 0.337 0.035 
2 Induction 1721 2.18 140 3.91 2.78 5.04 0.003 <0.001 
3 Probs labour/delivery 1721 2.18 29 2.79 2.39 3.19 0.009 <0.001 
4 Caesarean section 1721 2.18 249 6.59 5.73 7.45 <0.001 <0.001 
5 Probs Caesarean section 1721 2.18 3 6.67 3.40 9.94 0.114 0.004 
6 Perinatal probs 1721 2.18 52 3.48 2.45 4.51 0.018 <0.001 
7 Maternal postnatal probs 1721 2.18 98 2.88 2.55 3.21 <0.001 <0.001 
8 Drug-related probs 1721 2.18 8 2.50 1.07 3.93 0.678 0.508 
9 Mother/family 
dissatisfaction 
1721 2.18 7 2.42 1.39 3.46 0.659 0.327 
10 Non-clin probs/incident 1721 2.18 192 2.42 2.20 2.65 0.076 <0.001 
11 Record deficiency 1721 2.18 142 2.54 1.91 3.17 0.265 0.213 
12 Antenatal anaemia 1721 2.18 117 1.82 1.58 2.06 0.016 0.612 
13 Probs of anaesthesia 1721 2.18 4 2.25 1.76 2.74 0.807 0.333 
14 Probs of pain relief 1721 2.18 205 2.45 2.23 2.68 0.051 <0.001 
 
Table 5.9.  Comparison of length of stay for patients  
with and without adverse events in obstetrics. 
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The data in table 5.9 suggests that most types of adverse event in obstetrics are associated with some 
increase in the length of stay in hospital.   The greatest differences in lengths of stay were observed 
for adverse events which had clear clinical sequelae which would be expected to increase the length 
of stay.  For example, the occurrence of induction of labour, caesarean sections, perinatal 
complications and postnatal maternal complications were all associated with significant increase in 
the length of stay.   Other adverse events which might be expected to have little impact on the length 
of stay were indeed associated with smaller and sometimes non-significant increases in the length of 
stay.  For example, record deficiencies, non-clinical problems and incidents, and the antenatal 
presence of maternal anaemia all fell into this category.  
 
The significance of differences in length of stay between groups with different types of adverse 
event (rather than differences between each group and the base group of patients with no adverse 
events) can be assessed using the confidence interval estimates for the mean lengths of stay cited in 
the table.  Where the confidence intervals between a given two groups do not overlap, their means 
can be said to be significantly different.  The confidence interval and mean data given in table 5.9 is 
also displayed in figure 5.1 below.  It can be seen that, while some groups (particularly those 
containing low numbers of patients, such as those for criteria 5, 6, 8 and 9) have wide confidence 
intervals, most do not, and many instances of non-overlapping confidence intervals exist. 
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Figure 5.1.  Mean lengths of stay and associated 95% confidence intervals for groups of 
patients with a single adverse event (criteria numbers refer to table 5.9). 
 
Some caution should be exercised in drawing conclusions from this data, because of the limitations 
outlined earlier.  The subgroups of patients used in this analysis often contained quite small 
numbers, and many patients with adverse events were excluded from the analysis because they had 
multiple adverse events.  For example, 162 patients had an adverse event recorded under criterion 6 
(perinatal problems) but only 52 of these had only this adverse event and so were eligible for 
inclusion in the analysis.   However, it can be concluded that the data from this analysis of 
admissions in obstetrics supports the construct that different types of adverse events will be 
associated with different degrees of prolongation of the hospital stay.   Clinically significant adverse 
events were found to be associated with substantially greater increases in length of stay than more 
trivial and non-clinical adverse events, and some of the differences between groups with different 
types of adverse event were significant.   This also tends to support the contention that the 
association between adverse events and increased length of stay described earlier represents an 
effect of the adverse event itself, and that it is the consequences of the adverse event which cause the 
increased length of stay.  The alternative explanation of this association would be that patients who 
happen to be in hospital longer have a greater chance of encountering an adverse event during their 
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stay, but if this were so we would expect to see broadly similar degrees of association and increases 
in length of stay for all types of adverse events, and this was not the case. 
 
Analysis of relationship between adverse event rates and death among patients 
The fourth construct outlined in section 5.2.1 was that patients who died in hospital would have had 
more adverse events than those who were discharged alive.  This might be expected to be true for 
two reasons.  Firstly, patients who die have usually been more severely ill and more complex to 
manage than the norm, and so the likelihood of some adverse events occurring might be expected to 
be higher.  Secondly, some serious adverse events might contribute to or even cause a patient’s 
death. 
 
To test this construct, the whole sample of 12,676 admissions in 8 specialties was used.  In each 
specialty, the adverse event rate for patients who were discharged alive was compared with the 
adverse event rate for patients who died in hospital, using both t-tests and the non-parametric Mann-
Whitney test.  It must be noted that deaths in hospital are rare events, and can be virtually unknown 
in some specialties.  This means that this approach to testing the construct is only likely to be of use 
in specialties with relatively high death rates, or when extremely large samples of patients are used. 
 
The results are presented in table 5.10.  For each specialty it shows the numbers of admissions 
ending in the patient being discharged alive or dying, the mean adverse event rate for admissions in 
these two groups, and where possible the significance of differences in adverse event rate reported 
by the two statistical tests. 
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Specialty No of 
admissions 
Patients discharged 
alive 
Patients died in 
hospital 
t-test 
p-value 
Mann-
Whitney 
test 
  No Mean no 
of 
adverse 
events 
No Mean no 
of adverse 
events 
 p-value 
Accident and emergency 1031 1024 0.48 1 0.0 - - 
ENT 800 798 1.13 0 - - - 
General surgery 549 548 1.23 1 2.0 - - 
Gynaecology 566 566 0.88 0 - - - 
Obstetrics 3960 3949 0.89 0 - - - 
Ophthalmology 2252 2245 0.52 0 - - - 
Trauma and orthopaedics 2945 2901 1.02 40 2.80 < 0.001 < 0.001 
Urology 521 520 0.70 1 2.0 - - 
 
Table 5.10.  Comparison of number of adverse events per admission for  
patients discharged alive or dead in specialties 
 
In several of the specialties for which data is presented above no deaths occurred at all during the 
period when screening was taking place.  Effectively, there were only sufficient deaths in one 
specialty, trauma and orthopaedics, to test the construct.  In this specialty patients who died in 
hospital had almost three times as many adverse events as those who were discharged alive, a 
difference which both statistical tests indicate was significant.   We can conclude that the construct 
is supported by the data from this specialty, but should be cautious about generalising from the 
limited data available. 
 
Analysis of relationship between adverse event rate and method of admission  
The next construct, which was described in section 5.2.1, was that patients admitted as emergencies 
would have more adverse events than those admitted electively.  The rationale for this was that 
emergency admissions are likely to be more complex and more heterogeneous than elective cases.   
The former present unpredictable and often unstable health problems which require immediate 
diagnosis and treatment and may make unscheduled but urgent demands on healthcare services.  
The latter present more predictable and generally stable health problems, for which a planned 
sequence of diagnostic and therapeutic interventions can be identified.   For these reasons, we might 
expect that some sorts of adverse event would be commoner among patients admitted as 
emergencies. 
  
 
 
222
 
To test this construct, once again the whole sample of 12,676 admissions in 8 specialties was used.  
In each specialty, the adverse event rate for patients admitted electively was compared with the 
adverse event rate for patients admitted as emergencies, using both t-tests and the non-parametric 
Mann-Whitney test.  The results are presented in table 5.11 below.  For each specialty it shows the 
numbers of elective and emergency admissions, the mean number of adverse events for admissions 
in these two groups, and the significance of differences in numbers of adverse events reported by the 
two statistical tests. 
 
Specialty No of 
admissions 
Elective admissions Emergency 
admissions 
t-test 
p-value 
Mann-
Whitney 
test 
  No Mean no 
of adverse 
events 
No Mean no 
of adverse 
events 
 p-value 
Accident and emergency 1031 4 0.25 1027 0.48 0.429 0.492 
ENT 800 641 1.06 157 1.41 0.001 0.001 
General surgery 549 235 1.19 314 1.27 0.501 0.077 
Gynaecology 566 15 1.13 551 0.88 0.268 0.180 
Obstetrics 3960 4 1.5 3955 0.89 0.712 0.517 
Ophthalmology 2252 1986 0.49 254 0.71 0.001 0.001 
Trauma and orthopaedics 2945 1121 0.87 1812 1.14 < 0.001 < 0.001 
Urology 521 225 0.73 295 0.67 0.418 0.511 
 
Table 5.11.  Comparison of number of adverse events per admission for patients 
admitted electively and as emergencies 
 
Although the table presents data for all specialties, for the sake of completeness, it is clear that the 
lack of elective admissions in three specialties - accident and emergency, obstetrics and 
gynaecology - makes comparisons of adverse event rates between elective and emergency 
admissions in those specialties relatively meaningless.   The low numbers of elective admissions 
recorded in accident emergency and obstetrics are unsurprising, given the nature of the specialties 
concerned.  The low numbers of elective admissions in gynaecology reflects the fact that the Royal 
Sussex County Hospital only admitted gynaecology patients as emergencies, while the elective 
gynaecology service was provided by another hospital.  Obstetric admissions, even those for 
planned induction of labour or caesarean section, were generally recorded by the hospital as not 
elective. 
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In the remaining five specialties, three conform to the construct that emergency admissions would 
have more adverse events than elective admissions.  In ophthalmology, trauma and orthopaedics and 
ENT emergency admissions had, on average,  45%, 31%  and 33% more adverse events than 
elective admissions, a difference which is statistically significant in each case.   However, in the 
remaining two specialties, of general surgery and urology, no significant difference emerges.  It 
should be noted that the latter two specialties are those with the smallest sample sizes, and therefore 
the least statistical power to detect any difference.   With this point in mind, it is reasonable to 
conclude that the data supports the construct that emergency admissions will have more adverse 
events than elective admissions. 
 
Analysis of relationship between adverse events and patients’ age 
The final construct to be tested, outlined in section 5.2.1, was that elderly patients would have more 
adverse events than younger patients.  Like the analyses reported above, of the relationship between 
numbers of adverse events and patients’ discharge status and admission method, this construct is 
essentially concerned with the impact on adverse event rates of the complexity of patients’ health 
problems and the severity of illness they represent.   Elderly patients are more likely to have 
comorbidities, may be less able to tolerate the effects of treatment, and may take longer to recover 
from the effects of ill-health.  These factors are likely to make their care more complex to manage, 
and might therefore be expected to make some sorts of adverse event more common, and so a 
relationship between adverse event rates and patients’ ages would be expected. 
 
To test this construct, the whole sample of 12,676 admissions in 8 specialties was used.  In each 
specialty, age on admission (in years) of patients with 0, 1 and 2 or more adverse events was 
examined and compared, using the one way analysis of variance (ANOVA) and the non-parametric 
Kruskal Wallis analysis of variance by ranks.  The results are presented in table 5.12 below.  For 
each specialty, it shows the mean age on admission (in years) of patients with 0, 1 and 2 or more 
adverse events during their admission.   The Scheffé method for multiple pairwise comparisons of 
means was used to identify whether the differences between mean ages on admission for groups 
with 0 and 1 adverse events and 0 and 2 or more adverse events were significant (at the p < 0.05 
level).  Where significant differences existed, the relevant mean values in the table are marked with 
an asterisk. 
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Specialty No of 
adm 
Patients with 0 
adverse events 
Patients with 1 
adverse event 
Patients with 2 
or more adverse 
events 
One way 
ANOVA 
Kruskal-
Wallis 
analysis 
of 
variance 
  No Mean 
age 
No Mean 
age 
No Mean 
age 
  
Accident and 
emergency 
1031 613 45.5 352 46.7 66 46.7 0.722 0.626 
ENT 800 253 42.4 282 44.9 265 43.7 
 
0.379 0.368 
General surgery 549 168 54.3 214 55.0 167 57.3 
 
0.424 0.291 
Gynaecology 566 204 29.0 258 28.4 104 28.6 
 
0.740 0.911 
Obstetrics 3960 1721 28.3 1370 28.1 869 28.4 
 
0.161 0.243 
Ophthalmology 2252 1386 65.8 642 67.2 224 65.0 
 
0.301 0.656 
Trauma and 
orthopaedics 
2945 1202 49.4 940 54.2 
* 
803 59.8 
* 
< 0.001 < 0.001 
Urology 521 251 60.0 194 60.0 76 65.4 
 
0.094 0.040 
Note: Asterisk denotes mean age significantly different from that for patients with 0 adverse events (p < 0.05,  Scheffé 
method). 
 
Table 5.12.  Comparison of age on admission for patients with 0, 1 and 2 or more adverse events 
in specialties, and results of tests of the statistical significance of differences in age on admission 
 
 
The results of this analysis suggest that for most specialties there is no significant association 
between patients’ ages and their adverse event scores.  In accident and emergency, ENT, obstetrics, 
gynaecology and ophthalmology no relationship was observed.  In general surgery and urology, 
patients with more adverse events tended to be older, but the difference was not statistically 
significant.  As observed above, the sample sizes for these two specialties were small, and any 
difference would need to be quite large for it to be statistically significant.   However, in one 
specialty - trauma and orthopaedics - a clear and statistically significant association between adverse 
event scores and age on admission was detected.  Patients with 1 and 2 or more adverse events were 
on average about 5 and 10 years older on admission respectively than those with no adverse events. 
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These results need to be interpreted with some caution.  They suggest that the construct, that adverse 
events will be more common among elderly patients is not generally supported.   While an 
association was found in one specialty, it is worthy of note that no association was found in other 
specialties, despite quite large sample sizes.  For example, it might be expected in obstetrics that 
elderly mothers might have more adverse events than younger mothers, but this was apparently not 
the case.  Similarly, the association between age and adverse events found in trauma and 
orthopaedics might have been expected to be replicated in ophthalmology, since both are surgical 
specialties which deal with many elderly and very elderly patients, but it was not. 
 
 
5.3.2 Multivariate analysis of construct validity 
 
The bivariate statistical techniques used in section 5.3.1 to explore the construct validity of various 
adverse-event measures of healthcare quality have the advantage of being relatively easy both to 
undertake and to interpret.   However, analyses of the relationships between two variables can be 
seriously misleading if both of the variables being studied are associated with another variable or 
variables which are not included in the analysis.   Bivariate methods are well suited to experimental 
research designs, in which randomisation can eliminate the risks of bias or confounding and can 
ensure that only the relationship between the dependent and independent variable being studied is 
material, but they are less well able to cope in non-experimental or observational research studies. 
 
Multivariate statistical methods are particularly well suited to analysing data sets containing a 
number of variables, where few if any assumptions can be made about the nature of any 
relationships between them.   They can be used in situations in which there are multiple dependent 
and independent variables and where the classification of variables as either dependent or 
independent is not clear cut.   They can also be used to identify and quantify shared or overlapping 
variance among variables (which occurs when independent variables are associated with each 
other).  Moreover, while some multivariate methods require the data to meet certain conditions 
(generally multivariate normality, linearity and homoscedasticity), others, particularly those used to 
analyse categorical data, are relatively free of such restrictions. 
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However, multivariate analyses are often difficult to interpret.  Firstly, their meaning is often less 
intuitively evident to the user, the results are less easily related directly to the real world represented 
by the variables in the data set being analysed, and data errors or other faults in the analysis are 
generally harder to spot.  Secondly, the results of some multivariate methods can be quite sensitive 
to the methods chosen and the strategy for their application to the problem.  It has been suggested 
that a “judicious mix of multivariate and univariate statistics” is necessary to make a comprehensive 
analysis of a multivariate data set (Tabachnick and Fidell 1989, p7). 
 
In order to explore the construct validity of an adverse event measure using multivariate methods, it 
is necessary to examine the relationships among a number of variables, some of which are 
categorical or nominal (such as whether a patient was an emergency or elective admission), while 
others are ordinal or even ratio scale variables (such as the length of stay, or the number of adverse 
events).   Because some of the data is categorical, and few assumptions can be made about the 
distribution of the ordinal and ratio scale variables in the data set, it is appropriate to use a 
multivariate method designed for categorical data sets, known as multiway frequency analysis or 
loglinear analysis. 
 
Multiway frequency analysis can be used to examine the relationships between a number of 
categorical variables without presupposing that particular variables are dependent or independent.  It 
has two main purposes.  Firstly, it is used to explore the relationships or associations which exist 
between the variables.  Secondly, it can be used to build a model which allows the values of one 
variable to be estimated from the values of others, and which contains only those variables which 
have a significant effect on the variable whose value is being estimated.    
 
Multiway frequency analysis is essentially an extension of the principles underlying the familiar χ2 
test of association to the multivariate situation.   A linear model is created of the logarithm of 
expected cell frequencies in the multiway table produced by cross-tabulating every variable by 
every other variable.  The logarithms of expected cell frequencies are used (rather than the 
frequencies themselves) in order to transform the multiplicative formula for calculating expected 
cell frequencies familiar from the χ2 procedure to an additive one suitable for the general linear 
model used in many multivariate analytical approaches.  The formula used to predict the observed 
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cell frequencies contains a term (usually referred to as an effect) for each possible one-way, two-
way, three-way and higher order association for all variables, pairs of variables, triplets of variables, 
and so on.  For each possible combination of variable categories within an association, a parameter 
estimate is calculated.   When the formula contains an effect for every possible association in this 
way, it can predict all the observed cell frequencies exactly using the parameter estimates, and the 
model is said to be saturated.  
 
For each effect in the model (or each association), the significance of the partial association (that is, 
the degree of association adjusted for all other associations) can be calculated. The partial 
association represents the variance which can be ascribed solely to that effect rather than being 
shared with other effects.  Effects that have non-significant partial associations contribute little to the 
model and can be eliminated without impairing its ability to estimate the observed cell frequencies 
sufficiently accurately.  When all the non-significant effects have been eliminated, the model can be 
used to predict one variable from other variables. 
 
Multiway frequency analysis makes no assumptions about population distributions, and can be 
applied without limitations to categorical data and continuous variables which have been 
transformed to discrete categories.   The only limitation to using the technique is the size of expected 
frequencies in each cell.  When expected frequencies are low, they reduce the power of the 
technique to detect associations or effects which are significant.  In other words, they increase the 
chance that associations which are actually significant will be classified as non-significant.   If the 
number of cases in the sample is low compared with the number of variables and categories within 
variables in the data set, or if the distribution of events across categories is highly skewed indicating 
that some categories are very rare, there is a risk that expected frequencies will be low in some cells.  
The rule of thumb proposed by some authors is that expected cell frequencies for all two way 
associations should be examined to make sure that all are greater than one and no more than 20% 
are less than five. Of course, by eliminating variables or collapsing categories, the cells with low 
expected frequencies can be removed or combined, but this also affects the power of the analysis by 
removing its ability to detect associations involving the eliminated variables or relationships 
concerning the collapsed categories. 
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A multiway frequency analysis was first undertaken on all the screened admissions in the eight 
specialties studied.  This data set, consisting of a total of 12,676 admissions, was described in table 
5.2.  The variables from the data set chosen for inclusion in the multiway frequency analysis were 
those which had been used in the bivariate analyses of section 5.3.1, and they are listed in table 5.13 
below.    The three ratio scale variables - length of stay, age and adverse event score - were each 
converted to categorical variables by grouping data values to a relatively small number of 
categories.  One variable used in the bivariate analyses, the discharge type, was excluded from the 
multiway frequency analysis.   This variable had only two categories (discharged alive or died), but 
since deaths in hospital were very rare (the sample of 12,676 admissions only contained 43 deaths) 
the inclusion of this variable would have created many cells with unacceptably low expected 
frequencies.  It was anticipated that, with this set of variables for analysis, the multiway frequency 
analysis would provide evidence on four of the six constructs set out in section 5.1.2.  It could not 
inform the consideration of the constructs concerning the effects of different types of adverse event 
and the relationship between adverse event rate and discharge type because the necessary variables 
were not part of the data set analysed. 
 
Variable name 
 
Variable title Data type Levels 
SPEC 
 
Specialty Categorical 8 levels in total 
SEX Patient sex Categorical 2 levels (male, female) 
 
ADMTYPE Admission type Categorical 2 levels (elective, emergency) 
LOSGRP Length of stay Ratio scale, converted to 
categorical 
4 levels (0 days, 1-5 days, 6-10 
days, 11+ days) 
AGEGRP Age on admission Ratio scale, converted to 
categorical 
3 levels (0-50 years, 51-70 years, 
71+ years) 
AEGRP Adverse event score Ratio scale, converted to 
categorical 
4 levels (0, 1, 2, 3+ adverse events) 
 
Table 5.13.  Variables used in the multiway frequency analysis of 12,676 admissions from eight 
specialties screened for adverse events. 
 
The results of the first multiway frequency analysis undertaken for the whole data set are presented 
in table 5.14 below.   The first section of the table shows that only the first, second and third order 
effects were significant.  This means that no significant higher order effects (associations involving 
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four or more variables) were found.  The second part of the table lists the significant effects, with 
their partial associations (all effects with a significance of p < 0.05 are listed).   
 
 
Tests that K-way effects are zero: 
 
         K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1     17    35529.657   .0000     496094.081   .0000           0 
         2    108    26599.612   .0000      31346.738   .0000           0 
         3    334     1068.383   .0000      14994.674   .0000           0 
         4    533      310.356  1.0000        307.801  1.0000           0 
         5    417      162.933  1.0000        149.926  1.0000           0 
         6    126       20.606  1.0000         15.346  1.0000           0 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
 
 AEGRP*LOSGRP*SPEC                              63        128.771   .0000     8 
 LOSGRP*SPEC *AGEGRP                            42         70.923   .0035     7 
 SPEC *AGEGRP*SEX                               14        146.841   .0000     8 
 LOSGRP*SPEC *ADMTYPE                           21        160.631   .0000     8 
 LOSGRP*AGEGRP*ADMTYPE                           6         39.368   .0000     8 
 SPEC *AGEGRP*ADMTYPE                           14         99.515   .0000     8 
 SPEC *SEX*ADMTYPE                               7         35.002   .0000     8 
 AGEGRP*SEX*ADMTYPE                              2         22.675   .0000     8 
 AEGRP*LOSGRP                                    9        786.140   .0000    13 
 AEGRP*SPEC                                     21        433.923   .0000    11 
 LOSGRP*SPEC                                    21       2761.916   .0000    12 
 AEGRP*AGEGRP                                    6         20.102   .0027    13 
 LOSGRP*AGEGRP                                   6        572.496   .0000    15 
 SPEC *AGEGRP                                   14       4584.666   .0000    15 
 LOSGRP*SEX                                      3         23.285   .0000    12 
 SPEC *SEX                                       7       4396.296   .0000    12 
 AGEGRP*SEX                                      2        418.327   .0000    13 
 AEGRP*ADMTYPE                                   3         11.652   .0087    12 
 LOSGRP*ADMTYPE                                  3        167.791   .0000    11 
 SPEC *ADMTYPE                                   7       5118.443   .0000    15 
 AGEGRP*ADMTYPE                                  2         76.351   .0000    13 
 SEX*ADMTYPE                                     1          6.847   .0089    13 
 AEGRP                                           3       5255.669   .0000     2 
 LOSGRP                                          3      15421.426   .0000     2 
 SPEC                                            7       7081.866   .0000     2 
 AGEGRP                                          2       4489.366   .0000     2 
 SEX                                             1       1902.232   .0000     2 
 ADMTYPE                                         1       1379.070   .0000     2 
 
 
Table 5.14.  Results of multiway frequency analysis of 12,676 admissions  
from eight specialties screened for adverse events. 
 
It can be seen that there are eight significant third order effects, representing complex associations 
between three variables, and that six of these eight third order effects involve the specialty variable. 
Furthermore, five of the fourteen second order effects also involve the specialty variable.  The 
presence of both a third order effect involving adverse event rate and specialty (with length of stay) 
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and a second order effect involving adverse event rate and specialty support the first construct 
outlined in section 5.1.2, that rates of adverse events would vary across specialties. 
 
Because third order effects are difficult to interpret, and because one variable (specialty) is involved 
in most of the third order effects and many lower order effects, these results suggest that it is 
necessary to undertake separate multiway frequency analyses for each specialty rather than a single 
analysis across all specialties.   
 
Further multiway frequency analyses were then undertaken for each specialty separately.  These 
analyses can be found in full in appendix 5.2, but their results are summarised in table 5.15.  It 
shows, for each separate multiway frequency analysis of data for a single specialty, whether the 
results supported the constructs set out in section 5.1.2, and whether other significant associations 
between variables were also found. 
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Specialty (b) Patients 
with adverse 
event/multiple 
adverse events 
will stay in 
hospital longer 
(e) Patients 
admitted as 
emergencies will 
have more 
adverse events 
than those 
admitted 
electively 
 
(f) Elderly 
patients will 
have more 
adverse events 
than younger 
patients 
Other significant associations 
between variables 
 AEGRP* 
LOSGRP 
AEGRP* 
ADMTYPE 
AEGRP* 
AGEGRP 
 
Accident and 
emergency 
   Length of stay and age. 
Age and sex. 
ENT * *   Length of stay and age. 
Length of stay and admission 
type. 
Age and admission type. 
Gynaecology 
 
*    
Ophthalmology *  * Length of stay and age. 
Age and sex. 
Length of stay and admission 
type. 
Age and admission type. 
Sex and admission type. 
Orthopaedics *  * Length of stay and age. 
Length of stay and sex. 
Age and sex. 
Length of stay and admission 
type. 
Age and admission type. 
Sex and admission type. 
General surgery * *  Length of stay and age. 
Length of stay and admission 
type. 
Age and admission type. 
Urology    Length of stay and age. 
Age and sex. 
Age and admission type. 
 
Table 5.15.  Summary of the results of separate multiway frequency analyses for each specialty. 
 
The results in table 5.15 provide rather qualified support for the constructs being tested.   They 
certainly suggest that an association between adverse event rates and length of stay exists - the first 
of the three constructs examined.  However, for the second and third constructs they indicate that 
associations between adverse event rates and admission type and adverse event rates and age only 
exist in some specialties.   It should be remembered that the power of these analyses to detect 
significant associations is low because of the relatively small numbers of cases in some specialties, 
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and the asymmetric distribution of cases resulting in many cells with low expected frequencies. 
 
It is particularly useful to note the commonly occurring other associations listed in the final column 
of the table, since they provide some indications of the associations which might have confounded 
the earlier bivariate analyses presented in section 5.3.1.   It is not surprising that associations 
between both length of stay and age and between age and sex were frequently found.  The 
association between age and admission type commonly reported is less intuitively easy to explain. 
Of course, these multiway frequency analyses only indicate that an association exists; they do not 
provide information on the direction or strength of the association without either further analysis of 
the parameter estimates or the undertaking of separate bivariate analyses such as those already 
concluded for the constructs being tested. 
 
 
5.4 Conclusions 
 
It was noted at the outset of this chapter that this examination of construct validity was particularly 
important because, in the absence of meaningful criterion variables it was difficult or impossible to 
explore the criterion-related validity of adverse-event measures of quality.   In this situation, an 
examination of construct validity was both more methodologically appropriate and likely to provide 
greater insight into the behaviour of the measure or measures being tested. 
 
The series of analyses of adverse event data from the RSCH project presented above leave little 
doubt of the construct validity of the adverse-event measures tested.   As table 5.16 below 
demonstrates, each construct was supported by data in at least some specialties, and most were 
widely supported by data from several different specialties.  Overall, five of the six constructs tested 
were confirmed by the data from the RSCH project.  Only one construct was not supported by the 
data. 
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 Construct 
 
Summary of results 
a) Adverse event rates will vary 
between specialties. 
Confirmed. Both rates of individual types of adverse events and generic 
adverse event rates found to vary significantly across specialties. 
 
b) Adverse event rates will 
correlate with length of stay. 
Confirmed.  Patients with an adverse event stayed significantly longer in 
hospital than those without adverse events in 5 out of 8 specialties.  
Patients with multiple adverse events stayed significantly longer than 
those with just one adverse event in 5 out of 8 specialties.  Specialties 
where no difference found tended to be those with very short mean 
lengths of stay.  Also supported by multiway frequency analysis. 
 
c) Different types of adverse 
events will have different 
effect on length of stay. 
Confirmed in obstetrics. Patients with clinically significant adverse 
events found to stay longer in hospital than those with more minor or 
non-clinical adverse events. 
 
d) Patients who die will have had 
more adverse events than those 
who do not. 
Confirmed in trauma and orthopaedics, the only specialty in which there 
were sufficient deaths to test the construct. 
e) Emergency patients will have 
more adverse events than 
elective patients. 
Confirmed in 3 of the 5 specialties with a mixture of elective and 
emergency admissions.  Specialties where no difference found were 
those with small sample sizes.   Supported in some specialties by 
multiway frequency analysis. 
 
f) Elderly patients will have more 
adverse events than younger 
patients. 
Only confirmed in one specialty - trauma and orthopaedics -and not 
supported in 7 other specialties by bivariate analysis.   Significant 
association found in two specialties - trauma and orthopaedics and 
ophthalmology - in multiway frequency analysis. 
 
 
Table 5.16.  Overview of the results of construct validity analysis using RSCH project data. 
 
However, the multiway frequency analysis presented in section 5.3.2 also provided some reasons to 
be cautious in the interpretation of adverse-event measure data.  It highlighted the number of other 
associations which existed in the RSCH project data (such as those between age and sex, age and 
length of stay, length of stay and admission type, and so on).  While these do not affect our 
conclusions on the validity of the adverse-event measures being tested, they make the interpretation 
of such data more difficult and they particularly impede the making of valid comparisons between 
specialties, clinical teams, wards or other groupings. 
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Chapter 6 
 
Reliability of adverse-event measures of quality 
 
 
 
6.1 Introduction 
 
Chapter 3 reviewed the literature on adverse-event measures of quality and presented an analysis of 
the small number of studies of the reliability of these measures which have been undertaken.  It was 
demonstrated that, given the widespread use of adverse-event measures of quality, there was 
surprisingly little evidence that the reliability of these measures had been adequately assessed.  
Indeed, since the few published studies reached markedly different conclusions about the reliability 
of adverse-event measures of quality, even when the same measure was being tested, it was clear 
that the reliability of such measures needed to be investigated further. 
 
The approach taken to testing the reliability of any measurement instrument is shaped in part by the 
design and characteristics of the instrument itself, as was noted in chapter 2.  The construction and 
definition of adverse-event measures of quality were discussed in some detail in chapter 3.  An 
adverse-event measure is usually made up of a number of criteria, each of which relates to a 
particular type of adverse event.  When the measure is used to review the care provided to a patient, 
a series of dichotomous data values is produced, indicating for each criterion whether or not that 
type of adverse event was found.  A summary score is also sometimes constructed, totalling the 
number of adverse events found.   Many of the reliability studies reported in chapter 3 only assessed 
the reliability of the latter summary score rather than the reliability of each individual criterion 
within the adverse-event measure.   Though this provides a useful overall estimate of the reliability 
of the measure, it risks overestimating its reliability since quite different sets of adverse events 
recorded by a rater can produce the same summary score value.  Moreover, if the results of 
reliability testing are to be used to improve the measure to make it more reliable, reliability results 
for each criterion individually are needed.   For these reasons, it is advisable to report the reliability 
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of adverse-event measures in both ways - with statistics for each criterion individually and with 
statistics for the summary score based on the total number of adverse events found. 
 
The reliability of a measurement instrument can be tested experimentally, by undertaking specific 
studies in which the instrument is repeatedly applied and the results are compared.   Such studies 
have the advantage of being capable of isolating the variability in results which is attributable to 
interrater variation from other sources of variability, and so providing a credible and valid estimate 
of their reliability.   However, it is difficult to ensure that such reliability studies are undertaken in 
the same conditions in which the measure would normally be used, and there is a risk that 
differences in rater training, the time available to raters to collect data, rater motivation and skill 
level, and other areas could lead to the resulting estimates of reliability being inflated. 
 
An alternative approach to testing the reliability of a measurement tool is to analyse the data 
gathered by different raters using the tool and to test whether differences exist which might be 
attributable to rater variation.   This is methodologically and statistically more complex, since there 
may be many known and unknown confounding factors which cause the variations observed in the 
data, and while the known confounders can be controlled, the unknown sources of bias cannot. 
However, since this approach is based on data collected from the use of the measurement tool in a 
more realistic setting, the resulting estimates of reliability may have greater external validity. 
 
Since both these approaches to assessing reliability have their merits, two sets of investigations of 
the reliability of a number of adverse-event measures were undertaken for this study.  Firstly, a 
number of specific experimental studies were carried out, in which a set of patient admissions was 
reviewed repeatedly by different screeners and the results of these screenings were compared. 
Secondly, an analysis was undertaken of the adverse-event data from the RSCH project to examine 
whether there were variations in the rates of adverse events associated with differences in raters or 
screeners.   This chapter reports the findings from both sets of investigations. 
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6.2 Experimental studies of interrater and intrarater reliability 
 
6.2.1 Aims of interrater and intrarater reliability studies 
 
The aim of the interrater and intrarater reliability studies reported in this section was to assess the 
reliability of a number of adverse-event measures of quality experimentally through the repeated 
application of the measures to the same patient admissions.  It was noted in chapter 3 that estimates 
of reliability are known to be significantly affected by the conditions under which the study takes 
place and by the extent and quality of training provided to the raters or screeners applying the 
measures under test.   The studies reported here were designed to provide a realistic estimation of 
the reliability of these measures, obtained in conditions which approximated their normal use in an 
acute hospital setting.  They took place as part of the routine of data collection for the RSCH project, 
using the same staff and methods.   No special training or other measures were undertaken to 
prepare for the reliability studies, and the process of screening or reviewing patients’ records, 
abstracting data about adverse events and recording it was performed in the usual manner, using the 
same forms and computer systems. 
 
6.2.2 Methods 
 
Four separate but linked studies of the reliability of adverse-event measures of quality were 
undertaken using the staff and resources of the RSCH occurrence screening project, in three 
specialties - ENT, ophthalmology and obstetrics.    In each of these specialties, an adverse-event 
measure of quality had been developed and was already in routine use.  In ENT and ophthalmology, 
this measure was based on the generic adverse-event measure described in chapters 4 and 5.  In 
obstetrics, a measure developed specifically to reflect the healthcare process in that specialty had 
been developed (and was also described in chapter 5).    The reliability studies were undertaken on 
these measures as they stood, although, as the description of the development process in chapter 3 
makes clear, they had not necessarily been designed to maximise reliability. The intention was to 
provide a realistic estimate of the reliability of adverse-event measures such as these, rather than to 
establish a theoretical reliability which might be difficult to match in actual practice. 
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In each study, the reliability of the adverse-event measure under test was investigated by applying 
the measure twice to a series of patient admissions, and then comparing the results from these two 
applications of the measure to assess the degree of agreement between them.   In three studies of 
interrater reliability, the first and second applications of the measure were undertaken by different 
individuals with no knowledge of each other’s ratings.  In one study of intrarater reliability, the first 
and second applications of the measure were undertaken by the same person, but with an interval of 
time between the two applications sufficient to ensure that the person would not be able to 
remember the details of patient admissions or the results of the first application of the measure when 
applying it for the second time.  In all four studies, the reliability of the adverse-event measures 
being tested was then assessed by calculating various agreement statistics.   The studies were 
undertaken in three specialties (ENT, ophthalmology and obstetrics), with interrater reliability being 
tested in all three and intrarater reliability being tested in obstetrics only. 
 
In two specialties - ENT and ophthalmology - the interrater reliability of the adverse-event measures 
in use in those specialties was investigated by arranging for a sample of patient admissions to be 
screened for adverse events twice, by different screening staff on each occasion.  These studies both 
took place during the period February to April 1992.  Not all patient admissions during that period 
in the two specialties were included in the study, but to avoid any case-selection bias either all 
admissions on any given day were subjected to rescreening, or none were.  The first screening took 
place as part of the routine data collection process of the project.   The second screening was then 
undertaken by a different member of staff, with no knowledge of the results of the first screening 
and no communication with the member of staff who undertook the first screening.   The project 
staff involved in these two studies were, of course, aware that the reliability of their application of 
the adverse-event measures was being tested, and this could have influenced their behaviour and use 
of the measure.  The results of the first and second screening of each admission were then compared.    
 
In the third specialty - obstetrics - both the interrater reliability and the intrarater reliability of the 
adverse-event measure in use was investigated.   To measure the intrarater reliability of the measure, 
a consecutive series of patient admissions was identified which had taken place during the period 
September to November 1991 and had been screened at that time using the adverse-event measure.    
This sample of patient admissions was restricted to those which had been screened by one particular 
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individual member of the project staff, and the study took place in January to March 1992.  The 
patients’ casenotes were retrieved in chronological order of admission date, and each admission was 
then screened for a second time by the same member of the project staff, with no access to the 
results of the first screening. Each patient admission was screened for the second time 
approximately four months after it had first been screened. Given that the member of project staff 
had, in the intervening period, screened hundreds of other patients’ admissions, it was judged that 
she would not be able to remember the results she had recorded when she first screened these cases 
four months previously.  It should be noted that the member of project staff was not aware when 
undertaking the first screening of these admissions that they would subsequently be the subject of 
this intrarater reliability study, so her behaviour and use of the measure on first screening was not 
affected by the study.   The results of her first and second screening were then compared 
 
The interrater reliability of the adverse-event measure used in obstetrics was then investigated by 
arranging for the sample of patient admissions used in the intrarater study to be screened once again.  
This third screening was not undertaken by one of the project screening staff, but by a doctor 
qualified in obstetrics who undertook a brief training programme on how to interpret and apply the 
adverse-event measure.     The doctor undertaking this third screening had no knowledge of the 
results of the first and second screening of the admission undertaken by one of the project staff.  The 
results of the doctor’s screening were then compared with each of the previous screening results 
(from September-November 1991 and January-March 1992) separately, resulting in two sets of 
interrater comparisons. 
 
The four studies of interrater and intrarater reliability are summarised in table 6.1 below (note that 
the obstetric interrater reliability study involved the comparison of two different screenings of a set 
of obstetric cases by a member of project staff with that undertaken by a doctor qualified in 
obstetrics and effectively produced two sets of data, and so is listed as C and D). 
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Study Specialty Investigation No of 
cases 
First screening 
 
Second screening 
A ENT Interrater 
reliability 
146 Undertaken by a member of 
project screening staff, during 
study period of Feb-April 
1992. 
Undertaken by  a different 
member of project screening 
staff, on same day as first 
screening. 
B Ophthalmology Interrater 
reliability 
125 Undertaken by a member of 
project screening staff, during 
study period of Feb-April 
1992. 
Undertaken by a different 
member of project screening 
staff, on same day as first 
screening. 
C Obstetrics Interrater 
reliability 
108 Undertaken by a member of 
project screening staff during 
period Sept-Nov 1991. 
Undertaken by a doctor 
qualified in obstetrics during 
the period Jan-March 1992. 
D Obstetrics Interrater 
reliability 
110 Undertaken by a member of 
project screening staff during 
the period Jan-March 1992. 
Undertaken by doctor 
qualified in obstetrics during 
the period Jan-March 1992. 
E Obstetrics Intrarater 
reliability 
110 Undertaken by a member of 
project screening staff during 
period Sept-Nov 1991. 
Undertaken by the same 
member of project staff 
during the period Jan-March 
1992, approx 4 months after 
first screening. 
  
Table 6.1.  Summary of studies of interrater and intrarater reliability. 
 
Each study of interrater and intrarater reliability produced a paired data set containing the results of 
two applications of the adverse-event measure being tested to a set of patient admissions. The 
adverse-event measures whose reliability was being tested consisted of a number of screening 
criteria, each defining a particular type of adverse event.   The results of screening a patient 
admission using a measure was therefore a series of dichotomous data values (adverse event 
occurred or no adverse event occurred), one for each screening criterion in the measure.   In 
addition, a summary measure was constructed, totalling the number of adverse events found for a 
given patient admission. 
 
In order to assess the reliability of the adverse-event measures being tested, the two sets of data from 
separate screenings of the same patient admission needed to be compared and the degree of 
agreement measured.  It was noted earlier that comparisons should be made both for each criterion 
individually within the measure, and for the total number of adverse events found for a given patient 
admission.  These two forms of comparison require different statistical approaches. 
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Comparing the results obtained for each criterion in an adverse-event measure produces a 
crosstabulation of the results from each screening, as shown in table 6.2 below.   
.   
  Second screening 
  No adverse event Adverse event 
First No adverse event a b 
screening Adverse event c d 
 
Table 6.2.  Comparison of the results of repeated screening for a single adverse event criterion. 
 
The percentage agreement can thus be calculated as: 
a d
n
+ × 100  
where n is the total number of cases.  However, some degree of agreement would be expected 
through chance alone, and so the raw percentage agreement does not provide a useful or comparable 
measure of agreement.   The commonly accepted measure of agreement is the Ρ (kappa) statistic 
which measures how much the observed level of agreement exceeds that which would be expected 
by chance (Siegel and Castellan 1988, p284): 
κ = −− =
+ − + + + + +×
− + + + + +×
p p
p
a d
n
a b a c b d c d
n n
a b a c b d c d
n n
o c
c1 1
( )( ) ( )( )
( )( ) ( )( )  
 
The maximum value of Ρ is 1, representing perfect agreement, while a value of 0 represents no more 
agreement than would have been expected through chance alone.  Negative values of Ρ can occur, 
indicating that there is even less agreement than would be expected by chance, but the meaning of 
such a finding is not straightforward, and the scale of negative Ρ values is difficult to interpret.  A 
commonly used benchmark for the use of the Ρ statistic (Brennan and Silman, 1992) is set out in 
table 6.3 below, but it should be noted that this represents a pragmatic and rather arbitrary appraisal 
of the statistic’s meaning with no particular foundation in statistical reasoning.  The probability that 
the Ρ statistic is greater than zero can be calculated, to identify whether the degree of agreement 
found is significantly greater than that expected by chance alone. 
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Value of Ρ statistic Strength of agreement 
< 0.20 Poor 
0.21 - 0.40 Fair 
0.41 - 0.60 Moderate 
0.61 - 0.80 Good 
0.81 - 1.00 Very good 
 
Table 6.3.  Interpretation of the Ρ statistic (Brennan and Silman, 1992). 
 
In this study, the Ρ statistic was calculated for each criterion within the adverse-event measures 
tested, and the probability that the value of Ρ was significantly greater than 0 was calculated.   In 
addition, a value of Ρ was also calculated for the measure as a whole, by aggregating the numbers of 
agreements and disagreements, as shown in table 6.2, across all criteria in the measure.    It should 
be noted that Ρ has some drawbacks, particularly when the levels of agreement to be expected 
through chance are high because of the underlying prevalence of the characteristic being measured.  
In these circumstances, the value of Ρ is attenuated and so the  benchmarks set out in table 6.3 may 
be harder to meet (Thompson and Walter 1988).   In some circumstances when the prevalence of the 
characteristic being measured is low, the  Ρ statistic cannot be calculated because when table 6.2 
contains only a single non-zero row or column, pc = 1 and so the denominator in the formula for Ρ 
becomes zero. 
 
The total number of adverse events found for a patient admission is the commonly used summary 
score.   It has been common practice to use the Pearson product-moment correlation coefficient to 
assess agreement for ratio scale or continuous data items, as the review of previous studies of the 
reliability of adverse-event measures in chapter 3 demonstrated.   However, the Pearson correlation 
coefficient is a measure of association rather than agreement, and it does not take account of 
differences of scale or bias.  Moreover, it would be surprising if two measures of the same 
characteristic were not correlated, and so the correlation coefficient and associated significance test 
results are arguably irrelevant to the issue of agreement.  It should not be used to assess agreement 
(Bland and Altman 1986).   
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An alternative approach to assessing agreement for ratio scale or continuous data has been proposed 
by Bland and Altman (1986).  They recommend the use of a combination of graphical techniques 
and simple calculations involving the examination of mean differences between the two ratings or 
values.  By calculating the estimated limits of agreement based on the standard deviation of the 
differences, and confidence intervals for those limits of agreement, a numerical estimate of the 
extent of agreement is obtained.   This enables us to state that, for example, we can expect that in 
95% of cases the numerical difference between the two measurements will not exceed a given level.   
A judgement then needs to be made about the operational significance of the numerical difference 
observed, and the implications for the use of the measure being tested.  When comparing repeated 
applications of the same adverse-event measure, we would hope to see a  small numerical difference 
between the two results and would wish the mean difference to be close to zero (indicating that 
neither result was consistently higher or lower than the other). 
 
In this study, scatterplots were used to examine graphically the relationship between the number of 
adverse events found for patient admissions on the first and second screenings, and the associated 
Pearson correlation coefficients were calculated, taking into account the above provisos about their 
interpretation.   Then, the differences between ratings and limits of agreement were calculated, as 
described by Bland and Altman (1986). 
 
 
6.2.3 Results and discussion 
 
The results from each of the interrater reliability studies - in ENT, ophthalmology and obstetrics - 
are presented in turn below.  Then, the findings from the intrarater study in obstetrics are explored. 
Finally, a comparison of the results in each of the studies is made. 
 
Interrater reliability in ENT 
A total of 146 patient admissions were screened twice by different members of the project staff, and 
the results are presented in table 6.4 below.   For each screening criterion, the table shows how many 
patient admissions were recorded as no adverse event (N-N) by both screeners; as adverse event by 
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one and no adverse event by the other (N-V and V-N); and as an adverse event by both screeners 
(V-V).   It then shows the crude percentage agreement, and the value and significance of the Ρ 
statistic.  As was noted earlier, in some cases Ρ cannot be calculated because the cross-tabulation of 
screeners’ results contains only one non-zero row or column, resulting in an infinite denominator in 
the equation for the Ρ statistic. 
 
Crit 
no 
Criterion title N-N N-V V-N V-V Agree
ment 
(%) 
Ρ Significance 
of Ρ 
1 Adm for adv results o/p mgt 141 1 3 1 97 0.32 < 0.001 
2 Readmission for comp prev 
adm 
139 1 1 5 99 0.83 < 0.001 
3 Error in operative consent 122 8 13 3 86 0.15 < 0.001 
4 Unpl rem/inj/repair in surg 145 0 1 0 99 - - 
5 Unpl return to theatre 146 0 0 0 100 - - 
6 Path/hist varies from diag 146 0 0 0 100 - - 
7 Prob of transfusion 146 0 0 0 100 - - 
8 Hosp acquired infection 145 0 1 0 99 - - 
9 Medication error/reaction 132 8 4 2 92 0.21 < 0.01 
10 Cardiac/resp arrest in hosp 146 0 0 0 100 - - 
11 CVA/MI/PE in hosp after surg 145 1 0 0 99 - - 
12 Unexp transfer to spec care 145 1 0 0 99 - - 
13 Pt related clinical complcn 140 1 2 3 98 0.66 < 0.001 
14 Non-clin problem/incident 128 5 0 13 97 0.82 < 0.001 
15 Neuro deficit devel in hosp 146 0 0 0 100 - - 
16 Unexp patient death 146 0 0 0 100 - - 
17 Medical record deficiency 79 20 17 30 75 0.43 < 0.001 
18 Nursing record deficiency 42 18 16 70 77 0.52 < 0.001 
19 Pt/family dissatisfaction 138 1 1 6 99 0.85 < 0.001 
20 Discharge related problems 140 1 4 1 97 0.27 < 0.001 
E1 Early adm for elect proc 146 0 0 0 100 - - 
E2 Prep-op problems 129 4 1 12 97 0.81 < 0.001 
E3 Probs supply of theatre eqpt 146 0 0 0 100 - - 
E4 Missing/incompl audit sheet 128 5 9 4 90 0.31 < 0.001 
All All criteria 3206 75 73 150 96 0.65 < 0.001 
 
Table 6.4.  Agreement statistics by criterion for interrater study in ENT. 
 
The first point to note is that for twelve of the 24 adverse-event criteria used in the measure being 
tested in ENT, Ρ could not be calculated as noted above, largely because no adverse events were 
recorded in the sample of 146 patient admissions.   Many of the criteria in the adverse-event 
measure being tested related to relatively rare adverse events, and so it was not a cause for concern 
that no events were found in a fairly small sample.  However, this means that the study is effectively 
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not able to test the reliability of those criteria within the measure beyond calculating raw percentage 
agreements as shown in the table. 
 
However, for the remaining 12 criteria, Ρ varied from 0.15 to 0.85.  In each case, Ρ was significantly 
greater than zero, indicating that the level of agreement was significantly better than that expected 
through chance alone.   Comparing the Ρ values in table 6.4 with the benchmarks set out in table 6.3, 
it can be seen that 5 of the 12 criteria have Ρ values rated as “good” or “very good” (eg above 0.6) 
while only one falls into the “poor” category (less than 0.2).  Taking the measure as a whole, the 
overall Ρ statistic (based on an aggregation of the results from all 24 criteria) was 0.65.  These 
results suggest that the overall reliability of the measure is good, but that some criteria within the 
measure are much less reliable than others.  There is clearly potential to improve the reliability of 
the measure by either adjusting the definitions of those criteria or by removing them from the 
measure. 
 
Figure 6.1 below contains a scatterplot of the number of adverse events found on the first screening 
against the number of adverse events found on the second screening for the 146 admissions in ENT.  
Each data point on the scatterplot represents a single patient admission.  Where one or more data 
points overlap on the graph, a “sunflower plot” is used, with each petal or line representing one 
overlapping case, so that the clustering of data points can be seen.   
 
The graph shows agreement between the number of adverse events on first and second screening for 
many data points, though there are a number of data points representing substantial disagreements 
(for example, one case with 0 adverse events on first screening and 3 on second screening).  Overall, 
the number of adverse events found on first and second screening was the same for 51.4% of cases, 
and was within a range of ±1 adverse event for 89.9% of cases.  The Pearson correlation coefficient 
was 0.66, indicating moderately strong association (though the limited usefulness of this statistic in 
assessing agreement was noted earlier). 
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Figure 6.1.  Scatter plot of number of adverse events found on first and second screening 
for interrater study in ENT. 
 
 
 
Figure 6.2.  Difference in number of adverse events on first and second screening plotted against 
mean number of adverse events on first and second screening for interrater study in ENT. 
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Figure 6.2 above shows a second scatterplot, of the difference between the number of adverse events 
found on first and second screening against the mean of the two values.  It can again be seen that the 
degree of agreement is relatively good, with most data points on or close to the 0 line on the vertical 
axis.  No correlation between the mean and difference is visually evident, indicating that the level of 
agreement appears to be constant across cases with differing numbers of adverse events.  The mean 
difference is 0.01, suggesting that there was no tendency for the adverse-event score from the 
second screening to be either consistently higher and lower than that from the first screening, and so 
no systematic bias exists.  The estimated limits of agreement, within which 95% of all differences 
should fall, are -1.83 to +1.81 (with 95% confidence intervals for these estimates of -2.09 to -1.57, 
and 1.55 to 2.07 respectively).   This means that we could expect that the number of adverse events 
found on a second application of this adverse-event measure would be within about ±1.83 of the 
number found on the first application in 95% of cases.  In the worst case, taking the outer 95% 
confidence limits, we might conclude that the difference between adverse-event scores on two 
separate screenings would not exceed 2 in about 95% of cases.  Whether this level of reliability is 
acceptable depends in large part on the purpose to which the data is to be put, and this is discussed 
later in this section. 
 
Interrater reliability in ophthalmology 
A total of 120 patient admissions were screened twice by different members of the project staff, and 
the results are presented in table 6.5 below.  Once again, the table shows for each criterion how 
many patient admissions were recorded as no adverse event by both screeners (N-N); as an adverse 
event by one screener but not the other (N-V and V-N); and as an adverse event by both screeners 
(V-V).  The crude percentage agreement, and the value and significance of Ρ are also shown. 
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Crit 
no 
Criterion title N-N N-V V-N V-V Agree
ment 
(%) 
Ρ Significance 
of Ρ 
1 Adm for adv results o/p mgt 120 0 0 0 100 - - 
2 Readmission for comp prev 
adm 
118 0 0 2 100 1.00 < 0.001 
3 Error in operative consent 117 1 1 1 98 0.49 < 0.001 
4 Unpl rem/inj/repair in surg 106 3 4 7 94 0.63 < 0.001 
5 Unpl return to theatre 116 0 2 2 98 0.66 < 0.001 
6 Path/hist varies from diag 120 0 0 0 100 - - 
7 Prob of transfusion 120 0 0 0 100 - - 
8 Hosp acquired infection 118 2 0 0 98 - - 
9 Medication error/reaction 115 3 2 0 96 -0.02 - 
10 Cardiac/resp arrest in hosp 120 0 0 0 100 - - 
11 CVA/MI/PE in hosp after surg 120 0 0 0 100 - - 
12 Unexp transfer to spec care 120 0 0 0 100 - - 
13 Pt related clinical complcn 120 0 0 0 100 - - 
14 Non-clin problem/incident 117 1 2 0 98 -0.01 - 
15 Neuro deficit devel in hosp 120 0 0 0 100 - - 
16 Unexp patient death 120 0 0 0 100 - - 
17 Medical record deficiency 94 10 9 7 84 0.33 < 0.001 
18 Nursing record deficiency 42 18 16 70 77 0.52 < 0.001 
19 Pt/family dissatisfaction 113 0 5 2 96 0.43 < 0.001 
20 Discharge related problems 119 0 1 0 99 - - 
OP1 Probs of cataract extraction 118 0 1 1 99 0.66 < 0.001 
OP2 Specific post-op complications 96 4 11 9 88 0.48 < 0.001 
OP3 Surg proc with tissue biopsy 119 1 0 0 99 - - 
OP4 Prob rel to drug usage 115 2 2 1 97 0.32 < 0.001 
OP5 Oph nursing record review 93 10 10 7 83 0.31 < 0.001 
OP6 Sore throat after GA 111 0 2 7 98 0.87 < 0.001 
All All criteria 2907 55 68 116 96 0.63 < 0.001 
 
Table 6.5.  Agreement statistics by criterion for interrater study in ophthalmology. 
 
As in the results presented for ENT, the small sample size and the low incidence of some types of 
adverse events prevented the calculation of Ρ for 12 of the 26 criteria used in the measure.  For 12 of 
the remaining 14 criteria, Ρ varied from 0.31 to 1.00, but two criteria had Ρ values of -0.01 and -0.02 
suggesting no agreement beyond that expected by chance.     These results place 5 of the criteria in 
the “good” or “very good” agreement categories from table 6.3, 7 in the “fair or moderate 
agreement” categories and 2 in the “poor agreement” category.   For the measure as a whole, the Ρ 
statistic based on an aggregation of results from all 26 criteria was 0.63.   Clearly, the overall 
reliability of the measure is good, but there are some criteria within it which perform substantially 
less well than others.  Once again, there is potential to improve the reliability of the measure by 
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either adjusting the definitions of those criteria with poor reliability or by removing those criteria 
from the measure. 
 
Figure 6.3 below presents a scatterplot of the total number of adverse events found on first and 
second screening for the sample of 120 patient admissions, each admission being represented as a 
data point on the graph with “sunflowers” used to show where multiple data points overlap.  
Overall, in 55.2% of cases the same number of adverse events were found on first and second 
screenings, and in 92.8% of cases the number of adverse events found was within a range of ±1 
adverse event.  The Pearson correlation coefficient was 0.57, though once again the limited value of 
this statistic should be noted.    
 
 
 
Figure 6.3.  Scatter plot of number of adverse events found on first and second screening 
for interrater study in ophthalmology. 
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Figure 6.4.  Difference in number of adverse events on first and second screening plotted against 
mean number of adverse events on first and second screening for interrater study in ophthalmology. 
 
 
Figure 6.4 shows a second scatterplot, of the difference in the number of adverse events found on 
first and second screening against the mean of the two values.   It shows relatively good agreement, 
with most data points on or close to the 0 line on the vertical axis (denoting no difference, or 
complete agreement).   The mean difference is 0.16, suggesting that little or no systematic bias 
exists.   
 
 The estimated limits of agreement, within which 95% of all differences should fall, are -1.79 to 1.47 
(with 95% confidence intervals for these estimates of -2.04 to -1.54 and 1.22 to 1.72 respectively).   
In other words, we could expect that in 95% of cases, a second application of the adverse-event 
measure used in ophthalmology will result in an adverse-event score which is between 1.79 less 
than the first to 1.47 more than the first.   The scatterplot in figure 6.4 is slightly asymmetric along 
the x axis, which might suggest a weak relationship between the magnitude of the difference and the 
mean.  As a result these estimated limits of agreement might be too wide for lower numbers of 
adverse events, and too narrow for higher numbers. 
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Interrater reliability in obstetrics 
A total of 117 patient admissions in obstetrics were used in the interrater and intrarater reliability 
studies in obstetrics.  Each admission was screened three times - twice by a member of the project 
staff and a third time by a doctor qualified in obstetrics who first received a brief training 
programme on how to interpret and apply the adverse event measure.  It was therefore possible to 
make two assessments of the interrater reliability of the adverse event measure used in obstetrics, by 
comparing the results of each of the two project staff screenings in turn with the result of the 
screening by a doctor with obstetric experience.  The results of these two comparisons are reported 
below.  In practice, not all 117 of the patient admissions were screened three times, for a variety of 
logistic reasons to do with the availability of records, the project staff and the doctor involved in the 
study. As a result, there were 108 admissions for which there was data from both the first project 
staff screening and the clinician screening; and 110 admissions for which there was data from both 
the second project staff screening and the clinician screening. 
 
Table 6.6 shows the results obtained by comparing the first screening by the member of project staff 
with the doctor’s screening.  The table shows, for each criterion, how many patient admissions were 
recorded as having no adverse event by both screener and doctor (N-N); as having an adverse event 
by the screener but not having an adverse event by the doctor (V-N); as having no adverse event by 
the screener but as having an adverse event by the doctor (N-V); and as having an adverse event 
according to both the screener and the doctor (V-V).  The crude percentage agreement and the value 
and significance of  Ρ are also shown.   
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Crit 
no 
Criterion title N-N N-V V-N V-V Agree
ment 
(%) 
Ρ Significance 
of Ρ 
1 Management of SROM 97 4 2 5 94 0.59 < 0.001 
2 Elective induction of labour 88 7 1 12 93 0.71 < 0.001 
3 Problems of labour/delivery 90 15 1 3 86 0.25 < 0.001 
4 Caesarean section 87 2 1 18 97 0.91 < 0.001 
5 Problems of Caesarean section 102 3 1 2 96 0.48 < 0.001 
6 Perinatal 
problems/complications 
98 7 2 1 92 0.15 - 
7 Post-natal 
problems/complications 
98 6 0 4 94 0.55 < 0.001 
8 Drug-related problems 75 31 0 1 71 0.04 - 
9 Mother/family dissatisfaction 107 1 0 0 99 - - 
10 Non-clinical prob/incidents 87 3 13 5 85 0.31 < 0.001 
11 Obstetric record review 75 20 4 9 77 0.31 < 0.001 
12 Prob of anaesthesia 107 1 0 0 99 - - 
13 Prob of pain relief 96 2 4 6 94 0.64 < 0.001 
14 All criteria 1207 102 28 66 91 0.46 < 0.001 
 
Table 6.6.  Agreement statistics by criterion for interrater study in obstetrics,  
comparing results from first screening by project staff and screening by doctor. 
 
Table 6.7 shows the same analysis, this time for the comparison of the second project staff screening 
with the doctor’s screening.  Again the table shows, for each criterion, how many patient admissions 
were recorded as having no adverse event by both screener and doctor (N-N); as having an adverse 
event by the screener but not having an adverse event by the doctor (V-N); as having no adverse 
event by the screener but as having an adverse event by the doctor (N-V); and as having an adverse 
event according to both the screener and the doctor (V-V).  The crude percentage agreement and the 
value and significance of Ρ are also shown.   
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Crit 
no 
Criterion title N-N N-V V-N V-V Agree
ment 
(%) 
Ρ Significance 
of Ρ 
1 Management of SROM 95 4 6 5 91 0.45  < 0.001 
2 Elective induction of labour 91 9 0 10 92 0.65 < 0.001 
3 Problems of labour/delivery 89 11 3 7 87 0.43 < 0.001 
4 Caesarean section 89 1 1 19 98 0.94 < 0.001 
5 Problems of Caesarean section 104 4 1 1 95 0.27 < 0.01 
6 Perinatal 
problems/complications 
101 6 0 3 95 0.48 < 0.001 
7 Post-natal 
problems/complications 
96 3 4 7 94 0.63 < 0.001 
8 Drug-related problems 75 31 2 1 69 0.01 - 
9 Mother/family dissatisfaction 109 1 0 0 99 - - 
10 Non-clinical prob/incidents 79 1 23 7 78 0.29 < 0.001 
11 Obstetric record review 59 16 22 13 65 0.17 - 
12 Prob of anaesthesia 109 1 0 0 99 - - 
13 Prob of pain relief 97 1 5 7 95 0.67 < 0.001 
14 All criteria 1193 89 67 80 89 0.45 < 0.001 
 
Table 6.7.  Agreement statistics by criterion for interrater study in obstetrics,  
comparing results from second screening by project staff and screening by doctor. 
 
For table 6.6 on the first project staff/doctor screening comparison, Ρ varies from 0.04 to 0.91.  Of 
the 12 criteria for which Ρ could be calculated, only 3 fall into the “good” or “very good” agreement 
categories from table 6.3, while 7 have “fair” or “moderate” agreement and 2 “poor” agreement.  
Overall, the Ρ statistic for the adverse-event measure as a whole was 0.46.   In table 6.7, for the 
second project staff/doctor comparison, the results are similar.  Here, Ρ varies from 0.01 to 0.94.  
Again, 12 criteria had Ρ values, of which only 4 fall into the “good” or “very good” agreement 
categories, while 6 have “fair” or “moderate” agreement and 2 “poor” agreement.  In this case, the Ρ 
statistic for the adverse-event measure as a whole was 0.45. 
 
It is evident from tables 6.6 and 6.7 that the interrater reliability results for the adverse-event 
measure used in obstetrics was considerably lower than that found in either ENT or ophthalmology.  
This could indicate that either the measure itself is less reliable, or that the two screeners using the 
measure were applying it or interpreting it differently.    There is some evidence to support the latter 
conclusion, since across most criteria the doctor found more adverse events than the project staff.   
This tendency was particularly pronounced for the criterion concerning drug-related problems (such 
as missed doses, prescribing and administration errors, etc), where the doctor found far more 
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adverse events.  It may be that the doctor was able to use his clinical knowledge to interpret findings 
from the records, or it may be that this systematic bias reflects significant differences in the 
interpretation of the definition of the adverse-event measure or of information in patient records by 
the doctor and the member of project staff. 
 
Figures 6.5 and 6.6 below show scatterplots of the total number of adverse events found by different 
screenings.  Figure 6.5 compares the first project staff screening with the doctor’s screening, for the 
sample of 108 patients analysed in table 6.6 above.  Figure 6.6 compares the second project staff 
screening with the doctor’s screening, for the 110 patients reported on in table 6.7.   In both figures, 
each data point represents one admission and multiple overlapping data points are represented by 
“sunflower” plots. 
 
 
Figure 6.5  Scatter plot of number of adverse events found on first project staff screening  
and doctor’s screening for interrater study in obstetrics. 
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Figure 6.6  Scatter plot of number of adverse events found on second project staff screening  
and doctor’s screening for interrater study in obstetrics. 
 
These two scatterplots show much more disagreement than previous figures (6.1 and 6.3) for ENT 
and ophthalmology.  They confirm the existence of a consistent bias, with the doctor finding more 
adverse events than the member of project staff.    When the first project staff screening and the 
doctor’s screening are compared, only in 35.9% of cases did they agree about the number of adverse 
events found; in 70.1% of cases, the two ratings were within a range of ±1 adverse event. 
Comparing the second project staff screening and the doctor’s screening gives similar results - they 
agreed on the number of adverse events in 29.9% of cases, and were within a range of ±1 adverse 
event in 71.0% of cases.    The Pearson correlation coefficients for these two comparisons were 0.61 
and 0.57 respectively. 
 
Figures 6.7 and 6.8 below show two further scatterplots for the comparisons of project staff 
screening results with the doctor’s screening results.  The difference between the number of adverse 
events found is plotted against the mean of the two values.   
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Figure 6.7  Scatter plot of difference in number of adverse events on first project staff screening  
and doctor’s screening plotted against mean number of adverse events for interrater study in 
obstetrics. 
 
 
Figure 6.8.  Scatter plot of difference in number of adverse events on second project staff screening  
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and doctor’s screening plotted against mean number of adverse events for interrater study in 
obstetrics. 
 
These plots both show a far less consistent and reliable agreement between the two screenings than 
was seen in figures 6.2 and 6.4 for the studies in ENT and ophthalmology.  The mean differences 
are 0.69 and 0.20 respectively, suggesting that some systematic bias may exist, with the doctor 
identifying more adverse events than the member of project staff.   The estimated limits of 
agreement, within which 95% of all differences should fall, are also wider than those found in ENT 
and ophthalmology: -1.56 to 2.94 for the comparison of first project staff screening and doctor’s 
screening (95% confidence intervals -1.94 to -1.18 and 2.56 to 3.32), and -2.27 to 2.67 for the 
second project staff/doctor’ screening comparison (95% confidence intervals -2.68 to -1.88 and 2.26 
to 3.08).   
 
Intrarater reliability in obstetrics 
A total of 110 patient admissions were screened twice by a single member of the project staff.  The 
first screening and second screening were separated by about 4 months, a period judged sufficient 
for the member of staff concerned, who was concurrently involved in screening in several other 
specialties, to recollect any details of the cases or the results of the first screening when screening 
them for the second time.   The results are presented in table 6.8 below.  For each screening 
criterion, the table shows how many patient admissions were recorded as no adverse event (N-N) on 
both the first and second screening; as adverse event on first screening but not on second (V-N); as 
adverse event on second screening but not on first (N-V); or as adverse event on both screenings (V-
V).  It also gives the crude percentage agreement and the value and significance of Ρ. 
  
 
 
257
 
Crit 
no 
Criterion title N-N N-V V-N V-V Agree
ment 
(%) 
Ρ Significance 
of Ρ 
1 Management of SROM 97 6 2 5 92 0.52 < 0.001 
2 Elective induction of labour 97 0 3 10 97 0.85 < 0.001 
3 Problems of labour/delivery 98 9 1 2 91 0.25 < 0.001 
4 Caesarean section 90 1 0 19 99 0.96 < 0.001 
5 Problems of Caesarean section 106 1 2 1 97 0.39 < 0.001 
6 Perinatal 
problems/complications 
105 2 3 0 95 -0.02 - 
7 Post-natal 
problems/complications 
99 7 0 4 94 0.51 < 0.001 
8 Drug-related problems 107 2 0 1 98 0.49 < 0.001 
9 Mother/family dissatisfaction 110 0 0 0 100 - - 
10 Non-clinical prob/incidents 77 14 3 16 84 0.56 < 0.001 
11 Obstetric record review 69 28 6 7 69 0.14 - 
12 Prob of anaesthesia 110 0 0 0 100 - - 
13 Prob of pain relief 94 5 3 8 93 0.63 < 0.001 
14 All criteria 1259 75 23 73 93 0.56 < 0.001 
 
Table 6.8.  Agreement statistics by criterion for intrarater study in obstetrics. 
 
For the 12 criteria for which Ρ could be calculated, values varied from -0.02 to 0.96.  Using the 
benchmarks set out in table 6.3, 3 criteria are placed in the “good” or “very good” agreement 
categories, 7 in the “fair” or “moderate” categories and 2 in the “poor” agreement category.  For the 
measure as a whole, the Ρ value was 0.56, suggesting moderately good agreement. 
 
Figure 6.9 below presents a scatterplot of the total number of adverse events found on first and 
second screening for the sample of 110 patient admissions, each admission being represented as a 
data point on the graph with “sunflowers” used to show where multiple data points overlap.  
Overall, in 46.8% of cases the same number of adverse events were found on first and second 
screenings, and in 87.3% of cases the number of adverse events found was within a range of ±1 
adverse event.  The Pearson correlation coefficient was 0.70, though once again the limited value of 
this statistic should be noted.    
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Figure 6.9.  Scatter plot of number of adverse events found on first and second screening 
for intrarater study in obstetrics. 
 
 
Figure 6.10.  Difference in number of adverse events on first and second screening plotted against 
mean number of adverse events on first and second screening for intrarater study in obstetrics. 
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Figure 6.10 presents a second scatterplot, of the difference in the number of adverse events found on 
first and second screening against the mean of the two values.   Agreement is moderately good, 
though some systematic bias is visually evident, with a tendency for the second screening to find 
more adverse events than the first.  Indeed, the mean numerical difference between first and second 
screening was 0.48. 
 
The estimated limits of agreement, which contain 95% of all differences, are -0.88 to 2.32 (with 
95% confidence intervals of -1.19 to -0.57 and 2.01 to 2.63 respectively).    In other words, we could 
expect that in 95% of cases the difference between the first and second screening would be in the 
range -0.88 to 2.32. 
 
Summary of results of interrater and intrarater studies 
The series of tables and figures presented above provide a detailed but complex account of the levels 
of agreement found in a number of different but related studies.   In order to draw some general 
conclusions about the reliability of the adverse-event measures tested , table 6.9 presents a summary 
of the results from all the studies, in a form which supports the making of comparisons across them.    
For each study, the table lists some basic information about the study (cross-referenced to table 6.1 
which described the studies in more detail); the levels of agreement found for criteria within the 
adverse-event measures being tested, using the  statistic; and the level of agreement on overall 
adverse-event scores using the Pearson correlation coefficient and estimated limits of agreement. 
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Study (see table 6.1 for further details) 
 
A B C D E 
Specialty ENT Ophthal-
mology 
Obstetrics Obstetrics Obstetrics 
Reliability testing undertaken 
 
Interrater Interrater Interrater Interrater Intrarater 
No of patient admissions in sample 
 
146 120 108 110 110 
Overall Ρ statistic 
 
0.65 0.63 0.46 0.45 0.56 
Proportion of criteria with “good” or 
“very good” agreement (Ρ > 0.60) 
5/12 5/12 3/12 4/12 3/12 
Proportion of criteria with “poor” 
agreement (Ρ ? 0.20) 
1/12 2/12 2/12 2/12 2/12 
Pearsons correlation coefficient for 
adverse event scores 
0.66 0.57 0.61 0.57 0.70 
Mean numerical difference between 
adverse event scores 
0.01 -0.16 0.69 0.20 0.48 
Proportion of cases where adverse event 
scores agree 
51.4 55.2 35.9 29.9 46.8 
Proportion of cases where adverse event 
scores within range of ±1 adverse event 
89.9 92.8 70.1 71.0 87.3 
Estimated limits of agreement -1.83 to 
1.81 
-1.79 to 
1.47 
-1.56 to 
2.94 
-2.27 to 
2.67 
-0.88 to 
2.32 
Worst case limits of agreement based on 
outer 95% confidence intervals 
-2.09 to 
2.07 
-2.04 to 
1.72 
-1.94 to 
3.32 
-2.68 to 
3.08 
-1.19 to 
2.63 
 
Table 6.9.  Summary of results from studies of interrater and intrarater reliability  
of adverse-event measures of quality 
 
The findings summarised in table 6.9 in part confirm the results of previous studies of the reliability 
of adverse-event measures of quality, reviewed in chapter 3, though a more complex and detailed 
picture of the reliability of these measures also emerges.    Taken together, they suggest that the 
measures tested are of moderate to good reliability, though there is undoubted scope for 
improvement.   The overall  Ρ agreement statistic ranged from 0.45 to 0.65, and in each of the 
studies there were only one or two criteria within the adverse-event measures tested for which 
agreement was poor (Ρ ? 0.20).  The low incidence rates for some adverse events prevented the 
calculation of Ρ for some criteria, and for all the adverse-event measures tested will have 
constrained the value that  Ρ might reach, perhaps understating the reliability of the measures. 
 
The best reliability results were obtained in interrater tests in ENT and ophthalmology, followed by 
the intrarater test in obstetrics.  The least good reliability results were found in the interrater studies 
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in obstetrics.   It seems likely that both the definition of the adverse-event measures used and the 
way they were applied will have affected these results.  It might be argued that the generally lower 
reliability found for the obstetric adverse-event measure suggests it was less well designed and 
specified than the largely generic adverse-event measure used in ENT and ophthalmology.  It could 
also be said that the low reliability found in the two interrater studies in which a doctor undertook 
one of the screenings suggests that different raters, with different clinical backgrounds and training 
programmes may produce very different results with obvious adverse consequences for the 
reliability of measurement.   We might attribute the differences found to the brevity and implied 
inadequacy of the doctor’s training to undertaking the task (compared with the extensive experience 
of the member of project staff who undertook the other screening).  However, it could also be true 
that the doctor’s more extensive clinical knowledge and experience enabled him to identify adverse 
events which the member of project staff would overlook.    
 
Overall, the reliability statistics for the five studies were broadly in line with each other, suggesting 
that the reliability of these adverse-event measures may not vary much from specialty to specialty, 
and so these results could be extrapolated with caution to other specialties. 
 
It was interesting to note that in the single intrarater reliability study in obstetrics, the second 
screening by the member of project staff yielded more adverse events on average than the first. 
Because the study was organised retrospectively, the first set of screening data was collected as part 
of the routine working of the RSCH project, with no foreknowledge that those cases would be 
subject to this reliability study.    However, the second set of data was collected by the member of 
project staff in the knowledge that the reliability of the measure, and her application of it, was being 
examined.  When the two were compared, the second screening data contained more adverse events 
than the first screening data.   This provides some evidence to support the contention that the 
awareness of reliability testing in studies such as these may change rater behaviour (perhaps making 
them more careful and thorough, and so causing them to find more adverse events), and so affect the 
estimates of reliability that are obtained.    It illustrates the value of observational studies of 
reliability, which make use of routine data, such as those presented later in this chapter. 
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6.2.4 Conclusions 
These studies indicate that the adverse-event measures tested were of moderate to good reliability, 
in the settings in which they were examined.   Whether they are sufficiently reliable, depends on the 
purpose to which they are to be put, and the degree of error or variation which can be tolerated.  
While this judgement is inevitably subjective, two points should be borne in mind.  Firstly, these 
measures are generally intended to be used across groups of patients, to identify deficiencies in the 
quality of care, rather than to make decisions about individual patients.  The presence of some 
random variation, which might make the latter difficult, need not be as great a concern in the former, 
since the statistical importance of that variation will diminish as the group size grows.   Secondly, 
the reliability of these measures must be set alongside the reliability of other approaches to assessing 
the quality of care.   It was noted in chapter 2 that the definitional difficulties of quality 
measurement, and the practitioner-led tradition of development in quality measurement  had left 
many quality measures poorly defined, researched and validated.   In this context, the moderately 
good reliability of these adverse-event measures may be viewed quite positively. 
 
It is clear from these studies that the reliability of adverse event measures of quality can be 
improved, by adjusting their definitions and by paying greater attention to rater training.   The wide 
range of reliability statistics for individual criteria within the measures suggest that some criteria 
definitions needed to be revised, or removed from the measures.   While the impact of changes to 
the criteria which make up the adverse event measures on the validity of those measures should be 
taken into account, there is certainly potential to maximise reliability by paying particular attention 
to those areas where low levels of agreement were found.   It may be possible to make the 
definitions clearer and less ambiguous, and so to improve reliability.   These studies also highlight 
the important contribution that raters’ backgrounds, existing knowledge, and training are likely to 
make to the reliability of data collected using an adverse-event measure.  The use of a doctor, with 
significantly greater clinical knowledge and skills but significantly less training and experience in 
abstracting data on adverse events from patients’ records, resulted in rather poor reliability results. 
 
Given that the reliability of adverse-event measures of quality seems to vary from setting to setting, 
and to be influenced by many factors apart from the construction and definition of the measures 
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themselves, there is a strong argument for incorporating ongoing reliability testing into any routine 
use of such measures.   In other words, while research studies such as these may be helpful in testing 
the reliability of adverse-event measures of quality and providing some insight into the factors 
which contribute towards a high level of reliability, it may be unwise to rely upon them for 
assurance that in practice, the use of these measures will be reliable.   It may be advisable to 
undertake periodic sampled rescreening in order to monitor reliability, and to use mechanisms like 
regular workshops, case presentations and refresher training among raters to maintain reliability. 
 
 
6.3 Analysis of interrater variation in the RSCH project data 
 
6.3.1 Aims of study of interrater variation 
 
The aim of the study reported in this section was to assess the reliability of a number of adverse-
event measures of quality by examining the data collected through the RSCH occurrence screening 
project, which was outlined in chapter 3.     The data set produced by that project, which was 
available for analysis in this study, was described in section 5.2.2 
 
In that project, 14,815 patient admissions in 12 specialties were screened using a number of different 
adverse-event measures. Each patient admission was screened once, by one of four members of the 
project staff.  This study set out to examine the data from screening, and to identify any differences 
in the numbers and types of adverse events recorded during screening which might be attributable to 
screener variation. 
 
6.3.2 Method 
 
The data set available for study from the RSCH occurrence screening project has already been 
described in chapter 5.   During the life of the project between February 1990 and April 1992, 
14,815 patient admissions were screened by four members of the project staff.   These staff were all 
qualified nurses, and had all undergone a training programme in using the adverse-event measures 
employed in the project.   The data was collected using a purpose designed computer database, 
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which automatically recorded the identity of the member of staff who screened each patient 
admission.  However, this automatic recording was only introduced part way through the project, 
around January 1991.   As a result, of the 14,815 patient admissions screened during the project, 
only 6,708 admissions had the identity of the screener recorded and were therefore suitable for 
analysis in this study.     These 6,708 admissions were spread across 12 specialties, but were not 
distributed evenly.  In some specialties there were small numbers of cases, which could not support 
a meaningful statistical comparison of adverse-event rates between screeners, and so analysis was 
restricted to those specialties in which a sample of at least 400 patient admissions was available for 
study.  An overview of the resulting data set of 6,095 admissions in 8 specialties is presented in table 
6.10, which shows the numbers of patient admissions screened by each member of project staff, 
analysed by specialty. 
 
Specialty Member of project staff 
 
All  
staff 
 A 
 
B 
 
C 
 
D 
 
 
 
 
 
No % No % No % No % No % 
Accident and emergency 
 
37 5.9 84 13.3 237 37.6 273 43.3 631 10.4 
ENT 
 
- - 116 14.5 239 29.9 445 55.6 800 13.1 
Gynaecology 
 
8 1.4 68 12.0 191 33.8 298 52.7 565 9.3 
Obstetrics 
 
151 10.6 10.0 41.8 597 41.8 537 37.6 1428 23.4 
Ophthalmology 
 
36 3.5 33 3.2 346 33.5 619 59.9 1034 17.0 
General surgery 
 
- - 73 13.3 235 42.8 241 43.9 549 9.0 
Trauma and orthopaedics 
 
95 14.7 12 1.9 324 50.2 215 33.3 646 10.6 
Urology 
 
31 7.0 45 10.2 181 41.0 185 41.9 442 7.3 
All specialties 
 
358 5.9 574 9.4 2350 38.6 2813 46.2 6095 100 
 
Table 6.10.  Numbers of patient admissions screened by project staff, analysed by specialty. 
 
Table 6.10 shows that the screening workload was not distributed evenly across the four project staff 
involved in screening during the life of the project (referred to as A, B, C and D in the table), with 
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each screening about a quarter of the patient admissions as might be expected.  One member of staff  
(B) was part-time, and another member of staff (A) left the project part way through the period 
being studied, and this in part accounts for the variations evident in table 6.10 which shows, for 
example, that screener D screened almost four times as many patient admissions as screener B.  
However, regardless of these differences in overall workload, some substantial and significant 
variations in the distribution of cases between screeners are also evident from specialty to specialty 
(for table 6.10, χ2 = 544.5, p < 0.0001).   For example, screener B, who screened 9.4% of all patient 
admissions, screened only 1.9% of patient admissions in trauma and orthopaedics.  Screener A, who 
screened 5.9% of cases overall was responsible for screening 10.6% of cases in obstetrics.   In part, 
some of these variations result from an interaction between the timing of staff changes and the dates 
at which screening commenced or ceased in various specialties.   However, they probably also 
reflect the project staff’s working practices.   Though the project staff were in theory all allocated to 
work in all specialties, in fact some degree of specialisation developed, with some screeners taking 
the lead in particular specialties.   The non-random distribution of patient admissions across the four 
members of project staff which resulted should be borne in mind in the analysis of interrater 
variations which follows, since it could have introduced biases which would affect those findings. 
 
In order to examine the variation in the numbers and types of adverse events recorded by screeners, 
a number of bivariate and multivariate analyses were performed.   Firstly, the variation in the overall 
adverse event rate (the number of adverse events found on screening each patient admission) 
between different members of project staff was assessed for each specialty, using both parametric 
and non-parametric techniques (the one way analysis of variance and the Kruskal Wallis analysis of 
variance by ranks, and Kendall’s coefficient of concordance).  Secondly, the variation in rates of 
different types of adverse events (recorded for different criteria within the adverse-event measure) 
was examined in two specialties - ophthalmology and ENT - by comparing the event rates recorded 
by different project staff for each screening criterion in the adverse event measure used in those 
specialties.   For each criterion in the measure, χ2 tests were used to establish whether adverse event 
rates varied significantly among screeners, and standardised adjusted residuals were used to identify 
where these differences occurred.   Thirdly, multiple regression was used to identify whether linear 
relationships existed between the overall numbers of adverse events recorded for patient admissions 
and a number of other variables including patient demographics, length of stay and the identity of 
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the project staff involved in screening.   The proportion of variation in the numbers of adverse 
events which could be attributed to differences between project staff was calculated.  Each of these 
statistical approaches is described in more detail in the following sections.  In some cases, these 
techniques have already been described and used in chapters 4 or 5. 
 
6.3.3 Results and discussion 
 
Variation in the overall number of adverse events found by members of project staff 
Firstly, the sample of 6,095 patient admissions in 8 specialties described above was used to calculate 
the mean numbers of adverse events found per patient admission screened by the four members of 
the project staff (designated, as before, as A, B, C and D) in each specialty.    The results are 
presented in table 6.11.    Two statistical techniques were used to test whether the differences in 
numbers of adverse events found by members of the project staff were statistically significant - the 
parametric one way analysis of variance (ANOVA) and the non-parametric Kruskal-Wallis analysis 
of variance by ranks.  Both approaches were used because the data did not conform to the 
parametric assumptions underlying the ANOVA test, but this technique has greater power to detect 
statistically significant differences. The ANOVA test was able to identify which differences 
between members of project staff were significant (using the Scheffé method for multiple pairwise 
comparisons). The results of these statistical tests are also presented in table 6.11. 
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Specialty Screener No of 
cases 
Mean 
number 
of 
adverse 
events 
found 
95% 
confidence 
intervals for 
mean 
 
Significant 
differences 
(Scheffé 
method) 
One way 
ANOVA 
p-value 
Kruskal-
Wallis 
analysis of 
variance 
p-value 
Accident and A 37 0.45 0.27 - 0.64    
emergency B 84 0.43 0.28 - 0.58    
 C 237 0.31 0.25 - 0.38    
 D 273 0.55 0.46 - 0.63    
 All 631 0.44 0.39 - 0.49 C&D < 0.001 < 0.001 
ENT A - - -    
 B 116 0.78 0.63 -0.94    
 C 239 0.81 0.69 - 0.93    
 D 445 1.40 1.30 - 1.50    
 All 800 1.13 1.06 - 1.20 B&D, C&D < 0.001 < 0.001 
Gynaecology A 8 1.88 0.30 - 3.45    
 B 68 0.74 0.50 - 0.97    
 C 191 0.76 0.66 - 0.86    
 D 298 0.98 0.88 - 1.08 A&B, A&C,   
 All 565 0.89 0.82 - 0.96 A&D < 0.001 0.004 
Obstetrics A 151 1.05 0.84 - 1.26    
 B 143 0.90 0.73 - 1.08    
 C 597 0.71 0.64 - 0.78    
 D 537 0.97 0.88 - 1.06    
 All 1428 0.86 0.81 - 0.92 A&C, D&C < 0.001 0.001 
Ophthalmology A 36 0.28 0.12 - 0.43    
 B 33 0.70 0.41 - 0.98    
 C 346 0.42 0.36 - 0.49    
 D 619 0.52 0.46 - 0.58    
 All 1034 0.49 0.44 - 0.53 None 0.023 0.044 
General surgery A - - -    
 B 73 1.33 1.01 - 1.65    
 C 235 1.14 0.97 - 1.32    
 D 241 1.30 1.14 - 1.46    
 All 549 1.24 1.13- 1.35 None 0.369 0.088 
Trauma and A 95 1.34 1.07 - 1.60    
orthopaedics B 12 1.00 0.62 - 1.38    
 C 324 0.53 0.45 - 0.61    
 D 215 1.05 0.92 - 1.18    
 All 646 0.83 0.74 - 0.90 A&C, D&C < 0.001 < 0.001 
Urology A 31 1.26 0.89 - 1.62    
 B 45 0.71 0.47 - 0.95    
 C 181 0.57 0.47 - 0.67    
 D 185 0.67 0.56 - 0.78 A&B, A&C,   
 All 442 0.67 0.60 - 0.75 A&D < 0.001 0.001 
 
Table 6.11.  Comparison of numbers of adverse events found  
analysed by project staff and by specialty 
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In six of the eight specialties investigated, there were significant differences in the numbers of 
adverse events recorded by different members of the project staff, according to both the ANOVA 
and Kruskal Wallis tests.  In one specialty - ophthalmology - there were differences of borderline  
significance, and only in general surgery were no significant differences found.   Of course, the 
statistical significance of the differences in numbers of adverse events found is a product of both the 
actual size of the differences and the sample size in each specialty, and it is important to recognise 
that some statistically significant differences may be of limited operational significance.  For 
example, in accident and emergency the mean number of adverse events found by the project staff 
ranged from 0.31 to 0.55, and the differences though statistically significant may not be particularly 
important. 
 
It can also be seen from table 6.11 that some of the more extreme values, where one member of 
project staff was significantly out of step with his or her colleagues, occurred in areas where the 
person concerned had only screened a small number of patient admissions.   For example, in 
gynaecology, staff member A’s results are very different from his/her colleagues, but this member 
of staff only screened 8 patient admissions in this specialty.  It might be argued that in these cases, 
the member of project staff was still learning to use the adverse event measure in the specialty 
concerned, and this might have adversely affected the reliability of screening.   Incidentally, it can 
be seen from table 6.11 that although the 95% confidence intervals for A, B, C and D overlap, the 
Scheffé method finds significant differences (at the p < 0.05 level) between A&B, A&C, and A&D. 
The fact that the F statistic from the one way ANOVA test is highly significant (p < 0.001) means 
that one or more of the pairwise comparisons must be significant (Hays 1994, p458).  This apparent 
inconsistency can be attributed to the formula for calculating confidence intervals performing poorly 
with small samples such as this, where screener A had only screened 8 cases (Hays 1994, p223). 
 
There are specialties where statistically and operationally significant differences exist in the number 
of adverse events found which, although they might result from a number of other causes apart from 
screener variation, should give some cause for concern.  For example, in ENT the bulk of patient 
admissions were screened by project staff C and D, yet D recorded on average 73% more adverse 
events per patient admission than C. 
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It is apparent from table 6.11 that in a number of specialties, significant variations exist in the 
number of adverse events found by different members of the project staff.  These variations could 
represent differences in interpretation of the adverse-event measure; different levels of skill, 
expertise or clinical knowledge; or differences in practices (such as the use made of various parts of 
the clinical record).  However, they could also be an artefact, resulting from the non-random 
distribution of cases for screening across members of project staff described earlier or from other 
known or unknown confounding variables.   
 
One way to explore these variations further is to compare the variations in different specialties, in 
order to identify whether any systematic biases existed, with, for example, one member of project 
staff consistently finding more adverse events or fewer adverse events than his or her colleagues 
across a number of specialties.  To this end, table 6.12 presents the ranked performance of each 
member of project staff across all specialties.    In each specialty the four members of project staff 
have been ranked in order of the mean number of adverse events found per patient admission, with 
the highest number ranked 1 and the lowest number ranked 4.  In two specialties, only three of the 
staff were involved in screening and so they are ranked from 1 to 3.   The table also shows the mean 
rank for each member of the project staff. 
 
Specialty Project staff - ranked by mean no of adverse events  
(1 = highest mean; 4 = lowest mean) 
 A B C D 
Accident and emergency 2 3 4 1 
ENT - 3 2 1 
Gynaecology 1 4 3 2 
Obstetrics 1 3 4 2 
Ophthalmology 4 1 3 2 
General surgery - 1 3 2 
Trauma and orthopaedics 1 3 4 2 
Urology 1 2 4 3 
Mean rank across specialties 1.67 2.50 3.38 1.88 
 
Table 6.12.  Project staff ranked by mean number of adverse events found  
per patient admission, analysed by specialty. 
 
It is almost self-evident from the table that some systematic bias exists.   For example, D had the 
highest or second highest mean number of adverse events in all but one specialty, and an average 
ranking of 1.88, while C had the lowest or second lowest mean number of adverse events in all but 
  
 
 
270
one specialty, and an average ranking of 3.38.   The rankings of the four members of project staff in 
the eight specialties were used to calculate Kendall’s coefficient of concordance, W, which is a 
commonly used as a measure of the degree of agreement among a number of raters but in this case 
serves as a measure of the tendency for project staff to have consistently higher or lower rankings 
across specialties (Siegel and Castellan 1988, p270).    The W statistic ranges from 0 (indicating no 
agreement or consistent pattern of ranking) to 1 (indicating complete agreement or absolutely 
consistent rankings).   For the data in table 6.12, W = 0.33 (showing significant levels of agreement 
or consistency in rankings, p < 0.05) which suggests that there is some statistically significant 
pattern in the rankings, with some project staff consistently being ranked higher than others.  In 
other words, the visual impression from table 6.12 that staff members A and D tended, across all 
specialties, to find more adverse events than B and C is statistically confirmed. 
 
Variation in rates of adverse events found by project staff in ophthalmology and ENT 
It has already been noted earlier in this chapter that the summary score of the number of adverse 
events per patient admission can conceal important variations in the application of the adverse-event 
measure, since two sets of quite different circumstances and events can produce the same summary 
score.  In order to explore whether differences existed in the way that the project staff used these 
measures, a further analysis was undertaken of the data from two specialties - ophthalmology and 
ENT.  The incidence of adverse events was calculated separately for each criterion within the 
adverse-event measures used in these specialties, for each member of project staff, and compared 
using χ2 tests to establish whether significant differences existed.   The use of these tests, and of 
standardised adjusted residuals to identify the sources of significant variations, was discussed in 
chapter 5. 
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  Adverse event incidence rates (%) and standardised 
adjusted residuals (in square brackets) by member 
of project staff 
 
 χ2 statistic 
  A B C D All  
P value 
1 Adm for adv results o/p mgt 0.0 
[-0.4] 
0.0 
[-0.4] 
0.6 
[0.7] 
0.3 
[0.4] 
0.4 0.883 
2 Readmission for comp prev adm 8.3 
[2.5] 
3.0 
[0.3] 
2.6 
[0.6] 
1.6 
[-1.6] 
2.2 
 
0.056 
3 Error in operative consent 2.8 
[1.8] 
0.0 
[-0.4] 
0.6 
[0.0] 
0.5 
[-0.5] 
0.6 0.347 
4 Unpl rem/inj/repair in surg 2.8 
[-0.8] 
3.0 
[-0.7] 
7.8 
[2.1] 
4.9 
[-1.4] 
5.7 0.198 
5 Unpl return to theatre 0.0 
[-0.7] 
0.0 
[-0.6] 
0.9 
[-0.6] 
1.5 
[1.1] 
1.2 0.673 
6 Path/hist varies from diag 0.0 
 
0.0 
 
0.0 
 
0.0 
 
0.0 - 
7 Prob of transfusion 0.0 
 
0.0 0.0 0.0 0.0 - 
8 Hosp acquired infection 0.0 
[-0.3] 
0.0 
[-0.3] 
0.3 
[0.0] 
0.3 
[0.2] 
0.3 0.974 
9 Medication error/reaction 0.0 
[-0.7] 
0.0 
[-0.7] 
1.7 
[0.7] 
1.3 
[-0.2] 
1.4 0.720 
10 Cardiac/resp arrest in hosp 0.0 
 
0.0 0.0 0.0 0.0 - 
11 CVA/MI/PE in hosp after surg 0.0 
0.0 
0.0 0.0 0.0 0.0 - 
12 Unexp transfer to spec care 0.0 
[-0.3] 
0.0 
[-0.3] 
0.0 
[-1.0] 
0.3 
[1.2] 
0.2 0.718 
13 Pt related clinical complcn 0.0 
[-0.2] 
0.0 
[-0.2] 
0.0 
[-0.7] 
0.2 
[0.8] 
0.1 0.880 
14 Non-clin problem/incident 0.0 
[-1.0] 
9.1 
[2.5] 
1.2 
[-1.9] 
2.9 
[1.3] 
2.4 0.018 
15 Neuro deficit devel in hosp 0.0 
 
0.0 0.0 0.0 0.0 - 
16 Unexp patient death 0.0 
 
0.0 0.0 0.0 0.0 - 
17 Medical record deficiency 2.8 
[-1.5] 
21.2 
[2.1] 
6.1 
[-3.2] 
12.6 
[2.9] 
10.3 0.001 
18 Nursing record deficiency 0.0 
 
0.0 0.0 0.0 0.0 - 
19 Pt/family dissatisfaction 0.0 
[-0.9] 
0.0 
[-0.9] 
2.6 
[0.7] 
2.1 
[-0.1] 
2.1 0.599 
20 Discharge related problems 0.0 
[-0.4] 
0.0 
[-0.4] 
0.9 
[1.3] 
0.3 
[-0.9] 
0.5 0.633 
OP
1 
Probs related to cataract 
extraction 
2.8 
[0.3] 
9.1 
[1.7] 
4.0 
[0.6] 
3.1 
[-1.1] 
3.6 0.303 
OP
2 
Specific ophthalmic comps 0.0 
[-1.6] 
3.0 
[-0.9] 
7.2 
[0.4] 
7.1 
[0.5] 
6.8 0.311 
OP
3 
Ophthalmic proc with tissue 
biopsy 
0.0 
[-0.3] 
0.0 
[-0.3] 
0.3 
[0.5] 
0.2 
[-0.3] 
0.2 0.954 
OP
4 
Ophthalmic problems indic by 
specific drug usage 
2.8 
[0.5] 
3.0 
[0.6] 
0.6 
[-1.9] 
2.1 
[1.4] 
1.6 0.271 
OP
5 
Oph nursing record review 5.6 
[-0.4] 
12.1 
[1.1] 
3.8 
[-3.1] 
9.1 
[2.7] 
7.3 0.014 
 
Table 6.13.  Variation in adverse event incidence rates in ophthalmology  
analysed by member of project staff. 
 
Table 6.13 above shows the results of this analysis for ophthalmology.   There were a total of 1,034 
patient admissions in this specialty in the sample of 6,095 admissions described earlier. For each 
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screening criterion, the table shows the adverse event incidence rates - effectively the proportion of 
cases screened in which an adverse event was found under  that screening criterion.  Given that the 
number of adverse events found under a given criterion is always 0 or 1, this rate can also be 
interpreted as the mean number of adverse events per case (in other words, an incidence rate of 10% 
is the same as a mean number of events of 0.1).  Incidence rates are presented rather than mean 
numbers of events for reasons of convenience, because the incidence of events for individual criteria 
is low, and a rate of 0.2% is easier to read than a mean of 0.002.  The adverse event incidence rates 
are presented both for each member of project staff and for all staff.    The table also shows the 
results of the χ2 test performed on the numbers of adverse events found to show whether the 
differences in the incidence of adverse events for each criterion among members of project staff are 
significant.    
 
Where a significant difference was found, the standardised adjusted residuals (given in square 
brackets) can be used to help identify which members of project staff were the source of that 
significant difference.  The standardised adjusted residuals are approximately normally distributed 
with a mean of 0 and standard deviation of 1.0, so residuals of ±2.58 are significant at the 0.01 level 
(Everitt 1992, p47).   Testing significance at the relatively conservative 0.01 level is advisable, given 
the repeated use of these tests in the analysis. 
 
In interpreting table 6.13, it should be borne in mind that many of the cells in the crosstabulations 
used in χ2 tests had very low expected frequencies, which may cause the significance of any 
differences to be underestimated (Everitt 1992, p39).  However, it can be seen that significant 
variations in the adverse event incidence rates detected by different members of the project staff 
were only found for one of the 25 criteria listed in the table (at p < 0.01).   For only four criteria did 
one or more of the standardised adjusted residuals reach or exceed  ±2.5 (remembering that the 0.01 
significance level is ±2.58), and it is interesting to note that in each case a different member of 
project staff was involved.   Overall, the results presented earlier in table 6.11, which suggested that 
the numbers of adverse events found by different project staff in ophthalmology did not differ 
significantly, are confirmed and supported by this analysis of data for individual screening criteria 
within the adverse-event measure used in ophthalmology. 
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  Adverse event incidence rates (%) and 
standardised adjusted residuals (in square 
brackets) by member of project staff 
 
χ2 statistic 
  B C D All  
P value 
1 Adm for adv results o/p mgt 0.9 
[-0.8] 
1.7 
[-0.1] 
2.0 
[0.7] 
1.8 0.693 
2 Readmission for comp prev adm 1.7 
[-1.5] 
5.4 
[1.1] 
4.3 
[0.0] 
4.3 0.266 
3 Error in operative consent 3.4 
[0.6] 
4.2 
[1.8] 
1.6 
[2.1] 
2.6 0.105 
4 Unpl rem/inj/repair in surg 0.0 
[-1.4] 
2.1 
[0.9] 
1.6 
[0.2] 
1.5 0.309 
5 Unpl return to theatre 0.0 
[-0.4] 
0.0 
[-0.7] 
0.2 
[0.9] 
0.1 0.671 
6 Path/hist varies from diag 0.9 
[2.4] 
0.0 
[-0.7] 
0.0 
[-1.1] 
0.1 0.052 
7 Prob of transfusion 0.9 
[2.4] 
0.0 
[-0.7] 
0.0 
[-1.1] 
0.1 0.052 
8 Hosp acquired infection 0.0 
[-0.6] 
0.4 
[-0.6] 
0.2 
[-0.2] 
0.3 0.751 
9 Medication error/reaction 1.7 
[-0.3] 
3.8 
[2.1] 
1.3 
[-1.7] 
2.1 0.107 
10 Cardiac/resp arrest in hosp 0.0 
 
0.0 0.0 0.0 - 
11 CVA/MI/PE in hosp after surg 0.0 
 
0.0 0.0 0.0 - 
12 Unexp transfer to spec care 0.0 
[-0.4] 
0.4 
[1.5] 
0.0 
[-1.1] 
0.1 0.309 
13 Pt related clinical complcn 1.7 
[0.8] 
2.1 
[2.0] 
0.2 
[-2.5] 
1.0 0.045 
14 Non-clin problem/incident 6.9 
[0.2] 
7.5 
[0.9] 
5.6 
[-1.0] 
6.4 0.602 
15 Neuro deficit devel in hosp 0.0 
 
0.0 0.0 0.0 - 
16 Unexp patient death 0.0 
 
0.0 0.0 0.0 - 
17 Medical record deficiency 14.7 
[-1.2] 
16.3 
[-1.0] 
20.7 
[1.8] 
18.5 0.193 
18 Nursing record deficiency 24.1 
[-4.5] 
16.7 
[-9.8] 
62.2 
[12.2] 
43.1 < 0.001 
19 Pt/family dissatisfaction 1.7 
[0.3] 
1.3 
[-0.2] 
1.3 
[-0.1] 
1.4 0.936 
20 Discharge related problems 0.0 
[-1.2] 
0.4 
[-1.1] 
1.6 
[1.8] 
1.0 0.177 
ENT 
1 
Early adm for elective proc 0.0 
 
0.0 0.0 0.0 - 
ENT 
2 
Problems in pre-op period 14.7 
[-0.5] 
13.4 
[-1.5] 
18.4 
[1.8] 
16.4 0.204 
ENT 
3 
Problems with theatre 
equipment/supplies 
0.0 
[-0.6] 
0.4 
[0.6] 
0.2 
[-0.2] 
0.3 0.751 
ENT 
4 
Missing/incomplete ENT 
records 
5.2 
[-2.5] 
4.6 
[-4.4] 
18.4 
[5.8] 
12.4 < 0.001 
 
Table 6.14.  Variation in adverse event incidence rates in ENT analysed by member of project staff. 
 
Table 6.14 contains a similar analysis for the 800 patient admissions in ENT that were contained in 
the sample of 6,095 admissions described earlier.  Again, it shows the adverse event incidence rates 
for each member of staff and for all staff, criterion by criterion.  It also presents the results of χ2 tests 
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and the standardised adjusted residuals.  Results are only presented for three members of project 
staff (B, C and D) since no cases in this specialty were screened by staff member A. 
 
The same cautions apply, about the conservative effect of low expected frequencies on our estimates 
of the significance of differences, as they did for table 6.13.    In this analysis, there are only two 
criteria for which significant differences exist (p < 0.01) but in both cases the differences are highly 
significant, with threefold variations in the actual incidence rates, and standardised adjusted 
residuals of as much as 12.2.   Of the remaining 22 criteria, none show significant differences (at p < 
0.01).  It will be remembered that table 6.11 showed that the summary score, the number of adverse 
events per patient admission, varied significantly across members of project staff in ENT.  This 
analysis suggests that the source of that variation may have been largely attributable to two 
screening criteria within the adverse-event measure used.  For these two criteria, reliability, for 
whatever reason, was particularly poor, but for all the other 22 criteria in the measure it seems that 
reliability was much better.   In a sense, this table highlights the risks of relying on analyses of the 
summary score, and the benefits of exploring the use of adverse-event measures criterion by 
criterion.  It seems likely that the significant variation in performance across members of the project 
staff could be reduced by making some changes to the adverse event measure, or by undertaking 
further training focused on the criteria where variations exist. 
 
Multivariate analysis of the relationship between adverse event rates, patient characteristics and 
project staff 
It was noted earlier that the bivariate analyses presented above could be affected by a number of 
known or unknown confounding variables which might lead us to ascribe variations in rates of 
adverse events to differences among project staff when in fact they resulted from other 
characteristics in the data, or might also lead us to conclude that no significant variations existed 
between project staff when in fact they did, but were suppressed by other variables.   In order to 
address these concerns, a multivariate analysis of the data set of 6,095 patient admissions described 
earlier was undertaken, with the aim of identifying the extent to which the number of adverse events 
recorded was correlated with a range of variables in the data set, and identifying the contribution to 
that correlation made by variables representing the identity of the screener.     
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Given the stated aim, it was decided, though with some reservations outlined below, that the most 
appropriate multivariate technique to use was multiple regression (Tabachnick and Fidell 1989, 
p123), with the number of adverse events as the dependent variable and a range of other variables in 
the data set as independent variables.    Multiple regression is an extension of bivariate linear 
regression, in which a number of independent variables are used to build a linear equation to predict 
the value of a dependent variable.  In this application of the technique, with the number of adverse 
events as the dependent variable and a range of other variables including the identity of the screener 
as well as other case or patient characteristics as independent variables, the predictive power of the 
overall equation was of subsidiary interest.   Since the intention was to explore the role of screener 
variation, the main focus of the analysis was the component of any correlation identified which was 
attributable to the screener variables rather than to other characteristics. 
 
Multiple regression assumes multivariate normality, linearity and homoscedasticity. It also requires 
that the variables contained in the data set are not multicollinear.  In practice, few data sets conform 
entirely to these underlying theoretical assumptions but the technique is robust enough to cope with 
some divergence (Tabachnick and Fidell 1989, p131).  However, in the RSCH data set, there were a 
number of variables which needed to be entered into the regression analysis as independent 
variables but which clearly did not conform to these assumptions.   Moreover, there was no real 
justification for expecting a linear relationship between the dependent and independent variables.  
Although data transformations were used to address some of these problems, these limitations 
should be borne in mind in interpreting the results presented below. 
 
The variables listed in table 6.15 were used as the basis of a number of  multiple regression 
analyses, with the number of adverse events as the dependent variable.  The two categorical 
variables - specialty and project staff identity - were transformed into a series of dichotomous 
variables in order to allow them to be included in the multiple regression, though this process of 
course produced a number of collinear variables which presented some difficulties in the analysis.   
Initial analyses of the data demonstrated significant skews and so logarithmic transformations were 
used on two variables - length of stay, and number of adverse events  to improve the multivariate 
normality of the data set, though plots of predicted and residual values continued to show skewness.  
The correlation matrix was examined to ensure that the data set was not multicollinear, and it was 
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confirmed that no bivariate correlation coefficient was above the suggested limit of 0.9 (Tabachnick 
and Fidell 1989, p87).    Indeed,  most correlations were below 0.2, though notable exceptions 
included the correlation between OBS and SEX (-0.40) and between OPH and ADMTYPE (0.50).  
The highest correlations were observed between the dichotomous variables constructed from the 
categorical variables for specialty and project staff identity.  For example, the correlation between 
variables C and D was 0.74. These correlations resulted in some collinearity which at times 
necessitated the exclusion of one or more variables from some analyses described below. 
 
Variable Meaning 
 
Notes 
NPOS Number of adverse events Transformed to improve normality: 
LNPOS = log10(NPOS).   Used as dependent 
variable in regression analyses. 
 
SPEC Specialty. Categorical variable, transformed to a series of 
dichotomous variables: AE, ENT, GYN, OBS, 
SURG, TAO, UROL. 
 
SEX Sex of patient (0 = female, 1 = male) - 
 
ADMTYPE Admission type (0 = elective, 1 = emergency). - 
 
LOS Length of stay (days) Transformed to improve normality: 
LLOS = log10(LOS). 
 
AGEONADM Age of patient on admission (years). - 
 
SCREENER Identity of project staff who screened patient 
admission. 
Categorical variable transformed to a series of 
dichotomous variables: A, B, C, D. 
 
 
Table 6.15.  Description of RSCH data set used in multiple regression analyses. 
 
Initially, a standard multiple regression was performed including all the variables listed in table 6.15 
and using 6,081 of the 6,095 cases in the data set (14 cases were excluded because of missing data 
on one or more of the variables).  The results are shown in table 6.16, which lists the four 
dichotomous variables representing the project staff identity (A, B, C and D) and each of the other 
independent variables included in the regression analysis and for each one shows its regression 
coefficient and standardised regression coefficient in the resulting equation; the squared semipartial 
correlation coefficient, sr2,(which is the part of R2 which is uniquely attributable to that variable) 
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and the F statistic and its significance showing whether the coefficients and sr2 are significantly 
different from zero.   
 
Variable Coefficient 
B 
Standardised 
coefficient 
ϑ 
Squared 
semipartial 
correlation 
sr2 (unique) 
F statistic Significance of F 
statistic 
A 0.016 0.018 0.0003 2.09 0.145 
B -0.040 -0.057 0.0029 20.53 < 0.001 
C -0.061 -0.143 0.0177 126.70 < 0.001 
D - - 0 - - 
AE -0.039 -0.058 0.0020 14.30 < 0.001 
ENT 0.075 0.122 0.0061 43.39 < 0.001 
GYN 0.040 0.055 0.0024 16.84 < 0.001 
OBS - - 0 - - 
SURG 0.043 0.059 0.0019 13.47 < 0.001 
TAO 0.052 0.076 0.0031 21.81 < 0.001 
UROL 0.061 0.076 0.0030 21.62 < 0.001 
SEX 0.003 0.008 0.0001 0.39 0.533 
ADMTYPE 0.020 0.046 0.0009 6.57 0.010 
LLOS 0.174 0.284 0.0539 385.08 < 0.001 
AGEONADM < 0.001 0.025 0.0003 2.44 0.119 
   0.0946   
n = 6081 R2 = 
Adjusted R2 = 
R  = 
0.151 
0.149 
0.389 
F = 
Significance of F = 
77.023 
< 0.001 
 
Table 6.16.  Standard multiple regression of all variables on log of number of adverse events, for 
patient admissions in all specialties. 
 
It can be seen that between them, all the variables in the data set were able to account for only 
14.9% of the variation in the log of numbers of adverse events, though a significant multiple 
correlation was found.  Three of the four project staff variables were included in the regression 
equation (D was excluded, because of collinearity) and two had coefficients which were statistically 
significantly different from zero.  
 
The values of sr2 represent the unique contribution of each variable to the value of the overall 
correlation coefficient R2 (or more exactly, the amount by which R2 is reduced if that variable was 
deleted from the regression equation).  If there is no correlation whatsoever between the 
independent variables in the regression equation, the values of sr2 should sum to R2 but in practice 
the sum of sr2 is usually smaller than R2.  The difference represents shared variance (contributed by 
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combinations of two or more collinear independent variables).  In some circumstances, the sum of 
sr2 can exceed R2, when R2 is small, and then the interpretation of the sum of sr2 is problematic 
(Tabachnick and Fidell 1989, p151). 
 
With the above provisos, the values of sr2  can be summed to give the proportion of variation in the 
number of adverse events which is attributable to a particular group of variables.  The Sum of sr2 for 
the project staff variables in the data set is 0.021; in comparison the sum of sr2 for specialty variables 
is 0.019, and the value of sr2 for log length of stay was 0.054.   This means that the screener 
variables contributed 2.1% of the variation in log number of adverse events, the specialty variables 
1.9%, and the log length of stay variable 5.4%.   In other words, while this regression analysis had a 
relatively low power to predict the dependent variable, the log number of adverse events, only a 
small proportion of the overall correlation found was attributable to screener variables.   Most 
resulted from the other independent variables included in the regression analysis, particularly the log 
length of stay  variable, and from the shared variance attributable to unspecified combinations of 
independent variables. 
 
 
This analysis was then repeated for each of the specialties in turn.   This permitted the eight 
dichotomous variables representing specialty to be eliminated from the multiple regression, 
improving the ratio of cases to variables and so increasing the power of the analyses to identify 
statistically significant correlations.   More practically, this step recognised that previous analyses of 
the RSCH data set (see, for example, the multiway frequency analysis in chapter 5) had found very 
different results in different specialties, and had concluded that analyses across all specialties were 
of limited value because the differences between specialties (in both the clinical content of care and 
in the adverse-event measures used) were so important.    The results of these further analyses of 
each specialty in turn are listed below in table 6.17.   Once again, because of the collinearity of the 
project staff variables A, B, C and D, one of these variables was commonly excluded from the 
regression analysis.   Since it is primarily the contribution of variables A, B, C and D to the multiple 
correlation that is of interest, table 6.17 presents the regression data for these variables and the 
overall correlation data for each analysis. 
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Specialty Variable Coefficient 
B 
Standardised 
coefficient ϑ 
Squared 
semipartial 
correlation 
sr2 (unique) 
F statistic Significance 
of F statistic 
Accident and A -0.017 -0.025 0.0006 0.371 0.543 
emergency B -0.037 -0.030 0.0051 3.262 0.071 
 C -0.060 -0.177 0.0268 17.294 < 0.001 
 D - - - - - 
n = 630 R2 = 
Adjusted R2 = 
R  = 
0.033 
0.022 
0.182 
F = 
Significance of F = 
3.048 
0.004 
ENT A      
 B -0.001 -0.002 < 0.0001 0.003 0.958 
 C - - - - - 
 D 0.133 0.309 0.0749 67.697 < 0.001 
n = 798 R2 = 
Adjusted R2 = 
R  = 
0.125 
0.118 
0.353 
F = 
Significance of F = 
18.771 
< 0.001 
Gynaecology A 0.118 0.072 0.0051 2.938 0.087 
 B -0.069 -0.116 0.0124 7.178 0.008 
 C -0.046 -0.112 0.0114 6.591 0.011 
 D - - - - - 
n = 563 R2 = 
Adjusted R2 = 
R  = 
0.037 
0.027 
0.192 
F = 
Significance of F = 
3.562 
0.002 
Obstetrics A 0.041 0.060 0.0032 5.359 0.021 
 B 0.025 0.035 0.0011 1.904 0.168 
 C - - - - - 
 D 0.047 0.106 0.0095 16.169 < 0.001 
n = 1427 R2 = 
Adjusted R2 = 
R  = 
0.165 
0.161 
0.407 
F = 
Significance of F = 
40.168 
< 0.001 
Ophthalmology A -0.059 -0.061 0.0036 3.957 0.047 
 B 0.042 0.040 0.0016 1.725 0.189 
 C -0.022 -0.058 0.0033 3.571 0.059 
 D - - - - - 
n = 1028 R2 = 
Adjusted R2 = 
R  = 
0.062 
0.056 
0.249 
F = 
Significance of F = 
9.634 
< 0.001 
General surgery A      
 B 0.061 0.091 0.0071 4.701 0.031 
 C - - - - - 
 D 0.052 0.114 0.0110 7.330 0.007 
n = 549 R2 = 
Adjusted R2 = 
R  = 
0.184 
0.175 
0.429 
F = 
Significance of F = 
20.413 
< 0.001 
Trauma and A 0.161 0.274 0.0676 54.172 < 0.001 
orthopaedics B 0.073 0.298 0.0021 1.705 0.192 
 C - - - - - 
 D 0.109 0.246 0.0539 43.230 < 0.001 
n = 645 R2 = 
Adjusted R2 = 
R  = 
0.206 
0.197 
0.453 
F = 
Significance of F = 
23.549 
< 0.001 
Urology A 0.128 0.173 0.0273 12.484 0.001 
 B 0.012 0.020 0.0003 0.154 0.695 
 C -0.024 -0.061 0.0031 1.439 0.231 
 D - - - - - 
n = 441 R2 = 
Adjusted R2 = 
R  = 
0.053 
0.037 
0.229 
F = 
Significance of F = 
3.435 
0.001 
 
Table 6.17.  Standard multiple regression of all variables on log of number of adverse events, 
undertaken for patient admissions in each specialty separately. 
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It is immediately evident from table 6.17 that none of the multiple regression analyses produced a 
model which predicted the log of the number of adverse events particularly well.  Although all of 
them returned multiple correlation coefficients that were statistically significant, the variables listed 
in table 6.15 which were included in each multiple regression analysis accounted for at most just 
under 20% of the variation in the log of the number of adverse events - and at worst, accounted for 
only 2.2% of the variation.   This finding might be viewed quite positively, since it demonstrates 
that the project staff variables were generally not responsible for more than a relatively insignificant 
variation in the adverse event score.   But it also suggests that other variables (such as length of stay 
and admission type) which were shown to be associated with variations in the adverse event score in 
chapter 5, were also not strongly associated with adverse event score in this analysis.    One 
explanation might be that the data contained in the data set, despite the transformations performed to 
reduce skew, was sufficiently outside the various assumptions of the multiple regression technique 
discussed earlier to make the results of analysis overly conservative and reduce its power.  It could 
also be argued that the relationship between adverse event score and the various independent 
variables included in the analysis has already been demonstrated in chapter 5 to be non-linear to 
some degree, and so the linear model underlying multiple regression is not appropriate.     It seems 
that given the poor predictive value of these multiple regression models, the results should be 
interpreted with some caution and set alongside the findings from various bivariate analyses already 
presented and discussed. 
 
Table 6.18 presents a rather more concise analysis of the results from the multiple regressions 
contained in table 6.17.  For each specialty it shows the proportion of variation in the log of the 
number of adverse events which the regression model was able to explain; the proportion of 
variation which could be attributed to the project staff variables alone (calculated by summing the 
(;sr2) , a process which has some limitations, described below); and the statistical significance of the 
variation attributable to each member of the project staff. 
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Specialty Proportion of 
variation 
explained by 
all variables 
 
Proportion of 
variation 
explained by 
project staff 
variables  
Significance of individual project staff variables’s 
contribution to variation 
 
(P value associated with F statistic) 
 (Adjusted R2) (;sr2) A 
 
B C D 
Accident and emergency 
 
2.2% 3.2% 0.543 0.071 < 0.001 - 
ENT 
 
11.8% 7.5% n/a 0.958 - < 0.001 
Gynaecology 
 
2.7% 2.9% 0.087 0.008 0.011 - 
Obstetrics 
 
16.1% 1.4% 0.021 0.168 - < 0.001 
Ophthalmology 
 
5.6% 0.85% 0.047 0.189 0.059 - 
General surgery 
 
17.5% 1.8% n/a 0.031 - 0.007 
Trauma and orthopaedics 
 
19.7% 12.4% < 0.001 0.192 - < 0.001 
Urology 
 
3.7% 2.9% 0.001 0.695 0.231 - 
 
Table 6.18. Summary of selected results from standard multiple regression of all variables on log of 
number of adverse events, undertaken for patient admissions in each specialty separately 
 
One anomaly immediately evident in the table is that in two specialties, accident and emergency and 
gynaecology, ;sr2  is greater than the value of adjusted R2.  It was noted above that the sum of the 
squared semipartial correlation coefficients is usually interpreted as the unique contribution of those 
variables to the multiple correlation (or, in other words, the amount by which adjusted R2 would be 
reduced if the variables were removed from the regression), but that when the value of adjusted R2 is 
very small, ;sr2  can exceed it and this interpretation is no longer appropriate (Tabachnick and Fidell 
1989, p151).  
 
The multiple regression analyses suggest that somewhere between under 1% and just over 12% of 
the variation in adverse event scores could be attributed to the project staff, but they do not provide 
an explanation for much of the rest of the observed variation. When the results in table 6.18 are 
compared with the summary of findings from bivariate analyses in the same specialties in table 6.11, 
there are a number of similarities.  In both analyses, the variations in adverse event score associated 
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with the project staff seem to be least in ophthalmology and general surgery, and greatest in trauma 
and orthopaedics and ENT. 
 
The data in table 6.18 for individual project staff is more difficult to interpret, because the 
collinearity between the four variables caused one - either C or D - to be eliminated from the 
regression analysis for each specialty.   In addition, it should be remembered that the p values 
reported in the table are in part a product of the varying numbers of cases screened by each screener 
in each specialty (see table 6.10) as well as of variations in their association with the adverse event 
score.   However, it is notable that the results broadly echo those from bivariate analyses which were 
summarised in table 6.12, showing screener B to be the least associated with any variation, while 
screener D in particular appears to be associated with variation in every specialty for which results 
are available. 
 
6.3.4 Conclusions 
 
These studies of the data collected during the RSCH project seem to suggest that significant 
variations in the results of screening were associated with the identity of the project staff 
undertaking screening.    It is not possible to identify the causes of these variations, but it might be 
argued that the non-random distribution of cases across project staff, the development of some 
degree of specialty specialisation among staff, the existence of differences in actual practice in 
screening, differences in staff members’ interpretation of the written definitions of adverse-event 
measures, and differences in staff members’ clinical knowledge and skills would all have played a 
part.     It is not possible to attribute these variations solely to differences in screener performance or 
behaviour. 
 
However, these results suggest that, for whatever reason, the reliability of these adverse-event 
measures used in a realistic clinical setting with the usual potential distractions and logistic 
problems is likely to be lower than their reliability when used in the more controlled and artificial 
setting of the interrater and intrarater reliability studies reported earlier in this chapter.   This adds 
force to the argument, already made in section 6.2.4, that the continuing use of adverse-event 
measures such as these should incorporate some form of ongoing monitoring of reliability, through 
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periodic rescreening or data analysis linked to appropriate interventions aimed at maintaining and 
improving reliability, such as workshops, case presentations and refresher training for those 
undertaking screening. 
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Chapter 7 
 
Conclusions 
 
 
 
7.1 Introduction 
 
The research reported in this thesis was undertaken in order to expand our knowledge and 
understanding of the validity and reliability of adverse-event measures of quality in healthcare, as 
the objectives set out in chapter 1 made clear.  This final chapter is intended to draw together the 
results from the research reported in chapters 4, 5 and 6 with the evidence from previous studies 
which was presented in chapter 3, and to place those findings in context in order that their 
implications for those who might want to develop or use adverse-event measures of quality in 
healthcare are explored.     
 
First, the chapter presents an overview of the key findings and conclusions from the research 
presented in chapters 4, 5 and 6, and compares those findings with those reported elsewhere.   It then 
reviews a number of issues raised by the studies, and discusses their implications, and considers 
what specific conclusions the research offers to those developing or using adverse-event measures 
of quality in healthcare.  Finally, a number of limitations concerning the research reported in this 
thesis are outlined, and an agenda for future research is then set out. 
 
7.2 Research findings, conclusions and issues raised 
 
7.2.1 The validity of adverse-event measures of quality 
 
The questionnaire and interview study undertaken to explore the face and content validity of an 
adverse-event measure of quality produced broadly concordant results, which supported the use of 
these measures in measuring the quality of healthcare.   The questionnaire study found that while a 
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few criteria within the measure being tested were not supported by respondents, and many useful 
suggestions for improvements to the measure were made, there was overall support for the validity 
of the measure, and for the practicality of using such a measure in the context of a British acute 
hospital.   The interview study largely reiterated and supported the views expressed in the 
questionnaire study about the utility of adverse-event measures, and indicated that while there were 
some concerns about the potential for bias in quality measurement if adverse-event measures were 
the only source of information, there was considerable support for the use of such measures. 
 
 In considering what reliance we are able to place on the findings from the questionnaire study, we 
should take into account the evidence that in areas where respondents’ views could be compared 
with empirical data (on the incidence of adverse events) there was good general agreement, which 
suggests that respondents’ views in other areas may be similarly valid and reliable.   While the 
questionnaire study did not set out to sample the views of a representative sample of clinicians or 
other groups with an interest in adverse-event measures of quality, it was possible to compare the 
views expressed by quite different groups of respondents - practising clinicians and public health 
physicians.  Their opinions on the validity of the adverse-event measure were generally in 
agreement, with only minor differences of opinion in a few areas, which might suggest that the 
views expressed in the questionnaire study would command broader support from other groups too.   
Finally, the interview study, though much smaller in scale, produced similar results and conclusions 
from a different research method and so lends further support to the credibility and generalisability 
of the findings on the validity of adverse-event measures of quality.  
 
Overall, the two studies described in chapter 4 offer strong support for the content and face validity 
of the adverse-event measure of quality they tested.    It was noted in chapter 3 that no other studies 
of the face and content validity of adverse-event measures of quality were identified in the literature, 
so the studies reported in chapter 4 cannot be compared with evidence from elsewhere. 
 
In chapter 5, the construct validity of some adverse-event measures of quality was assessed, using 
the data drawn from the RSCH occurrence screening project.  Six constructs were tested, of which 
three had already been tested and supported in previous studies reviewed in chapter 3.     A series of 
bivariate analyses and a multivariate analysis using loglinear or multiway frequency analysis 
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confirmed support for five of the six constructs across a number of specialties.   It was, however, 
clear that other, sometimes complex associations existed in the data set which could confound 
comparisons made using measures of quality based on adverse events.  Earlier studies reported in 
chapter 3 had already demonstrated in other settings and with other adverse-event measures of 
quality that three of the six constructs tested were supported. 
 
Most of the previous research into the validity of adverse-event measures described in chapter 3 
concerned the criterion-related validity of such measures.   It was noted that the fundamental 
problem for such studies was the identification of an appropriate and meaningful criterion variable.  
Most of the studies used some form of implicit professional review, with one or more clinicians 
making judgements about whether or not an adverse event had occurred, and if so rating its effects, 
causation and so on.   Even if the methodological flaws in a number of these studies (such as an 
absence of blinding, and the use of inappropriate measures of association to rate agreement) are 
ignored, the evidence from a number of sources that such implicit reviews have low validity and 
reliability in themselves makes it unlikely that this approach to testing validity can be relied upon.  
In this light, the evidence presented above on the face, content and construct validity of these 
measures may be given additional weight. 
 
7.2.2 The reliability of adverse-event measures of quality 
 
The experimental and observational studies undertaken to explore the reliability of adverse-event 
measures of quality produced rather more equivocal findings.     The experimental studies broadly 
indicated that the measures tested had moderate to good reliability.   The measures were certainly 
capable of improvement, since some criteria within each measure were particularly unreliable and 
their removal or modification would certainly result in improved reliability.    However, these 
experimental studies highlighted the important contribution of rater training to reliability, with the 
poorest reliability found in a study which involved a screener with extensive clinical experience but 
limited training in using the measure.  They also provided some data which suggested that more 
adverse events were found by the screeners in the experimental studies than during their use of the 
same measures in the RSCH occurrence screening project, which supports the hypothesis that 
experimental studies of reliability may have poor generalisability because raters behave differently 
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during the experimental study (are, for example, more careful or attentive in applying the measures) 
from the way they would behave when using the measure in non-experimental conditions.   It was 
noted in chapter 3 that the results from earlier experimental studies of the reliability of adverse-event 
measures were rather mixed, and reached varying conclusions about their reliability.   It might be 
argued, in the light of the findings reported above, that these heterogeneous findings reflect 
differences in the adverse-event measures tested and in the approaches to rater training employed. 
 
The observational study of reliability, based on an analysis of data from the RSCH occurrence 
screening project, suggested that significant variations in the results of screening were associated 
with the identify of the screeners applying the adverse-event measures used.  While it was not 
possible to attribute these variations solely to differences in screeners’ performance or behaviour, 
and a number of other causes could be posited, it seemed likely that the substantial differences 
sometimes observed indicated that the reliability of the adverse-event measures being used was not 
as high as the experimental studies might have indicated.  No other similar analyses were identified 
in the literature reviewed in chapter 3, so it is not possible to compare these findings with others 
from elsewhere. 
 
Overall, the results of the studies of reliability give some cause for concern.  While they suggest that 
the reliability of adverse-event measures can be quite high, they also indicate that reliability is rather 
dependent on the individual measure and the conditions in which it is used.   They suggest that the 
reliability of adverse-event measures in actual practice may be lower that the theoretical estimates of 
reliability derived by developers of those measures might suggest. 
 
 
7.2.3 General issues and considerations raised by the research 
 
Testing the validity and reliability of measures is an essential part of their development.  It should 
give cause for concern that many adverse-event measures of quality, and measures of other kinds, 
have become widely used despite an absence of empirical evidence to demonstrate that they offer 
valid and reliable information on the concepts that they purport to measure.   This research raises 
four key questions concerning the testing of validity and reliability which deserve further discussion: 
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a) How should information about different dimensions of validity and reliability be integrated 
in assessing measures of healthcare quality? 
It was evident from the research that the results of validity and reliability testing are unlikely 
to be unequivocal and unanimous, and may even point to quite different conclusions about 
the performance of the measure being tested.   For example, within the concept of validity 
there are a number of dimensions - criterion-related, construct, face and content - which 
when tested may give divergent results.   The developers and users of measures need to be 
able to balance such divergent results and reach decisions about whether to develop further 
or deploy such measures on the basis of this information.     When a measure has apparently 
poor validity and poor reliability, those decisions are relatively easy to make.  But if, for 
example, a measure combines good validity and poor reliability, it is less clear whether and 
how it should be used.   It could be argued that the users of such measures should be 
encouraged to use only those measures with proven good validity and good reliability, and 
that other measures should remain the preserve of their developers until their performance 
has been improved. 
 
Perhaps one general lesson which emerges from the research is that broadly based 
assessments of validity and reliability, which make assessment across a number of different 
dimensions rather than focusing on a single dimension (such as criterion-related validity), 
may be more useful and provide more assurance to the users of measures.   Where, for 
example, there is research evidence from a range of settings, using both observational and 
experimental methods, of the criterion-related, construct, face and content validity and 
interrater and intrarater reliability of a measure - then, perhaps, its users can feel justifiably 
confident about how the measure will perform in actual practice. 
 
b) How meaningful are the results of experimental approaches to assessing reliability? 
The results of reliability testing reported in chapter 6 raise some concerns about the 
differences in apparent reliability when a measure is being formally tested and when it is 
simply being used in actual practice.  The environment for experimental studies of reliability 
- with specially trained and well-motivated raters, more time and resources for applying the 
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measure, better feedback on performance, or whatever - may be quite atypical of the 
environment for actual practice.   However, experimental studies of reliability eliminate the 
many potential confounding factors and biases which make the interpretation of observation 
studies of reliability so difficult.   It might be argued either that the users of measures should 
seek both experimental and observational evidence of reliability from the developers of 
those measures, or that experimental studies of the reliability of such measures should be 
undertaken in conditions which as much as possible approximate the settings of actual 
practice in which the measure would be used.  There is a clear parallel here with the debate 
over the use of experimental and observational methods in testing the effectiveness of 
healthcare interventions, and with the development of both explanatory and pragmatic trials 
of such interventions. 
 
c) How generalisable are the results of validity and reliability testing undertaken by the 
developers of measures of healthcare quality? 
The studies reported in chapters 4, 5 and 6 raise important questions about how much the 
users of measures can rely on the testing undertaken by their developers.  Ideally, once a 
measure has been tested and its validity and reliability have been demonstrated, we should 
then be able to use it without any further debate or discussion about these issues.  However, 
these studies suggest that the external validity or generalisability of the testing undertaken by 
the developers of measures might be limited.  In other words, while the developers of 
measures might be able to show that they are valid and reliable in the conditions in which 
they are tested, those conditions may be quite atypical of the environment in which the 
measure is subsequently used and the differences may have profound implications for 
validity and reliability.    
 
This means that it may be wise to treat data on validity and reliability from the developers of 
measures as maximal estimates of the validity and reliability which might be obtained rather 
than necessarily as indicators of the performance which can be expected in normal practice.    
It may be advisable for the potential users of any measure to seek and rely on reports of 
validity and reliability from other users of that measure, in circumstances as similar as 
possible to those in which it is to be used, and to place greater reliance on those data than on 
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those from the developers of the measure. When this kind of data on validity and reliability 
is not available, or if there is reason to believe that the generalisability of validity and 
reliability data for the measure is particularly low, it could be argued that some testing of 
reliability and validity should be incorporated into the actual use of the measure.  Indeed, the 
importance of rater training and other conditions to the reliability of measurement means 
that the regular testing of reliability (through, for example, periodic intrarater or interrater 
rescreening linked to the feedback of results and comparative analyses) may be a necessary 
step in the routine use of such measures. 
 
d) What is the relationship between validity and reliability for measures of healthcare quality? 
The studies reported in chapters 4, 5 and 6 also suggest that there may be a balance to be 
struck between the validity and reliability of adverse-event measures of quality.  It was noted 
earlier that the development of the measures used in the RSCH occurrence screening project 
and whose validity and reliability was tested in this research was led by clinicians within the 
project.   Their priorities were not necessarily to maximise either validity or reliability, but it 
could be argued that the former rather than the latter was the more important consideration 
in their eyes.  Certainly, the comments from respondents in the questionnaire and interview 
studies were more concerned with issues of validity than reliability.   This may have resulted 
in the production of measures with high validity (reported in chapters 4 and 5) but rather less 
good reliability (reported in chapter 6).   Some of the changes to the measures suggested by 
the examinations of reliability undertaken and reported in chapter 6 which would improve 
their reliability seem, on the face of it, likely to also reduce their validity.    There is a known 
statistical relationship between validity and reliability for any measure, as was noted in 
chapter 2.  The lower the reliability of a measure is, the lower the maximum achievable 
validity will be.  But, beyond that, there may circumstances in which decisions about the 
content, structure or definition of a measure have to be made which may either increase 
validity at the expense of reliability, or vice versa. 
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7.2.4 Implications for the development and use of adverse-event measures of quality 
 in healthcare 
 
This research reinforces the conclusions of many earlier studies reviewed in chapter 3 which 
indicate that adverse events are an important phenomenon, worthy of study and measurement 
because of their implications for patients and healthcare organisations and because of the insight 
they offer into the quality of care and how it might be improved.   Broadly, it supports the use of 
such measures in quality measurement in healthcare as being a meaningful and worthwhile 
component of wider quality assurance programmes, with two caveats.  Firstly, measurement of 
quality should not focus solely on data about adverse events but should also take account of other 
important characteristics and dimensions of quality.  Secondly, measures based on adverse events 
should be developed and used in ways that assure their validity and reliability. 
 
This research suggests that the developers of adverse-event measures of quality should be more 
rigorous in testing the validity and reliability of their measures before recommending them to 
potential users.    It is evident that high validity and reliability cannot be assumed, and the study of 
validity and reliability during the development of measures is likely to identify opportunities to 
make improvements to the measures. 
 
In turn, the users of adverse-event measures of quality should, perhaps, be more discerning or 
demanding in their selection and application of measures, seeking better evidence from more 
extensive testing of the validity and reliability of the measures which they adopt.   They should also 
be more mindful of the potential threats to validity and reliability inherent in the conditions in which 
measures are actually used, and should ensure not only that measures are used as they were intended 
to be used, with the appropriate level of rater training and support, but also that some element of 
ongoing measurement of the performance of the measure is incorporated into its routine use. 
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7.3 Further research 
 
When this research is viewed in the context of the framework for evaluating measures of healthcare 
quality proposed by the Institute of Medicine (1990) which was discussed in chapter 2, it can be 
seen that this research has a worthy but narrow focus, and that many important dimensions of the 
performance of such measures have not been evaluated.   This research has been primarily focused 
on what that framework labelled the scientific grounding of such measures - but there are equally 
important considerations to do with their general design, efficiency and latitude which have not been 
addressed.     Future research should be aimed at broadening the scope of this evaluation, and 
exploring these other aspects of the performance of adverse-event measures. 
 
Given that it was argued in chapter 2 that the limitations of quality assurance programmes in 
healthcare often lay more in the process of quality improvement than in their approaches to quality 
measurement, it is an important limitation of this research that it was confined to an examination of 
the use of adverse-event measures in quality measurement.   There are a range of other issues 
concerning the application of the adverse event data produced by measurement in changing clinical 
practice and bringing about quality improvements which need to be addressed.   For example, the 
utility of different approaches to presenting the data, and the nature of organisational arrangements, 
incentives and mechanisms for then using that data, deserve further examination. 
 
For almost all the adverse-event measures of quality discussed in chapter 3, and for all the research 
reported in chapters 4, 5 and 6, the primary source of data has been the written clinical record.  
Many of the concerns about the validity and reliability of such measures arise, directly or indirectly, 
from the nature, structure and content of those records.  For example, the reliability with which 
adverse events can be identified depends, among other things, on the quality of record keeping.   
With the growing use of information technology in healthcare, and the increasing availability of a 
wide range of clinical data on various computer systems, there may be opportunities to both reduce 
the cost of identifying adverse events and increase the validity and reliability with which they are 
identified by making greater use of automated approaches to screening for adverse events.   The 
potential for such techniques merits further research. 
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Appendices 
 
 
 
4.1 Generic adverse-event measure of quality developed for and used in  
 the RSCH occurrence screening project. 
 
  
 
 
313
 G01 Unexpected admission following outpatient management. 
   
 Unexpected admission following treatment in the outpatient or accident  
 and emergency department of the hospital, or in the community. 
  
  
 DEFINITION 
  
 The patient's admission was the direct result of the adverse results of or  
 some complication of outpatient management, given by hospital staff in  
 outpatients departments or Accident and Emergency, or by general  
 practitioners or other community health services. 
  
  
 EXCEPTIONS 
  
 Patients whose admission is expected or planned as a result of a chronic  
 condition such as unstable diabetes, carcinoma, glaucoma or cataracts, or  
 progressive renal failure. 
  
  
 GUIDANCE NOTES 
  
 Look for evidence of delayed diagnosis or treatment, failures or  
 breakdowns in service provision, complications of outpatient drug therapy  
 or procedures. 
  
 If the admission resulted from care provided by another district, or by  
 community services outside the Health Authority, this should be noted. 
  
 EXAMPLES 
  
 Delayed diagnosis; any condition attributed to outpatient procedures e.g.  
 radiation burns;  wound infections;  delayed treatment. 
 In renal medicine, sudden worsening renal failure due to drug therapy e.g.  
 ACE inhibitors, tetracycline, NSAI's, diuretics, infection when on  
 immunosuppressive therapy.  
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G02 Unexpected readmission to hospital. 
   
 Unexpected readmission to hospital following a previous admission. 
  
  
  
 DEFINITION: 
  
 The reason for the patient's readmission was the development/diagnosis 
 of complications arising from a previous admission, or the incomplete  
 management of problems diagnosed or present during the previous  
 admission. 
  
  
 EXCEPTIONS: 
  
 Patients whose re-admission was planned and documented at the time of  
 the previous admission, or who are expected to have multiple admissions.  
  
  
  
 GUIDANCE NOTES: 
  
 Look for complications or problems unresolved during the previous  
 admission requiring readmission and examine carefully all readmissions  
 within 7 days of previous discharge. 
  
 For General Surgery record all re-admissions within 7 days of discharge.  
  
 If the previous admission was to a hospital outside this district, this should 
  be noted. 
  
  
 EXAMPLES: 
  
 Following dilatation and curretage, patient readmitted for retained  
 products. 
 Patient readmitted with unresolved infection following inpatient  
 antibiotic treatment for chest infection. 
 In Renal patients:  Readmission for bleeding following renal biopsy; 
 Readmission post renal transplant for surgical complication , i.e. not  
 rejection;   
 Readmission post Tenchoff catheter placement for P.D. fluid leak, or AT  
 ANY TIME for hernia; 
 Readmission post A-V fistula formation for infection, or revision of  
 fistula.  [See also RE 02] 
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 G03 Error in obtaining consent to operative procedure. 
   
 Errors made in obtaining and documenting the patient's consent to  
 operative procedure(s). 
  
  
 DEFINITION 
  
 The operation consent form(s) for the procedure(s) carried out on the  
 patient cannot be found in the notes, or can be found but contain error(s). 
  
  
  
 EXCEPTIONS 
  
 Patients undergoing emergency surgery, where the patient and patient's  
 family could not give their consent in advance of surgery.  Reasons for  
 this should be documented in the notes. 
 Omission of the hospital name at the top of the consent form should not  
 be included under this criteria. 
 Life threatening problems found and dealt with during surgery. 
  
 GUIDANCE 
  
 Look for operation consent forms on which: 
 - the details of the procedure do not correspond with the operation notes. 
  
 - sections are not completed or are incorrect,inaccurate illegible or  
 contain abbreviations.  L. and R. for left and right is permissible if 
 clear.  Omission of "hospital": 
 - doctor's or patient's signature missing. 
  
 EXAMPLES of renal operations: Renal transplant, Transplant  
 nephrectomy, A-V fistula formation, Ureteric stent formation, Tenchoff  
 catheter placement or removal, renal biopsy, parathyroidectomy. 
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 G04 Unplanned removal/injury/repair of structure during surgery. 
   
 Unplanned removal, injury, or repair of an organ or structure during surgery 
  or invasive procedure. 
  
  
 DEFINITION: 
  
 During surgery or invasive procedure,the unplanned removal,injury or  
 repair of an organ or structure occurred. 
  
 EXCEPTIONS: 
  
 There are no exceptions to this criteria. 
  
 GUIDANCE NOTES: 
  
 Compare operation proposed on consent form with operation performed  
 as documented in the notes. Look for evidence of: 
 a) Departure from proposed procedure.  
 b) Injury to an organ or structure. 
 c) Removal of healthy organs or tissue. 
 d) Repair to structures/organs inadvertantly damaged. 
 e) Confirmation of above by reference to pathology reports. 
 f) Any injury to the patient undergoing anaesthesia and surgery. 
  
 Look particularly closely at procedures where the risk of such incidents is  
 higher, such as:  intubations, percutaneous aspirations, biopsies,  
 catheterisations, endoscopic procedures, lumbar punctures. 
  
 EXAMPLES: 
  
 Perforation of bowel during during endoscopic procedure. 
 Corneal abrasion occurred while under anaesthetic for colporrhaphy. 
 Paralysis of vocal cord due to recurrent laryngeal nerve damage during  
 parathyroidectomy. 
 Nephrectomy after renal biopsy because of bleeding but NOT because of  
 severe irreversible rejection. 
  
 EXCEPTIONS: 
 Some renal operations e.g. Renal transplant may necessitate extra  
 procedures, (once surgeon has opened the abdomen) to be successful, e.g.  
 native nephrectomy and use of patient's own ureter. 
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 G05 Unplanned return to theatre. 
   
 Unplanned return to theatre for complications of a previous procedure. 
  
  
  
 DEFINITION 
  
 An unplanned return to theatre for a second or subsequent procedure  
 occurred. 
  
  
 EXCEPTIONS 
  
 Planned second procedures, or second stages of two stage procedures. 
  
  
 GUIDANCE 
  
 For indications of whether the return to theatre was planned, check the  
 operation notes for the first procedure.  Check for procedures repeated  
 because of lack of success on first attempt. 
  
 Check for surgical correction of complications e.g. insertion of a drain  
 for a wound infection. 
  
  
 EXAMPLES 
  
 Return to theatre following haemorrhoidectomy for haemostasis for  
 post-operative bleeding. 
 Return to theatre for re-suturing following burst abdominal wound. 
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 G06 Delay or error in diagnosis 
   
 An error or undue delay in diagnosing the patient's condition is documented. 
  
  
 DEFINITION 
  
 An error or undue delay in diagnosing the patient's condition is  
 documented in the record, which has resulted in a significant difference in  
 the patient's care or treatment.  Errors or delays may come to light  
 through: 
 a)  Pathology/histology results following surgery 
 b)  Postmortem report 
 c)  Documentation of delayed diagnosis in later medical records 
 d)  Documentation of error in diagnosis in later medical records 
   
 EXCEPTIONS 
  
 There are no exceptions to this criterion. 
  
 GUIDANCE 
  
 Check medical notes for evidence of delays in diagnosing conditions, or  
 for erroneous diagnoses later corrected.  Check for negative histology  
 reports following surgery. For all deaths where post-mortems are carried  
 out, check the post-mortem report opinion on cause of death against the  
 ante-mortem diagnosis and treatment. 
   
 Renal patients: Level of Diagnosis.   
 An accurate diagnosis of renal failure may be made, but the patient not  
 treated due to unsuitability for dialysis therapy.  There may be an  
 accompanying inaccurate guess as to the cause of renal failure, the true  
 diagnosis later revealed at post-mortem.  This is irrelevant to the  
 treatment the patient received. 
  
 INFORMATION TO RECORD 
  
 Record details of the timescale on which decisions about diagnosis were  
 made and changed, and evidence of the effect of any delay or error on the  
 patient's care and treatment. 
   
 EXAMPLES 
 Fracture missed on original admission, but later diagnosed and treated. 
 Mastectomy performed and histological report shows tissue to be benign.  
 Polyps removed presumed benign, sent for histological examination and  
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 G07 Transfusion problems:reactions,complications,usage. 
   
 Problems arising from transfusions of blood or blood derivatives, such as  
 significant complications and reactions or misuse of the service or  
 unavailability of blood or blood derivatives. 
  
 DEFINITION 
  
 Following transfusion of blood or blood derivatives, significant reaction(s) 
  or complication(s) occurred, or the Blood Transfusion Service was  
 misused or blood/blood derivatives were unavailable.  
  
  
 EXCEPTIONS 
  
 There are no exceptions to this criterion. 
  
 GUIDANCE 
  
 Look for mismatch of blood group. 
 Look for evidence of reaction/complication such as rash, rigor, breathing  
 difficulties, temperature spike greater than 37.5C , tachycardia, loin pain, 
  chest pain, hypotension, jaundice following transfusion (within 12  
 hours), renal failure.  Check for evidence that the complication/reaction  
 was addressed, such as slowing or stopping transfusion rate, drug therapy,  
 etc. 
 Single unit transfusions are not indicated (except for some renal patients)  
 therefore record details.  
  
 Renal patients:  Dialysis patients often receive transfusions for severe  
 symptomatic anaemia, usually two units per transfusion, but occasionally  
 one. 
  
  
 EXAMPLES 
  
 Urticaria and pyrexia following transfusion of whole blood. 
 Mis-matched blood given in error followed by renal failure. 
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 G08 Hospital acquired infection. 
   
 Infection acquired during the patient's admission. 
  
  
  
 DEFINITION 
  
 The patient developed an infection during their admission, which was  
 acquired after they had been admitted. 
  
  
 EXCEPTIONS 
 There are no exceptions to this criterion. 
  
 GUIDANCE 
  
 Look for evidence of freedom from infection or presence of infection in  
 medical or nursing notes on admission and check laboratory reports.  
 Compare with later documentation of signs and symptoms and laboratory  
 reports. 
 Urinary:  Match up positive culture with reports of signs and symptoms,  
 such as dysuria, haematuria, frequency, pyrexia. 
 Urinary tract infections are not a relevant event in the care of renal  
 patients, and should NOT therefore be recorded.  
 Chest:  Match up signs and symptoms such as coughing, pyrexia, purulent 
 sputum and a positive culture. If negative result but signs and symptoms  
 present check if patient is on antibiotics. If so, count as variation. 
 Wound:  Match signs and symptoms e.g.pyrexia, redness, swelling, and  
 drainage around surgical site, with positive culture.  
 Other infections:  Match signs and symptoms with positive laboratory  
 report. 
 Check date of diagnosis and onset of infection, and admission notes, to  
 establish whether the infection was acquired pre or post admission. 
  
 EXAMPLES 
 Urinary tract infections in catheterised patients. 
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 G09 Antibiotic/drug utilisation problems. 
   
 One (or more) of the specified drug/antibiotic usage problems occurred. 
  
  
 DEFINITION 
  
 One of more of the following specified drug/antibiotic usage problems  
 occurred: 
  
 a)  Medications omitted, prescribed or  given in error, given at wrong      
 rate,delayed with no reason given. 
 b)  Medication reactions and anaphylaxis. 
  
 GUIDANCE 
  
 Check kardex for any documented medication errors. Note subsequent  
 action. 
 Check for comments made by the pharmacist in notes or on prescription  
 sheet. 
 Include in (a), error in prescribed dose in patients suffering from renal  
 failure.  Check prescription sheet for changed dosage. 
  
 EXAMPLES 
  
 Penicillin prescribed or given when known allergy documented. 
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 G10-1 Cardiac or respiratory arrest, 
   
 Cardiac arrest,or respiratory arrest, occurring during the admission. 
  
  
  
 DEFINITION 
  
 The patient had a cardiac arrest or respiratory arrest, during their  
 admission. 
  
  
 EXCEPTIONS 
  
 There are no exceptions to this criterion. 
  
  
 GUIDANCE 
  
 Look for evidence in records leading up to the event, such as major  
 changes in vital signs, administration of medication or other treatments  
 just prior to the event,which might suggest its cause. 
  
 Check records of treatment of the arrest/shock itself, such as calling of  
 crash team, availability of resuscitation equipment,etc. 
 Check records for ECG prior to surgery and also availability of ECGs. See  
 if result of ECG is in record.   
 Look for other clinical indicators- 
 - reports of tests for urea and electrolytes, (especially if K+ > 6.0) 
 - evidence of adequate hydration (fluid charts, medical notes) or overload 
  
 - if monitored, evidence of rhythm changes 
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 G10-3 CVA or MI or PE following surgery. 
   
 A CVA or MI or PE occurred following a surgical procedure during the same 
  admission. 
  
  
 DEFINITION: 
  
 A cerebrovascular accident or myocardial infarction occurred within the  
 48 hour period immediately following a surgical procedure, or pulmonary  
 embolus occurred at any stage following surgery. 
  
  
 EXCEPTIONS: 
  
 There are no exceptions to this criterion. 
  
  
 GUIDANCE NOTES: 
  
 In Urology notes, also include patients who suffered  a CVA, MI or PE at  
 any time during their admission. 
 Please note whether there were any cardiovascular symptoms not addressed  
 by admitting doctor and whether ECG was considered. 
  
 Pulmonary embolus:  Look for documentation for clotting time  
 pre-surgery and note whether anti-coagulant therapy was considered.   
 Look at accounts of post-operative nursing care:  deep breathing  
 exercises, passive or active limb exercises and consideration for referral  
 to physiotherapy and early ambulation. 
  
  
 EXAMPLES 
  
 Pulmonary embolus following bowel resection. 
 Cerebrovascular accident following hysterectomy. 
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 G11 Unexpected transfer to higher dependency unit. 
   
 Unexpected transfer from general care to higher dependency unit. 
   
  
 DEFINITION: 
  
 Patient was transferred unexpectedly from general care to a higher  
 dependency unit. 
  
  
 EXCEPTIONS: 
  
 Planned transfers. 
  
  
 GUIDANCE 
  
 Transfers to higher dependency units include transfers to coronary care  
 units,intensive therapy units here or in other hospitals. 
  
 Check pre-operative medical records for evidence  that a transfer was  
 planned. 
 Look for reasons for transfer and examine events leading up to transfer.  
 Check pre-operative medical records for evidence that a transfer was  
 planned. 
  
  
 EXAMPLES: 
  
 Patient transferred to intensive therapy unit following routine  
 herniorrhaphy with breathing difficulties. 
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 G12-1 Patient related clinical complications occurred. 
   
 One or more of the specified patient-related clinical complications  
 occurred. 
  
  
 DEFINITION 
  
 One or more of the following patient-related clinical complications  
 occurred during the admission: 
 b) IV problems: Overload.  Phlebitis requiring treatment. Time Venflon  
 tissued and times of subsequent action.  Infected IV sites. 
 c) Pain control not addressed. 
 d) Development/worsening of skin problems resulting from pressure. 
 e) Faecal impaction developed during admission requiring physical  
 evacuation. 
 g) Deep vein thrombosis not evident on admission. 
 h) Wound haematoma in breast surgery patients 
 i) Urinary retention occurred following surgery using epidural     
 anaesthesia. 
 EXCEPTIONS 
 There are no exceptions to this criterion. 
  
 GUIDANCE 
 Check whole of medical and nursing records for complications specified. 
 Note whether preventive measures taken and complications addressed. 
 b) Note time Venflon is recorded as tissued in nursing kardex, time  
 reported to doctor and time Venflon replaced. Record descriptions of  
 infected IV sites and action taken.                                     c) Look for  
 complaints of pain not addressed and the effect of analgesia not  
 evaluated.  Look for pain-control charts. In General Surgery, record for  
 abdominal emergency admissions their arrival in A and E Dept, and time  
 when first analgesia given. 
 d) For each patient who develops skin problems, record original nursing  
 assessment of pressure risk, date problem first noticed, subsequent action. 
 h) Check Breast Operation form and nursing kardex. 
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 G12-2 Patient-related non-clinical problems/incidents occurred 
   
 One or more of the specified patient-related non-clinical problems or  
 incidents occurred. 
  
  
 DEFINITION 
  
 One or more of the following patient-related non-clinical problems or  
 incidents occurred: 
  
 a) Theatre booking cancelled/delayed. 
 b) No ITU bed available when clinically needed 
 c) Patient transferred/admitted to/receiving care on an inappropriate ward 
  because of bed shortages. 
 d) Delay in obtaining a second opinion from another specialty as recorded  
 in the notes. 
 e) Casenotes, X-rays or other records or results missing/not available  
 when needed. 
 g) Patient had slip or fall, or other accident. 
 h) Equipment failure. 
 i) Necessary equipment not available when needed. 
 j) Prescribed drugs not obtainable. 
 k) Delay in undergoing diagnostic or therapeutic procedures. 
 l) Portering service problems 
 m) Staff unavailable 
 n) Other 
 
 EXCEPTIONS 
  
 There are no exceptions to this criterion 
  
 GUIDANCE 
 Check medical and nursing records.  Document the causes of the problem 
 or incident if possible.  Record if theatre instruments unavailable. Note if  
 theatre delayed/cancelled due to TSSU problems or if ECG or other  
 missing report delays operation.  If notes are missing, record reason. 
 b) For General Surgery patients, record reason for non-availability of ITU 
  bed if given. Record age of patient, with stated diagnosis and reasons for  
 ITU admission. 
  
 EXAMPLES 
 Patient's X-rays are missing when they go to theatre. 
 Specimen results not available for review of treatment e.g. frozen section. 
 Patient staying nil by mouth while waiting long period due to theatre  
 rescheduling. 
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 G14 Neurological deficit on discharge not present on admission 
   
  Neurological deficit developed which was not present when the patient was  
 admitted. 
  
  
 DEFINITION 
  
 The patient developed a  neurological deficit during their admission which 
  was not present when they were admitted. 
  
  
 EXCEPTIONS 
  
 Patients coming under criteria G10-3 and G12-1 and patients developing  
 planned or expected neurological deficit. 
                  
   
 GUIDANCE 
  
 Look for evidence of neurological damage or compromise throughout the  
 medical and nursing records.   Look particularly for neurological deficits 
  resulting from surgery. Check assessments of orientation and sensory,  
 circulatory and motor function. Look for evidence of seizures, urinary or  
 faecal incontinence, or intractable pain which were not present or not  
 documented on admission. 
  
 EXAMPLES 
 Facial palsy post-parotidectomy.  Foot-drop following knee replacement  
 or discectomy.  Radial nerve palsy following humeral fracture plating.  
 Laryngeal nerve palsy following parathyroidectomy.  Median nerve palsy  
 (or ulnar or radial) following formation of A-V fistula. 
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 G15 Transfer to another hospital 
   
 Patient transferred to another hospital for one of the specified reasons. 
  
  
 DEFINITION 
  
 Patient transferred to another acute hospital for one of the following  
 reasons: 
  
 - because of staff shortages, bed shortages, or ward closures 
  
 - for treatments normally available at this hospital 
  
 EXCEPTIONS 
  
 Transfers for treatment and tests not normally available at this hospital,  
 and tertiary referrals. Transfers of patients to be nearer to  
 home/relatives. 
  
 GUIDANCE 
  
 Look for the reasons for the transfer, and check the appropriateness of  
 the original admission to this hospital. 
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 G16 Unexpected death 
   
 Unexpected patient deaths. 
  
  
 DEFINITION 
  
 Patient died unexpectedly during admission 
  
 EXCEPTIONS 
  
 Patients admitted for terminal care or receiving terminal care, and  
 patient recorded category C under the district resusitation policy. 
  
 GUIDANCE 
  
 Check nursing and medical records for evidence that the death was  
 unexpected or any indications that it might have been prevented. 
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 G17 Medical record review 
   
 Review of quality, consistency and completeness of medical records. 
  
  
  
 DEFINITION 
  
 One (or more) of the following specified deficiencies were found in the  
 medical records: 
  
 a) Admission clerking not dated.                                        
 b) Notes not filled in every third day and at other important stages of    
 clinical management. 
 e) Notes illegible or unsigned. 
 f) Incomplete or contradictory recording of information. 
 g) Breast Operation Form incomplete (Breast Surgery patients only). 
 h) Clinical information form not present in notes or incomplete. 
  
 EXCEPTIONS 
  
 There are no exceptions to this criterion 
  
 GUIDANCE 
  
 Check throughout medical records for the specified deficiencies. 
 See BHA guidance for the writing of the clinical record. 
 In b), if a patient is discharged within 3 days, ensure that an entry in the  
 notes is made post-operatively by doctor.  (Especially relevant in  
 Ophthalmology.) g) Check completeness of form except for histology  
 results which will not be available before patient discharge. 
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 G18 Nursing record review 
   
 Review of quality, consistency and completeness of nursing records. 
  
  
 DEFINITION 
  
 One or more of the specified deficiencies were found in the nursing  
 records: 
  
 a) No nursing assessment completed within 24 hours of admission 
 b) Patient's care plan missing or not updated 
 d) Incomplete, contradictory, or inadequate recording of information 
 e) Nurses' signatures missing on drug chart. 
 f) Property form not completed/no disclaimer.  
 g) Evidence of nursing insensitivity. 
  
  
 EXCEPTIONS 
  
 There are no exceptions to this criterion. 
  
 GUIDANCE 
  
 Check throughout the nursing records for the specified deficiencies 
 Compare TPR frequency with nursing orders in care plan. Ensure frequency  
 of observations reflects the condition of the patient.  
  
  
 EXAMPLES 
  
 Patient's care plan giving post-operative nursing orders including care of  
 intravenous infusion remains unchanged during remainder of patient's stay 
  in hospital. 
 Quarter hourly observations following surgery become less frequent  
 without corresonding adjustment in care plan. 
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 G19 Evidence of patient and/or family dissatisfaction 
   
 Evidence of patient and/or family dissatisfaction in records 
  
  
 DEFINITION 
  
 There is evidence in the medical or nursing records, that the patient and  
 /or the patient's relatives or friends expressed dissatisfaction with the care 
  given to the patient. 
  
 EXCEPTIONS 
  
 There are no exceptions to this criterion. 
  
  
 GUIDANCE 
  
 Look for information on cause of dissatisfaction and how it was expressed  
 in nursing and medical records.  Look for evidence that the  
 patient/family complaint was handled  appropriately. 
  
 All discharges taken against medical advice should be carefully checked  
 against this criterion. 
  
 Look for dissatisfaction with food, cleanliness, conduct of staff, clinical  
 care, noise at night in ward, lack of privacy. 
  
  
 EXAMPLES 
  
 Patient's daughter complains to staff nurse that a window was left open  
 overnight causing her mother to become chilled. 
 Patients complain about dirty washing facilities. 
 Patient took own discharge when operation postponed and incomplete  
 explanation given by ward staff. 
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 G20 Discharge related problems 
   
 Problems relating to the patient's discharge occurred. 
  
  
 DEFINITION 
  
 One (or more) of the following specified problems occurred in relation to  
 the patient's discharge: 
 e) For General Surgery: Discharge checklist not completed.                 
 c) Absence of copy of discharge summary to GP. (With renal patients also  
 to referring hospital doctor.) 
 d) Discharge delayed for non-clinical (organisational or social) reasons 
 f) No evidence of patient information leaflet given to patient on     
 discharge.  
 EXCEPTIONS 
 There are no exceptions to this criterion 
  
 GUIDANCE 
  
 Look through medical notes for copy of discharge prescription and letter  
 to general practitioner. Look for evidence of assessment of patient for  
 community services, provision of necessary dressings, drugs to take out,  
 liaison with relatives and evidence of planned nursing discharge. Look for  
 reasons for discharge delay. 
  
 EXAMPLES 
  
 Elderly patient remained in hospital for three weeks following medical  
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4.2 Pilot questionnaire used in the questionnaire study of clinician  
opinion. 
 
Occurrence Screening
Validity Study
QUESTIONNAIRE
About this questionnaire 
This questionnaire contains a set of screening criteria, it is
intended to find out how good you think each screening criterion would
be at selecting cases where there was some lapse in the standard of
care. Clearly, none of the criteria can select every case where there
has been some lapse, and every criterion will select some cases where
there has been no lapse in the standard of care. The lower these
"false negative" and "false positive" rates can be made, the better
the screening criteria will be at selecting cases where the quality
of care has been lower than it should have been. Therefore, both
your opinion on the screening criteria as they are now, and your
suggestions for improvements to the criteria will be very welcome.
Filling in this questionnaire 
There is one sheet in this questionnaire for each screening criterion,
and each sheet is laid out in exactly the same way.
The first part of the sheet gives you information about the screening
criterion. It gives the title of the criterion, and its definition,
and lists any known exceptions to the criterion. It also gives some
guidance notes and example cases, which would be used by the person
who was screening patients' records to guide them in applying the
criterion.
The second part of the sheet contains a series of questions which we
would like you to answer, about the screening criterion. Please
answer these questions about the criterion exactly as it stands.
Having answered the questions, we would like you to give any
suggestions for amendments or alterations to any part of the screening
criterion which you feel would make it better at selecting cases where
there has been some lapse in the standard of care.
Returning the questionnaire 
When you have completed the questionnaire, please place it in the
enclosed stamped addressed envelope and return it to me at CASPE
Research.
Study report 
If you would like to receive a copy of the study report	 E tick
based on the responses to these questionnaires, please	 box
tick the box on the right.
- 334 -
GO1 - Admdssion for the adverse results of or complications resulting fnmn out-patient management.
DEFINITION
The patient's admission was the direct result of the adverse results of or some complication of out-patient management,
given by hospital staff in outpatients departments or Accident and Emergency, or by general practitioners or other
community health services.
EXCEPTIONS
Patients whose admission is expected or planned as a result of a chronic condition such as unstable diabetes, carcinoma,
glaucoma or cataracts.
GUIDANCE NOTES
Look for evidence of delayed diagnosis or treatment, failures or breakdowns in service provision, complications of
outpatient drug therapy or procedures.
If the admission resulted from care provided by another district, or by community services outside the Health Authority,
this should be noted.
EXAMPLES
Delayed diagnosis; any condition attributed to out-patient procedures e.g. radiation burns; wound infections; delayed
treatment.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
	
Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: :	 :	 :	 :	 1	 :	 :	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion? [] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
Identified in cases which fit this criterion would be?
0%	 100%
:	 :	 :	 :	 :	 :	 1	 1	 :	 1 
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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GO2 - Re-admission for complications arising from a previous admission, or because of the incomplete management of
problems on a previous admission.
DEFINITION
The reason for the patient's re-admission was the development/diagnosis
of complications arising from a previous admission, or the incomplete management of problems diagnosed or present during
the previous admission.
EXCEPTIONS
Patients whose re-admission was planned and documented at the time of the previous admission, or who are expected to
have multiple admissions.
GUIDANCE NOTES
Look for complications or problems unresolved during the previous admission requiring re-admission and examine carefully
all re-admissions within 7 days of previous discharge.
If the previous admission was to a hospital outside this district, this should be noted.
EXAMPLES
Following dilatation and curretage, patient re-admitted for retained products.
Patient re-admitted with unresolved infection following in-patient anti-biotic treatment for chest infection.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
o%	 100%
1 	
	Never
	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
• 1	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 All
patients
	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
s.	 How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
: :	 :	 :	 :	 :	 :	 1	 1	 :
No	 Very
effect	 serious effect
7.	 Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[]Yes
	
[] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G03 - Errors mmde in obtaining and documenting the patient's consent to operative procedure(s).
DEFINITION
The operation consent form(s) for the procedure(s) carried out on the patient cannot be found in the notes, or can be
found but contain error(s).
EXCEPTIONS
Patients undergoing emergency surgery, where the patient and patient's family could not give their consent in advance
of surgery. Reasons for this should be documented in the notes.
Life threatening problems found and dealt with during surgery.
GUIDANCE
Look for operation consent forms on which:
- the details of the procedure do not correspond with the operation notes.
- sections are not completed or are incorrect, inaccurate illegible or contain abbreviations. L. and R. for left and
right is permissible if clear.
- doctor's or patient's signature missing.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
	
Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion? [] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
Identified in cases which fit this criterion would be?
0%	 100%
: :	 1	 :	 1	 :	 1	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G04 - Unplanned rempval, injury, or repair of an organ or structure during surgery or invasive procedure.
DEFINITION
During surgery or invasive procedure,the unplanned removal ,injury or repair of an organ or structure occurred.
EXCEPTIONS
There are no exceptions to this criteria.
GUIDANCE NOTES
Compare operation proposed on consent form with operation performed as documented in the notes. Look for evidence of:
a) Departure from proposed procedure.
b) Injury to an organ or structure.
c) Removal of healthy organs or tissue.
d) Repair to structures/organs inadvertently damaged.
e) Confirmation of above by reference to pathology reports.
f) Any injury to the patient undergoing anaesthesia and surgery.
Look particularly closely at procedures where the risk of such incidents is higher, such as: intubations, percutaneous
aspirations, biopsies, catheterisations, endoscopic procedures, lumbar punctures.
EXAMPLES
Perforation of bowel during during endoscopic procedure.
Corneal abrasion occurred while under anaesthetic for colporrhaphy.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
•
:	 :	 :	 :	 :	 :	 :	 :	 :
Not at
	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
1 1	 :	 :	 :	 :	 :	 1	 :	 :	 :
	Never
	 Always
	
found
	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
cm	 100%
:	 :	 :	 :
	 •
	 1	 :	 :	 :	 :	 I
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
0 Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
1 1	 :	 :	 1	 :	 :	 :	 1	 :	 I
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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GO5 - Unplanned return to theatre for complications of a previous procedure.
DEFINITION
An unplanned return to theatre for a second or subsequent procedure occurred.
EXCEPTIONS
Planned second procedures, or second stages of two stage procedures.
GUIDANCE
For indications of whether the return to theatre was planned, check the operation notes for the first procedure. Check
for procedures repeated because of lack of success on first attempt.
Check for surgical correction of complications e.g. insertion of a drain for a wound infection.
EXAMPLES
Return to theatre following haemorrhoidectomy for haemostasis for post-operative bleeding.
Return to theatre for re-suturing following burst abdominal wound.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. DO you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
1 :	 :	 :	 :	 :	 :	 :	 :	 :	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
•
:	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion? [] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%
: :	 1	 :	 :	 :	 :	 II	 : 	 : 	
100%
:
No
	
	 Very
serious effecteffect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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GO6 - Pathology or histology report varies significantly from pre- operative diagnosis, or post-aortas report varies
significantly from the ante-mortem diagnosis.
DEFINITION
Pathology or histology results following surgery are significantly at variance with pre-operative diagnosis, and this
variance has resulted in a significant difference in a patient's care or treatment; or the post-mortem report is
significantly at variance with the ante-aortas diagnosis and this variance has resulted in a significant difference in
a patient's care or treatment.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE
Check for negative histology reports following surgery. For all deaths where post-mortems are carried out, check the
post-mortem report opinion on cause of death against the ante-mortem diagnosis and treatment.
Note whether post-aortas has been carried out or not.
EXAMPLES
Mastectomy performed and histological report shows tissue to be benign. Polyps removed presumed benign, sent for
histological examination and found to be malignant on report.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 1	 :	 :	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
in	 100%
: :	 1	 :	 :	 :	 :	 :	 :	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: 1	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 All	
.
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
E] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
: 1	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
I] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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GO7 - Problems arising from transfusions of blood or blood derivatives, such as significant canplications and reactions
or misuse of service.
DEFINITION
Following transfusion of blood or blood derivatives, significant reaction(s) or complication(s) occurred, or the Blood
Transfusion Service was misused.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE
Look for mismatch of blood group.
Look for evidence of reaction/complication such as rash, rigor, breathing difficulties, temperature spike greater than
37.5C , tachycardia, loin pain, chest pain, hypotension, jaundice following transfusion (within 12 hours), renal
failure. Check for evidence that the complication/reaction was addressed, such as slowing or stopping transfusion rate,
drug therapy, etc. Single unit transfusions are never indicated, therefore record details.
EXAMPLES
Urticaria and pyrexia following transfusion of whole blood.
His -matched blood given in error followed by renal failure.
1. Mow closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
I	 II
Not at
	
Very closely
related
	
related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
	
Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
No	 All
patients
	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[I More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
I] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
Identified in cases which fit this criterion would be?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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GOB - Infection acquired during the patient's admission.
DEFINITION
The patient developed an infection during their admission, which was acquired after they had been admitted.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE
Look for evidence of freedom from infection or presence of infection in medical or nursing notes on admission and check
laboratory reports. Compare with later documentation of signs and symptoms and laboratory reports.
Urinary: Match up positive culture with reports of signs and symptoms, such as dysuria, haematuria, frequency, pyrexia.
Chest: Match up signs and symptoms such as coughing, pyrexia, purulent
sputum and a positive culture. If negative result but signs and symptoms present check if patient is on antibiotics.
If so, count as variation.
Wound: Match signs and symptoms e.g.pyrexia, redness, swelling, and drainage around surgical site, with positive
culture.
Other infections: Match signs and symptoms with positive laboratory report.
Check date of diagnosis and onset of infection, and admission notes, to establish whether the infection was acquired
pre or post admission.
EXAMPLES
Urinary tract infections in catheterised patients.
Wound abscess post appendicectomy.
How closely do you think this criterion is related to the quality of care that patients receive?
0%
: :	 :	 :	 :	 :	 :	 1	 :	 :	
100%
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
	
Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: :	 :	 :	 :	 :	 1	 :	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%
: :	 :	 :	 :	 :	 :	 :	 :	 :	
100%
:
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
1.
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GO9 - One (or more) of the specified drug/antibiotic usage problems occurred.
DEFINITION
One of more of the following specified drug/antibiotic usage problems occurred:
a) Medications omitted, prescribed or given in error, given at wrong rate, delayed with no reason given.
b) Medication reactions and anaphylaxis.
GUIDANCE
Check kardex for any documented medication errors. Note subsequent action.
Check for comments made by the pharmacist in notes or on treatment card.
EXAMPLES
Penicillin prescribed or given when known allergy documented.
Anaphylactic shock in patient given intravenous antibiotics.
Omnopon infusion found to have been running at twice prescribed rate overnight.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 1	 :	 :
Not at
	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
: :	 1	 :	 :	 :	 :	 :	 :	 :	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: 	 • 	 :	 1	 :	 :	 1	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
Identified in cases which fit this criterion would be?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G10-1 - Cardiac arrest,or respiratory arrest, occurring during the admission.
DEFINITION
The patient had a cardiac arrest or respiratory arrest, during their admission.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE
Look for evidence in records leading up to the event, such as major changes in vital signs, administration of medication
or other treatments just prior to the event,which might suggest its cause. Check records of treatment of the
arrest/shock itself, such as calling of crash team, availability of resuscitation equipment, etc.
Check records for ECG prior to surgery and also availability of ECGs. See if result of ECG is in record.
Look for other clinical indicators-
- reports of tests for Urea and Electrolytes
- evidence of adequate hydration (fluid charts, medical notes) or overload
- if monitored, evidence of rhythm changes
If unsuccessful, check for evidence of correct procedures followed after death.
1. Now closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
Not at
	
Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
: :	 1	 : :	 :	 :	 :	 :	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
• :	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
0 Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive? [] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G10-3 - A CVA or MI or PE occurred following a surgical procedure durtng the same admission.
DEFINITION
A cerebrovascular accident, myocardial infarction or pulmonary embolus occurred at any time during the admission
following surgery.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE NOTES
Note whether there were any cardiovascular symptoms not addressed by admitting doctor and whether ECG was
considered.
Pulmonary embolus: Look for documentation for clotting time pre-surgery and note whether anti-coagulant therapy was
considered. Look at accounts of post-operative nursing care: deep breathing exercises, passive or active limb
exercises and consideration for referral to physiotherapy and early ambulation.
EXAMPLES
Pulmonary embolus following bowel resection.
Cerebrovascular accident following hysterectomy.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
•
:	 :	 :	 :	 :	 :	 1	 :	 :	 :
Not at
	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
0%	 100%
Never	 Always
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 1	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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Gil - Unexpected transfer from general care to higher deperdency unit.
DEFINITION
Patient was transferred unexpectedly from general care to a higher dependency unit.
EXCEPTIONS
Planned transfers.
GUIDANCE
Transfers to higher dependency units include transfers to coronary care units, intensive therapy units here or in
other hospitals.
Check pre-operative medical records for evidence that a transfer was planned.
Look for reasons for transfer and examine events leading up to transfer.
Check pre-operative medical records for evidence that a transfer was planned.
EXAMPLES
Patient transferred to intensive therapy unit following routine herniorrhaphy with breathing difficulties.
Patient transferred to coronary care following cardiac arrest.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
• :	 :	 :	 :	 :	 :	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :
	
Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: :	 :	 :	 :	 :	 :	 1	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
: :	 1	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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612-1 - One or more of the specified patient-related clinical ccaplications occurred.
DEFINITION
One or more of the following patient-related clinical complications occurred during the admission:
b) IV problems: Overload. Phlebitis requiring treatment.
C) Pain control not addressed.
d) Development/worsening of skin problems resulting from pressure.
e) Faecal impaction developed during admission requiring physical evacuation.
g) Deep vein thrombosis not evident on admission.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE
Check whole of medical and nursing records for complications specified.
Note whether preventive measures taken and complications addressed. Check
for pain control chart.Lcck for complaints of pain not addressed and effect of analgesia not evaluated.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 1	 1	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
1	
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: :	 :	 :	 :	 :	 :	 1	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
•
:	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G12-2 - One or more of the specified patient-related non-clinical problems or incidents occurred.
DEFINITION
One or more of the following patient-related non-clinical problems or incidents occurred:
a) Theatre booking cancelled/delayed.
b) No ITU bed available when clinically needed
c) Patient transferred/admitted to/receiving care on an inappropriate ward because of bed shortages.
d) Delay in obtaining a second opinion from another specialty.
e) Casenotes, X-rays or other records or results missing/not available when needed.
g) Patient had slip or fall, or other accident.
h) Equipment failure.
1) Necessary equipment not available when needed.
j) Prescribed drugs not obtainable.
k) Delay in undergoing diagnostic or therapeutic procedures.
1) Portering service problems
m) Staff unavailable
EXCEPTIONS
There are no exceptions to this criterion
GUIDANCE
Check medical and nursing records. Document the causes of the problem or incident if possible. Check for list of
valuables recorded. Note if theatre instruments unavailable. Note if theatre delayed/cancelled due to TSSU problems or
If ECG or other missing report delays operation. If notes are missing record reason.
EXAMPLES
Patient's X-rays are missing when they go to theatre.
Specimen results not available for review of treatment e.g. frozen section.
Patient staying nil by mouth while waiting long period due to theatre rescheduling.
How closely do you think this criterion is related to the quality of care that patients receive?
0%
:	 :	 :	 :	 :	 :	 1	 :	 :	 :	
100%
:
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 1	 :	 :	 :	 :	 :	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
No	 All
patients	 patients
4. D3 you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
B.	 How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
Identified in cases which fit this criterion would be?
0%	 100%
: :	 :	 :	 :	 1	 :	 :	 :	 :
No	 Very
effect	 serious effect
7.	 Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
0 Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
1.
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614 - Neurological deficit developed which was not present when the patient was admitted.
DEFINITION
The patient developed a neurological deficit during their admission which was not present when they were admitted.
EXCEPTIONS
Patients coming under criteria G10/3 and G12/1 and patients developing planned or expected neurological deficit.
GUIDANCE
Look for evidence of neurological damage or compromise throughout the medical and nursing records. Look particularly
for neurological deficits resulting from surgery. Check assessments of orientation and sensory, circulatory and motor
function. Look for evidence of seizures, urinary or faecal incontinence, or intractable pain which were not present or
not documented on admission.
EXAMPLES
Facial palsy post-parotidectomy. Frozen shoulder post-laryngectomy.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 I
Not at
	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
	
Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 All
patients
	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
:- :	 :	 :	 I.	 :	 ;
	I.	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive? 0 Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G16 - Unexpected patient deaths.
DEFINITION
Patient died unexpectedly during admission
EXCEPTIONS
Patients admitted for terminal care or receiving terminal care, and patient recorded category C under the district
resusitation policy.
GUIDANCE
Check nursing and medical records for evidence that the death was unexpected or any indications that it might have been
prevented.
1. How closely do you think this criterion is related to the quality of care that patients receive?
OX	 100%
:-	 1	 :	 I	 :	 :	 :	 :	 :	 1	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
	
:-	 :	 :	 :	 :	 :	 1	 :	 :	 :	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
:-	 I.	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of mare than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
B.	 How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of mare
identified in cases which fit this criterion would be?
0%	 100%
•
:	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7.	 Do you think this screening criterion could be altered to make it relate more closely to the quality of mare
that patients receive? [] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G17 - Review of quality, consistency and completeness of medical records.
DEFINITION
One (or more) of the following specified deficiencies were found in the medical records:
a) Admission clerking not dated or not present.
b) Notes not filled in every third day and at other important stages of clinical management.
e) Notes illegible or unsigned.
EXCEPTIONS
There are no exceptions to this criterion
GUIDANCE
Check throughout medical records for the specified deficiencies. See BHA guidance for the writing of the clinical
record. In b), if a patient is discharged within 3 days, ensure that an entry in the notes is made post-operatively
by doctor. (Especially relevant in Ophthalmology.)
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 :	 1	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 I
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
• :	 :	 :	 :	 1	 :	 :	 :	 :	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
• :	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7.	 Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G18 - Review of quality, consistency and completeness of nursing records.
DEFINITION
One or more of the specified deficiencies were found in the nursing records:
a) No nursing assessment completed within 24 hours of admission
b) Patient's care plan missing or not updated
d) Incomplete, contradictory, or inadequate recording of information
e) Nurses' signatures missing on drug chart.
f) Property form not completed/no disclaimer.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE
Check throughout the nursing records for the specified deficiencies
Camaro TPR frequency with nursing orders in care plan. Ensure frequency of observations reflects the condition of the
patient.
EXAMPLES
Patient's care plan giving post-operative nursing orders including care of intravenous infusion remains unchanged during
remainder of patient's stay in hospital.
Quarter hourly observations following surgery become less frequent without corresonding adjustment in care plan.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: 1	 :	 :	 :	 :	 :	 :	 :	 :	 :
Not at
	 Very closely
related
	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
reomnas?
	
0%	 100%
1 :11:	 I
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
:-	 : :	 :	 :	 :	 :	 :	 :	 1	 :
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
E] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
Identified in cases which fit this criterion would be?
0%	 100%
: 1 	 :	 : 	 :	 :	 I
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
(]Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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619 - Evidence of patient and/or fondly dissatisfaction in records.
DEFINITION
There is evidence in the medical or nursing records, that the patient and /or the patient's relatives or friends
expressed dissatisfaction with the care given to the patient.
EXCEPTIONS
There are no exceptions to this criterion.
GUIDANCE
Look for information on cause of dissatisfaction and how it was expressed in nursing and medical records. Look for
evidence that the patient/family complaint was handled appropriately.
All discharges taken against medical advice should be carefully checked against this criterion.
Look for dissatisfaction with food, cleanliness, conduct of staff, clinical care, noise at night in ward, lack of
privacy.
EXAMPLES
Patient's daughter complains to staff nurse that a window was left open overnight causing her mother to become chilled.
Patients complain about dirty washing facilities.
Patient book own discharge when operation postponed and incomplete explanation given by ward staff.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
: :	 :	 :	 :	 I	 I	 ::	 	 1	 	 : 
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients routine medical and nursing
records?
	
0%	 100%
: 1	 :	 :	 :	 :	 :	 :	 :	 :	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
1	
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion? [] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Worse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
identified in cases which fit this criterion would be?
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 :	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
[] Yes	 [] No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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G20 — Problems relating to the patient's discharge occurred.
DEFINITION
One (or more) of the following specified problems occurred in relation to the patient's discharge:
c) Absence of copy of discharge summary to GP
d) Discharge delayed for non-clinical (organisational or social) reasons
EXCEPTIONS
There are no exceptions to this criterion
GUIDANCE
Look through medical notes for copy of discharge prescription and letter to general practitioner. Look for evidence of
assessment of patient for oonnunity services, liaison with relatives and evidence of planned nursing discharge. book
for reasons for discharge delay.
EXAMPLES
Elderly patient remained in hospital for three weeks following medical decision for discharge,awaiting placement in
nursing home.
1. How closely do you think this criterion is related to the quality of care that patients receive?
0%	 100%
:	 :	 1	 :	 ;	 1	 :	 :	 :	 :	 :
Not at	 Very closely
related	 related
2. Do you think the information needed for this criterion could be found in patients' routine medical and nursing
records?
	
0%	 100%
: :	 :	 :	 :	 :	 :	 :	 1	 :
	Never	 Always
	
found	 found
3. If all acute patients were screened using this criterion, what proportion of patients do you think would fit
the criterion?
0%	 100%
I.	 .	 I.
No	 All
patients	 patients
4. Do you think that a detailed review of cases which fit this criterion would show that those cases had more
lapses in the quality of care than those not fitting the criterion, or fewer lapses than those not fitting the
criterion?
[] More lapses in quality of care than others
[] Same level of lapses as others
[] Fewer lapses than others
5. Do you think that a detailed review of cases which fit this criterion would show that those cases had, on
average, a better quality of care than those not fitting the criterion, or a worse quality of care than those
not fitting the criterion?
[] Better quality of care than others
[] Same quality of care as others
[] Norse quality of care than others
6. How serious, in terms of the effect on the patient's health, do you think the lapses in the quality of care
Identified in cases which fit this criterion would be?
0%	 100%
: :	 I.	 :	 :	 :	 :	 I:	 .	 :	 :
No	 Very
effect	 serious effect
7. Do you think this screening criterion could be altered to make it relate more closely to the quality of care
that patients receive?
Yes	 (]No
If you answered YES to question 7, please give details of the amendments you would suggest below. Please
continue overleaf if you need more space.
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4.3 Final questionnaire used in the questionnaire study of clinician  
opinion. 
 
Medical Audit Occurrence Screening
QUESTIONNAIRE
About this questionnaire 
This questionnaire contains a set of 20 screening criteria. it is
intended to find out how good you think each screening criterion would
be at selecting cases where there has been some lapse in the quality
of care. Clearly, none of the criteria can select every case where
there has been such a lapse, and every criterion will select some
cases where there has been no lapse in the quality of care. The
lower these "false negative" and "false positive" rates can be made,
the better the screening criteria will be at selecting cases where the
quality of care has been lower than it should have been. 	 Therefore
both your opinions on the screening criteria as they are now, and your
suggestions for improvements to the criteria will be very welcome.
Filling in this questionnaire 
The middle two pages of this questionnaire contain a table, in which
each of the 20 screening criteria is listed. For each criterion,
there are five questions for you to answer. The first four questions
are answered by giving a rating from 0 to 10, and the fifth question
is answered by ticking either YES or NO. There is also some space for
you to write comments about the criterion.
On the back page of the questionnaire is some supplementary
information about each of the screening criteria. It explains their
meanings in more detail, and gives some examples of the sorts of cases
which might be selected by each criterion.
Confidentiality
The answers you give and comments you make in this questionnaire will
not be passed on to anyone apart from the research team, nor will they
be used in an identifiable way in the research report.	 The
questionnaire numbering will only be used to follow up unreturned
questionnaires, and to examine differences in opinions amongst
different clinical groupings.
	 It will not be used to identify
individual respondents.
Study report 
If you would like to receive a copy of the study report	 N tick
based on the responses to these questionnaires, please 	 box
tick the box on the right.
Returning the questionnaire 
When you have completed the questionnaire, please place it in the
enclosed stamped addressed envelope and return it to me at:
CASPE Research, King Edward's Hospital Fund,
14 Palace Court, Bayswater, London W2 4HT.
Thank you again for your help with this study.
Kieran Walshe.	 - 356 -
Research Co-ordinator,
CASPE Research.
Screening criterion
(for more information about each criterion, see the table on the back
page of this questionnaire).
How closely do you
think this criterion
Is related to the
quality of care that
patients receive?
Please rate it from:
0 (not at all
related)
to
10 (very closely
related).
Do you think the
Information needed
for this criterion
could be found in
patients routine
medical and nursinc
records?
Please give a mt.'.
from:
0 (never found)
to
10 (always found).
1. Admission for adverse results of or complications resulting from
outpatient management.
2. Readmission for complications arising from a previous admission, or
because of the incomplete management of problems on a previous admission.
3. Errors made in obtaining and documenting the patient's consent to
operative procedures.
4. Unplanned removal, injury or repair of an organ or structure during
surgery or invasive procedure.
5. Unplanned return to theatre for complications resulting from a previous
procedure.
6. Pathology or histology report varies significantly from preoperative
diagnosis, or postmortem report varies significantly from antemortem
diagnosis.
7. Problems arising from transfusions of blood or blood derivatives, such as
significant complications or reactions, or misuse of service. 
8. Infection acquired during the patient's stay in hospital.
9. Medications omitted, prescribed or given in error; medication reactions
and anaphylaxis.
M.	 Cardiac or respiratory arrest occurring during the patient's stay in
hospital.
11.	 A CVA or MI or PE occurred during the patient's stay in hospital,
following a surgical procedure during the same admission.
U.	 Unexpected transfer of patient from general care to higher dependency
unit (ITU, CCU, etc).
13. One or more of the specified patient-related clinical complications
occurred.
14. One or more of the specified patient-related non-clinical/organisational
problems or incidents occurred.
15. Neurological deficit developed which was not present when the patient was
admitted.
16. Unexpected patient death.
17. Inadequacies found in the quality, consistency and completeness of the
medical records.
18. Inadequacies found in the quality, consistency and completeness of the
nursing records. 
19. Evidence of patient and/or family dissatisfaction.
20. Problems relating to the patient's discharge occurred.
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If you have any comments on any of the screening
criteria, or any suggestions for ways in which
they could be improved, please write them in
this column.
If all acute patients
were screened using
this criterion, what
proportion of patients
do you think would fit
the criterion? Please continue on a separate sheet if there is
not enough space for your comments below.
Do you think this
criterion could be
altered to make it
relate more closely to
the quality of care
that patients receive?
How serious, in terms
of its effect on the
patient's health, do
you think the
circumstances outlined
In this criterion would
be?
Please rata the
proportion, from:
0 (no patients)
to
M (all patients).
Please tick YES or NO.
If you answer YES,
please give details of
amendments in the
comments column.
Please rata the effect,
from:
0 (no effect)
to
10 (very serious
effect)
[ ] Yes	 [ ] No
[	 Yes	 [ ] No
[ ] Yes	 [ ] No
] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ J Yes	 [ J No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ]Yes	 [ ] No
] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
[ ] Yes	 [ ] No
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The information provided on this page is intended to assist you in completing the questionnaire, by explaining the meaning of
each screening criterion, and providing some examples of cases which would be selected by that criterion.
Screening criterion Further details: detailed definition of criterion, known exceptions, and
examples of cases which would be selected by the criterion.
1. Admission for adverse results of or
complications resulting from
outpatient management.
Admission was direct result of complications of outpatient management,
given by hospital staff in outpatients/A&E, or by community staff. 	 For
example, delayed diagnosis, complications of outpatient procedures, etc.
2. Readmission for complications arising
from a previous admission, or because
of the incomplete management of
p roblems on a previous admission.
Readmission was the direct result of complications of a previous
admission, or of problems which were not resolved on a previous admission.
Expected/planned readmissions are not included.
3. Errors made in obtaining and
documenting the patient's consent to
operative procedures.
For example, the consent form is missing, or incomplete, or illegible.
Emergencies, where consent cannot be obtained, are excepted.
4. Unplanned removal, injury or repair
of an organ or structure during
surgery or invasive procedure,
Intended to pick up inadvertent or mistaken damage to or removal of
tissue/organs.	 For example, perforation of the bowel during an endoscopic
procedure, or corneal abrasion under general anaesthetic.
5. Unplanned return to theatre for
complications resulting from a
p revious procedure.
For example, return to theatre for resuturing of operation wound. 	 Planned
returns to theatre for two stage procedures, and expected returns to
theatre (such as trauma cases) are excepted.
6. Pathology or histology report varies
significantly from preoperative
diagnosis, or postmortem report
varies significantly from antemortem
diagnosis.
Cases where histology reports following surgery contradict presurgery
findings, or cause of death cited in post-mortem at odds with antemortem
clinical conclusions. For example, mastectomy performed, and histological
examination shows tissue to be benign.
7. Problems arising from transfusions of
blood or blood derivatives, such as
significant complications or
reactions, misuse of service.
Such as severe reactions to blood transfusions, delay in transfusion due
to unavailability of supply, or transfusions given when not clinically
necessary (for example, single unit transfusions).
8. Infection acquired during the
patient's stay in hospital.
Match signs and symptoms with positive diagnosis and laboratory report.
Check date of onset and date of admission to establish when infection
acquired.	 For example, wound abcess post appendicectomy.
9. Medications omitted, prescribed or
given in error; medication reactions
and anaphylaxis.
For example, penicillin prescribed when known allergy documented, or IV
infusion found to be running at twice prescribed rate.
10. Cardiac or respiratory arrest
occurring during the patient's stay
In hospital.
Check for evidence in records that arrest might have been expected. 	 Check
handling of arrest - availability of resuscitation equipment, crash team.
11. A CVA or MI or PE occurred during the
patient's stay in hospital, following
a surgical procedure during the same
admission.
A cerebrovascular accident, myocardial infarction or pulmonary embolus
occurred postoperatively. 	 Check for evidence of cardiovascular symptoms
preoperatively, and of appropriate post-operative care.
12. Unexpected transfer of patient from
general care to higher dependency
unit (ITU. CCU.	 etc).
Patient transferred from a general ward to a high dependency unit
unexpectedly.
13. One or more of the specified patient-
related clinical complications
occurred,
Complications such as: development/worsening of pressure areas; deep vein
thrombosis; inadequate pain control; faecal impaction requiring physical
evacuation developed during the admission.
14. One or more of the specified patient-
related non-clinical/organisational
problems or incidents occurred,
Problems such as: patient slips and falls; theatre booking
delayed/cancelled; patient on inappropriate ward due to bed shortages;
records missing; equipment failures/unavailability; delay in undergoing
diagnostic procedures.
15. Neurological deficit developed which
was not present when the patient was
admitted.
Check for evidence of neurological damage occurring during the admission,
especially from surgery. 	 For example, facial palsy post parotidectomy.
16. Unexpected patient death. Patients receiving terminal care, or patients who are not for
resuscitation, are excepted.
17. Inadequacies found in the quality,
consistency and completeness of the
medical	 records,
Notes not filled in regularly, at important stages of clinical management.
Notes illegible, undated, or unsigned.	 For example, no notes
postoperatively, or no documentation of decision to discharge.
18. Inadequacies found in the quality,
consistency and completeness of the
nursing records.
Nursing assessment not done within 24 hours of admission, or care plan
missing/not updated, or Kardex illegible, undated, unsigned,	 incomplete.
19. Evidence of patient and/or family
dissatisfaction.
For example, patient's daughter complains that food is cold and inedible.
Patient takes own discharge when operation postponed several times.
Patient complains about attitude/manner of member of staff.
20. Problems relating to the patient's
discharge occurred.
Such as delays in discharge for non-clinical 	 reasons (such as waiting for
rest-home vacancy), or inadequate discharge planning.
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4.4 Transcription of all textual comments made by respondents to the  
questionnaire study of clinician opinion. 
 
In this listing, the comments from respondents have been grouped into three main areas: comment 
about the adverse-event measure in general; comment relating to specific screening criteria or 
adverse events within the measure; and those pertaining to the questionnaire study design and 
implementation.   Within each area, comments have been grouped around subjects or themes. 
 
All comments have been transcribed as they were written. 
 
 
1. Comments on the adverse-event measure 
 
 Grouping of adverse events within criteria 
 2001 Difficult to assess - some criteria include a range of possible incidents/factors 
which may be serious at one end of the range to trivial at the other. 
 2041 Many of the proposed groups combine trivial with serious events 
 7111 Some of the questions cover too wide a field with incidents ranging from the 
trivial to the life-threatening - eg those on drugs and blood transfusions. 
 
 Precision of definition of adverse events 
 2001 It is always difficult to be precise and perhaps not vital if used as a screen for 
further evaluation.  However subjectivity on individual cases cannot be 
avoided. 
 2003 A number of these criteria depend on appropriate record keeping and 
subjective decisions about what is acceptable medical performance.  These 
need to be achieved/established before these criteria have validity. 
 2016 Found most categories too general ie could be of major impact/little impact 
within same category. 
 2017 Specify instances - standards needed 
 2026 Some effort made to define severity of complications [needed] 
 
 Denominator for adverse event rates 
 2003 What about patients for whom events might have been expected but did not 
happen - denominator problem. 
 
 General validity of measure 
 2016 Idea OK but would need to be finely tuned. 
 2019 As screening criteria I think most of the 20 are very useful, though I found 
difficulty grading quality relevance 
 2022 No of criteria need to be reduced 
 2028 I think many of the criteria have the potential to be highly sensitive - if the 
information was available in the notes (which it isn't) - but are of low 
specificity.  
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 2031 I think the abysmal quality of clinical records will scupper other aspects of 
quality/audit and need to be first area addressed 
 2040 Medical audit by occurrence screening is a useful form of medical audit it is 
however unsatisfactory in that medical audit should compare normal practice 
against an optimum standard eg an old procedure against a modern 
procedure 
 2041 I would prefer an examination of a sample of notes to detect not only 
occurrences but also whether the patient's care conformed to agreed 
standards and resulted in the expected (anticipated) outcome. 
 2044 The effects on the patient are obviously related to the nature of the mistake - 
these criteria act as indicators only - review with medical and nursing staff is 
necessary to determine the impact of the mistake - also necessary to 
determine how inevitable the mistake (ie postop infection) is  - eg food 
poisoning is avoidable, UTI may not be 
 2057 The vast majority of patient complaints dissatisfaction and litigation have 
their origins in failure of communication.  None of these criteria addresses 
itself to this (eg 3 or 19).  The occurrence is largely unmeasured because 
doctors seldom write what they tell their patients or even whether they did.  
Areas of communication failure are - about the disease, about the procedure, 
about the complications, about aftercare and about prevention.  How can we 
audit all this? How can we detect occurrences of this failure?  Food for 
thought here.   Also what about cancellation of admission long duration of 
waiting, deterioration of condition while waiting?  probably under 14 but I'm 
not entirely sure. 
 2070 the whole approach horrifies me - bad apples vs continuous quality 
improvement.  Too much emphasis on outliers - it hasn't worked in US. 
 2072 This questionnaire convinces me even more that this type of audit is costly, 
has a low payback rate and is threatening and about blame.  90% of the 
clinical issues will have a perfectly rational explanation.  let us learn from the 
American experience 
 2105 Can I suggest you consider criteria related to the frequency of medical 
attention ie ward rounds, time before first seen, frequency of consultant 
examination etc.  Also inappropriate investigation - example repeat X-rays or 
Ba meal in 95 year olds when not clinically useful. 
 2117 Do you really mean all acute patients screened - complications are rare 
occurrences.  It is usually helpful to focus on positive as well as negative 
aspects of quality of care. 
 2121 Nearly all the criteria are too loosely defined at the present.  The need to be 
much more specific in connection with this the answers in column 4 (effect) 
will vary when the criteria are tightened. 
 2127 Time and cost are the issues that seem a problem.  To go through all records 
would take a long time especially if all this information is being sought.   
Will the benefits be worth the costs of this approach? 
 2137 Estimates of value could depend on whether is truly medical audit as 
perceived by doctors or risk management as seen by lawyers - maybe you 
should try this on a sample of regional solicitors! 
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 2155 Some criteria cover many situations - some of which may be serious - in 
health or quality terms - and some may be irrelevant.  in other words they are 
quite general.  I think this is an advantage.  If the screening criteria are too 
specific then relevant cases may be missed. 
 2161 My chief difficulty with this approach is that it tries to establish a uniform set 
of criteria for all specialties.  To take a simple example a cardiac/respiratory 
arrest would be unexpected and worthy of investigation if it occurred in a 
patient admitted say for cold surgery, if the patient was admitted for a 
suspected myocardial infection the picture that emerges is quite different.  It 
also lumps together variations of a problem with quite different 
consequences.  For example, medication errors and medication reactions are 
all included in one criterion. 
 2179 Most of the clinical indicators are valid in terms of quality of care but there 
will be great difficulty identifying blame even where an event is 
documented.  I would hope that the worst case scenarios outlined on the back 
page are very rare indeed.  However, there may be many patients where (eg 
patient is given antibiotic and bacteria is resistant) there are errors which lead 
to sub-optimal treatment.  0-10 means very variable outcome possible.  I 
thought the measures were well derived. 
 7102 I am growing less enthusiastic about occurrence screening as it is negative in 
approach.  it does not encourage new ideas and smacks of policing.  Junior 
doctors may (some do) see the monthly review as at Bromley as a list of their 
mistakes. 
 
2. Comments on specific screening criteria 
  
 1. Admission for adverse results of outpatient management 
 2003 This category is too broad - delayed diagnosis and acknowledged 
complications are two different issues. 
 2010 Relate to predicability of adverse event. 
 2019 Could be very powerful if only could be deduced from routine records 
 2020 Clinical judgements - not sure whether in reality screening criteria 
 2028 Need to be more specific 
 2030 Would depend on what events specified and ease of extraction from records 
 2031 Intended to audit GP management? 
 2032 Limit this to one or two diagnoses only 
 2040 More specific 
 2042 You have to relate it in some way to the patients' expressed wishes on 
admission since some reluctance to be admitted leads to longer o/p than 
might be usual practice 
 2045 Difficult to conceptualise criterion 
 2052 Depends on nature of adverse effect 
 2053 Specify a time period since last outpatients?  I think it would need to be more 
diagnosis specific eg diabetes and admission for amputation 
 2065 Almost always impossible to detect 
 2067 Relative risk stated before preventative treatment results added 
 2072 Effect is not measurable - could be any from 1 to 10. 
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 2082 use limiter for diagnosis to exclude well known complications 
 2087 Outpatient management is probably good even if goes wrong sometimes. 
 2088 GP information 
 2091 The relationship to the waiting list is important here, and the ranking of 
urgency. 
 2092 Difficult criterion to identify. 
 2094 Not as a screening criterion but was it an event that was predicted as a 
possibility. 
 2097 Urgency of admission? 
 2098 Define OPD management eg medical/surgical etc. 
 2099 Effect will vary enormously depending on adverse  occurrence - cannot score 
for overall group. 
 2100 Separate various factors eg active treatment causing problems, from delay 
causing problems. 
 2112 Waiting times should be separated from clinical process/outcome problems. 
 2113 Add unexpected. 
 2124 Could be used effectively in fracture clinics, dermatology etc 
 2129 Readmissions within 28 days. 
 2135 Major problem with this and 2 are the false negatives - no readmission may 
reflect poor quality care.  Effect on patient's health may be much more if they 
are not readmitted. 
 2137 Need to differentiate between iatrogenic as opposed to side effects. 
 2139 Add: which would not have occurred had optimum management in the 
opinion of peer group been given. 
 2144 Drug interactions specifically for side effects. 
 2146 By defining what is appropriate outpatient management for each specialty. 
 2147 The adverse results or complications themselves could be clearly defined and 
serious. 
 2150 Effect would vary from 0-10 depending on seriousness of complication. 
 2151 Target diagnoses. 
 2158 Some complications are an implicit risk of the treatment eg marrow down 
from chemotherapy. 
 2162 Not always preventable and therefore a quality issue? 
 2178 Some complications appear unavoidable.  Seriousness not defined. 
 2178A No sense of degree of seriousness of the complication ? avoidable. 
 2180 Specify severity of complications and appropriate treatment. 
 2197 More specific adverse reactions. 
 7100 Outpatient management is increasing brinkmanship with admission being a 
no go area. 
 7101 Omit delayed diagnosis. 
 
 2. Readmission for complications relating to previous admission              
 2003 A judgement is needed on predictable and unpredictable events. 
 2019 Split readmission and incomplete management 
 2028 Need to be more specific - how do you define "complication" or "incomplete 
management"? 
 2041 Chronic incurable vs curable? 
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 2042 Clarification of factors in readmission 
 2045 Compare to expected complication rate under good practice 
 2049 Some definition or grading of complications is needed to enable any useful 
comment/assessment 
 2052 Depends upon the complication 
 2062 Length of initial stay?  Delivery of discharge information. 
 2072 Omit - any good geriatrician will tell you how inappropriate this is. 
 2081 Timing - ie 7 days etc. 
 2098 Too wide a set of possible circumstances included here. 
 2112 Separate things discharges may be risked knowing that readmission may be 
needed - this may be good quality of care for most. 
 2113 Add unexpected. 
 2120 Within 7 days of discharge. 
 2144 Deep vein thrombosis. 
 2158 Just stick to second half of statement. 
 2178 Difficult to define in such a general sense ?readmissions. 
 2178A No sense of degree of seriousness. 
 2199 Specify complications eg wound infection. 
 7203 Formalised case notes with protocol and/or problem oriented medical records 
listing abnormal results. 
 
 3. Error in obtaining consent to operative procedure       
 2001 Can only be evaluated with patient input 
 2019 Shows sloppy approach but not necessarily directly related to healthcare 
quality 
 2025 It is more important to document that the patient fully understands the 
procedure 
 2028 Need to be more specific - eg no consent obtained/documented 
 2031 Quality of expression etc is closest related to quality of care but never 
documented 
 2032 More of QA implications together with possible legal consequences 
 2036 Recording manner and way in which consent was given and received 
 2041 ? adverse outcome 
 2053 Use as a tracer situation as it may imply a general laxity in care 
 2062 Review of procedures required 
 2065 More important to assess whether adequate explanation was given 
 2088 Are operative procedures clearly understood by all staff? 
 2092 Feedback from patient. 
 2094 Some attempt at how the patient understood - not a screening criterion 
though. 
 2099 Restrict to missing or inconsistent consent. 
 2113 Very peculiar question. 
 2115 Too vague. 
 2139 Meaning of proportion question not clear here as not everyone has a 
procedure. 
 2162 Quality ++ 
 2178 Depends on condition and consent to what? 
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 2190 relate consent to patient understanding of procedure. 
 2193 Answered in relation to "documenting consent" - obtaining consent is more 
directly related to quality of care but no information currently available 
particularly about the process of quality of the consent obtained. 
 5006 Not applicable to GU medicine. 
 5047 Revision of consent procedures as addressed at present. 
 7102 Leave out obtaining as impossible to find out circumstances at time. 
 
 4. Unplanned removal/injury/repair of organ/structure during surgery 
 2003 This criterion needs to address removal necessitated by poor quality care - 
unplanned removal of diseased organs is good quality care unless poor 
diagnostic performance. 
 2004 Definite complication 
 2019 Specify more to allow for whether in difficult/understandable clinical 
conditions or normal uncomplicated anatomy.  Even so, sometimes just bad 
luck 
 2028 Need specialist knowledge to recognise from the records that it was 
unplanned 
 2036 Record whether negligence was involved and whether it was inevitable 
 2041 ? effect - eg wrong leg 
 2042 You have to distinguish unplanned due to unexpected extent of disease from 
unplanned due to operator error 
 2053 Delete unplanned removal and unplanned repair - leave surgical injury 
 2087 Could be bad or good for patient - competent or incompetent work. 
 2094 Not as a screening criterion but what were the consequences. 
 2100 State whether in planned procedure resulted from mistaken action or 
unexpected finding. 
 2103 Inadvertent rather than unplanned. 
 2113 Unplanned and not necessitated by findings at operation. 
 2124 Consider auditing referral to another specialty as a result of complication eg 
hysterectomy and then referral to urology. 
 2139 Care may be good despite removal or repair being unplanned. 
 2140 Should say unintended rather than unplanned. 
 2144 Small numbers. 
 2147 Unplanned mistakes could be defined and serious. 
 2154 Include assessment of patients comprehension of what they have consented 
to and associated risks. 
 2168 It is an accident which can occur even in expert hands - it isn't a quality 
issue. 
 2178 Useful question.  Must be of highest importance. 
 2178A Some damage unavoidable. 
 2189 Word repair should be omitted. 
 5999 This is a very varied group and I would split this into serious and non-serious 
problems. 
 7203 Regular review of surgical "mishaps". 
 7102 There are acceptable risks to some organs in some difficult procedures. 
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 5. Unplanned return to theatre 
 2030 Very difficult to assess in some cases 
 2033 Some complications may not be related to quality of care 
 2040 Time interval 
 2053 A time period may need to be specified eg re-op within 1 week 
 2067 Possibly selected conditions with less risk if confined those to signs of age 
 2113 From a previous related procedure. 
 2120 Concentrate on routine procedures in first instance. 
 2135 As for 1,2 the return to theatre reflects good quality care the complications 
poor quality care so effect left blank. 
 2144 Burst wound, secondary haemorrhage. 
 2172 Specificity? 
 2178 Not all procedures can be perfectly excellent. 
 2178A No sense of degree of seriousness ? avoidable. 
 2197 More specific reason. 
 7203 Regular review of "returns to theatre". 
 
 6. Pathology/histology varies from diagnosis 
 2025 Depends on the exact circumstances 
 2028 Focus on a small number of specific diagnoses - eg appendicitis - aim to take 
a random sample of all deaths or ?just screen PM incidence 
 2031 Simply forcing doctors to record a diagnosis preop has strong bearing on 
quality of care 
 2035 Effect varies far too much to be used non-specifically 
 2039 Separate issues - histology/diagnosis, diagnosis/death 
 2041 ? effect - eg wrong treatment 
 2042 PM reports differ in 20-90% of cases" often this may not matter if the disease 
is not treatable anyway.  But pre-op histology is different 
 2053 Judgement needed on significance of difference in relation to alternative 
outcome for patient 
 2081 It all depends - need to subdivide 
 2082 Define significant? eg different ICD chapter? 
 2088 I differentiate between effect of postmortem and histology report. 
 2091 Links between path and clinical notes usually poor - eg records not updated 
when new evidence appears particularly PM. 
 2094 How was the management affected prediagnosis at PM/histology by the 
[illegible] 
 2097 Pathology report varies significantly from preop diagnosis such that 
procedure was inappropriate (this would exclude biopsy report not as 
expected but action appropriate). 
 2098 Your example (overleaf) is a very extreme occurrence of the criteria. 
 2099 Investigation protocols. 
 2100 Separate antemortem from postmortem pathology. 
 2113 Need to clarify severity of variance. 
 2137 10-20% of PMs differ substantially - what is "significant"? 
 2139 Effect question is impossible to answer as a generalisation - some patients 
are adversely affected others are not! 
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 2147 Depends on diagnoses. 
 2158 Not a helpful criterion though. 
 2162 Quality ++ but ? effect on outcome. 
 2178 Well known for PM results to differ 20-40%.  Depends on degree of 
seriousness. 
 2178A What about the normal appendix that is removed? 
 7203 PM especially - have target uptakes by consultant? 
 7102 Perioperative not preoperative - true diagnosis often made at the operation. 
 
 7. Transfusion problems: reactions, complications, usage 
 2001 Too varied - from anaphylaxis to delay 
 2005 What does misuse mean? other than single unit.  Either define explicitly or 
leave out. 
 2019 Bipolar again - split complications reactions from misuse of service 
 2024 Misuse of service important 
 2028 Be more specific - what reactions.  ?screen for blood transfusions in certain 
common conditions 
 2039 Reactions due to mismanagement/omission 
 2040 More details of situation 
 2041 Severity of response 
 2043 ?factors in transfusion reactions 
 2054 Misuse of service is different from problems arising... 
 2065 Doesn't distinguish "inevitable" reactions from errors 
 2071 Omit misuse of service - this will have an overall impact on the service 
offered to all patients but is a very different matter to blood reactions 
 2082 Limit to mismatched transfusion or transmission of infection - some 
reactions are to be expected. 
 2091 Misuse is of a different magnitude to severe reactions - one may kill the 
other may be far less. 
 2094 Consequences. 
 2099 Restrict to avoidable. 
 2113 Are we assuming blood matching errors cause the reactions? 
 2121 Make criterion more specific eg just look for people receiving 1 unit. 
 2137 Ragbag - a mismatch is a rare disaster, overordering is almost universal. 
 2139 Some problems are avoidable, others unavoidable could put "avoidable 
problems arising etc" 
 2162 Not always preventable but clearly important in outcome terms and therefore 
valid as a criterion for medical audit. 
 2172 Separate out unnecessary transfusions from reactions etc. 
 2178 Depends on degree of risk involved. 
 2178A What precisely does misuse of service mean? 
 2180 Specify misuse of service. 
 2187 Misuse of service - not understood.  Leave out or redefine. 
 2196 Misuse is potentially serious.  Reactions do not imply poor service unless 
they could be anticipated. 
 7102 Must be seen in context of clinical need. 
 7103 I would separate complications and misuse. 
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 8. Hospital acquired infection                             
 2001 Precise definitions needed 
 2004 Monitor outbreaks - not individuals? 
 2020 Needs further refinement 
 2028 Difficult to detect from notes 
 2030 Need to measure avoidability of infection 
 2031 Getting them to record is an uphill course 
 2035 Too non-specific 
 2036 How was infection acquired, type eg chest, wound etc 
 2041 Severity 
 2047 Extremely difficult to define hosp acquired infection 
 2058 Site of infection - yes if wound infection but no if UTI/chest infection 
 2062 Infection acquired by clinical procedures or defective domestic arrangements 
 2065 Definition of infection 
 2072 Change to nosocomial infections. 
 2081 Varies - as in 9 
 2083 Can be difficult to conclusively identify source 
 2092 Examine clean ops subset. 
 2098 Scorings relate to severity. 
 2099 Restrict to nosocomial ? infections, surgical infections. 
 2137 What is infection? 
 2139 Try separating chest infection, wound infection, urine infection etc. 
 2146 Infections following elective procedures. 
 2158 Wound infections are important, recurrence of chest infection in chronic 
bronchitis is unimportant. 
 2178 Criteria don't embody any degree of seriousness. 
 2178A ? avoidable no sense of degree of seriousness. 
 7203 Burns and wound infections (theatre cases excluding open trauma). 
 7102 In orthopaedics very serious, in urology trivial.  May be unavoidable. 
 
 9. Antibiotic/drug utilisation problems                    
 2001 Covers huge range of possibilities from severe to minor 
 2012 Division of indicator [needed] by severity of outcome 
 2019 Again helpful to split indicator - rare complications from known 
hypersensitive very different 
 2025 There is a big difference between drugs omitted and drugs given in error 
 2036 These are mostly due to negligence however anaphylaxis/reaction where 
allergy is not known is not negligence 
 2039 Error = quality of care not reactions not due to carelessness 
 2041 Could be trivial or life threatening 
 2053 Delete medication reactions and anaphylaxis as they may be less due to 
quality of care 
 2054 Medication reactions/anaphylaxis are different to medication omitted.. etc 
 2058 Anaphylaxis only if it was already known that pt allergic to drug otherwise it 
can't be predicted. 
 2062 Anaphylaxis and reactions should not be linked with errors 
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 2065 Distinguish errors of prescribing, dispensing and delivery to patient 
 2071 Split the two parts - medications omitted prescribed or given in error are very 
closely related to quality, reactions and anaphylaxis may be. 
 2072 Separate errors of prescribing and administration from reactions 
 2081 Vague - some errors could be very minor, some life-threatening 
 2083 Omitted/given in error causes and effects very different - ?separate 
 2099 Omit reactions, anaphylaxis. 
 2100 Separate omissions etc where no adverse reaction happened from those 
where it did. 
 2124 Define criteria more precisely eg compare prescription orders with timing of 
doses given. 
 2126 Giving wrong medication and medication reaction different - unless you 
state reaction to known drug allergy. 
 2137 As above difference between human side effects and medical cockup 
 2139 Errors and omissions are one criterion (always avoidable); reactions are 
another (may or may not be avoidable). 
 2140 First part of question only. 
 2146 Medications given for which there are contraindications, medications given 
in incorrect dosage. 
 2148 A ragbag of problems. 
 2158 Anaphylaxis only important if known previous reaction not elicited. 
 2178 Potentially fatal easier to see criterion in this question. 
 2178A A better question but again a range of effects is possible. 
 2183 Better two separate criteria. 
 2189 Too many parts to the question. 
 2196 As above, reactions need not result from poor practice. 
 2197 Needs splitting omissions from reactions. 
 2199 Range too wide from medication to anaphylaxis. 
 7209 The range of possibilities described is too great (trivial reactions to 
anaphylaxis). 
 7102 Leave out omitted or ask a separate question. 
 
 10. Cardiac or respiratory arrest in hospital 
 2001 ?age related 
 2003 Mixture of structure/process/outcome audit here 
 2004 Concentrate on outcome [of resuscitation] not occurrence 
 2028 Detailed info from records probably not available 
 2035 Omit 
 2036 Inevitable or not? 
 2040 Reasons for admission to hospital - more details of illness and age? 
 2041 Outcome 
 2065 Worth checking for avoidable factors 
 2091 Sensitive indicator of quality. 
 2094 Why - is it predictable/avoidable. 
 2099 Following maladministration of drugs? 
 2120 Criterion should be age-related. 
 2137 Depends on casemix/risk; eg acute MI or elective hernia? 
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 2154 May not be quality of care but underlying condition. 
 2158 Not a helpful criterion. 
 2164 Little impact on patients health in general but dramatic effect on odd 
individual patients. 
 2178 Question strictly one of avoidability. 
 2178A If unexpected or avoidable. 
 7209 Checking for evidence of possible arrest could be difficult. 
 
 11. CVA or MI or PE following surgery 
 2028 Good criterion 
 2034 Difference between CVA/MI and PE due to potentially preventable cause eg 
non-use of prophylaxis during surgery 
 2035 Omit 
 2036 Preexisting predisposition to CVA or PE 
 2041 Embolus is more easily prevented 
 2053 Within ? time period of admission to include MI occurring shortly after 
discharge 
 2058 CVA/MI are mostly due to independent pathology - only precipitating event 
would be hypotension.  PE - consider whether routine prophylaxis 
considered. 
 2065 Definitions required for each. 
 2091 But again CVA/MI are clinically different from PE.  The latter should be 
totally avoidable, the former may not be. 
 2115 Does this question mean poor management of cardiac/respiratory arrest 
 2120 Criterion should be age-related. 
 2124 A more sensitive indicator if related to specific events following specific 
surgery eg DVT/PE following THR. 
 2131 CVA and MI not in same category as PE. 
 2146 Depends on screening test used, particularly for PE. 
 2148 PE - quality; MI/CVA may be. 
 2151 Stick to Pes in surgical patients. 
 2158 Stick to post-surgery with or without prophylaxis. 
 2178 Examples differ eg PE should be more easily preventable. 
 2178A If avoidable. 
 2183 Isn't PE more preventable than the other two. 
 7203 Pes in orthopaedic lower limb surgery. 
 
 12. Unexpected transfer to special care/higher dependency unit  
 2003 ? value 
 2028 How do you define unexpected transfer 
 2032 Depends on nature of problem - difficult to generalise 
 2035 Give specific circumstances 
 2036 Definition of unexpected 
 2039 Ability to transfer may indicate a high level of care 
 2041 Outcome 
 2043 What if could have been foreseen 
 2048 Reason for transfer should be probed - eg haemorrhage/MI 
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 2051 Not clear whether this is considered a good thing or bad thing 
 2058 Better to be moved to ITU than not! 
 2067 Policies for transfer explicit 
 2124 Confine this to pts admitted for routine procedures. 
 2129 Pulmonary embolus and venous thromboembolism more preventable 
 2178 Decision to transfer not against patient's interests. 
 2178A Depends if result of an avoidable incident. 
 7208 Could mean better care! 
 
 13. Patient related clinical complications occurred         
 2001 Vague 
 2003 ? take account of patient condition and interaction with services 
 2005 Inadequate pain control - how defined or recorded 
 2019 Separate inadequate pain control - sadly probably very rarely routinely 
recorded 
 2028 How do you define inadequate pain relief and detect from notes? 
 2030 Needs careful specification and recording of events 
 2032 Important quality of care criteria 
 2041 Outcome 
 2053 Confine the lists to say 3 or 4 easily definable and relevant situations 
 2065 Each complication must be defined. 
 2099 Depends entirely on what condition is chosen. 
 2100 Too many things in the one category. 
 2101 Explain - do you mean 1-12 above? 
 2112 Depends on the [?] available. 
 2137 Too miscellaneous; need to select out. 
 2147 Effect depends on complications. 
 2150 Separate out inadequate pain control. 
 2167 Too vague not useful. 
 2178 Wide range of different conditions - criterion difficult. 
 2178A Again no one answer to all these scenarios. 
 2187 Not clear what is specified because it isn't. 
 7203 Uncertain about DVT - not as strong as pressure sores and infection. 
 7208 Could be more specific. 
 
 14. Patient-related non-clinical problems/incidents occurred 
 2001 Vague 
 2003 Needs checklist 
 2005 ? delay in undergoing diagnostic procedures 
 2019 Separate missing records from rest 
 2028 Most of this information is not recorded 
 2032 These are the quality issues on which patients judge their care 
 2040 More specific 
 2041 Could be trivial or life threatening 
 2052 Depends upon exactly what is meant - more precise please! too open-ended 
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 2113 Question needs tightening up as some are clearly lifethreatening ie 
nonavailability of equipment others inconvenient ie bed on another ward, 
delays. 
 2137 better than 13 because reflects evident failures. 
 2172 By individual complication. 
 2178 Frequent, irritating, organisational, avoidable. 
 2178A What is the alternative to some of these - no treatment? 
 7208 Falls, especially fractures, need separate heading. 
 
 15. Neurological deficit on discharge not present on admission 
 2024 This assumes that no neurological deficit was present on initial examination. 
 2028 OK for well defined conditions 
 2040 Reasons for admission and procedures done 
 2041 Outcome 
 2042 You need to be more specific - ?surgical post-op, ?medical expected or 
unexpected or drug related etc 
 2053 Very difficult to separate from an underlying disease process. 
 2091 Effect depends on whether CVA or single nerve palsy. 
 2099 For specific procedure-related events. 
 2126 Depends on nature of deficit and whether it was part of natural history. 
 2137 Would score higher but may include deficit related to primary disease. 
 2150 Death would be recorded but possibly not enough details of surrounding 
circumstances. 
 2158 Avoid developing stroke inclusion. 
 2178 Depends on type of deficit and whether avoidable or careless. 
 2178A Depends on whether avoidable or not. 
 2183 Depends on length of stay and age of patients. 
 7208 It depends on the procedure. 
 7100 Not in general form very relevant - specific circumstances maybe. 
 
 16. Unexpected death                                         
 2004 Its very vague 
 2012 I felt a bit daft indicating this had serious effect on patients health 
 2028 Define unexpected! 
 2029 Omit 
 2040 Reason for death may be unrelated to condition treated 
 2043 Can learn from unexpected events - will have long term benefits 
 2049 This seems an unhelpful criterion - too vague to be of value, too vague to be 
easily assessed 
 2051 Coroner's job surely 
 2072 Omit or include with complications 
 2082 Define unexpected - is death following hip replacement in very old people 
expected or not? 
 2099 Exclude other occurrences included in other criteria. 
 2137 Unexpected = ?? 
 2178 Again a question of avoidability. 
 2178A Depends on whether avoidable or not ? some other unknown pathology. 
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 2183 I presume the death would be recorded but not always the unexpectedness. 
 7209 Difficult to see how to categorise death (is 10-20% unexpected?) 
 7103 Even though unexpected it may have been unavoidable. 
 
 17. Medical record deficiency                          
 2019 Needs more specification of significant inadequacies 
 2028 Need to define a standard against which to compare 
 2032 Assumptions are made that sloppiness in recordkeeping infer sloppiness of 
care 
 2039 If records incomplete will be no record ? able to recognise incomplete - 
recognise routine omissions 
 2041 Could be trivial 
 2051 Inadequacies in records should be apparent from records, almost by 
definition - can the question be improved 
 2053 Far too vague - specify signal events eg USA has lots of experience with this 
- BP, smoking history, alcohol history, social history not recorded 
 2065 Clear guidelines required. 
 2099 Use specific omissions. 
 2124 Audited against a "gold standard" of medical/nursing records and scored 
accordingly. 
 2144 Duplicate records to enable discrepancy noted? 
 2146 Require standardised proformas. 
 2162 Part of wider concept of quality of care. 
 2167 Needs to be more specific. 
 2178 No excuse in quality sense acceptable. 
 2178A It depends on circumstances - total picture. 
 2197 Split quality from other questions. 
 7203 Irrelevance is more of a problem. 
 7209 Maybe think about levels of severity of omission. 
 
 18. Nursing record deficiency       
 2028 In contrast to medical records, nursing records are usually comprehensive 
and available. 
 2178A Note does not precisely relate to the question here. 
 
 19. Evidence of patient and/or family dissatisfaction        
 2001 Should involve surveys 
 2005 Specified complaints by type on scale 
 2028 Unlikely to find relevant info in notes 
 2040 More detail of cause of dissatisfaction 
 2041 Could be trivial 
 2053 Specify with clinical treatment as opposed to non-clinical parameters? 
 2065 Only possible to detect by talking to patients 
 2092 Written complaints only. 
 2099 Stratification needed. 
 2103 Previous history of complaints ie threshold for dissatisfaction. 
 2126 I have assumed dissatisfaction with care not the magazines available. 
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 2137 Specify how defined, recorded etc 
 2154 If not recorded, not useful. 
 2172 Categorisation. 
 2178 Criteria not comparable. 
 2178A You cannot compare cold food with an operation cancelled several times. 
 2197 Split patient from family. 
 7209 I'm extending my answer to cover more than just organisational 
dissatisfaction. 
 
 20. Discharge related problems  
 2001 Needs patient input 
 2005 Inadequate discharge planning - what's that 
 2028 Unlikely to find relevant info in notes 
 2036 Needs to be defined more 
 2039 Information exchange to GP 
 2053 Probably best picked up by length of stay greater than say 28 days 
 2081 More detailed problems. 
 2096 Need to separate out hospital related poor quality ie poor discharge planning 
from external forces ie resthome bed not available. 
 2112 Social delays (DSS etc) should be excluded unless that is [?] poor case 
management. 
 2162 Quality ++ 
 2172 Categorisation into difficulties due to hospital care and due to home 
arrangements 
 2178 Matter of record.  No excuse. 
 2178 Depends on type of patient. 
 7209 Should disaggregate screwed up discharge procedures and waiting for 
nursing home etc. 
 
3. Comments on the questionnaire study 
 
 General scaling comments 
 2004 Scale 1-10 is too wide 
 2183 I have assumed that 0 to 10 is a log scale rather than a linear 1 eg 1 means 
very rare not 10% and 9 means very common not 90%.  
 
 Relationship to quality questions 
 2019 Often difficult to quantify because of mixture of poor quality and bad clinical 
luck - bipolar causation 
 2028 Because of low specificity I found column 1 v difficult to complete. 
 2096 It is really all most important. 
 
 Effect on health question 
 2010 If there is a desire to relate the criteria to the effects on health these are too 
general for comment and require more specification. 
 2096 In some cases even the patient dissatisfaction could be an indication of 
serious and significant events. 
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 2135 Difficult to score effect as for each adverse event the consequences may be 
trivial or very severe and it is difficult to generalise. 
 2178B General comment given the criteria in 6 to 20 I don't think it is possible to 
comment on effect.  Effect has so many individual variables. 
 2179 I don't know and couldn't make a valid guess. 
 2191 In several places on this questionnaire the answers would be "could be 
important" type of reply ie inadequacy in patient records which are common 
but usually have little consequence yet occasionally can be important. 
 
 Scale for expected incidence/proportion question 
 2001 Proportion likely to be less than 10% for most. 
 2004 Estimating proportion anticipated seems unhelpful at this stage. 
 2024 Couldn't answer this column 
 2034 No idea but I suppose will vary between hospitals and specialties 
 2036 I didn't understand the proportion column.  Do you mean the proportion of 
all acute admission who would fulfil the criteria - thats what I took it to mean 
although I'm not sure that's what you wanted. 
 2057 The proportion column is less meaningful than it might have been - if 
0=none and 10=all then it stands to reason that each unit is 10% unless a 
complex scale is used.  Most criteria would be prevalent between 0-10% 
which doesn't discriminate between them 
 2082 Column for proportion should be rate per 100 or rate per 1000 not 0-10 
 2084 We found the proportion column almost impossible to answer - but 
otherwise found the questionnaire useful. 
 2096 I have absolutely no data available on this important question. 
 2097 The proportion column is too condensed. 
 2999 I found the occurrence proportion difficult as many complications occur but 
not at 10% range! 
 
 Problems of completion 
 2015 Completed independently by medical and nursing personnel - both had 
difficulty completing especially columns 2,3,4 
 2019 Thought I'd find it very difficult, but thanks to your explanatory notes it 
wasn't so bad. 
 2028 I found questionnaire very difficult to complete and suspect its repeatability 
will be v low. 
 2048 I have addressed these questions from the viewpoint of medical audit and not 
the wider clinical audit.  I have very little confidence in my replies to 
records/proportions/effects questions. 
 2068 I found this a very difficult questionnaire.  very subjective.  Mostly guesses.  
I very nearly didn't fill it in.  i don't think that the results will be very useful. 
 2085 I am sorry my answers are so unsatisfactory - the adverse effects depend so 
much on the eventual outcome - however, they should not occur.  The 
process items indicate efficiency but may have no effect on outcome 
 2091 Well thought out, some confusing questions eg 17 and 18.  I bet clinicians 
would answer the questions differently?  Why give it to non-clinical people 
to fill out? 
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 2093 The proportion question is difficult to interpret. 
 2094 I understand what this is about in theory - answering the questions by valid 
indicators of rating is really not easy to achieve in practice.   This took 30 
mins and I do not feel I have done justice to everything.  I wonder how many 
of those filling this in will understand what the questions really mean?  some 
clinicians may do better - or have better data to go on. 
 2101 V difficult to answer especially "effect" - since various incidents would have 
very different effects. 
 2117 It is almost impossible to give general values for these criterion - they have 
differing significance with age, specialty etc.   
 2131 I find this very difficult, since I do not know what these criteria themselves 
mean especially improvement. 
 2137 A bold adventure - I have tried to be consistent (and it took 45 minutes!).  
Did MMA not do validation studies in USA?   
 2164 A bit too long - needed a big threshold to be overcome to face filling it in. 
 2172 I have great doubts over validity of my responses.  it was extremely difficult 
to answer - for example, death diagnosed as due to cerebral haemorrhage 
instead of abscess wouldn't matter much but diagnosis of head cancer when 
benign cyst would matter a great deal. 
 2174 I always find this sort of questionnaire extraordinarily difficult to complete 
and I wonder if it has much value. 
 2178 There was so much difference between degrees of seriousness of examples 
given and of imprecision of questions as to render the questionnaire virtually 
useless.  there appears to be lacking of what may be available and what is 
pure happenstance.  I doubt whether clinicians would appreciate this type of 
enquiry.   
 2183 Most answers are guesstimates.   About 25 minutes to fill in with 1 phone 
interruption.  I don't feel I can complete column 5 (improvement) in most 
cases as I have not direct experience and little knowledge of studies which 
would validate these criteria. 
 2191 I found this questionnaire difficult to complete in places - partly due to lack 
of knowledge on my own part.  I've done my best but some answers are little 
more than wild guesses. 
 2999 Only my dedication to audit caused me to persist! 
 
 Questionnaire layout 
 2016 Sorry did not see back page until filled in middle pages. 
 2053 The preamble and questionnaire are nicely designed - well done.  I found the 
questions very difficult to answer 
 2057 Whoever completes this questionnaire accurately and without previous 
experience in 20 minutes should be a candidate for MENSA! - it is not 
complex, just thought and labour intensive. 
 2058 It was not clear that further information was available on the last page. 
 2062 Possibly design could be improved - it isn't user-friendly to turn to the back 
page quite so often 
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4.5 Interview schedule used in interview study of clinician opinion. 
 
This appendix contains the proforma which was used to structure and record the interviews with 
study participants about the validity of adverse event measures. 
 
 
What do you see as the advantages and disadvantages of occurrence screening, in measuring and 
assessing the quality of inpatient care? 
 
- What are its advantages? 
 
- What are its disadvantages? 
 
 
How strong do you think the parallels are between occurrence screening and more traditional 
problem focused audits - such as CEPOD/NCEPOD, M&M meetings, etc 
 
- What are the similarities? 
 
- What are the differences? 
 
 
How useful do you think occurrence information would be in:  
 
- measuring quality of care for individual patients? 
 
- measuring quality of care for groups of patients (eg in aggregate)? 
 
- creating and promoting changes in practice/quality? 
 
 
Do you think occurrence screening is equally applicable to all areas or specialty of inpatient 
care?   If not 
 
- What areas is it best suited for? 
 
- What areas is it least suited for? 
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What do you think would be important factors in getting an audit system based on occurrence 
screening to work well, and what would impede it? 
 
- Helps? 
 
- Hindrances? 
 
 
What do you think are the most important/useful products, results or outcomes of occurrence 
screening - and what are the least important/useful products? 
 
- Most important/useful? 
 
- Least important/useful? 
 
 
Would you use (or do you use) occurrence screening in your own specialty/hospital in medical 
audit/clinical audit? 
 
- By itself, in combination with other systems, not at all... 
 
- Why? 
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5.1 Obstetrics adverse-event measure of quality developed for and used 
 in the RSCH occurrence screening project 
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 OB01A Management of spontaneous rupture of membranes. 
   
 Management of spontaneous rupture of membranes in specified  
 circumstances. 
  
 DEFINITION 
  
 Spontaneous rupture of membranes occurred in the following specified  
 circumstances: 
 a) SROM occurred more than 24 hours prior to admission. 
 b) Mother presented to hospital following SROM and was discharged prior  
 to delivery. 
  
 INFORMATION TO RECORD 
  
 For (a): Record length of time elapsed between SROM and admission to  
 hospital and reason for delay if known and time and date of eventual  
 delivery. 
 For (b): Record time of SROM, time of review by RSCH doctor, time of  
 readmission and the mode of onset of labour e.g. spontaneous onset,  
 stimulation. 
 
 
  
 OB02A Elective induction of labour. 
   
 The mother underwent elective induction of labour. 
  
  
 DEFINITION 
  
 The mother underwent elective induction of labour for one of the  
 following specified reasons: 
 a) Post-maturity. 
 b) PIH. 
 c) Maternal medical reasons. 
 d) Fetal medical reasons. 
 e) Social reasons. 
 f) No reason given. 
 g) Other reasons. 
  
 GUIDANCE 
  
 Induction of labour means that the membranes are still intact and there  
 are no contractions when intervention takes place. 
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 OB03A Problems of labour/delivery. 
   
 Specified problems occurred during labour/delivery. 
  
  
 DEFINITION 
  
 One or more of the specified problems occurred during labour/delivery: 
 a) Failed trial of scar. 
 b) Failed forceps delivery. 
 c) Third degree tear. 
 d) Maternal injury. 
 e) More than three hours in active second stage of labour. 
 f) Undiagnosed breech presentation. 
 g) Undiagnosed multiple birth. 
 h) Delivery of infant following previous sterilisation. 
 i) Low lying placenta seen at booking scan.                                    
 
 GUIDANCE 
  
 Check mother's record for evidence of the above and record details.        
 e) Active 2nd stage means the cervix is fully dilated AND active pushing  
 has commenced.                                                             
 
 INFORMATION TO RECORD 
  
 For a) Trial of scar. 
 1) Parity with respect to previous caesarean section. 
 2) Gestation.  
 3) Reason for trial of scar ( e.g. maternal preference or advice of  
 obstetrician if discernible).  
 4) Method of onset of labour.  If labour was induced, record type e.g.  
 prostin or propess pessary, ARM, syntocinon and time from induction  
 until start of labour i.e. when 3 cms. 
 5) Length of each stage. (1st stage: 3cm to fully;  2nd stage: fully to  
 delivery). 
 6) Outcome. 
          
 For b) Failed forceps. 
 1) Maternal height 
 2) Evidence of the baby being large 
 3) Was labour augmented 
 4) Evidence of the mother having inadequate analgesia during labour 
 5) Length of time fully dilated 
 6) Position of head 
 7) Station 
 8) Evidence of maternal distress 
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 9) Evidence of fetal distress 
 10) Reasons for failure 
 11) Apgars 
 12) Was this attempt a "trial of forceps" and was it in theatre 
  
 For Third Degree Tear: 
  
 Record: 
 1) Type of delivery - vaginal, Ventouse, forceps. 
 2) Position of mother at delivery. 
 3) Position of baby at birth. 
 4) Episiotomy, if performed. 
 5) Other relevant factors - e.g. hand presented with head. 
  
 i) For Low Lying Placenta: look at scan report at booking 
  
 Record:  
 1) Any bleeding pre-delivery and stage of gestation. 
 2) Mode of eventual delivery. 
 3) Whether admitted because of bleed from asymptomatic placenta praevia. 
  
 4) If Ultrasound located low lying placenta, whether USS repeated, at  
 what gestation, and whether placenta still low lying at that time. 
 
 
 
 OB04A Caesarean section 
   
 Reasons for caesarean section 
  
  
 DEFINITION 
  
 The mother underwent caesarean section for specified reasons, classified  
 as a) elective or b) emergency. 
  
 GUIDANCE 
  
 Check mother's record for required information. 
  
 INFORMATION TO RECORD 
  
 Record the reasons given for performing caesarean section and whether  
 elective or emergency. 
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 OB05A Problems of caesarean section 
   
 One or more of the specified problems occurred relating to caesarean  
 section 
 
  
 DEFINITION 
  
 One or more of the following problems occurred relating to caesarean  
 section: 
 a) Unplanned injury to, or repair of an organ or structure. 
 b) Excessive blood loss, e.g. more than 1 litre. 
 c) Deep vein thrombosis or pulmonary embolus. 
 d) Wound infection. 
 e) Other problems. 
 f) Baby needed resuscitation by intubation or bagging. 
  
 GUIDANCE:  
  For f) state whether Elective or Emergency Caesarean  
 
 
 
 OB06 Neo-natal problems 
   
 Neo-natal (up to 28 days following a live birth) problems occurred. 
  
  
 DEFINITION 
 One or more of the following neo-natal problems occurred: 
 a)  Congenital defects (noted in first 10 days). 
 b)  Apgar score less than 7 at 5 minutes. 
 c)  Small for gestational age: Birthweight of less than the 10th      
 percentile for that gestation.  
 d)  Big baby: Birthweight greater than  the 90th percentile for that      
 gestation. 
 e)  Apnoea: Episode of stopping breathing for longer than 20 seconds. 
 f)  Transfer to SCBU.  (Record reason). 
 g)  Infection: record cot position on ward where possible. 
 h)  Feeding problems including: poor effort at feeding, poor milk supply,   
    obsessional feeding.  
 i)  Hypothermia.  Temperature less than 35 degrees Celsius or however     
  defined. 
  
 GUIDANCE 
 Check mother's and baby's record for above problems and record details. 
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 OB06A Perinatal problems. 
   
 Specified perinatal problems occurred. 
  
  
 DEFINITION 
   
 One or more of the following perinatal problems occurred: 
      a) Injury to the baby during delivery requiring follow-up. 
      b) Apgar score less than 7 at 5 minutes. 
      c) Infection. 
      d) Hypoglycaemia. 
      e) Death of baby. 
      f) Stillbirth. 
  
 GUIDANCE 
  
 Check mother and baby's record for evidence of the above problems. 
  
 
  
 OB07A Post - natal problems. 
   
 The mother experienced specifed post-natal problems. 
  
  
 DEFINITION 
  
 The mother experienced one or more of the specified post-natal problems: 
  
 a) Post-partum haemorrhage, blood loss of more than 500 mls. 
 b) Secondary haemorrhage, (after 24 hours and before 10 days post-partum) 
 c) Anti-D not given within 24 hours when indicated. 
 d) Infection not present on admission. 
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 OB08A Problems with analgesia/anaesthesia 
   
 Problems with analgesia/anaesthesia occurred 
  
  
 DEFINITION 
  
 One or more of the following specified problems with analgesia or  
 anaesthesia occurred: 
  a) Epidural or spinal anaesthetic problems e.g. spinal headache,  
 prolonged block or urinary retention longer than 8 hours following  
 administration. 
  b) Neurological deficit not present on admission. 
  c) Baby drowsy due to transmission of sedative effect of mother's  
 analgesia. 
  d) Non-availability of analgesia/anaesthesia when required. 
  
 GUIDANCE 
  
 Check mother's and baby's record for evidence of the above problems. 
 
 
 
 OB09 Drug-related problems 
   
 One or more drug-related problems occurred. 
  
  
 DEFINITION 
 One or more of the following specified drug usage problems occurred: 
  
 a)  Medications omitted, prescribed or given in error, given at wrong   
 rate, delayed with no reason given. 
 b)  Medication reactions and anaphylaxis. 
 c)  Incomplete record e.g. omission of midwife's or doctor's signature. 
  
 GUIDANCE 
 Check mother's and baby's record for evidence of the above problems and  
 record action taken. 
 All drugs administered should be recorded in the notes. 
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 OB10 Mother/family dissatisfaction. 
   
 Evidence of mother and/or family dissatisfaction 
  
  
 DEFINITION 
 There is evidence in the mother's record that the mother or mother's  
 relatives or friends expressed dissatisfaction with the care given 
 including complaints of inadequate pain control. 
  
  
 GUIDANCE 
 Look for information on cause of dissatisfaction and how it was expressed  
 in midwifery and medical records.  Look for evidence that the  
 mother/family complaint was handled appropriately; 
  
 All discharges taken against medical advice should be carefully checked  
 against this criterion. 
  
 
 
 OB11 Mother or baby related non-clinical problems 
   
 Mother or baby related non-clinical problems/incidents occurred. 
  
  
 DEFINITION 
  
 One or more of the specified mother or baby related non-clinical problems  
 or incidents occurred: 
  
 a)  Theatre delay 
 b)  Delay in obtaining a second opinion from another speciality 
 c)  Casenotes, X-rays or other records or results missing/not available  
 when needed 
 d)  Mother or baby had slip or fall or other accident 
 e)  Equipment failure 
 f)  Necessary equipment not available when needed 
 g)  Delay in undergoing diagnostic/therapeutic procedures e.g. ultrasound  
 scan. 
 h)  Inadequate referral notes with intrauterine transfers 
  
 GUIDANCE 
 Check medical and midwifery records.  Document the causes of the  
 problem or incident if possible.  Check for list of valuable recorded.  Note 
  if theatre instruments unavailable.  Note if theatre delayed/cancelled due  
 to TSSU problems or missing report delays operation.  
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 OB12 Obstetric record review 
   
 Review of quality, consistency and completeness of mother's and baby's  
 records and related documentation 
  
 DEFINITION 
  
 One or more of the following specified deficiencies were found in the  
 records or related documentation:  
 a) observations not recorded on partogram at half-hourly intervals - give  
 reasons why if not. 
 b) lack of continuity or incomplete/contradictory recording of  
 information. 
 c) documentation missing 
 d) notes illegible 
 e) doctor's or midwife's signature missing after entries in notes and after  
 delivery. 
 f) signature not printed 
  
   
 GUIDANCE 
 Check mother's and baby's records and related documentation.  
 
 
 
 OB14 Problems of obstetric anaesthesia 
   
 Problems of obstetric anaesthesia 
  
  
DEFINITION 
 
 The patient experienced one or more of the following problems relating to  
 anaesthesia: 
   
 a)  Delay. 
 b)  Technical problems. 
 c)  Intra-operative problems. 
 d)  Post-operative problems. 
 e)  Neonatal problems attributable to anaesthesia. 
  
 GUIDANCE 
  
 a)  Delay  - due to non-availability of anaesthetist, results of clotting  
 screen (eg for pre-eclampsia) delayed, etc 
  
 b)  Technical problems.  General anaesthesia: difficulty with intubation,  
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 oesophageal intubation, equipment malfunction, etc.  Epidural or spinal  
 anaesthesia: failure to produce block/inadequate block, proceeding to  
 general anaesthesia, second anaesthetist needed to site block, dural tap,  
 prolonged procedure, total spinal, etc. 
  
 c)  Intra-operative problems - broken teeth, corneal abrasion,  
 cardio-respiratory problems, difficulty in reversing anaesthetic, patient  
 aware during procedure. 
  
 d)  Post-operative problems - hypotension, respiratory depression, ITU  
 admission, backache, neurological dysfunction, (including headache,  
 weakness), bladder dysfunction, patient death within one week of  
 anaesthesia. 
  
 e)  Neonatal problems possibly attributable to anaesthesia - poor Apgar  
 score,(< 6 at 1 minute, < 8 at 5 minutes), resuscitation required (eg. IVI  
 inserted,  ventilation for more than 5 minutes), transfer to SCBU, need to 
  give Narcan to baby. 
  
 INFORMATION TO RECORD 
  
 Record category of problem(s) identified, and brief details of situation and 
 
 
 
 OB15 Problems of epidural/non-epidural pain relief in obstetrics 
   
 Problems of epidural and non-epidural pain relief in obstetric inpatients. 
 
  
 DEFINITION 
 
 The patient experienced one or more of the following problems while  
 receiving epidural or non-epidural pain relief. 
  
 a)  Delay. 
 b)  Technical problems. 
 c)  Post-epidural problems. 
 d)  Neonatal problems attributable to analgesia. 
 e)  Poor/inadequate analgesia of any type. 
  
 GUIDANCE 
  
 a)  Delay - Epidural requested but not given.  Non-availability of  
 anaesthetist.  Delayed results of clotting screen (eg in pre-eclampsia).  
  
 b)  Technical epidural problems - unable to site epidural, second  
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 anaesthetist required, prolonged procedure, dural tap, unilateral block,  
 inadequate block, resiting required, etc. 
  
 c)  Post-epidural problems - headache, bladder dysfunction, backache,  
 neurological dysfunction. 
  
 d)  Neonatal problems possibly attributable to analgesia - poor Apgar  
 scores (< 6 at 1 minute, < 8 at 5 minutes),resuscitation required - IVI  
 sited, ventilation for more than 5 minutes, transfer to SCBU, need to give 
  Narcan to baby, etc. 
  
 e)  Poor/inadequate analgesia of any type - as documented by  
 medical/midwifery staff in notes, or complained of by mother. 
  
 f)  Pethidine given to mother during labour - record 1) Amount given 
                                                      2) Time given 
                                                      3) Time of delivery  
  
  
 INFORMATION TO RECORD                                 
  
 Record category of problem found, and brief details of the situation and  
 its management. Record details of Pethidine administration for assessment  
 of collective use. 
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5.2 Results of multiway frequency analyses undertaken to examine construct  
 validity of adverse-event measures used in the RSCH occurrence  
 screening project 
 
 
 
Tests that K-way effects are zero. 
 
         K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1     10     4256.920   .0000      11431.487   .0000           0 
         2     38      124.116   .0000        152.947   .0000           0 
         3     68       32.982   .9999         32.247   .9999           0 
         4     57        6.490  1.0000          6.028  1.0000           0 
         5     18         .000  1.0000           .000  1.0000           0 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
  
LOSGRP*AGEGRP                                   6         24.075   .0005     3 
AGEGRP*SEX                                      2         73.308   .0000     3 
SEX*ADMTYPE                                     1          3.808   .0510     4 
AEGRP                                           3       1051.909   .0000     2 
LOSGRP                                          3       1397.994   .0000     2 
AGEGRP                                          2        422.858   .0000     2 
ADMTYPE                                         1       1384.099   .0000     2 
 
 
Table 1.  Results of multiway frequency analysis of 1,028 admissions  
in accident and emergency screened for adverse events. 
 
  
 
 
392
 
 
Tests that K-way effects are zero. 
 
K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1     10     2290.814   .0000       5420.326   .0000           0 
         2     38      141.290   .0000        258.183   .0000           0 
         3     68       56.194   .8460         80.487   .1428           0 
         4     57       34.537   .9919         27.964   .9996           0 
         5     18        5.768   .9971          4.633   .9993           0 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
AEGRP*SEX*ADMTYPE                               3         12.423   .0061     4 
AEGRP*LOSGRP                                    9         27.989   .0010     4 
LOSGRP*AGEGRP                                   6         19.051   .0041     3 
AEGRP*ADMTYPE                                   3         11.907   .0077     4 
LOSGRP*ADMTYPE                                  3         32.597   .0000     4 
AGEGRP*ADMTYPE                                  2         13.555   .0011     4 
AEGRP                                           3        149.307   .0000     2 
LOSGRP                                          3       1520.861   .0000     2 
AGEGRP                                          2        303.111   .0000     2 
ADMTYPE                                         1        314.883   .0000     2 
 
Table 2.  Results of multiway frequency analysis of  798 admissions  
in  ENT screened for adverse events. 
 
 
 
 
Tests that K-way effects are zero. 
 
         K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1      9     3121.788   .0000      13144.549   .0000           0 
         2     29       32.216   .3105        106.971   .0000           0 
         3     39       13.800   .9999         11.908  1.0000           0 
         4     18         .000  1.0000           .000  1.0000           0 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
 
AGEGRP*ADMTYPE                                  2          7.306   .0259     3 
AEGRP                                           3        273.992   .0000     2 
LOSGRP                                          3       1068.590   .0000     2 
AGEGRP                                          2       1133.079   .0000     2 
ADMTYPE                                         1        646.127   .0000     2 
 
 
Table 3.  Results of multiway frequency analysis of  566 admissions  
in  gynaecology screened for adverse events. 
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Tests that K-way effects are zero. 
 
         K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1      9    21521.229   .0000      85368.955   .0000           0 
         2     29      502.109   .0000        607.517   .0000           0 
         3     39         .909  1.0000           .499  1.0000           0 
         4     18         .000  1.0000           .000  1.0000           0 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
 
AEGRP*LOSGRP                                    9        489.761   .0000     2 
AEGRP                                           3       1464.418   .0000     2 
LOSGRP                                          3       5936.417   .0000     2 
AGEGRP                                          2       8696.615   .0000     2 
ADMTYPE                                         1       5423.780   .0000     2 
 
 
Table 4.  Results of multiway frequency analysis of  3,958 admissions  
in  obstetrics screened for adverse events. 
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Tests that K-way effects are zero. 
 
         K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1     10     9228.247   .0000      36677.981   .0000           0 
         2     38      534.665   .0000       1724.113   .0000           0 
         3     68       89.887   .0390        101.703   .0051           0 
         4     57       36.879   .9823         32.534   .9962           0 
         5     18        9.087   .9577          6.807   .9917           0 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
 
LOSGRP*SEX*ADMTYPE                              3         11.194   .0107     5 
AGEGRP*SEX*ADMTYPE                              2         12.234   .0022     4 
AEGRP*LOSGRP                                    9         59.446   .0000     5 
AEGRP*AGEGRP                                    6         14.177   .0277     6 
LOSGRP*AGEGRP                                   6         61.055   .0000     5 
AGEGRP*SEX                                      2        110.287   .0000     6 
LOSGRP*ADMTYPE                                  3        138.942   .0000     4 
AGEGRP*ADMTYPE                                  2         66.359   .0000     6 
SEX*ADMTYPE                                     1          4.034   .0446     6 
AEGRP                                           3       1991.975   .0000     2 
LOSGRP                                          3       4952.723   .0000     2 
AGEGRP                                          2        669.688   .0000     2 
SEX                                             1        102.777   .0000     2 
ADMTYPE                                         1       1511.087   .0000     2 
 
 
Table 5.  Results of multiway frequency analysis of  2,231 admissions  
in  ophthalmology screened for adverse events. 
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Tests that K-way effects are zero. 
 
         K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1     10     3906.491   .0000       6204.237   .0000           0 
         2     38     1727.670   .0000       2286.209   .0000           0 
         3     68      110.408   .0009        108.715   .0013           0 
         4     57       49.996   .7330         50.350   .7210           0 
         5     18         .955  1.0000           .843  1.0000           0 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
 
 
LOSGRP*AGEGRP*ADMTYPE                           6         19.686   .0031     5 
AGEGRP*SEX*ADMTYPE                              2         19.645   .0001     5 
AEGRP*LOSGRP                                    9        250.205   .0000     7 
AEGRP*AGEGRP                                    6         18.433   .0052     7 
LOSGRP*AGEGRP                                   6        350.884   .0000     7 
LOSGRP*SEX                                      3         11.461   .0095     6 
AGEGRP*SEX                                      2        343.451   .0000     7 
LOSGRP*ADMTYPE                                  3        126.744   .0000     8 
AGEGRP*ADMTYPE                                  2         71.516   .0000     8 
SEX*ADMTYPE                                     1          5.495   .0191     8 
AEGRP                                           3        698.386   .0000     2 
LOSGRP                                          3       2790.238   .0000     2 
AGEGRP                                          2        241.877   .0000     2 
SEX                                             1         17.845   .0000     2 
ADMTYPE                                         1        158.150   .0000     2 
 
 
Table 6.  Results of multiway frequency analysis of  2,916 admissions  
in  orthopaedics screened for adverse events. 
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Tests that K-way effects are zero. 
 
         K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1     10      807.314   .0000       1073.543   .0000           0 
         2     38      209.020   .0000        216.161   .0000           0 
         3     68       41.771   .9949         38.573   .9985           0 
         4     57       41.597   .9375         37.806   .9765           0 
         5     18        3.994   .9998          3.168  1.0000           0 
 
 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
 
AEGRP*LOSGRP                                    9         79.032   .0000     5 
LOSGRP*AGEGRP                                   6         35.825   .0000     5 
AEGRP*ADMTYPE                                   3         10.699   .0135     5 
LOSGRP*ADMTYPE                                  3         14.888   .0019     5 
AGEGRP*ADMTYPE                                  2         34.907   .0000     5 
SEX*ADMTYPE                                     1          7.817   .0052     5 
AEGRP                                           3         99.438   .0000     2 
LOSGRP                                          3        687.844   .0000     2 
AGEGRP                                          2          8.478   .0144     2 
ADMTYPE                                         1         11.407   .0007     2 
 
 
Table 7.  Results of multiway frequency analysis of  549 admissions  
in  general surgery screened for adverse events. 
 
 
  
 
 
397
 
 
Tests that K-way effects are zero. 
 
K     DF   L.R. Chisq    Prob  Pearson Chisq    Prob   Iteration 
 
         1     10     1233.396   .0000       2134.724   .0000           0 
         2     38      117.602   .0000        123.885   .0000           0 
         3     68       41.345   .9956         44.908   .9862           0 
         4     57       39.242   .9650         35.416   .9890           0 
         5     18         .646  1.0000           .390  1.0000           0 
 
 
 
 
Tests of PARTIAL associations. 
 
Effect Name                                    DF  Partial Chisq    Prob  Iter 
 
AEGRP*SEX*ADMTYPE                               3         10.637   .0139     3 
LOSGRP*AGEGRP                                   6         71.936   .0000     3 
AGEGRP*SEX                                      2         13.586   .0011     4 
AGEGRP*ADMTYPE                                  2          9.917   .0070     4 
AEGRP                                           3        320.418   .0000     2 
LOSGRP                                          3        631.231   .0000     2 
AGEGRP                                          2         14.601   .0007     2 
SEX                                             1        257.693   .0000     2 
ADMTYPE                                         1          9.452   .0021     2 
 
 
Table 8.  Results of multiway frequency analysis of  520 admissions  
in  urology screened for adverse events. 
 
 
 
 
 
 
